data_1srz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1srz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.585 HG22 ' N ' ' A' ' 99' ' ' CYS . 40.6 mm . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 121.209 0.528 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.585 ' N ' HG22 ' A' ' 98' ' ' ILE . 1.3 p -57.3 149.32 20.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.138 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.9 t -38.25 113.53 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.768 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.61 ' HZ3' ' HB2' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -67.23 -14.26 62.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.767 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.448 ' O ' HG21 ' A' ' 105' ' ' THR . 45.1 t -53.5 -38.91 64.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.209 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.503 ' O ' HG22 ' A' ' 111' ' ' VAL . 2.5 m-85 -53.34 -37.89 62.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.178 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.4 mt -50.92 -45.45 60.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.332 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.448 HG21 ' O ' ' A' ' 102' ' ' SER . 7.0 t -92.52 131.28 37.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 111.202 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.511 HD13 ' HE2' ' A' ' 153' ' ' LYS . 38.0 tp -145.34 132.28 20.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.443 ' HG3' ' ND2' ' A' ' 108' ' ' ASN . 5.6 tp10 -63.02 127.02 29.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.18 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.443 ' ND2' ' HG3' ' A' ' 107' ' ' GLU . 75.3 m-80 55.14 45.73 25.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.885 0.374 . . . . 0.0 110.415 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.0 157.44 26.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -130.62 139.7 50.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.746 0.308 . . . . 0.0 110.831 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 103' ' ' TYR . 96.1 t -106.51 132.95 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.576 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.436 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 3.7 m-85 -94.78 73.44 3.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.764 ' HA ' HG13 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -60.95 157.03 16.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 111.228 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 40.9 m -158.53 69.47 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.778 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.464 ' O ' HD12 ' A' ' 118' ' ' LEU . . . -162.98 -44.92 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.642 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.44 -121.84 6.51 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.297 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.456 ' HA ' ' CD1' ' A' ' 98' ' ' ILE . 2.1 p30 -144.76 52.0 1.24 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.051 0.453 . . . . 0.0 111.474 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.55 ' N ' HD13 ' A' ' 118' ' ' LEU . 7.0 mp -88.08 158.13 50.21 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.909 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 121' ' ' LEU . 85.1 Cg_exo -44.05 111.02 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.621 2.214 . . . . 0.0 112.601 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 70.77 -33.55 0.27 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.828 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.599 ' HG ' ' HB3' ' A' ' 124' ' ' ALA . 17.0 tp 64.28 43.9 4.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.05 0.452 . . . . 0.0 110.624 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.898 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 64.5 t0 -79.4 59.06 2.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.013 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.29 -29.48 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.375 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.672 ' HB2' ' HB3' ' A' ' 144' ' ' CYS . . . -49.68 147.53 3.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 111.923 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.555 ' NH2' ' HD3' ' A' ' 141' ' ' ARG . 51.6 mtp85 -138.72 126.78 22.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.764 HG13 ' HA ' ' A' ' 113' ' ' LEU . 33.7 m -116.72 130.3 71.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.029 0.442 . . . . 0.0 111.674 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.9 mt-10 -102.5 109.79 21.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.586 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.526 ' CE1' HG21 ' A' ' 126' ' ' VAL . 21.2 m-85 -75.52 147.12 39.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.481 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 5.6 tpm_? -162.28 125.94 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.472 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.41 ' H ' ' HE ' ' A' ' 129' ' ' ARG . 56.6 m -89.29 149.14 23.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.074 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.57 163.31 0.79 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.634 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.63 57.3 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.43 2.753 . . . . 0.0 113.131 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -158.06 -43.3 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.3 m-85 -108.91 138.76 44.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.665 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -101.6 127.51 48.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.091 0.472 . . . . 0.0 110.993 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.04 131.23 46.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.184 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.39 65.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.25 -135.63 2.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.396 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.48 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 80.6 p -73.37 62.08 0.69 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.445 ' HA ' ' HB2' ' A' ' 128' ' ' PHE . 98.5 p -57.61 -7.02 0.57 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.288 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.555 ' HD3' ' NH2' ' A' ' 125' ' ' ARG . 39.7 ttm180 -140.65 134.37 30.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.672 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.578 ' O ' HG22 ' A' ' 126' ' ' VAL . 47.6 t -146.39 119.5 8.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.492 HG13 ' OG ' ' A' ' 150' ' ' SER . 3.2 p -95.98 121.56 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 0.0 111.223 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 49.7 t -69.22 138.3 53.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.601 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.898 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 80.6 p -164.51 133.11 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.165 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 57.38 40.76 27.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.849 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 63.9 18.25 61.84 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.126 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -145.27 139.79 27.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 117.099 0.449 . . . . 0.0 111.45 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.56 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 32.7 m95 -72.12 139.0 48.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.195 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.492 ' OG ' HG13 ' A' ' 143' ' ' VAL . 75.4 m -57.49 -57.74 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.005 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 t -109.42 143.11 27.1 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-O 120.862 0.363 . . . . 0.0 111.87 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.0 148.14 93.79 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.125 2.55 . . . . 0.0 112.693 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.511 ' HE2' HD13 ' A' ' 106' ' ' LEU . 87.5 tttt -53.34 135.64 51.36 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.527 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.48 ' HB3' ' H ' ' A' ' 139' ' ' SER . 97.5 Cg_endo -85.4 -151.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.906 2.404 . . . . 0.0 112.872 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.433 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.0 p-80 -153.7 151.09 29.25 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.4 m -97.28 129.85 44.54 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.766 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -108.78 135.4 50.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.027 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.84 140.2 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.982 -179.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.754 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 1.9 pp . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.182 0.515 . . . . 0.0 111.983 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.508 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 38.0 m -64.58 147.22 53.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.791 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 102' ' ' SER . 80.4 p -40.12 118.0 0.84 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 110.699 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -70.94 9.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.514 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 100' ' ' SER . 59.2 m -68.96 -39.2 79.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.189 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.902 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.8 m-85 -52.18 -37.84 55.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.984 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.618 HD13 ' H ' ' A' ' 104' ' ' LEU . 6.3 mp -50.22 142.48 9.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 0.0 111.03 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 31.9 p 61.84 132.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.673 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.1 tp -145.4 136.14 24.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.613 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.407 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 88.7 tt0 -57.12 132.3 52.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.389 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.493 ' HB3' ' OD1' ' A' ' 131' ' ' ASP . 76.4 m-20 57.52 42.81 23.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.617 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.76 172.82 45.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.517 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -141.66 146.37 36.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 0.0 110.476 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 60.6 t -118.12 127.44 75.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.424 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.7 m-85 -88.22 119.06 28.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.849 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.4 tp -83.53 146.73 28.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.266 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 33.2 m -162.16 66.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.65 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -160.82 -42.35 0.02 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.848 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.02 -119.5 5.4 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.655 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -137.78 47.88 2.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.162 0.506 . . . . 0.0 111.042 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 71.7 mt -75.72 158.46 82.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.125 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.03 120.46 4.22 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.159 1.906 . . . . 0.0 111.625 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 51.98 31.32 8.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.2 0.524 . . . . 0.0 110.155 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.754 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 13.9 tp 42.44 37.42 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.712 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -70.63 141.06 51.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.907 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.56 -24.62 9.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.78 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.721 ' HB2' ' HB2' ' A' ' 144' ' ' CYS . . . -57.25 152.89 13.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.761 0.315 . . . . 0.0 111.092 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.772 ' HD2' HH21 ' A' ' 141' ' ' ARG . 23.0 ptt-85 -165.45 133.19 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.679 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 33.9 m -120.54 143.5 32.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.039 0.447 . . . . 0.0 111.798 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HB2' ' NH1' ' A' ' 141' ' ' ARG . 40.7 tp10 -108.48 121.86 45.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.057 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.418 ' CE1' HG22 ' A' ' 126' ' ' VAL . 2.8 m-85 -83.7 154.48 23.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.602 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 5.1 tpm_? -157.57 127.28 6.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.23 143.84 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.905 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.493 ' OD1' ' HB3' ' A' ' 108' ' ' ASN . 12.8 p-10 -54.07 148.96 19.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.48 77.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.015 2.477 . . . . 0.0 112.862 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 131' ' ' ASP . 64.4 t0 179.02 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.72 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -108.84 142.84 38.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.876 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.463 ' H ' ' HD1' ' A' ' 135' ' ' HIS . 13.1 p-80 -101.88 130.8 48.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.176 0.512 . . . . 0.0 110.961 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.659 HD22 ' HA ' ' A' ' 140' ' ' SER . 32.6 tp -70.25 126.82 30.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.964 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.446 HG22 ' C ' ' A' ' 136' ' ' LEU . 41.7 t -137.89 71.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.937 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.49 -135.67 2.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.846 -1.169 . . . . 0.0 113.102 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.724 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 67.0 m -75.94 52.79 0.72 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.92 0.391 . . . . 0.0 110.601 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.659 ' HA ' HD22 ' A' ' 136' ' ' LEU . 47.2 t -46.25 -39.85 10.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.071 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.772 HH21 ' HD2' ' A' ' 125' ' ' ARG . 23.9 tpt180 -104.11 137.46 42.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.589 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.8 t -143.05 101.69 3.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.346 . . . . 0.0 110.597 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' A' ' 150' ' ' SER . 7.7 p -96.8 129.89 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.065 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.721 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 1.8 m -74.62 146.99 42.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.395 0.617 . . . . 0.0 112.111 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 48.0 t -163.94 124.67 2.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.358 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 62.9 38.35 11.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.114 0.483 . . . . 0.0 110.419 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 63.12 25.73 68.46 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.562 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 145' ' ' SER . 23.6 pt20 -143.72 138.24 28.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.059 0.43 . . . . 0.0 111.262 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.508 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 59.4 m95 -65.04 138.02 58.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.466 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.643 ' HB2' HG13 ' A' ' 143' ' ' VAL . 47.5 t -57.43 -48.54 78.86 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.057 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 82.6 p -135.14 136.86 25.56 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.816 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.97 156.35 49.87 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.04 2.494 . . . . 0.0 112.438 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.902 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 28.5 mtpp -52.42 129.17 42.81 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.428 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.724 ' HB3' ' H ' ' A' ' 139' ' ' SER . 60.7 Cg_endo -72.89 -143.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.728 2.285 . . . . 0.0 112.246 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.45 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 23.0 p-80 -153.71 145.25 23.23 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.986 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 81.7 m -96.23 125.87 41.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.509 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -109.06 142.99 38.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.385 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 159' ' ' ASN . 61.9 t -61.83 139.96 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.044 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.427 ' N ' HG12 ' A' ' 158' ' ' VAL . 22.1 p30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.026 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.708 HD13 ' HA ' ' A' ' 117' ' ' ASP . 46.7 mm . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.377 0.608 . . . . 0.0 112.342 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.564 ' N ' HG22 ' A' ' 98' ' ' ILE . 1.5 p -59.99 161.21 6.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.196 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -39.78 131.8 1.79 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.109 0.48 . . . . 0.0 111.453 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 21.8 pttp -96.48 78.56 3.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.674 0.749 . . . . 0.0 110.009 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.9 t -164.13 -34.9 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.076 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.631 ' HH ' ' HA ' ' A' ' 152' ' ' PRO . 2.7 m-85 -56.8 -26.33 57.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.192 0.52 . . . . 0.0 109.63 178.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.478 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 53.5 mt -50.23 -44.11 53.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.671 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.2 p -92.66 139.66 30.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.647 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 46.6 tp -143.07 133.72 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.389 . . . . 0.0 111.163 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.472 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 39.6 tt0 -67.8 129.98 41.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.333 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.472 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 76.1 m-80 56.6 37.09 28.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.964 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 130' ' ' CYS . . . -176.44 149.5 9.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.998 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -108.25 139.26 43.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.845 0.355 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 94.9 t -106.54 121.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.815 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -82.74 124.99 30.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.239 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.733 HD11 ' H ' ' A' ' 115' ' ' GLY . 3.4 tm? -85.84 145.04 27.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.475 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.571 ' H ' HD23 ' A' ' 113' ' ' LEU . 28.7 m -155.75 63.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 110.854 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.733 ' H ' HD11 ' A' ' 113' ' ' LEU . . . -161.04 -104.44 0.19 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.178 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 166.99 -129.64 1.96 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.739 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.708 ' HA ' HD13 ' A' ' 98' ' ' ILE . 58.7 m-20 -150.27 46.79 0.9 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 111.044 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.9 154.27 37.87 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.823 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.506 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 76.1 Cg_exo -46.78 122.13 5.68 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.466 2.111 . . . . 0.0 112.112 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 119' ' ' PRO . . . 72.77 -40.74 0.48 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.528 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 121' ' ' LEU . 14.8 tp 59.51 51.18 6.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.956 0.408 . . . . 0.0 110.943 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -73.26 66.25 0.89 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.247 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.31 -36.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.623 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.792 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -51.39 153.9 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.954 0.407 . . . . 0.0 111.483 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.497 ' O ' ' HB ' ' A' ' 114' ' ' THR . 50.8 ttp85 -158.94 126.07 4.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.176 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.544 HG22 ' CZ3' ' A' ' 149' ' ' TRP . 24.6 m -108.17 136.67 42.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.022 0.439 . . . . 0.0 111.648 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -100.29 115.98 31.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.686 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -80.09 143.04 34.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 129' ' ' ARG . 37.7 ttt85 -167.22 118.82 0.9 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.423 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 51.3 m -89.18 154.13 20.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.981 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -52.77 158.34 2.25 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.305 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.518 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 82.0 Cg_exo -47.49 162.81 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.829 2.353 . . . . 0.0 112.245 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.5 m-20 77.93 -35.07 0.19 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.791 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 132' ' ' PRO . 11.6 m-85 -106.32 127.14 53.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -108.34 131.1 55.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.034 0.445 . . . . 0.0 111.375 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.537 ' C ' HD13 ' A' ' 136' ' ' LEU . 3.2 tm? -74.79 132.86 41.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.292 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.0 t -133.07 71.53 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.785 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.92 -132.5 1.82 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.057 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.603 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 61.2 p -72.83 61.56 0.55 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 110.648 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.532 ' HB3' HD11 ' A' ' 136' ' ' LEU . 97.0 p -55.6 -15.59 3.09 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.775 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -140.64 139.89 34.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.716 0.293 . . . . 0.0 111.266 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 96.6 p -139.54 117.01 11.35 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.255 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.493 ' HB ' ' HG ' ' A' ' 150' ' ' SER . 73.7 t -84.18 125.01 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 111.52 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.792 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 42.1 t -79.3 131.03 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.306 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.4 t -173.25 137.53 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 0.0 111.156 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 56.35 37.93 29.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.505 ' C ' ' HA ' ' A' ' 99' ' ' CYS . . . 56.78 24.66 49.62 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.644 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -143.07 134.55 26.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.657 0.265 . . . . 0.0 111.087 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.544 ' CZ3' HG22 ' A' ' 126' ' ' VAL . 66.0 m95 -77.76 140.03 39.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.255 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.493 ' HG ' ' HB ' ' A' ' 143' ' ' VAL . 63.1 m -57.4 -47.61 81.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.661 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.565 ' HG1' ' HB2' ' A' ' 139' ' ' SER . 67.4 p -127.46 138.9 33.79 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.631 ' HA ' ' HH ' ' A' ' 103' ' ' TYR . 34.8 Cg_endo -64.86 -162.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.471 2.114 . . . . 0.0 112.566 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 14.4 mmmm -83.86 131.65 51.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.974 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.603 ' HB3' ' H ' ' A' ' 139' ' ' SER . 89.5 Cg_endo -81.75 -149.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.675 2.25 . . . . 0.0 112.483 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -153.71 134.1 13.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.945 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.486 ' SG ' HD22 ' A' ' 136' ' ' LEU . 92.4 m -104.93 142.43 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.235 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -135.21 137.59 42.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.881 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 159' ' ' ASN . 8.7 p -67.15 139.08 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.4 ' N ' HG23 ' A' ' 158' ' ' VAL . 74.5 m-80 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.913 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.851 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 21.3 pt . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.597 0.713 . . . . 0.0 112.72 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.513 ' HB2' HD21 ' A' ' 121' ' ' LEU . 92.2 m -57.36 167.41 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.767 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.6 p -40.17 143.77 0.26 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.751 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.622 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 4.6 ttmp? -99.68 78.45 2.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.227 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.2 t -166.24 -36.2 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.062 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -56.94 -32.4 65.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 110.389 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.411 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 64.5 mt -52.87 -46.18 67.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.568 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.2 p -92.63 137.69 32.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 0.0 111.194 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.516 ' HB2' ' HZ2' ' A' ' 153' ' ' LYS . 29.2 tp -145.38 136.36 24.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.382 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.418 ' HG3' ' ND2' ' A' ' 108' ' ' ASN . 42.2 tp10 -69.53 138.1 53.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.9 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.418 ' ND2' ' HG3' ' A' ' 107' ' ' GLU . 76.2 m-20 58.01 36.3 25.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.283 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 179.94 176.88 47.68 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.755 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -139.78 136.46 34.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.717 HG22 ' HA ' ' A' ' 128' ' ' PHE . 94.9 t -106.11 123.86 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.8 m-85 -76.6 122.5 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.29 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.702 HD22 ' N ' ' A' ' 114' ' ' THR . 2.8 tt -95.35 140.6 30.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.711 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.702 ' N ' HD22 ' A' ' 113' ' ' LEU . 30.1 m -158.49 62.65 0.43 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.085 0.469 . . . . 0.0 110.739 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.424 ' C ' HD13 ' A' ' 121' ' ' LEU . . . -172.44 -16.28 0.02 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.716 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -49.77 147.59 6.75 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.372 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 1.5 m-20 73.31 41.98 0.45 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 122.714 0.406 . . . . 0.0 111.753 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -141.82 149.4 53.02 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.59 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -50.28 116.94 2.77 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.481 2.121 . . . . 0.0 111.822 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.505 ' HB3' ' N ' ' A' ' 147' ' ' GLY . . . 50.06 36.17 11.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.544 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.851 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 14.3 tp 52.22 42.24 30.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.491 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.89 142.27 57.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.589 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.76 33.93 84.78 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.425 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' A' ' 144' ' ' CYS . . . -93.44 144.09 25.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.892 0.377 . . . . 0.0 111.452 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -145.53 128.45 16.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.804 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 34.4 m -136.11 142.15 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.751 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 41.4 tt0 -108.69 121.39 44.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.435 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.717 ' HA ' HG22 ' A' ' 111' ' ' VAL . 2.3 m-85 -86.86 44.11 1.14 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.841 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.632 ' HD3' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -67.16 133.5 49.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 110.667 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.443 ' SG ' HD23 ' A' ' 106' ' ' LEU . 69.5 m -105.16 155.85 18.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.638 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -53.7 156.84 4.34 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.116 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 86.6 Cg_exo -47.66 162.94 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.808 2.339 . . . . 0.0 112.466 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.559 ' HB3' ' ND2' ' A' ' 159' ' ' ASN . 57.3 m-20 78.31 -31.4 0.16 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.151 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.41 ' H ' ' C ' ' A' ' 132' ' ' PRO . 2.6 m-85 -105.0 130.17 53.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.719 0.295 . . . . 0.0 110.393 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -111.39 130.58 55.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 111.516 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.79 HD23 ' HA ' ' A' ' 140' ' ' SER . 36.2 tp -78.05 136.4 37.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.419 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.0 66.06 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.14 -135.66 2.34 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.206 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.485 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 82.8 p -72.62 63.91 0.61 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.991 0.425 . . . . 0.0 110.78 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.79 ' HA ' HD23 ' A' ' 136' ' ' LEU . 88.0 p -56.08 -11.49 1.13 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.452 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 141' ' ' ARG . 69.3 mtt-85 -140.54 136.87 33.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 57.9 m -137.05 126.66 25.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.368 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.9 p -116.71 130.15 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.922 0.391 . . . . 0.0 111.262 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.816 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 33.2 m -96.83 147.92 23.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.852 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.1 p -171.31 27.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.299 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.49 ' O ' ' HG3' ' A' ' 146' ' ' GLN . 70.7 tp60 -176.26 37.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.06 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.505 ' N ' ' HB3' ' A' ' 120' ' ' ALA . . . 60.0 10.49 14.58 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.769 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -141.52 134.25 28.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.688 0.28 . . . . 0.0 110.92 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.496 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 38.7 m95 -64.86 134.97 55.18 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.564 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.2 m -57.42 -57.07 14.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.224 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 68.6 p -103.69 131.75 21.72 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.26 140.57 89.38 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.81 2.34 . . . . 0.0 111.895 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.516 ' HZ2' ' HB2' ' A' ' 106' ' ' LEU . 61.2 tttp -47.09 132.93 9.1 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.276 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.485 ' HB3' ' H ' ' A' ' 139' ' ' SER . 65.1 Cg_endo -89.26 -151.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.024 2.483 . . . . 0.0 113.004 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.446 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 20.8 p-80 -153.76 138.09 16.65 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.06 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.465 ' SG ' HD12 ' A' ' 136' ' ' LEU . 85.7 m -98.69 133.27 43.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.855 0.36 . . . . 0.0 110.83 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -103.02 136.93 41.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.727 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.68 142.42 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.901 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.559 ' ND2' ' HB3' ' A' ' 133' ' ' ASP . 23.4 p30 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.992 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 98' ' ' ILE . 2.6 pp . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 121.143 0.497 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.473 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 0.1 OUTLIER -63.8 151.55 41.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.964 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.0 t -39.89 111.18 0.18 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.015 0.436 . . . . 0.0 111.125 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -63.6 -22.37 66.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.984 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 t -53.5 -32.17 49.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.653 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -76.23 45.28 0.36 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.608 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.508 HD23 HD21 ' A' ' 113' ' ' LEU . 93.9 mt -132.82 -37.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 0.0 110.677 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 t -92.54 132.77 36.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.964 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.4 HD13 ' HZ1' ' A' ' 153' ' ' LYS . 37.6 tp -145.44 125.06 13.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.54 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -82.83 45.15 0.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.066 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 p30 179.55 36.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.363 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.63 -155.39 26.37 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.959 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -142.06 150.55 41.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.818 0.342 . . . . 0.0 110.7 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.419 HG11 ' HB ' ' A' ' 126' ' ' VAL . 98.1 t -106.56 125.19 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.496 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.0 m-85 -85.38 76.83 10.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.58 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.736 HD13 ' H ' ' A' ' 115' ' ' GLY . 3.4 tm? -54.96 141.52 33.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.339 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 23.6 m -157.46 61.33 0.49 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.657 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.736 ' H ' HD13 ' A' ' 113' ' ' LEU . . . 173.38 41.94 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.732 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.82 123.42 6.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.186 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 66.25 52.27 1.15 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.475 HD12 ' C ' ' A' ' 115' ' ' GLY . 10.7 mp -119.29 148.42 45.26 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.532 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -54.73 82.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.031 2.487 . . . . 0.0 111.748 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 62.12 13.45 5.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.576 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.669 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 7.3 mp 47.92 59.54 4.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.782 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.0 46.02 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.049 0.452 . . . . 0.0 110.567 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 171.64 -26.16 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.281 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.613 ' HB1' ' HA3' ' A' ' 115' ' ' GLY . . . -50.52 155.21 1.12 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 111.298 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 114' ' ' THR . 39.0 ptt180 -160.65 130.48 5.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.281 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.568 HG13 ' HA ' ' A' ' 113' ' ' LEU . 34.8 m -107.62 134.12 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.163 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 96.3 mt-10 -95.03 122.05 37.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.704 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.475 ' CE1' HG21 ' A' ' 126' ' ' VAL . 30.3 m-85 -88.28 149.08 24.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.654 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.405 HH11 ' HG3' ' A' ' 129' ' ' ARG . 40.1 ttt85 -153.62 126.97 8.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.739 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 16.6 t -89.24 151.28 22.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.016 0.436 . . . . 0.0 111.505 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -52.75 151.63 7.94 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.486 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.8 73.63 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.186 2.591 . . . . 0.0 112.747 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -176.31 -42.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.699 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.612 ' HB2' ' SG ' ' A' ' 130' ' ' CYS . 4.5 m-85 -109.51 143.53 39.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.545 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -99.44 135.05 41.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.304 0.574 . . . . 0.0 111.514 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' A' ' 140' ' ' SER . 35.5 tp -70.9 124.06 23.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.928 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.15 63.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.379 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -171.21 -128.63 1.05 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.921 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.654 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 60.1 m -73.54 57.14 0.54 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.878 0.371 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.454 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 38.9 t -51.66 -25.47 7.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.269 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 12.9 mtp-105 -137.82 129.71 28.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.572 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.452 ' HA ' ' HG1' ' A' ' 151' ' ' THR . 49.9 m -127.21 120.2 28.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.874 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.8 p -104.99 124.6 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.413 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 38.9 t -72.79 151.74 41.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.169 0.509 . . . . 0.0 111.587 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.5 m -161.44 121.71 2.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.563 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 57.92 43.17 21.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.315 0.578 . . . . 0.0 109.848 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 61.0 28.2 68.4 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.444 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -142.92 130.29 21.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.691 0.282 . . . . 0.0 110.61 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.514 ' CZ3' HG12 ' A' ' 126' ' ' VAL . 35.9 m95 -72.11 132.07 43.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.59 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.9 m -57.51 -60.64 3.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.452 ' HG1' ' HA ' ' A' ' 142' ' ' SER . 70.9 p -99.78 133.32 21.82 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.245 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 23.1 Cg_exo -64.9 -158.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.684 2.256 . . . . 0.0 112.326 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.467 ' HE3' ' HE2' ' A' ' 128' ' ' PHE . 14.2 mmmm -87.51 129.49 50.91 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.767 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.654 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.4 Cg_endo -75.26 -156.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.401 2.067 . . . . 0.0 112.803 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.72 148.77 26.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.938 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.43 ' HB3' ' CB ' ' A' ' 134' ' ' PHE . 97.1 m -97.07 130.54 44.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -108.72 135.11 50.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.692 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 158' ' ' VAL . 7.4 p -72.12 128.81 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.935 -179.876 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.541 HG22 ' HA ' ' A' ' 117' ' ' ASP . 1.5 pp . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.575 0.226 . . . . 0.0 111.482 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 6.1 t 59.38 150.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.576 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.694 ' HB2' ' HD1' ' A' ' 149' ' ' TRP . 57.4 m -39.86 125.55 1.9 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.976 0.417 . . . . 0.0 111.301 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.526 ' HD3' HD21 ' A' ' 104' ' ' LEU . 16.8 tppt? -86.31 -36.43 19.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.537 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.9 p -69.0 40.3 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.456 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 5.5 m-85 -128.41 -47.97 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.605 HD11 ' N ' ' A' ' 105' ' ' THR . 0.4 OUTLIER -54.8 -30.0 55.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.995 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.605 ' N ' HD11 ' A' ' 104' ' ' LEU . 6.8 t -92.48 132.43 36.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.775 0.321 . . . . 0.0 111.138 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.723 ' HB2' ' HZ3' ' A' ' 153' ' ' LYS . 34.5 tp -145.39 128.59 16.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.467 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -74.1 130.28 39.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.961 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.506 ' N ' HD21 ' A' ' 108' ' ' ASN . 2.0 m120 60.23 38.88 19.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.621 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.75 151.86 13.1 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.845 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -110.68 137.0 48.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.49 126.74 62.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -79.35 60.39 3.13 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.006 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.429 HD22 ' HB3' ' A' ' 104' ' ' LEU . 60.2 tp -58.5 140.96 53.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.546 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 31.3 m -155.62 55.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.492 0.663 . . . . 0.0 109.85 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.645 ' HA3' ' HB3' ' A' ' 124' ' ' ALA . . . 168.46 99.98 0.13 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.843 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 117' ' ' ASP . . . -165.32 151.34 20.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.774 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.541 ' HA ' HG22 ' A' ' 98' ' ' ILE . 38.8 t70 77.23 41.21 0.15 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.037 0.446 . . . . 0.0 110.975 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 120' ' ' ALA . 3.2 mm? -144.14 150.9 50.49 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.448 ' C ' ' H ' ' A' ' 121' ' ' LEU . 12.0 Cg_endo -55.47 81.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.841 2.361 . . . . 0.0 112.187 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 73.69 -38.07 0.39 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.271 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.448 ' H ' ' C ' ' A' ' 119' ' ' PRO . 17.6 tp 55.2 80.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.89 0.376 . . . . 0.0 110.746 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.02 48.69 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.139 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -178.26 26.12 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.36 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.645 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -80.52 142.3 34.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.616 0.246 . . . . 0.0 110.669 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.546 ' O ' ' HB ' ' A' ' 114' ' ' THR . 45.7 mtp85 -131.73 150.48 52.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 111.278 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.622 HG21 ' H ' ' A' ' 127' ' ' GLU . 7.6 p -154.49 158.27 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.279 0.562 . . . . 0.0 111.252 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.622 ' H ' HG21 ' A' ' 126' ' ' VAL . 43.6 tt0 -136.94 89.71 2.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.106 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.456 ' CE1' HG12 ' A' ' 126' ' ' VAL . 4.2 m-85 -59.11 148.57 30.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.714 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.8 tpt85 -159.52 128.36 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 35.4 t -89.22 150.23 22.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.301 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -53.67 156.61 4.52 Favored Pre-proline 0 N--CA 1.462 0.149 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.34 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 80.0 Cg_exo -45.64 162.02 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.978 2.452 . . . . 0.0 112.718 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 28.1 m-20 77.83 -36.57 0.22 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.61 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 132' ' ' PRO . 1.9 m-85 -107.49 128.65 54.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.919 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.469 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -102.86 137.16 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.077 0.465 . . . . 0.0 111.409 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.496 HD22 ' H ' ' A' ' 138' ' ' GLY . 6.9 tt -78.89 127.24 31.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.339 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.438 ' N ' HD22 ' A' ' 136' ' ' LEU . 26.3 t -130.07 65.66 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.496 ' H ' HD22 ' A' ' 136' ' ' LEU . . . -170.54 -125.38 0.8 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.636 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.813 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 29.2 t -73.37 59.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 111.295 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.3 t -58.29 -24.77 60.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.603 ' HD2' ' N ' ' A' ' 142' ' ' SER . 4.0 tmm_? -140.55 131.29 25.76 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.421 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 50.7 m -132.23 153.32 50.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.499 ' H ' ' HG ' ' A' ' 150' ' ' SER . 77.3 t -142.78 125.3 13.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.278 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.533 ' SG ' ' HB1' ' A' ' 124' ' ' ALA . 61.3 m -68.18 153.86 42.89 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -157.45 -23.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.285 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 146' ' ' GLN . 4.2 tp-100 -159.2 58.16 0.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.031 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 73.57 -8.08 11.28 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.914 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.74 136.17 33.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 111.023 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.694 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 60.2 m95 -60.57 150.32 32.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.752 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.499 ' HG ' ' H ' ' A' ' 143' ' ' VAL . 79.9 p -54.21 -58.77 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 t -104.25 144.88 29.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.378 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.456 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 17.7 Cg_endo -59.25 -147.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.993 2.462 . . . . 0.0 113.034 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.723 ' HZ3' ' HB2' ' A' ' 106' ' ' LEU . 55.0 tttp -108.92 135.32 20.15 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.604 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.813 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 73.4 Cg_endo -76.68 -155.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.492 2.128 . . . . 0.0 113.037 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -153.77 161.24 42.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 88.1 m -96.11 131.62 42.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.787 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.469 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 4.2 tp-100 -118.84 138.14 52.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.917 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.65 136.56 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.237 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 24.1 p30 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.04 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 98' ' ' ILE . 1.7 pp . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.185 0.517 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.599 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 72.8 m -59.89 140.37 56.7 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.8 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.4 p -37.93 113.36 0.27 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.087 0.47 . . . . 0.0 111.62 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.554 ' HB3' HD13 ' A' ' 104' ' ' LEU . 98.3 mttt -69.43 1.95 3.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.316 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.2 p -59.63 -37.52 78.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.879 0.371 . . . . 0.0 110.569 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.5 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 1.4 m-85 -54.38 -35.43 62.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.851 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 101' ' ' LYS . 79.3 mt -53.53 139.45 31.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.33 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 30.9 p 60.52 130.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.497 0.498 . . . . 0.0 111.106 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.72 HD12 ' HE2' ' A' ' 153' ' ' LYS . 30.9 tp -145.37 134.88 23.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.305 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pm0 -63.62 133.03 52.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.323 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 58.42 42.99 20.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.41 -177.58 43.66 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.563 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -142.03 151.89 42.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.607 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 86.5 t -129.14 123.98 59.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.349 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.5 m-85 -89.79 119.42 30.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.748 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.9 tp -80.92 145.3 31.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.858 0.361 . . . . 0.0 110.932 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 23.7 m -158.88 56.16 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.733 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.572 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . -159.0 -108.88 0.25 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.818 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 158.68 -124.67 1.4 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.863 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -151.4 53.03 0.84 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.189 0.519 . . . . 0.0 110.228 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 97.3 mt -99.35 156.89 34.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.879 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 121' ' ' LEU . 80.6 Cg_exo -44.32 111.24 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.45 2.1 . . . . 0.0 112.182 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.66 -38.99 0.44 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.593 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.463 ' HA ' HD12 ' A' ' 121' ' ' LEU . 16.5 tp 58.23 51.94 7.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.968 0.413 . . . . 0.0 111.122 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.3 60.4 1.52 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.008 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.29 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.396 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.572 ' HB1' ' HA3' ' A' ' 115' ' ' GLY . . . -49.92 152.27 1.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.486 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.498 ' O ' ' HB ' ' A' ' 114' ' ' THR . 79.1 ttt180 -155.63 122.05 5.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.409 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 26.8 m -111.82 134.71 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.159 0.504 . . . . 0.0 111.772 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -87.34 141.84 28.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.226 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.584 ' CE1' HG23 ' A' ' 126' ' ' VAL . 14.4 m-85 -117.09 140.23 49.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.491 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -162.36 131.02 4.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.661 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 7.1 t -89.22 155.11 19.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.909 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 133' ' ' ASP . 45.9 m-20 -52.75 151.62 7.95 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.496 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.03 76.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.284 2.656 . . . . 0.0 113.133 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 131' ' ' ASP . 33.4 t70 -178.68 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.702 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.534 ' HB2' ' SG ' ' A' ' 130' ' ' CYS . 5.0 m-85 -108.93 145.83 34.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.55 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -101.08 140.03 35.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.32 0.581 . . . . 0.0 111.287 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 137' ' ' VAL . 2.4 tm? -79.61 127.09 31.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.971 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.537 ' N ' HD13 ' A' ' 136' ' ' LEU . 44.6 t -132.38 71.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.549 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.98 -130.25 1.56 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.879 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.771 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 31.4 t -73.53 58.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 111.268 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.444 ' HB3' HD11 ' A' ' 136' ' ' LEU . 96.5 p -51.71 -26.29 9.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.122 0.487 . . . . 0.0 109.885 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -140.62 128.95 22.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.272 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 99.8 p -125.74 128.27 47.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 111.038 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 89.1 t -103.13 117.56 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 42.6 t -64.54 136.69 57.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.455 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.1 t -164.47 130.29 2.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 111.201 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 39.5 tt0 56.75 43.16 25.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.28 0.562 . . . . 0.0 110.538 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 60.53 17.4 47.95 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.94 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -143.52 135.03 26.2 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.886 0.343 . . . . 0.0 111.128 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.599 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 95.5 m95 -68.97 135.19 50.57 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.838 0.352 . . . . 0.0 111.126 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -57.46 -55.16 38.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.3 p -103.97 132.11 21.33 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.63 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 54.3 Cg_endo -69.37 136.49 34.15 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.797 2.331 . . . . 0.0 112.473 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.72 ' HE2' HD12 ' A' ' 106' ' ' LEU . 85.9 tttt -40.01 129.03 1.6 Allowed Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.459 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 95.2 Cg_endo -79.2 -154.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.906 2.404 . . . . 0.0 113.221 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.418 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 20.6 p-80 -153.74 169.42 23.38 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.902 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 92.3 m -98.72 136.79 38.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.418 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -131.25 131.14 43.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 110.857 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.43 132.08 29.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.322 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.904 179.862 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.417 HD13 ' OD1' ' A' ' 117' ' ' ASP . 6.7 tt . . . . . 0 N--CA 1.441 -0.91 0 CA-C-O 120.919 0.39 . . . . 0.0 111.042 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 14.4 m -48.85 138.41 11.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.376 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.7 m -39.86 128.45 2.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.416 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HE3' HD12 ' A' ' 98' ' ' ILE . 33.1 mmtp -82.0 -15.95 51.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.923 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.7 m -53.11 -42.41 65.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.085 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -57.5 -41.48 80.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.014 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 104' ' ' LEU . 3.6 mp -77.88 40.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.8 m -147.39 62.68 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.653 ' HA ' ' HZ3' ' A' ' 153' ' ' LYS . 49.9 tp -94.55 124.97 38.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.849 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.421 ' OE1' ' ND2' ' A' ' 108' ' ' ASN . 0.0 OUTLIER -90.58 41.0 1.04 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.017 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.421 ' ND2' ' OE1' ' A' ' 107' ' ' GLU . 78.4 m-20 -160.12 27.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.697 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 161.07 -146.48 12.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.997 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.65 ' HB3' ' HZ1' ' A' ' 110' ' ' LYS . 7.9 mtpm? -141.94 143.37 33.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.296 -0.452 . . . . 0.0 110.663 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.71 119.84 54.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.831 0.348 . . . . 0.0 110.519 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.437 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 1.7 m-85 -71.71 123.02 21.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.907 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.656 HD12 ' H ' ' A' ' 115' ' ' GLY . 3.4 tm? -89.17 141.34 28.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.2 m -157.95 54.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.868 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.656 ' H ' HD12 ' A' ' 113' ' ' LEU . . . -146.96 -105.57 0.43 Allowed Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.934 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.659 ' H ' HD23 ' A' ' 121' ' ' LEU . . . 165.82 -126.46 1.48 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.42 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.417 ' OD1' HD13 ' A' ' 98' ' ' ILE . 32.3 t70 -167.32 67.17 0.09 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.157 0.504 . . . . 0.0 109.984 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.683 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 71.5 mt -127.97 168.76 14.32 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.116 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.683 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 76.3 Cg_exo -38.18 97.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.635 2.224 . . . . 0.0 112.125 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 70.68 -20.05 0.21 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.847 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 116' ' ' GLY . 19.8 tp 62.31 54.01 2.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.93 0.395 . . . . 0.0 110.76 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.678 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 33.1 t70 -56.83 129.51 41.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.182 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.74 26.31 38.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.988 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.836 ' HB2' ' HB3' ' A' ' 144' ' ' CYS . . . -79.64 156.91 27.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.494 ' O ' ' HB ' ' A' ' 114' ' ' THR . 56.4 ttp85 -154.34 145.27 22.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.407 . . . . 0.0 111.405 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.579 HG21 ' CZ3' ' A' ' 149' ' ' TRP . 26.7 m -148.35 138.23 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.582 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HG3' ' NH1' ' A' ' 141' ' ' ARG . 43.3 tt0 -110.79 115.83 30.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.582 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.558 ' HE2' ' HG3' ' A' ' 153' ' ' LYS . 2.0 m-85 -73.95 143.0 45.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -156.3 117.84 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.704 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.528 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 95.2 m -92.32 156.25 17.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.571 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -52.7 153.11 6.01 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.476 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.37 78.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.128 2.552 . . . . 0.0 112.668 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -177.46 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.646 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.638 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 0.6 OUTLIER -108.61 134.52 51.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.924 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.479 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 20.3 p-80 -102.66 127.33 49.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.122 0.486 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.725 HD21 ' HA ' ' A' ' 140' ' ' SER . 26.6 tp -70.21 126.61 30.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.131 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.7 67.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.638 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -174.74 -135.31 2.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.072 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.743 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 65.0 m -74.74 55.04 0.66 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.725 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.8 t -48.42 -43.53 34.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.09 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.57 ' HD2' ' N ' ' A' ' 141' ' ' ARG . 0.4 OUTLIER -102.02 133.63 46.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.9 m -133.91 130.0 37.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.713 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.61 123.97 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.299 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.836 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 41.1 t -100.7 145.21 28.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.687 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.678 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 81.1 p -168.14 35.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 175.8 39.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.276 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 61.71 10.98 27.52 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.112 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.15 134.81 28.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.562 0.22 . . . . 0.0 110.592 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.579 ' CZ3' HG21 ' A' ' 126' ' ' VAL . 56.1 m95 -73.42 137.11 44.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.366 . . . . 0.0 111.13 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.2 t -57.49 -59.66 4.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.35 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.64 ' HG1' ' HB3' ' A' ' 139' ' ' SER . 82.7 p -96.44 134.52 23.32 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 15.9 Cg_exo -67.53 146.28 73.5 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.935 2.423 . . . . 0.0 111.949 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.653 ' HZ3' ' HA ' ' A' ' 106' ' ' LEU . 88.2 tttt -51.17 122.93 19.24 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.858 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.743 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.2 Cg_endo -75.25 -150.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.734 2.289 . . . . 0.0 112.953 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.465 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.5 p-80 -153.74 139.88 18.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.638 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 67.5 m -98.79 139.28 34.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.003 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.479 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 39.3 tt0 -102.93 132.53 49.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.11 126.91 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.338 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.395 179.667 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.542 ' HA ' HD13 ' A' ' 121' ' ' LEU . 1.4 pt . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 120.745 0.307 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.51 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 99.7 m -64.16 136.18 57.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 102' ' ' SER . 54.4 m -41.42 131.12 2.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.275 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.529 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -76.63 15.56 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.177 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 100' ' ' SER . 50.4 m -68.93 -39.81 79.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 111.433 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.533 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 1.8 m-85 -64.59 -70.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -46.98 156.97 0.18 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.97 0.414 . . . . 0.0 111.484 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.6 m 64.67 73.13 0.43 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.34 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.564 HD12 ' HZ1' ' A' ' 153' ' ' LYS . 49.3 tp -93.14 136.52 33.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.333 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.83 135.06 57.58 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 58.97 40.93 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.075 0.464 . . . . 0.0 110.186 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.37 169.58 41.81 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.934 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -136.93 129.66 30.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.958 0.409 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 58.4 t -111.15 126.53 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.227 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.5 m-85 -70.87 111.33 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.19 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.585 ' HA ' HG11 ' A' ' 126' ' ' VAL . 58.5 tp -80.84 145.26 31.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.931 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.4 m -161.88 54.42 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.849 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.629 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -174.76 61.26 0.11 Allowed Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.697 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.46 -53.37 45.52 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 114.634 0.613 . . . . 0.0 114.634 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -164.08 54.7 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.425 0.613 . . . . 0.0 111.821 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.654 ' N ' HD13 ' A' ' 118' ' ' LEU . 7.1 mp -87.74 159.19 49.75 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.355 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -47.52 83.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.541 2.16 . . . . 0.0 111.638 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 59.83 23.12 12.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.902 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.674 ' N ' HD11 ' A' ' 121' ' ' LEU . 7.8 mp 52.22 53.26 12.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.62 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 38.6 t70 -76.79 44.93 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.211 0.529 . . . . 0.0 110.329 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 125' ' ' ARG . . . 172.5 -27.65 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.536 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.629 ' HB2' ' HA3' ' A' ' 115' ' ' GLY . . . -51.8 144.55 11.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.783 0.325 . . . . 0.0 111.251 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.498 ' O ' ' HB ' ' A' ' 114' ' ' THR . 84.2 mtm180 -147.84 136.98 22.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.003 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 113' ' ' LEU . 31.6 m -121.91 131.98 71.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.004 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.16 124.2 39.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.606 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 128' ' ' PHE . 0.8 OUTLIER -87.09 138.17 31.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.98 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -145.92 127.47 15.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.491 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.517 ' SG ' HD13 ' A' ' 136' ' ' LEU . 96.5 m -89.29 145.32 25.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.692 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 134' ' ' PHE . 3.2 t70 -55.63 146.79 43.58 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.616 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 131' ' ' ASP . 88.4 Cg_exo -36.82 137.0 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.863 2.376 . . . . 0.0 112.593 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 51.5 m-20 75.0 22.21 1.85 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.512 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.51 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 16.9 m-85 -134.97 131.54 37.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.562 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -106.03 135.23 47.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.926 0.393 . . . . 0.0 110.836 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 140' ' ' SER . 17.5 tp -78.15 143.07 37.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.406 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 155' ' ' HIS . 14.5 p -134.92 59.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.834 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 169.28 -126.15 1.34 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 119.013 -1.565 . . . . 0.0 113.764 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.933 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 29.9 t -65.66 65.8 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.796 0.332 . . . . 0.0 111.258 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.763 ' HA ' HD21 ' A' ' 136' ' ' LEU . 95.6 p -61.88 -26.55 68.22 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.331 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -140.68 125.23 17.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.502 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m -116.35 137.33 52.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.793 0.33 . . . . 0.0 110.736 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 92.3 t -131.32 115.45 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.038 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 69.7 m -80.31 153.19 28.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.832 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 40.8 t -152.43 -23.01 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.661 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -146.58 46.18 1.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.15 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.502 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 64.74 24.18 69.58 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.882 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -141.7 132.74 26.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.293 0.237 . . . . 0.0 110.483 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.51 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 72.4 m95 -66.41 145.22 55.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 110.864 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.3 t -56.27 -48.61 76.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.294 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.484 HG23 ' HA ' ' A' ' 139' ' ' SER . 1.0 OUTLIER -135.52 139.24 30.59 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-O 120.847 0.356 . . . . 0.0 111.765 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.533 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 17.8 Cg_endo -59.76 137.7 78.44 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.444 2.763 . . . . 0.0 113.842 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.793 ' HD3' ' HD2' ' A' ' 154' ' ' PRO . 2.7 tppp? -50.42 126.75 22.72 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.77 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.933 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 96.1 Cg_endo -85.03 -140.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.096 2.531 . . . . 0.0 112.278 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.44 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.69 149.31 27.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.876 0.369 . . . . 0.0 111.077 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.3 m -95.32 132.74 40.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.363 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -123.58 139.4 54.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.359 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.23 133.73 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.779 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.934 179.942 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 121.053 0.454 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.7 m -63.43 153.1 36.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.635 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 102' ' ' SER . 47.7 t -39.44 104.02 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.167 0.508 . . . . 0.0 110.879 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.636 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -66.46 3.95 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.328 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.458 ' H ' ' C ' ' A' ' 100' ' ' SER . 47.7 t -68.11 -38.62 82.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.49 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.49 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 2.3 m-85 -51.5 -38.4 53.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.13 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 83.1 mt -53.77 -43.51 69.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.725 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.2 t -92.61 136.59 33.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.641 ' HB2' ' HZ2' ' A' ' 153' ' ' LYS . 34.8 tp -145.42 128.94 17.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.909 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.92 42.24 0.62 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.284 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -154.08 -31.31 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.801 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.541 ' HA2' ' OD1' ' A' ' 131' ' ' ASP . . . -153.9 -148.37 4.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.174 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -131.15 137.42 49.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.779 0.323 . . . . 0.0 110.827 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 60.1 t -108.72 121.82 62.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.864 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -69.17 124.32 23.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.513 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.724 HD12 ' H ' ' A' ' 115' ' ' GLY . 3.1 tm? -99.7 142.16 31.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.395 0.617 . . . . 0.0 111.804 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.575 ' H ' HD22 ' A' ' 113' ' ' LEU . 22.6 m -157.47 42.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.861 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.724 ' H ' HD12 ' A' ' 113' ' ' LEU . . . 162.0 95.81 0.11 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.629 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.32 43.28 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.354 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.513 ' O ' HD23 ' A' ' 118' ' ' LEU . 53.1 p-10 -173.13 33.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 0.0 110.647 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.62 ' HB2' HD22 ' A' ' 121' ' ' LEU . 86.1 mt -141.13 140.76 21.71 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.526 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.54 117.36 3.58 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.579 2.186 . . . . 0.0 112.813 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 71.18 -38.03 0.41 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.63 HD23 ' HB1' ' A' ' 124' ' ' ALA . 46.5 mt 63.04 55.23 1.99 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.799 0.333 . . . . 0.0 110.789 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -76.54 48.97 0.58 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.617 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.16 -20.11 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.789 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.828 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.97 143.02 4.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 111.672 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.584 ' HD2' HH22 ' A' ' 141' ' ' ARG . 84.9 mtm180 -136.57 141.6 43.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.414 ' O ' HG21 ' A' ' 126' ' ' VAL . 33.8 m -138.13 136.2 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -114.27 113.4 24.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.49 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 3.0 m-85 -77.99 147.03 35.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.148 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 129' ' ' ARG . 38.1 ttt85 -158.07 129.34 6.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.078 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 31.1 m -89.07 139.52 30.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.02 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.541 ' OD1' ' HA2' ' A' ' 109' ' ' GLY . 82.3 m-20 -52.63 151.44 7.92 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.232 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.69 77.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.023 2.482 . . . . 0.0 112.422 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 131' ' ' ASP . 65.1 t0 -179.44 -41.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.432 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 2.9 m-85 -110.09 140.93 43.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.229 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -102.72 127.8 49.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.863 0.364 . . . . 0.0 110.573 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.444 HD21 ' HG2' ' A' ' 154' ' ' PRO . 2.7 tm? -77.35 129.34 35.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.07 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.82 72.46 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.24 -135.89 2.41 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.632 -1.271 . . . . 0.0 113.318 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 152' ' ' PRO . 68.6 m -76.37 54.54 0.92 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.708 0.29 . . . . 0.0 110.94 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 88.8 p -47.07 -37.46 9.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.541 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.584 HH22 ' HD2' ' A' ' 125' ' ' ARG . 40.6 ttt85 -99.4 138.27 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.505 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.1 t -150.37 132.0 14.88 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.726 0.298 . . . . 0.0 110.655 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.472 ' HB ' ' HG ' ' A' ' 150' ' ' SER . 83.5 t -117.66 127.41 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.298 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.828 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 49.9 t -71.43 140.17 49.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -169.19 129.35 1.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.592 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 56.76 40.28 29.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 59.12 22.54 55.75 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.407 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.18 132.51 24.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.648 0.261 . . . . 0.0 110.687 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -69.5 141.29 53.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.839 0.352 . . . . 0.0 111.034 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.472 ' HG ' ' HB ' ' A' ' 143' ' ' VAL . 70.0 m -57.4 -54.41 47.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.05 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 65.0 p -115.71 137.34 23.17 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.399 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.47 ' O ' ' HB2' ' A' ' 139' ' ' SER . 31.7 Cg_exo -58.76 142.2 98.54 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.817 2.345 . . . . 0.0 112.227 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.641 ' HZ2' ' HB2' ' A' ' 106' ' ' LEU . 62.6 tttp -50.42 130.93 25.89 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.247 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.444 ' HG2' HD21 ' A' ' 136' ' ' LEU . 59.4 Cg_endo -72.39 -152.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.649 2.232 . . . . 0.0 112.555 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.422 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.63 143.7 22.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.133 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 81.1 m -98.15 129.68 44.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.37 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -119.28 140.82 49.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.937 0.398 . . . . 0.0 111.516 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.07 135.92 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.786 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.888 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 1.043 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 94.5 mt . . . . . 0 N--CA 1.457 -0.094 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.8 m -62.48 150.52 39.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.717 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 102' ' ' SER . 57.5 m -40.68 105.07 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.543 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -69.13 15.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.719 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 100' ' ' SER . 46.9 t -68.92 -35.38 76.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.061 0.458 . . . . 0.0 110.029 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -51.65 -35.19 41.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.241 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.4 mt -53.47 -43.93 68.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.211 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.4 m -92.56 128.61 38.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 34.9 tp -145.45 132.91 20.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.366 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.41 132.91 47.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.492 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 56.24 43.98 25.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.545 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.81 163.82 32.99 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.519 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.653 ' HZ1' ' HB2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -138.89 134.39 33.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.775 0.322 . . . . 0.0 110.684 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.49 HG12 ' HB ' ' A' ' 126' ' ' VAL . 57.7 t -114.13 126.96 71.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.647 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -73.34 124.82 26.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.211 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.9 tp -89.54 143.35 26.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.225 0.535 . . . . 0.0 112.088 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.562 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.2 m -162.37 52.4 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.395 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 161.95 103.39 0.18 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.709 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.86 47.84 0.22 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.113 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.515 ' C ' HD22 ' A' ' 118' ' ' LEU . 2.7 p30 -174.5 36.43 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.35 . . . . 0.0 111.156 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 118' ' ' LEU . 2.2 mm? -134.98 151.85 76.22 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.582 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.4 124.26 11.64 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.345 2.03 . . . . 0.0 111.424 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 53.16 32.0 12.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.069 0.461 . . . . 0.0 110.279 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 1.043 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 14.7 tp 50.58 46.73 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.927 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -66.68 141.08 57.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.122 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.8 31.36 80.65 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.469 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.678 ' CB ' ' HG ' ' A' ' 121' ' ' LEU . . . -85.65 145.17 27.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.737 0.303 . . . . 0.0 110.976 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.562 ' O ' ' HB ' ' A' ' 114' ' ' THR . 53.4 ttt-85 -160.4 127.07 4.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.692 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.49 ' HB ' HG12 ' A' ' 111' ' ' VAL . 28.3 m -137.54 136.96 46.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.68 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -102.38 122.71 44.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.123 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.565 ' HE2' ' HG3' ' A' ' 153' ' ' LYS . 5.7 m-85 -83.61 150.21 26.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.134 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -157.04 126.13 5.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.588 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 73.4 m -89.91 136.91 32.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.218 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -57.78 159.33 10.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.965 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 88.3 Cg_exo -40.89 152.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.96 2.44 . . . . 0.0 112.721 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 57.8 m-20 78.03 -34.38 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.039 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 132' ' ' PRO . 2.7 m-85 -106.02 128.21 53.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.3 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.27 140.08 39.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.14 0.495 . . . . 0.0 111.878 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.817 HD23 ' HA ' ' A' ' 140' ' ' SER . 36.5 tp -78.11 128.44 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.704 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.42 64.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.577 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.73 -135.83 2.05 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.219 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.667 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 63.8 m -72.04 63.92 0.51 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.114 0.483 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.817 ' HA ' HD23 ' A' ' 136' ' ' LEU . 38.1 t -55.31 -16.96 3.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.467 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -140.64 136.03 32.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.89 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 79.2 p -135.57 141.87 45.23 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.436 ' H ' ' HB3' ' A' ' 150' ' ' SER . 95.5 t -135.82 126.18 42.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.066 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 124' ' ' ALA . 57.2 m -92.95 148.46 21.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.039 0.447 . . . . 0.0 111.735 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.6 t -163.15 26.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.148 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 175.86 39.51 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.275 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 62.66 19.37 60.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.495 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -142.38 132.77 24.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.664 0.268 . . . . 0.0 110.641 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -64.56 143.01 58.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.967 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.436 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 48.5 t -57.14 -47.43 81.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.714 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 59.8 p -127.68 133.57 25.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.342 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.25 142.99 77.61 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.879 2.386 . . . . 0.0 112.619 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.565 ' HG3' ' HE2' ' A' ' 128' ' ' PHE . 87.4 tttt -48.86 128.24 14.39 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.28 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.667 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.0 Cg_endo -75.91 -150.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.704 2.269 . . . . 0.0 112.672 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.434 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.6 p-80 -153.69 151.51 29.74 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.08 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 90.2 m -98.61 137.09 37.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.727 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -120.4 135.83 54.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.362 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.65 143.63 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.973 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.4 HD21 ' HA ' ' A' ' 133' ' ' ASP . 23.5 p30 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.09 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 117' ' ' ASP . 12.8 mt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.923 0.392 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.522 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 72.9 m 58.77 149.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.876 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -40.41 100.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.404 ' HG3' HD11 ' A' ' 104' ' ' LEU . 27.7 ttpp -59.9 -20.61 58.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.861 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.8 p -53.24 -33.51 53.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.292 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -56.95 -44.87 82.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.662 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.417 HD22 HG11 ' A' ' 126' ' ' VAL . 92.7 mt -49.61 -39.98 37.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.7 p -92.55 131.87 37.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.652 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.724 ' HB2' ' HZ3' ' A' ' 153' ' ' LYS . 55.4 tp -145.36 130.68 18.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.18 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.57 132.3 47.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.433 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.77 43.89 24.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.566 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.19 164.4 34.92 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.472 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -136.7 134.35 37.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.736 0.303 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 127' ' ' GLU . 86.9 t -106.48 126.07 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.391 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.58 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.5 m-85 -74.71 127.43 33.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.634 HD11 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -81.6 140.97 34.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.076 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.634 ' N ' HD11 ' A' ' 113' ' ' LEU . 28.2 m -158.1 56.11 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.083 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.422 ' H ' HD11 ' A' ' 113' ' ' LEU . . . -153.99 -101.87 0.2 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.012 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.97 -131.55 1.66 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.225 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.566 ' HA ' HD12 ' A' ' 98' ' ' ILE . 39.0 t70 -165.8 58.38 0.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.974 0.416 . . . . 0.0 110.34 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.582 ' N ' HD13 ' A' ' 118' ' ' LEU . 8.0 mp -131.38 156.98 79.39 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.515 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.415 ' C ' ' H ' ' A' ' 121' ' ' LEU . 95.6 Cg_exo -42.89 119.89 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.445 2.097 . . . . 0.0 112.468 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.99 -40.24 0.47 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.672 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 119' ' ' PRO . 21.2 tp 55.23 57.21 5.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.949 0.404 . . . . 0.0 110.857 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -51.19 137.1 23.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.15 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.22 33.52 64.78 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.895 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.6 ' HB2' ' HB2' ' A' ' 144' ' ' CYS . . . -84.35 148.53 26.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.523 0.201 . . . . 0.0 110.595 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.407 ' O ' ' HB ' ' A' ' 114' ' ' THR . 66.1 mtm-85 -144.87 141.96 29.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.985 0.421 . . . . 0.0 111.338 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.577 HG22 ' CE1' ' A' ' 128' ' ' PHE . 23.9 m -147.8 132.08 9.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.715 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.7 mt-10 -93.05 131.43 38.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.292 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.577 ' CE1' HG22 ' A' ' 126' ' ' VAL . 4.3 m-85 -103.47 145.84 29.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.029 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.5 ' HG2' HH11 ' A' ' 129' ' ' ARG . 2.9 ptp85 -168.89 129.98 1.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.651 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 26.2 t -89.22 150.5 22.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.235 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -52.68 155.8 3.68 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.32 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 84.9 Cg_exo -46.28 159.21 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.68 2.254 . . . . 0.0 112.149 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 25.3 m-20 78.27 -37.53 0.22 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.61 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.41 ' H ' ' C ' ' A' ' 132' ' ' PRO . 20.7 m-85 -108.05 128.96 55.13 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -108.66 133.52 52.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 111.596 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 138' ' ' GLY . 7.9 tt -71.42 137.53 48.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.02 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.663 HG21 HE21 ' A' ' 157' ' ' GLN . 42.8 t -131.37 73.08 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.769 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.5 ' N ' HD23 ' A' ' 136' ' ' LEU . . . 177.46 -133.43 2.22 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.081 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.777 ' HB2' ' HG1' ' A' ' 151' ' ' THR . 43.6 p -73.72 62.6 0.81 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 99.8 p -56.27 -14.93 3.19 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.801 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.638 ' HD2' ' O ' ' A' ' 141' ' ' ARG . 7.6 ppt_? -140.62 140.52 35.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.599 0.237 . . . . 0.0 110.964 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 56.1 m -136.55 148.93 47.84 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.855 0.359 . . . . 0.0 111.278 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 124' ' ' ALA . 6.7 p -143.21 129.87 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.374 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.6 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 98.3 m -75.06 174.93 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.509 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.7 t -172.21 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.452 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -150.8 49.5 0.86 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.59 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 65.68 19.35 67.08 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.259 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -142.82 132.19 23.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.548 0.213 . . . . 0.0 110.731 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.522 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 97.7 m95 -65.15 135.83 55.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.647 0.261 . . . . 0.0 110.941 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.8 t -57.48 -52.76 64.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.483 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.777 ' HG1' ' HB2' ' A' ' 139' ' ' SER . 72.7 p -104.3 146.15 32.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.971 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' A' ' 153' ' ' LYS . 32.7 Cg_endo -63.83 -152.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.622 2.215 . . . . 0.0 112.739 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.763 ' HD2' ' HD2' ' A' ' 154' ' ' PRO . 59.0 tptt -121.77 123.62 27.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.262 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.763 ' HD2' ' HD2' ' A' ' 153' ' ' LYS . 98.3 Cg_endo -85.45 -146.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.66 2.24 . . . . 0.0 113.214 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -153.72 -149.28 0.28 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 85.6 m -133.07 134.83 44.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.663 HE21 HG21 ' A' ' 137' ' ' VAL . 8.3 tt0 -116.85 130.03 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.456 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.0 p -62.14 137.99 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.125 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.6 p30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.954 -179.846 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.566 ' HA ' HD11 ' A' ' 121' ' ' LEU . 11.4 pt . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.527 0.679 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.612 ' SG ' HD22 ' A' ' 121' ' ' LEU . 3.2 p -60.7 136.04 57.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.726 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.424 ' C ' ' H ' ' A' ' 102' ' ' SER . 80.4 p -39.89 130.31 2.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.592 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -75.11 16.12 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.345 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 100' ' ' SER . 79.6 p -68.96 -44.8 72.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.866 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.574 ' HH ' ' HA ' ' A' ' 152' ' ' PRO . 3.0 m-85 -59.07 -36.83 75.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.412 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.55 HD23 HD21 ' A' ' 113' ' ' LEU . 94.9 mt -50.55 149.39 3.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.747 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 30.3 p 62.66 137.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.115 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.634 HD11 ' HE2' ' A' ' 153' ' ' LYS . 36.1 tp -145.41 139.66 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.26 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -68.04 130.0 41.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.235 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 57.37 41.74 25.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.713 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.49 152.82 10.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.636 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.48 132.01 56.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.724 0.297 . . . . 0.0 110.685 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.563 HG22 ' HA ' ' A' ' 128' ' ' PHE . 98.5 t -108.32 121.96 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.288 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.7 m-85 -74.82 126.08 30.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.152 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -108.58 142.06 39.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.411 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.589 ' N ' HD13 ' A' ' 113' ' ' LEU . 94.7 m -163.58 97.66 0.88 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.608 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.561 ' O ' HD21 ' A' ' 118' ' ' LEU . . . 163.08 -30.26 0.27 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.883 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -41.58 150.14 0.26 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.528 -0.368 . . . . 0.0 113.901 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.596 ' O ' HD22 ' A' ' 118' ' ' LEU . 32.5 m-20 72.23 37.11 0.99 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.826 0.45 . . . . 0.0 111.704 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.596 HD22 ' O ' ' A' ' 117' ' ' ASP . 3.3 mm? -142.44 148.67 48.2 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.953 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.86 97.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.797 2.332 . . . . 0.0 112.616 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.459 ' HA ' ' H ' ' A' ' 98' ' ' ILE . . . 55.64 17.06 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.574 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.857 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 10.4 mp 46.11 62.44 2.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.25 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.53 46.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.169 0.509 . . . . 0.0 110.376 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 121' ' ' LEU . . . 166.86 27.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.029 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.857 ' HB2' ' HB3' ' A' ' 121' ' ' LEU . . . -81.46 142.08 33.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.754 0.311 . . . . 0.0 111.397 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.56 130.29 34.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.621 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.657 HG21 ' HZ3' ' A' ' 149' ' ' TRP . 19.0 m -136.1 144.13 34.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.468 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 87.2 tt0 -119.09 122.05 41.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.229 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.563 ' HA ' HG22 ' A' ' 111' ' ' VAL . 9.4 m-85 -85.65 53.51 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.965 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.48 ' HB3' ' NH1' ' A' ' 129' ' ' ARG . 12.8 mtp-105 -58.88 128.62 38.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 0.0 111.001 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 61.3 m -89.55 147.21 24.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.891 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 133' ' ' ASP . 52.6 p-10 -52.81 153.0 6.27 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.031 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.36 75.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.001 2.468 . . . . 0.0 112.755 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.5 t70 179.93 -40.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 3.5 m-85 -108.63 139.65 43.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.259 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -102.86 131.45 49.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.053 0.454 . . . . 0.0 110.757 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.722 HD21 ' HA ' ' A' ' 140' ' ' SER . 23.2 tp -69.91 131.9 45.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.982 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.1 t -136.25 67.8 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.94 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.59 -136.5 2.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.47 -1.348 . . . . 0.0 113.376 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.588 ' HG ' ' HB ' ' A' ' 151' ' ' THR . 62.2 m -74.62 58.12 0.77 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.997 0.427 . . . . 0.0 110.565 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.722 ' HA ' HD21 ' A' ' 136' ' ' LEU . 39.3 t -47.63 -44.03 26.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.416 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -102.62 133.03 48.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.968 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.411 ' HG ' ' HE3' ' A' ' 149' ' ' TRP . 45.7 t -138.32 125.23 21.18 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.64 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 96.8 t -111.89 125.62 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.086 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.62 ' HB2' ' HB1' ' A' ' 124' ' ' ALA . 73.9 m -72.83 143.35 47.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.017 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.5 p -163.51 128.69 3.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.097 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 1.5 mp0 55.79 38.21 29.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.451 . . . . 0.0 109.917 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 62.29 28.21 70.53 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.351 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -143.23 131.53 22.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.576 0.227 . . . . 0.0 110.593 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.657 ' HZ3' HG21 ' A' ' 126' ' ' VAL . 46.9 m95 -69.85 137.43 51.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 111.117 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.2 t -57.49 -56.46 21.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.644 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.588 ' HB ' ' HG ' ' A' ' 139' ' ' SER . 82.0 p -111.75 137.64 21.32 Favored Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.574 ' HA ' ' HH ' ' A' ' 103' ' ' TYR . 32.2 Cg_exo -58.41 147.17 86.96 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.879 2.386 . . . . 0.0 112.268 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.634 ' HE2' HD11 ' A' ' 106' ' ' LEU . 85.9 tttt -52.79 125.65 39.16 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.499 ' HB2' HD11 ' A' ' 136' ' ' LEU . 74.8 Cg_endo -76.78 -154.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.76 2.306 . . . . 0.0 112.655 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -153.67 150.67 28.82 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.229 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 76.5 m -97.33 134.91 39.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.228 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.461 HE22 HG12 ' A' ' 158' ' ' VAL . 2.7 tm0? -124.47 131.42 53.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.715 0.293 . . . . 0.0 110.721 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.461 HG12 HE22 ' A' ' 157' ' ' GLN . 7.3 p -74.09 129.27 36.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 111.641 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.184 -0.913 . . . . 0.0 111.091 179.758 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.612 ' HA ' HD11 ' A' ' 121' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 120.872 0.367 . . . . 0.0 111.104 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.566 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 39.1 m -57.1 143.77 37.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.866 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.6 t -39.88 128.56 2.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.075 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.647 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -72.73 -14.27 61.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.364 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.5 p -53.1 -47.06 68.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.53 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -59.44 -41.27 89.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.252 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.48 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 86.8 mt -51.86 -36.89 49.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.23 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.5 p -92.49 141.42 28.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.608 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.435 HD21 ' H ' ' A' ' 108' ' ' ASN . 1.9 tt -140.84 120.93 13.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.532 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 108' ' ' ASN . 3.8 mm-40 -82.64 30.05 0.43 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.435 ' H ' HD21 ' A' ' 106' ' ' LEU . 72.3 m-80 -166.14 25.68 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.54 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.15 -156.67 23.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.656 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -141.96 134.01 27.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.632 0.253 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 94.0 t -106.59 121.18 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.023 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.2 m-85 -74.78 116.35 15.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.437 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.426 HD13 HD23 ' A' ' 104' ' ' LEU . 51.2 tp -83.28 142.77 30.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.393 . . . . 0.0 111.422 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.3 m -163.28 61.17 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.393 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.767 ' HA3' ' HB3' ' A' ' 124' ' ' ALA . . . -152.39 -39.35 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.839 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.06 -125.74 7.35 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.885 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.435 ' HA ' HD13 ' A' ' 121' ' ' LEU . 52.0 p-10 -147.47 48.3 1.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.999 0.428 . . . . 0.0 111.163 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.656 ' N ' HD13 ' A' ' 118' ' ' LEU . 6.7 mp -80.77 161.38 63.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.402 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.423 ' C ' ' H ' ' A' ' 121' ' ' LEU . 83.6 Cg_exo -43.82 94.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.459 2.106 . . . . 0.0 112.343 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.25 -9.03 0.65 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.961 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.945 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 7.6 mp 61.46 57.68 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.593 0.235 . . . . 0.0 110.883 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -75.12 49.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 110.587 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 178.99 -13.68 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.905 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.945 ' HB2' ' HB3' ' A' ' 121' ' ' LEU . . . -50.75 147.54 4.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.928 0.394 . . . . 0.0 111.335 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 143' ' ' VAL . 43.8 mmm-85 -146.25 133.57 20.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.657 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 128' ' ' PHE . 35.7 m -127.03 132.13 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 111.584 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 52.4 mm-40 -103.32 138.63 39.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.839 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.448 ' CE1' HG21 ' A' ' 126' ' ' VAL . 9.6 m-85 -105.58 145.06 31.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.043 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -148.52 122.53 9.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.355 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 59.3 m -89.22 143.89 26.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.052 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 133' ' ' ASP . 1.4 m-20 -52.8 151.94 7.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.883 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.28 75.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.13 2.553 . . . . 0.0 112.722 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' ASP . 38.9 t70 178.89 -36.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.646 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -108.8 136.67 47.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.068 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -102.84 130.13 49.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 0.0 110.532 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 140' ' ' SER . 35.8 tp -71.46 130.32 41.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.056 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.33 68.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.785 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 174.61 -129.21 1.55 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 119.512 -1.327 . . . . 0.0 113.347 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.723 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 30.1 t -68.86 63.63 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.89 0.376 . . . . 0.0 111.259 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.508 ' HA ' HD22 ' A' ' 136' ' ' LEU . 93.4 p -57.77 -23.99 54.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.526 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -140.61 136.17 32.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.79 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.587 ' HG ' ' HB3' ' A' ' 149' ' ' TRP . 46.7 t -127.92 125.48 39.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.559 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.438 ' H ' ' HB3' ' A' ' 150' ' ' SER . 46.3 t -97.72 120.24 46.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.244 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 52.7 t -77.94 122.94 26.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.506 ' HG ' ' H ' ' A' ' 146' ' ' GLN . 88.4 p -104.65 -123.72 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.703 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.506 ' H ' ' HG ' ' A' ' 145' ' ' SER . 52.3 tt0 -75.88 55.89 0.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.68 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.03 21.13 66.13 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.776 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -143.09 137.07 28.91 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.65 0.262 . . . . 0.0 111.239 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.587 ' HB3' ' HG ' ' A' ' 142' ' ' SER . 83.3 m95 -67.24 139.79 57.37 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.875 0.369 . . . . 0.0 111.51 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.438 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 46.7 t -57.49 -53.86 53.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.978 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.4 t -127.06 141.41 40.59 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.698 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.3 145.32 98.19 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.174 2.583 . . . . 0.0 112.979 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -49.91 134.76 21.24 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.381 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.723 ' HB3' ' H ' ' A' ' 139' ' ' SER . 97.0 Cg_endo -79.48 -149.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.749 2.299 . . . . 0.0 112.759 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.417 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.2 p-80 -153.72 145.71 23.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 75.2 m -96.81 127.52 42.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.544 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -111.09 129.48 55.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.064 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.22 136.29 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.826 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.886 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.496 HD11 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.675 0.274 . . . . 0.0 110.693 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 61.2 m -55.88 135.7 51.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.509 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.4 p -42.15 127.27 3.49 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -77.86 16.23 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.5 m -68.26 -42.25 79.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 110.359 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.503 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.2 m-85 -62.03 -46.28 89.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.728 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.711 HD11 HD12 ' A' ' 113' ' ' LEU . 92.4 mt -64.64 -30.63 71.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.979 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.2 p -92.46 72.63 5.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.633 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.639 HD22 ' H ' ' A' ' 109' ' ' GLY . 1.3 tt -94.54 124.27 38.46 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 38.5 tt0 -81.84 34.99 0.41 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.082 0.468 . . . . 0.0 111.38 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.536 ' N ' HD22 ' A' ' 106' ' ' LEU . 7.3 m120 -160.75 -49.17 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.4 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.639 ' H ' HD22 ' A' ' 106' ' ' LEU . . . -86.68 -151.96 20.51 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.964 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 111' ' ' VAL . 86.0 tttt -142.04 -42.33 0.34 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.811 0.339 . . . . 0.0 110.602 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 104' ' ' LEU . 10.5 p 48.55 115.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.947 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -75.17 127.48 33.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.111 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.711 HD12 HD11 ' A' ' 104' ' ' LEU . 56.3 tp -90.84 146.23 24.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.065 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 24.8 m -157.11 53.97 0.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.398 0.618 . . . . 0.0 109.912 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.96 107.68 0.2 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.702 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.53 140.67 7.72 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.862 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.4 t70 73.87 53.38 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.137 0.494 . . . . 0.0 111.073 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.3 mp -140.27 152.4 66.89 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.657 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -57.24 113.75 1.63 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.228 1.952 . . . . 0.0 110.999 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 56.55 18.27 3.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.143 0.497 . . . . 0.0 109.887 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.569 ' HG ' ' CB ' ' A' ' 124' ' ' ALA . 14.9 tp 45.54 42.94 8.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.069 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -62.78 137.39 58.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.63 37.53 61.8 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.979 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.785 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -98.73 142.76 29.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.685 0.279 . . . . 0.0 110.867 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.506 ' O ' ' HB ' ' A' ' 114' ' ' THR . 66.2 mtm-85 -131.49 138.54 49.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.94 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 126' ' ' VAL . 28.6 m -144.53 134.75 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.273 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -113.68 105.93 13.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.39 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 66.3 m-85 -68.78 146.49 52.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.102 0.477 . . . . 0.0 111.625 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' A' ' 129' ' ' ARG . 41.3 ttt85 -153.16 125.42 8.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.657 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.603 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 56.5 m -89.26 139.97 29.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.558 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.508 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 47.4 p-10 -54.26 161.09 2.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.703 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.542 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 1.8 Cg_endo -45.04 152.44 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.835 2.357 . . . . 0.0 111.899 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 35.0 t70 79.62 -29.57 0.14 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -106.45 132.43 52.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.711 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -112.28 136.02 52.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.992 0.425 . . . . 0.0 111.191 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.468 HD21 ' CB ' ' A' ' 140' ' ' SER . 29.6 tp -77.3 129.77 36.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.3 t -136.2 68.91 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.861 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 176.82 -129.99 1.57 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.267 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.733 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 31.3 t -70.06 62.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.035 0.445 . . . . 0.0 111.206 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.468 ' CB ' HD21 ' A' ' 136' ' ' LEU . 36.2 t -58.13 -23.13 53.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.81 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -127.28 139.71 52.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.654 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.449 ' HG ' ' HB3' ' A' ' 149' ' ' TRP . 47.6 t -144.48 134.82 24.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.687 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -122.54 125.56 72.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.785 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 7.5 m -64.46 148.46 50.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.331 0.586 . . . . 0.0 112.091 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.6 p -166.82 124.26 1.29 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.32 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 59.3 39.02 22.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.082 0.468 . . . . 0.0 110.079 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 62.11 24.1 64.74 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.659 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -142.42 135.93 29.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.505 0.193 . . . . 0.0 110.81 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.449 ' HB3' ' HG ' ' A' ' 142' ' ' SER . 59.5 m95 -64.33 133.03 51.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.741 0.305 . . . . 0.0 110.546 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -57.44 -59.43 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.009 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.9 p -94.11 135.48 24.54 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.778 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.16 142.91 82.37 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.726 2.284 . . . . 0.0 111.915 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.493 ' HZ2' ' HA ' ' A' ' 106' ' ' LEU . 88.0 tttt -50.72 129.29 27.41 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.302 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.733 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.8 Cg_endo -75.69 -148.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.692 2.261 . . . . 0.0 112.47 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.438 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 15.5 p-80 -153.69 143.32 21.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.172 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 88.3 m -97.63 130.85 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.031 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -124.02 143.36 50.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.184 0.516 . . . . 0.0 111.794 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.0 137.27 25.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.982 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.2 p30 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.173 -0.917 . . . . 0.0 111.002 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.845 HG23 ' HB2' ' A' ' 121' ' ' LEU . 4.4 pt . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.029 0.443 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.68 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 2.4 p -53.5 136.55 38.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.698 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 102' ' ' SER . 46.8 t -40.4 128.83 2.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.973 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -74.46 23.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.528 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 100' ' ' SER . 77.7 p -68.87 -41.16 78.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.029 0.442 . . . . 0.0 110.506 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.488 ' C ' ' H ' ' A' ' 105' ' ' THR . 1.7 m-85 -67.92 -25.29 65.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.449 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 104' ' ' LEU . 79.0 mt -68.86 23.9 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 103' ' ' TYR . 9.2 t -148.36 129.55 14.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.504 HD23 ' SG ' ' A' ' 130' ' ' CYS . 43.5 tp -145.44 127.37 15.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 107' ' ' GLU . 41.9 tp10 -82.36 46.15 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.095 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -158.89 -30.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.215 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.617 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -158.33 -150.77 5.86 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.386 -0.912 . . . . 0.0 113.349 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -130.23 152.07 50.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.816 0.341 . . . . 0.0 111.005 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.43 HG23 ' CE2' ' A' ' 128' ' ' PHE . 61.0 t -105.79 126.4 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -80.17 69.18 6.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.973 ' HA ' HG11 ' A' ' 126' ' ' VAL . 3.3 tm? -63.73 145.12 56.35 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.558 ' N ' HD12 ' A' ' 113' ' ' LEU . 56.4 m -149.06 81.74 1.43 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.022 0.439 . . . . 0.0 111.391 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 177.03 -103.01 0.17 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.216 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.627 ' H ' HD23 ' A' ' 121' ' ' LEU . . . 59.58 144.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.073 0.389 . . . . 0.0 114.073 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 57.6 m-20 71.86 49.84 0.25 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' A' ' 120' ' ' ALA . 3.4 mm? -142.23 138.68 16.88 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.883 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -74.55 33.94 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.376 2.051 . . . . 0.0 112.192 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 118' ' ' LEU . . . 172.19 -44.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.732 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.845 ' HB2' HG23 ' A' ' 98' ' ' ILE . 15.2 tp 59.7 43.9 14.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 64.4 t0 -79.97 58.49 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.822 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.37 -27.09 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.738 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.714 ' HB1' ' HB3' ' A' ' 144' ' ' CYS . . . -48.83 153.53 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.063 0.458 . . . . 0.0 111.707 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -139.5 136.67 34.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.369 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.973 HG11 ' HA ' ' A' ' 113' ' ' LEU . 29.1 m -125.66 139.26 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.07 0.462 . . . . 0.0 111.942 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -120.71 98.24 5.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.397 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.467 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 4.6 m-85 -64.65 147.45 52.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.347 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -159.95 115.52 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.409 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.617 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 91.7 m -89.17 149.16 23.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.456 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.454 ' OD1' ' HA2' ' A' ' 109' ' ' GLY . 1.3 m-20 -52.7 158.35 2.2 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.083 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.519 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 99.3 Cg_exo -43.04 159.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.906 2.404 . . . . 0.0 112.564 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 49.8 m-20 80.76 -31.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.79 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.86 143.97 33.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.414 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -133.99 131.31 38.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.973 0.416 . . . . 0.0 111.015 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' A' ' 154' ' ' PRO . 24.4 tp -78.32 133.77 37.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.668 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.99 71.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.66 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.67 -133.61 2.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.955 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.586 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 58.7 m -76.05 54.82 0.88 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.739 0.304 . . . . 0.0 110.958 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.426 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 95.7 p -50.0 -41.31 46.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -99.38 130.23 45.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.482 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 44.0 t -134.9 127.27 30.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.902 0.382 . . . . 0.0 110.74 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.5 t -93.81 128.67 45.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.357 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.714 ' HB3' ' HB1' ' A' ' 124' ' ' ALA . 48.9 t -83.03 134.43 35.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.887 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 79.3 p -175.04 132.95 0.32 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.972 0.415 . . . . 0.0 111.853 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 53.53 46.29 26.42 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.881 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.68 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . 52.76 23.35 14.52 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.961 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -142.49 130.22 21.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.66 0.267 . . . . 0.0 110.824 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.456 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 65.3 m95 -75.98 135.18 40.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 111.03 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 m -57.52 -53.98 51.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.036 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 80.8 p -107.5 129.53 24.11 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.477 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 139' ' ' SER . 38.8 Cg_exo -60.74 142.87 98.97 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.745 2.296 . . . . 0.0 111.866 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -51.76 125.87 30.74 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.305 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.586 ' HB3' ' H ' ' A' ' 139' ' ' SER . 80.8 Cg_endo -79.26 -149.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.666 2.244 . . . . 0.0 112.433 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.462 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 15.2 p-80 -153.95 141.47 19.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.741 0.305 . . . . 0.0 111.446 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 95.1 m -98.58 132.76 43.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.602 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -103.03 133.92 47.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.426 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.86 138.67 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.738 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 133' ' ' ASP . 24.6 p30 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.029 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.634 HD13 ' N ' ' A' ' 98' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.966 0.412 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.4 ' O ' ' C ' ' A' ' 100' ' ' SER . 69.4 m -57.44 146.54 29.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.518 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 99' ' ' CYS . 52.8 m -35.85 120.98 0.63 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.017 0.437 . . . . 0.0 111.491 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -72.82 3.22 5.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.883 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.6 p -66.48 -41.95 88.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.353 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.553 ' HD2' ' HZ ' ' A' ' 128' ' ' PHE . 2.1 m-85 -54.23 -42.28 69.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.307 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.25 -35.89 74.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 111.079 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -92.55 69.39 4.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.41 HD11 ' CE ' ' A' ' 153' ' ' LYS . 28.7 tp -94.61 130.99 40.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.187 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -67.57 136.06 53.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.289 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.508 ' HB3' ' OD1' ' A' ' 131' ' ' ASP . 75.4 m-20 55.83 44.11 26.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.353 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.59 164.65 34.44 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.493 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -136.99 130.91 32.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 0.0 110.489 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.541 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 48.5 t -106.5 123.09 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.3 m-85 -78.4 125.84 29.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.019 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.8 tp -85.18 150.91 24.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.252 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.8 m -156.59 56.8 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.531 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -157.0 -105.15 0.22 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.21 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.57 -127.43 1.34 Allowed Glycine 0 CA--C 1.516 0.146 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.752 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.15 41.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.298 0.57 . . . . 0.0 110.466 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.5 mt -95.02 152.01 39.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.36 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 121' ' ' LEU . 86.6 Cg_exo -42.96 123.11 3.01 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.369 2.046 . . . . 0.0 111.998 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.433 ' HB2' ' HA ' ' A' ' 146' ' ' GLN . . . 73.63 -37.44 0.37 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.401 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.481 ' HG ' ' HB1' ' A' ' 124' ' ' ALA . 22.9 tp 55.88 45.15 24.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 111.18 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 8.1 t70 -65.51 133.42 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.69 -28.54 13.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.477 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.78 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.15 143.3 3.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.742 0.306 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 125' ' ' ARG . 40.6 mmm-85 -129.6 144.9 51.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.21 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 32.8 m -142.38 134.93 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.553 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -107.97 116.84 32.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.704 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.553 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.5 m-85 -80.16 147.68 31.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.993 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -156.19 124.91 5.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.974 0.416 . . . . 0.0 110.815 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 136' ' ' LEU . 68.7 m -89.52 146.42 24.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.119 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.508 ' OD1' ' HB3' ' A' ' 108' ' ' ASN . 12.1 p-10 -55.28 154.97 10.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.735 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.538 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 2.3 Cg_endo -45.08 155.38 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.935 2.423 . . . . 0.0 111.906 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.4 m-20 78.57 -34.72 0.17 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.776 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 10.7 m-85 -106.53 126.51 52.36 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -106.89 137.19 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 111.296 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.845 HD21 ' HA ' ' A' ' 140' ' ' SER . 33.6 tp -71.24 136.84 48.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.724 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.31 67.78 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.577 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.75 -136.06 2.32 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.295 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.551 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 92.9 p -74.13 59.74 0.76 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.873 0.368 . . . . 0.0 110.75 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.845 ' HA ' HD21 ' A' ' 136' ' ' LEU . 97.0 p -47.94 -34.72 9.53 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.179 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.426 HH11 ' HG3' ' A' ' 141' ' ' ARG . 21.2 mmt85 -109.55 138.79 45.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.706 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.407 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 45.3 t -143.57 127.03 16.84 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.91 117.8 50.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.775 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 50.7 t -71.82 140.43 49.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.936 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 43.8 t -169.43 131.97 1.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.819 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.433 ' HA ' ' HB2' ' A' ' 120' ' ' ALA . 26.1 mt-30 56.35 41.8 28.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.583 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.67 25.06 50.25 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -141.68 132.51 25.83 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.489 0.185 . . . . 0.0 110.662 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.407 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 72.6 m95 -71.26 138.95 49.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.074 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.9 t -57.44 -58.46 8.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.279 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 82.8 p -101.78 136.55 19.52 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.6 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 33.3 Cg_exo -60.44 138.83 83.1 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.736 2.291 . . . . 0.0 111.954 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 103' ' ' TYR . 84.5 tttt -47.99 131.48 12.01 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.341 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.551 ' HB3' ' H ' ' A' ' 139' ' ' SER . 88.4 Cg_endo -84.37 -148.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.873 2.382 . . . . 0.0 113.029 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.425 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.6 p-80 -153.66 149.69 27.81 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.965 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 91.4 m -97.91 136.16 38.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.01 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -136.93 133.98 36.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 134' ' ' PHE . 8.7 p -65.6 142.55 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.277 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.491 ' N ' HG22 ' A' ' 158' ' ' VAL . 74.6 m-20 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.668 HG23 ' H ' ' A' ' 118' ' ' LEU . 14.7 pt . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.495 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 36.1 m 55.97 142.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.3 p -44.08 130.67 6.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.944 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.413 ' HA ' ' HG ' ' A' ' 104' ' ' LEU . 18.0 ptpt -77.45 10.75 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.513 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.2 m -68.93 -44.76 72.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 110.693 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 103' ' ' TYR . 1.2 m-85 -62.63 -33.1 74.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.253 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.486 HD22 HD21 ' A' ' 113' ' ' LEU . 65.8 mt -49.8 -45.45 49.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.1 t -92.51 138.65 31.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.109 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.47 HD22 ' HA3' ' A' ' 109' ' ' GLY . 28.6 tp -143.75 126.41 16.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.023 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.483 ' HG3' ' ND2' ' A' ' 108' ' ' ASN . 17.0 tp10 -73.45 124.59 26.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.018 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.483 ' ND2' ' HG3' ' A' ' 107' ' ' GLU . 74.4 m-20 56.3 49.15 15.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.524 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.47 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -170.74 148.42 11.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.891 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.702 ' HB2' ' HD2' ' A' ' 129' ' ' ARG . 55.1 mtpt -102.53 138.84 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.417 ' CG1' HG22 ' A' ' 126' ' ' VAL . 59.5 t -111.74 119.22 59.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.541 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.523 ' C ' HG23 ' A' ' 126' ' ' VAL . 2.6 m-85 -83.14 60.43 5.51 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.268 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.486 HD21 HD22 ' A' ' 104' ' ' LEU . 63.2 tp -59.52 145.99 42.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.15 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.638 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 27.1 m -158.86 53.31 0.41 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.587 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.667 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . 177.14 105.08 0.19 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.147 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.547 ' N ' HD22 ' A' ' 121' ' ' LEU . . . -163.12 138.16 5.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.784 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.466 ' O ' HD12 ' A' ' 118' ' ' LEU . 8.2 t70 73.2 42.21 0.45 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.98 0.419 . . . . 0.0 111.055 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.78 ' HB2' HD23 ' A' ' 121' ' ' LEU . 9.5 mp -137.38 150.1 67.63 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -44.87 89.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.987 2.458 . . . . 0.0 112.818 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 56.0 13.58 1.18 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.734 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.781 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 58.7 mt 50.09 60.32 3.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.538 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.799 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 9.1 t70 -76.11 45.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.229 0.538 . . . . 0.0 110.412 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.59 25.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.127 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.781 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -84.13 153.19 23.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.719 0.295 . . . . 0.0 111.002 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.638 ' O ' ' HB ' ' A' ' 114' ' ' THR . 4.4 tmm_? -151.48 140.67 21.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.441 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.523 HG23 ' C ' ' A' ' 112' ' ' PHE . 1.6 p -151.35 148.28 14.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.493 0.663 . . . . 0.0 112.107 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -113.3 118.11 33.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.689 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.499 ' HE1' HG12 ' A' ' 126' ' ' VAL . 6.3 m-85 -89.0 145.58 25.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.097 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.702 ' HD2' ' HB2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -159.57 138.94 11.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.437 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.445 ' SG ' HD22 ' A' ' 136' ' ' LEU . 66.0 m -89.24 144.21 26.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.681 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.538 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 9.0 p-10 -54.02 160.68 2.15 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 131' ' ' ASP . 2.8 Cg_endo -44.98 149.72 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.86 2.374 . . . . 0.0 111.692 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 36.1 t70 80.64 -31.37 0.12 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.578 -178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -108.86 132.44 54.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.191 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -108.94 148.09 31.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.169 0.509 . . . . 0.0 111.925 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.5 ' CD1' ' HB2' ' A' ' 140' ' ' SER . 1.1 tm? -79.2 128.73 33.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.701 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.63 60.31 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.66 0.266 . . . . 0.0 111.602 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.65 -133.85 1.87 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.206 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.576 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 63.9 m -73.4 59.64 0.6 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.392 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.5 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 38.9 t -62.49 -2.48 1.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.432 ' H ' ' C ' ' A' ' 139' ' ' SER . 79.2 ttt180 -140.65 133.96 29.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.517 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 61.2 m -147.41 134.02 19.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.52 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.488 HG11 ' O ' ' A' ' 124' ' ' ALA . 94.3 t -128.73 122.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 111.316 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.679 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 55.4 m -85.16 140.87 30.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.497 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.799 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 79.7 p -169.65 31.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.063 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 177.47 34.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.061 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 59.6 14.97 31.02 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.465 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -142.63 133.73 25.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.536 0.208 . . . . 0.0 110.686 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.495 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 74.2 m95 -66.89 137.61 56.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.699 0.285 . . . . 0.0 110.761 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.0 m -57.39 -56.22 24.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.552 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 66.9 p -106.23 136.69 19.31 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.764 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 53.2 Cg_exo -55.89 151.58 40.31 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.865 2.377 . . . . 0.0 112.187 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.451 ' HE3' HD12 ' A' ' 106' ' ' LEU . 4.8 tmtm? -51.21 121.74 16.96 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.575 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.576 ' HB3' ' N ' ' A' ' 139' ' ' SER . 47.7 Cg_endo -69.71 -160.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.676 2.25 . . . . 0.0 112.975 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.74 148.98 27.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.72 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 97.1 m -97.88 139.6 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 0.0 111.408 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -130.98 129.77 42.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.1 p -63.7 143.31 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.189 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.429 ' N ' HD21 ' A' ' 159' ' ' ASN . 2.6 m120 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.973 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 120.731 0.3 . . . . 0.0 110.497 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 149' ' ' TRP . 80.4 m 64.27 133.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.243 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.514 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 37.3 t -41.56 127.69 3.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.905 0.383 . . . . 0.0 111.245 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -75.5 -37.42 60.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.503 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 105' ' ' THR . 47.9 t -53.21 -43.38 67.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.664 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.782 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.4 m-85 -59.38 -34.89 72.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.514 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 104' ' ' LEU . 89.3 mt -55.22 -43.87 74.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.988 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 102' ' ' SER . 6.9 t -92.55 145.98 24.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.975 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 tp -144.36 130.1 19.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.342 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.15 132.95 42.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.392 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.406 ' N ' HD21 ' A' ' 108' ' ' ASN . 2.6 m120 57.49 41.01 26.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.614 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.97 152.0 10.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.057 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -104.78 154.02 20.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.58 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.465 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 99.1 t -131.17 118.52 41.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.298 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.591 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.2 m-85 -73.08 80.08 1.23 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.513 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.703 ' HA ' HG13 ' A' ' 126' ' ' VAL . 7.7 tt -51.88 140.25 20.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.155 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.629 ' N ' HD22 ' A' ' 113' ' ' LEU . 20.6 m -153.33 53.73 0.74 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.267 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.744 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . 128.0 110.24 1.55 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.869 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -171.31 50.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.024 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.611 ' HA ' ' HB ' ' A' ' 98' ' ' ILE . 12.3 p-10 -171.29 39.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 110.821 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 121' ' ' LEU . 3.2 mm? -145.36 153.68 52.39 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.248 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 121' ' ' LEU . 5.0 Cg_endo -48.41 81.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.959 2.439 . . . . 0.0 111.873 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 75.2 -40.81 0.44 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.035 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.635 HD23 ' HB1' ' A' ' 124' ' ' ALA . 19.2 tp 53.07 58.98 4.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.06 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.35 84.5 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.588 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 121' ' ' LEU . . . 163.9 -35.8 0.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.912 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.744 ' HB1' ' HA3' ' A' ' 115' ' ' GLY . . . -49.81 150.67 2.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.725 0.298 . . . . 0.0 111.171 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.549 ' O ' ' HB ' ' A' ' 114' ' ' THR . 58.6 ttp180 -157.67 118.02 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.232 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.703 HG13 ' HA ' ' A' ' 113' ' ' LEU . 30.4 m -97.89 133.65 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.2 mt-10 -92.56 115.99 28.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -76.33 150.88 36.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.996 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.465 ' HG2' HH11 ' A' ' 129' ' ' ARG . 11.3 tpt180 -158.65 131.78 7.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 83.6 m -90.28 155.71 18.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.155 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -52.6 158.03 2.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.223 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.55 62.97 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.178 2.585 . . . . 0.0 112.737 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -177.12 -29.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.781 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 4.1 m-85 -108.66 139.91 42.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.335 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . 0.412 ' H ' ' ND1' ' A' ' 135' ' ' HIS . 16.5 p-80 -102.85 133.37 48.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.179 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.68 HD22 ' HA ' ' A' ' 140' ' ' SER . 37.1 tp -76.17 131.16 39.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.871 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.3 t -135.92 68.04 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.789 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.54 -131.94 1.76 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.151 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.539 ' HG ' ' HD3' ' A' ' 154' ' ' PRO . 62.5 p -71.39 63.29 0.38 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 110.661 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.68 ' HA ' HD22 ' A' ' 136' ' ' LEU . 93.0 p -55.67 -20.28 13.61 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.911 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -140.59 136.58 32.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 111.141 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 60.5 m -129.58 136.22 49.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.708 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.487 HG11 ' O ' ' A' ' 124' ' ' ALA . 82.2 t -117.85 132.82 66.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.274 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 75.4 m -60.19 142.74 53.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.299 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.7 t -173.02 120.01 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 58.15 42.68 21.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.902 0.382 . . . . 0.0 110.782 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 64.48 11.57 48.38 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.667 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -142.84 135.66 27.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.271 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 54.4 m95 -67.22 142.23 57.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.669 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.4 m -55.08 -57.48 11.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.8 p -98.91 133.78 22.02 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.807 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.08 -160.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.315 2.01 . . . . 0.0 112.255 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.782 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 4.5 mmmp? -84.95 130.23 53.25 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.831 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.675 ' HD2' ' HZ1' ' A' ' 153' ' ' LYS . 90.1 Cg_endo -81.1 -151.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.636 2.224 . . . . 0.0 112.545 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -153.73 139.94 18.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 78.6 m -98.71 127.72 44.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.541 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -105.17 141.03 37.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.337 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.407 HG21 ' N ' ' A' ' 159' ' ' ASN . 7.5 p -60.31 140.22 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.078 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.407 ' N ' HG21 ' A' ' 158' ' ' VAL . 24.3 p30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.971 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.497 ' O ' HD12 ' A' ' 98' ' ' ILE . 1.5 pp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.499 0.666 . . . . 0.0 112.003 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.637 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 3.6 m -83.36 146.09 28.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.144 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.4 m -40.21 121.21 1.32 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 111.029 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -70.73 -24.06 62.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.154 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.5 t -53.05 -42.15 65.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.722 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.93 -42.96 99.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.545 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.421 ' O ' HG21 ' A' ' 111' ' ' VAL . 94.2 mt -57.07 -38.24 73.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.414 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 t -92.5 135.69 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 111.312 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.66 HD11 ' HZ3' ' A' ' 153' ' ' LYS . 21.3 tp -145.41 129.76 17.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.715 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -81.4 38.52 0.49 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.49 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.9 p30 177.21 26.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.388 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.582 ' O ' ' HB3' ' A' ' 106' ' ' LEU . . . 168.84 155.89 10.08 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.535 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.712 ' HZ1' ' HB2' ' A' ' 110' ' ' LYS . 9.8 mtmp? -101.32 146.01 28.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.116 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 104' ' ' LEU . 64.5 t -105.4 120.77 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 111.38 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.419 ' CE1' ' HD2' ' A' ' 129' ' ' ARG . 1.6 m-85 -84.59 68.26 10.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.841 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.863 ' HA ' HG13 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -62.56 147.52 48.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.02 0.438 . . . . 0.0 111.295 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.9 m -133.2 70.84 1.46 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.1 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.464 ' HA3' HD22 ' A' ' 121' ' ' LEU . . . -165.18 -98.25 0.12 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.94 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.06 127.6 0.01 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.391 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 62.1 t0 60.31 49.48 7.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.973 0.416 . . . . 0.0 111.369 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.642 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 68.8 mt -131.83 143.3 48.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.732 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.5 85.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.667 2.245 . . . . 0.0 111.581 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 61.79 17.11 8.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.202 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.642 ' HG ' ' HB2' ' A' ' 118' ' ' LEU . 7.4 mp 40.72 53.84 3.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.844 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.43 45.59 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.228 0.537 . . . . 0.0 110.234 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 121' ' ' LEU . . . -176.2 -25.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.779 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -57.51 147.4 26.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.875 0.369 . . . . 0.0 111.211 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.468 ' HG2' HH11 ' A' ' 125' ' ' ARG . 50.5 ttp85 -133.36 137.81 46.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.629 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.863 HG13 ' HA ' ' A' ' 113' ' ' LEU . 32.8 m -120.12 135.76 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.017 0.437 . . . . 0.0 111.643 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -112.89 113.58 25.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.095 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -76.01 141.86 42.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 111.654 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.419 ' HD2' ' CE1' ' A' ' 112' ' ' PHE . 71.1 mtt-85 -148.91 108.88 4.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.117 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 95.6 m -89.54 160.75 16.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.957 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -52.69 156.6 3.12 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.448 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.5 56.07 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.06 2.507 . . . . 0.0 112.588 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -153.07 -37.45 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.648 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -108.8 134.18 51.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.636 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -101.22 132.92 46.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.171 0.51 . . . . 0.0 111.176 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 140' ' ' SER . 23.0 tp -76.39 129.99 37.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.693 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.5 t -136.3 61.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.697 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.14 -138.01 2.41 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.503 -1.332 . . . . 0.0 113.406 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.641 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.4 m -74.6 57.8 0.75 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 110.975 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.677 ' HA ' HD23 ' A' ' 136' ' ' LEU . 38.0 t -49.94 -38.36 36.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.001 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.04 136.18 44.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 53.4 m -146.42 125.99 13.31 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.811 0.339 . . . . 0.0 111.304 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 76.5 t -104.95 125.39 59.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.669 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 48.1 t -71.42 151.86 43.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.099 0.476 . . . . 0.0 111.587 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -168.72 122.97 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.892 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.6 tt0 54.48 43.23 30.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.263 0.554 . . . . 0.0 109.634 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 58.01 29.2 61.95 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.858 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -139.69 131.34 27.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.641 0.258 . . . . 0.0 110.408 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.455 ' HZ3' HG12 ' A' ' 126' ' ' VAL . 73.0 m95 -75.45 139.34 42.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 111.625 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.1 t -57.42 -58.48 8.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.199 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.589 ' HB ' ' HG ' ' A' ' 139' ' ' SER . 77.3 p -106.93 134.64 19.77 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.514 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 139' ' ' SER . 35.5 Cg_exo -57.8 142.41 96.16 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.668 2.246 . . . . 0.0 112.041 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.66 ' HZ3' HD11 ' A' ' 106' ' ' LEU . 87.2 tttt -51.62 125.86 29.43 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.131 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.641 ' HB3' ' N ' ' A' ' 139' ' ' SER . 61.1 Cg_endo -73.21 -152.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.595 2.197 . . . . 0.0 112.427 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.437 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.7 p-80 -153.68 133.67 13.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.905 0.383 . . . . 0.0 111.295 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 16.6 m -98.83 132.46 44.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.912 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -124.38 139.66 53.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.051 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.97 134.52 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.3 p30 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.984 -179.858 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 118' ' ' LEU . 15.3 pt . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 121.675 0.75 . . . . 0.0 112.856 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.56 ' HB2' ' NE1' ' A' ' 149' ' ' TRP . 2.4 p -62.01 136.84 58.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.563 178.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -40.02 127.54 2.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.253 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -77.43 14.94 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.434 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -68.9 -39.01 79.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.027 0.442 . . . . 0.0 110.432 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.774 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.6 m-85 -56.3 -34.08 66.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.523 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.592 HD11 HD22 ' A' ' 113' ' ' LEU . 86.3 mt -74.71 38.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.685 -179.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 103' ' ' TYR . 74.2 m -147.46 114.48 6.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 111.0 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.5 mt -145.5 128.21 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -82.58 43.13 0.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -177.02 -43.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.017 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 130' ' ' CYS . . . -79.11 -162.37 23.19 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.732 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 111' ' ' VAL . 22.7 tptm -142.12 -43.81 0.34 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.723 0.297 . . . . 0.0 110.805 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 11.9 p 49.1 120.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.015 179.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.3 m-85 -84.38 117.92 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.579 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.592 HD22 HD11 ' A' ' 104' ' ' LEU . 55.1 tp -83.52 145.51 28.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 111.447 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.0 m -158.51 53.06 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.803 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.988 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 165.33 105.48 0.19 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.825 -179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.64 140.02 6.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.634 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.455 ' O ' HD21 ' A' ' 118' ' ' LEU . 57.2 m-20 62.52 43.98 7.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.86 0.362 . . . . 0.0 111.216 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.553 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 84.5 mt -134.82 144.68 51.54 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 121' ' ' LEU . 82.3 Cg_exo -46.18 96.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.965 2.443 . . . . 0.0 113.796 -179.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 121' ' ' LEU . . . 68.62 -29.83 0.17 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.589 ' HB3' ' HB1' ' A' ' 124' ' ' ALA . 32.0 mt 65.11 51.27 1.7 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.829 0.347 . . . . 0.0 111.019 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -77.17 51.42 0.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.548 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.64 -21.03 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.205 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.988 ' HB2' ' HA3' ' A' ' 115' ' ' GLY . . . -47.94 148.45 1.67 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.735 0.302 . . . . 0.0 111.418 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.525 ' O ' ' HB ' ' A' ' 114' ' ' THR . 70.1 mtt-85 -141.73 141.07 33.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.525 HG12 ' HZ3' ' A' ' 149' ' ' TRP . 34.5 m -133.59 137.02 53.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 111.14 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -116.17 99.25 7.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 46.3 m-85 -68.06 139.39 56.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.42 . . . . 0.0 111.106 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -142.71 133.17 24.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.243 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 136' ' ' LEU . 60.7 m -89.19 148.7 23.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 133' ' ' ASP . 45.7 p-10 -52.67 153.93 5.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.31 72.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.235 2.623 . . . . 0.0 113.204 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 131' ' ' ASP . 38.9 t70 178.66 -39.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.048 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -107.0 139.18 41.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.904 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -102.83 134.26 46.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 111.151 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' A' ' 154' ' ' PRO . 19.8 tp -76.54 131.92 39.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.923 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.58 66.23 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.861 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -171.98 -136.91 2.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.149 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.617 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 45.4 p -76.55 53.98 0.91 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.989 0.423 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.476 ' HA ' HD23 ' A' ' 136' ' ' LEU . 47.6 t -49.07 -43.91 41.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.246 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -99.48 133.24 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.657 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.406 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.5 t -141.23 125.08 17.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.684 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 90.5 t -100.19 123.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.385 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 47.2 t -76.7 136.12 39.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.621 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.2 t -172.68 134.01 0.61 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.774 0.321 . . . . 0.0 111.183 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.427 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 0.5 OUTLIER 57.4 41.44 26.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.85 18.55 25.89 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.998 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -141.09 131.09 24.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 110.619 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.56 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 33.6 m95 -73.03 138.29 45.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.173 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 54.0 m -57.45 -52.99 63.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.004 179.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 78.8 p -114.4 136.95 22.38 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.481 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 30.0 Cg_exo -62.03 -159.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.512 2.141 . . . . 0.0 112.428 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.774 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 60.8 mtpt -96.66 125.77 45.68 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.965 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.671 ' HB2' HD11 ' A' ' 136' ' ' LEU . 68.1 Cg_endo -74.36 -148.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.282 1.988 . . . . 0.0 111.939 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.439 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 20.6 p-80 -153.74 143.11 21.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.902 0.382 . . . . 0.0 111.283 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 79.3 m -96.72 132.99 41.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.168 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -131.31 140.26 49.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.398 . . . . 0.0 111.481 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.7 p -64.34 137.72 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.01 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.881 179.975 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.236 0.541 . . . . 0.0 111.463 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.652 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 3.2 m -63.58 173.4 1.68 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.55 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.411 ' HB2' ' CD1' ' A' ' 149' ' ' TRP . 52.0 m -42.4 129.22 3.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 111.195 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.612 ' HD2' HD11 ' A' ' 104' ' ' LEU . 24.0 tptm -76.89 -31.43 56.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.432 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.8 p -53.08 -43.86 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.945 -179.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.822 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.3 m-85 -56.9 -41.45 78.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.694 0.283 . . . . 0.0 111.065 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.612 HD11 ' HD2' ' A' ' 101' ' ' LYS . 90.9 mt -58.65 139.95 55.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.3 m 65.35 137.72 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.168 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.492 HD21 ' SG ' ' A' ' 130' ' ' CYS . 46.2 tp -145.43 133.68 21.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.417 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.76 140.51 56.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.22 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 65.19 30.82 11.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.394 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 175.7 -168.26 40.52 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.042 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.688 ' HD3' ' N ' ' A' ' 111' ' ' VAL . 1.5 tmtp? -141.95 143.29 33.17 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.688 ' N ' ' HD3' ' A' ' 110' ' ' LYS . 71.2 t -106.39 120.73 57.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.929 0.395 . . . . 0.0 111.458 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.55 ' HE1' ' HB3' ' A' ' 129' ' ' ARG . 3.3 m-85 -70.22 125.99 28.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.045 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.618 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -105.78 141.64 36.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.939 0.4 . . . . 0.0 110.94 -179.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.618 ' N ' HD13 ' A' ' 113' ' ' LEU . 35.6 m -158.89 65.61 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.619 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.784 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -156.83 -43.53 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.649 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.76 -132.46 19.91 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.886 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -115.7 34.78 4.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.987 0.422 . . . . 0.0 111.225 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 120' ' ' ALA . 96.5 mt -64.19 162.91 27.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.911 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 81.9 Cg_exo -43.57 80.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.772 2.315 . . . . 0.0 112.01 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 59.19 22.96 11.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.405 -178.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.879 ' HB3' ' HB1' ' A' ' 124' ' ' ALA . 6.8 mp 44.41 62.7 1.92 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.228 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.686 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 38.7 t70 -74.97 42.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.096 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 121' ' ' LEU . . . 161.89 28.72 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.394 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.879 ' HB1' ' HB3' ' A' ' 121' ' ' LEU . . . -77.58 122.17 24.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.706 0.288 . . . . 0.0 111.1 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -90.88 134.79 34.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.655 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.509 HG12 ' CH2' ' A' ' 149' ' ' TRP . 30.1 m -145.78 140.59 21.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.669 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -121.25 120.43 35.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.415 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.436 ' O ' HD21 ' A' ' 136' ' ' LEU . 2.0 m-85 -84.38 47.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 110.992 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.55 ' HB3' ' HE1' ' A' ' 112' ' ' PHE . 21.2 tpp180 -64.33 126.77 28.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.509 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.514 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 65.3 m -98.47 158.95 15.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.324 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 133' ' ' ASP . 55.6 m-20 -52.69 148.28 13.43 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.831 -179.516 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.18 79.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.204 2.602 . . . . 0.0 112.717 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 131' ' ' ASP . 9.1 t0 -179.14 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.599 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -108.78 130.85 55.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.199 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -102.75 130.64 49.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.904 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 140' ' ' SER . 22.8 tp -75.48 133.82 40.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.412 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.86 70.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.688 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.46 -132.65 1.96 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.819 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.568 ' HG ' ' HB ' ' A' ' 151' ' ' THR . 70.8 m -76.12 55.13 0.92 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.708 0.29 . . . . 0.0 111.028 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.545 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 90.0 p -49.25 -43.11 42.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.671 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -100.46 133.93 44.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.229 178.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 126' ' ' VAL . 47.4 t -144.02 136.22 26.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.389 . . . . 0.0 110.953 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 57.5 t -122.46 117.05 50.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.343 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 149' ' ' TRP . 46.1 t -65.8 155.31 36.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.109 0.481 . . . . 0.0 111.502 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.686 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 46.5 t -166.44 122.01 1.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.838 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 57.68 44.13 21.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.081 0.467 . . . . 0.0 110.62 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.563 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 64.72 20.65 66.45 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.636 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -141.4 127.03 18.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.64 0.257 . . . . 0.0 110.749 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.676 ' HA ' ' HA ' ' A' ' 144' ' ' CYS . 58.0 m95 -71.94 139.36 48.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.934 0.397 . . . . 0.0 111.372 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.4 t -57.53 -62.46 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.378 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.568 ' HB ' ' HG ' ' A' ' 139' ' ' SER . 71.1 p -95.38 137.08 22.12 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.755 -179.392 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.461 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 45.1 Cg_endo -67.69 140.38 51.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.882 2.388 . . . . 0.0 112.418 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.822 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 64.4 tttm -53.87 121.2 27.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.264 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.503 ' HB3' ' H ' ' A' ' 139' ' ' SER . 86.5 Cg_endo -81.32 -147.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.832 2.355 . . . . 0.0 112.932 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.487 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 19.5 p-80 -153.61 144.72 22.89 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 64.8 m -98.47 142.64 29.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -133.7 139.24 46.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.829 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.59 138.41 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.507 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.889 179.935 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.766 HD13 ' HA ' ' A' ' 117' ' ' ASP . 4.9 pt . . . . . 0 CA--C 1.519 -0.239 0 CA-C-O 120.861 0.362 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.587 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 74.6 m 62.31 134.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.971 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.3 m -40.32 119.97 1.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.716 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -74.83 -9.72 58.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.869 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.6 t -58.75 -19.93 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.837 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.54 ' HA ' ' HZ3' ' A' ' 153' ' ' LYS . 4.7 m-85 -64.62 -46.28 83.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.166 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.606 HD13 ' C ' ' A' ' 104' ' ' LEU . 1.7 pp -76.98 33.3 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.893 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.436 ' H ' ' C ' ' A' ' 103' ' ' TYR . 61.6 p -147.54 58.54 1.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.36 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.407 ' HA ' HD11 ' A' ' 106' ' ' LEU . 44.4 tp -94.49 135.75 35.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.5 -178.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.527 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 87.9 tt0 -66.59 138.48 57.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.352 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.527 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 75.1 m-20 56.56 40.13 29.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.304 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.28 168.46 41.53 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.214 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 28.9 mtpp -141.68 139.52 32.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.733 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.591 ' HB ' ' HA ' ' A' ' 104' ' ' LEU . 35.7 t -118.76 126.13 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -80.25 121.4 25.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.141 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.783 ' HA ' HG12 ' A' ' 126' ' ' VAL . 3.1 tm? -85.04 143.5 28.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.917 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.582 ' N ' HD12 ' A' ' 113' ' ' LEU . 43.4 m -152.96 65.96 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.574 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.521 ' H ' HD12 ' A' ' 113' ' ' LEU . . . -158.1 -107.4 0.24 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.886 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.15 -124.29 1.3 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.848 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.766 ' HA ' HD13 ' A' ' 98' ' ' ILE . 37.6 t70 -148.68 47.84 1.02 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.237 0.541 . . . . 0.0 110.644 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.535 ' HB2' HD12 ' A' ' 121' ' ' LEU . 2.9 mm? -94.19 150.89 39.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.505 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.451 ' C ' ' H ' ' A' ' 121' ' ' LEU . 88.9 Cg_exo -43.47 105.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.37 2.047 . . . . 0.0 111.985 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 72.45 -37.95 0.4 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.357 -179.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.76 HD23 ' HB1' ' A' ' 124' ' ' ALA . 14.1 tp 58.06 56.24 4.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 0.0 111.16 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -70.14 69.29 0.34 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 179.59 -30.48 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.237 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.76 ' HB1' HD23 ' A' ' 121' ' ' LEU . . . -49.05 153.04 0.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.972 0.415 . . . . 0.0 111.398 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.503 ' HD2' ' NH2' ' A' ' 141' ' ' ARG . 53.9 ttp180 -153.56 135.86 14.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.714 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 113' ' ' LEU . 34.4 m -127.52 137.16 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.108 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -100.94 121.15 41.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.37 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.474 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.3 m-85 -86.03 150.77 24.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 15.8 ptm180 -163.96 134.86 4.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.759 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 68.0 m -89.2 155.11 19.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.496 -179.304 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -52.71 163.27 0.82 Allowed Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.383 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.73 52.07 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.205 2.603 . . . . 0.0 112.708 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -155.59 -39.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.5 m-85 -108.9 141.02 41.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.651 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -102.1 134.11 45.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.123 0.487 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 138' ' ' GLY . 3.4 tm? -72.97 130.86 41.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.622 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.418 ' N ' HD13 ' A' ' 136' ' ' LEU . 26.6 t -134.57 66.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.573 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . 0.474 ' H ' HD13 ' A' ' 136' ' ' LEU . . . 177.03 -129.68 1.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 119.71 -1.233 . . . . 0.0 113.212 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.679 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 31.3 t -68.75 65.41 0.12 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.979 0.419 . . . . 0.0 111.384 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 94.5 p -63.12 -18.35 63.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.874 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.503 ' NH2' ' HD2' ' A' ' 125' ' ' ARG . 50.2 mtp85 -140.66 137.31 33.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.768 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.474 ' HG ' HG23 ' A' ' 126' ' ' VAL . 90.0 p -135.21 128.17 31.46 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.758 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.91 126.63 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.96 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.36 139.21 45.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.016 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -170.57 131.41 0.9 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.552 179.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 58.76 38.58 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.57 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 60.9 19.14 55.69 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.998 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -144.7 133.11 21.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.619 0.247 . . . . 0.0 111.239 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.587 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 94.1 m95 -70.34 135.58 48.97 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.83 0.348 . . . . 0.0 110.995 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.0 t -57.42 -56.26 24.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.372 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.484 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 55.4 p -97.08 133.14 24.49 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 8.2 Cg_exo -71.97 149.11 52.55 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.22 2.613 . . . . 0.0 111.941 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.54 ' HZ3' ' HA ' ' A' ' 103' ' ' TYR . 29.2 mtpp -47.42 125.57 9.64 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-O 120.64 0.257 . . . . 0.0 111.216 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.679 ' HB3' ' H ' ' A' ' 139' ' ' SER . 58.0 Cg_endo -71.49 -146.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.63 2.22 . . . . 0.0 112.401 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.482 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.7 145.41 23.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.451 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 70.8 m -96.66 133.64 40.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.82 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -124.76 136.29 53.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 p -64.67 137.15 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.035 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.958 179.937 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.411 ' CG2' ' HA ' ' A' ' 117' ' ' ASP . 1.5 pp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.803 0.335 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.1 m 61.18 160.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.197 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.9 t -39.82 128.67 2.08 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.662 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.59 ' HA ' HD22 ' A' ' 104' ' ' LEU . 17.5 tppt? -76.6 -27.94 55.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.362 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.2 m -53.14 -38.33 62.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.317 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 111' ' ' VAL . 2.8 m-85 -60.85 -39.23 88.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.278 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.59 HD22 ' HA ' ' A' ' 101' ' ' LYS . 2.1 mm? -53.37 -42.45 66.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.222 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.435 HG23 ' N ' ' A' ' 106' ' ' LEU . 68.7 m -92.54 141.26 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.533 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 107' ' ' GLU . 5.3 tt -142.57 127.05 17.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.611 -179.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.573 ' N ' HD23 ' A' ' 106' ' ' LEU . 17.3 tp10 -67.14 128.08 35.01 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 60.36 36.51 20.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.753 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -177.02 -177.96 46.37 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.06 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -142.8 144.84 32.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.624 0.25 . . . . 0.0 110.779 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 103' ' ' TYR . 65.3 t -105.21 124.98 60.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.862 0.363 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.2 m-85 -75.53 127.52 33.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.056 -179.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.59 ' C ' HD12 ' A' ' 113' ' ' LEU . 3.4 tm? -90.97 143.3 26.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.541 ' N ' HD12 ' A' ' 113' ' ' LEU . 33.7 m -156.19 62.17 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.235 0.54 . . . . 0.0 110.573 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -159.62 -102.26 0.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.017 -179.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.528 ' H ' HD23 ' A' ' 121' ' ' LEU . . . 174.59 -128.4 1.44 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.008 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.411 ' HA ' ' CG2' ' A' ' 98' ' ' ILE . 52.7 p-10 -159.27 48.19 0.31 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.931 0.396 . . . . 0.0 111.004 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.516 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 6.1 mp -98.99 163.57 18.49 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.221 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.516 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 81.2 Cg_exo -39.63 106.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.433 2.088 . . . . 0.0 112.193 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . 0.44 ' HB2' ' O ' ' A' ' 119' ' ' PRO . . . 72.54 -32.29 0.24 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.716 -179.453 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.528 HD23 ' H ' ' A' ' 116' ' ' GLY . 27.5 tp 56.12 47.59 19.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.114 0.483 . . . . 0.0 110.228 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.81 136.18 46.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.968 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.74 31.96 51.94 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.168 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.72 ' H ' ' HB2' ' A' ' 144' ' ' CYS . . . -80.33 119.87 23.63 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.507 ' HB2' ' HB ' ' A' ' 114' ' ' THR . 67.0 mtt-85 -84.58 134.59 34.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.496 HG21 ' HE1' ' A' ' 128' ' ' PHE . 28.0 m -149.7 134.14 9.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.422 179.036 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -114.45 112.96 23.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.964 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.496 ' HE1' HG21 ' A' ' 126' ' ' VAL . 1.9 m-85 -80.29 136.5 36.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.635 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -165.04 131.79 2.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.343 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' CYS . . . . . 0.487 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 40.9 m -89.3 157.17 18.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.33 0.586 . . . . 0.0 112.497 -179.069 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 58.2 m-20 -52.67 159.24 1.79 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.997 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 21.1 Cg_endo -59.9 75.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.17 2.58 . . . . 0.0 112.43 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 131' ' ' ASP . 64.5 t0 -174.63 -40.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.048 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -116.08 132.33 56.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.182 178.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -102.74 127.45 49.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.138 0.494 . . . . 0.0 111.288 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.773 HD12 ' HB3' ' A' ' 140' ' ' SER . 3.4 tm? -69.98 132.88 46.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.262 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 36.6 t -134.82 76.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.816 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.44 -133.96 2.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.247 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.714 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 40.9 t -74.61 56.42 0.69 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' SER . . . . . 0.773 ' HB3' HD12 ' A' ' 136' ' ' LEU . 95.7 p -53.86 -30.33 45.14 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.825 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.563 ' HD2' ' OG ' ' A' ' 140' ' ' SER . 7.9 mpt_? -99.41 137.06 38.45 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.496 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 126' ' ' VAL . 51.5 m -150.63 137.73 19.31 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.256 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 13.8 p -134.05 131.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 111.036 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.72 ' HB2' ' H ' ' A' ' 124' ' ' ALA . 4.1 m -58.14 154.93 12.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.332 0.587 . . . . 0.0 112.226 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.4 p -173.28 113.64 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.759 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 146' ' ' GLN . 8.0 tt0 60.92 48.46 6.68 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.096 0.474 . . . . 0.0 110.544 -179.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 58.22 18.08 33.76 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.355 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -141.63 138.22 32.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 110.639 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' TRP . . . . . 0.407 ' CZ3' HG23 ' A' ' 126' ' ' VAL . 60.9 m95 -68.1 135.29 51.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.219 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -57.48 -60.18 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.176 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.488 ' HB ' ' OG ' ' A' ' 139' ' ' SER . 33.3 p -99.79 132.69 22.55 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.799 0.333 . . . . 0.0 111.889 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.414 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 37.2 Cg_exo -60.6 150.75 80.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.977 2.452 . . . . 0.0 112.442 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 128' ' ' PHE . 57.5 tttp -55.91 129.81 72.41 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.714 ' HB3' ' N ' ' A' ' 139' ' ' SER . 59.4 Cg_endo -72.37 -152.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.729 2.286 . . . . 0.0 112.996 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' HIS . . . . . 0.416 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.4 p-80 -153.72 139.61 18.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 86.4 m -98.72 143.31 29.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.494 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -128.2 136.44 51.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.576 179.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.67 135.65 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.305 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.917 179.814 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.486 ' OE1' ' N ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.555 0.217 . . . . 0.0 111.078 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.44 ' N ' ' HG2' ' A' ' 92' ' ' GLU . . . 55.75 -139.78 0.94 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.131 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -173.8 133.72 0.46 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.775 0.321 . . . . 0.0 110.75 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.0 t80 57.72 -129.03 1.59 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.369 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.4 t -71.13 128.87 34.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.83 0.348 . . . . 0.0 111.13 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.927 ' HD3' ' HA ' ' A' ' 119' ' ' PRO . 2.1 ptp85 -80.7 47.6 0.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.306 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.585 HG22 ' N ' ' A' ' 99' ' ' CYS . 40.6 mm -145.34 141.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.209 0.528 . . . . 0.0 111.659 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.585 ' N ' HG22 ' A' ' 98' ' ' ILE . 1.3 p -57.3 149.32 20.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.138 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.9 t -38.25 113.53 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.768 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.61 ' HZ3' ' HB2' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -67.23 -14.26 62.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.767 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.448 ' O ' HG21 ' A' ' 105' ' ' THR . 45.1 t -53.5 -38.91 64.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.209 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.503 ' O ' HG22 ' A' ' 111' ' ' VAL . 2.5 m-85 -53.34 -37.89 62.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.178 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.4 mt -50.92 -45.45 60.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.332 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.448 HG21 ' O ' ' A' ' 102' ' ' SER . 7.0 t -92.52 131.28 37.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 111.202 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.511 HD13 ' HE2' ' A' ' 153' ' ' LYS . 38.0 tp -145.34 132.28 20.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.443 ' HG3' ' ND2' ' A' ' 108' ' ' ASN . 5.6 tp10 -63.02 127.02 29.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.18 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.443 ' ND2' ' HG3' ' A' ' 107' ' ' GLU . 75.3 m-80 55.14 45.73 25.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.885 0.374 . . . . 0.0 110.415 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.0 157.44 26.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -130.62 139.7 50.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.746 0.308 . . . . 0.0 110.831 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 103' ' ' TYR . 96.1 t -106.51 132.95 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.576 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.436 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 3.7 m-85 -94.78 73.44 3.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.764 ' HA ' HG13 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -60.95 157.03 16.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 111.228 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 40.9 m -158.53 69.47 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.778 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.464 ' O ' HD12 ' A' ' 118' ' ' LEU . . . -162.98 -44.92 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.642 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.44 -121.84 6.51 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.297 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.456 ' HA ' ' CD1' ' A' ' 98' ' ' ILE . 2.1 p30 -144.76 52.0 1.24 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.051 0.453 . . . . 0.0 111.474 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.55 ' N ' HD13 ' A' ' 118' ' ' LEU . 7.0 mp -88.08 158.13 50.21 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.909 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.927 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 85.1 Cg_exo -44.05 111.02 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.621 2.214 . . . . 0.0 112.601 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.709 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 70.77 -33.55 0.27 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.828 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.599 ' HG ' ' HB3' ' A' ' 124' ' ' ALA . 17.0 tp 64.28 43.9 4.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.05 0.452 . . . . 0.0 110.624 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.898 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 64.5 t0 -79.4 59.06 2.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.013 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.29 -29.48 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.375 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.672 ' HB2' ' HB3' ' A' ' 144' ' ' CYS . . . -49.68 147.53 3.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 111.923 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.555 ' NH2' ' HD3' ' A' ' 141' ' ' ARG . 51.6 mtp85 -138.72 126.78 22.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.764 HG13 ' HA ' ' A' ' 113' ' ' LEU . 33.7 m -116.72 130.3 71.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.029 0.442 . . . . 0.0 111.674 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.9 mt-10 -102.5 109.79 21.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.586 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.526 ' CE1' HG21 ' A' ' 126' ' ' VAL . 21.2 m-85 -75.52 147.12 39.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.481 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 5.6 tpm_? -162.28 125.94 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.472 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.41 ' H ' ' HE ' ' A' ' 129' ' ' ARG . 56.6 m -89.29 149.14 23.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.074 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.57 163.31 0.79 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.634 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.63 57.3 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.43 2.753 . . . . 0.0 113.131 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -158.06 -43.3 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.3 m-85 -108.91 138.76 44.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.665 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -101.6 127.51 48.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.091 0.472 . . . . 0.0 110.993 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 4.9 tt -65.04 131.23 46.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.184 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.8 t -133.39 65.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.25 -135.63 2.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.396 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.48 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 80.6 p -73.37 62.08 0.69 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.445 ' HA ' ' HB2' ' A' ' 128' ' ' PHE . 98.5 p -57.61 -7.02 0.57 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.288 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.555 ' HD3' ' NH2' ' A' ' 125' ' ' ARG . 39.7 ttm180 -140.65 134.37 30.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.672 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.578 ' O ' HG22 ' A' ' 126' ' ' VAL . 47.6 t -146.39 119.5 8.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.492 HG13 ' OG ' ' A' ' 150' ' ' SER . 3.2 p -95.98 121.56 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 0.0 111.223 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.672 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 49.7 t -69.22 138.3 53.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.601 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.898 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 80.6 p -164.51 133.11 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.165 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 57.38 40.76 27.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.849 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 63.9 18.25 61.84 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.126 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -145.27 139.79 27.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 117.099 0.449 . . . . 0.0 111.45 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.56 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 32.7 m95 -72.12 139.0 48.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.195 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.492 ' OG ' HG13 ' A' ' 143' ' ' VAL . 75.4 m -57.49 -57.74 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.005 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 t -109.42 143.11 27.1 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-O 120.862 0.363 . . . . 0.0 111.87 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.0 148.14 93.79 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.125 2.55 . . . . 0.0 112.693 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.511 ' HE2' HD13 ' A' ' 106' ' ' LEU . 87.5 tttt -53.34 135.64 51.36 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.527 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.48 ' HB3' ' H ' ' A' ' 139' ' ' SER . 97.5 Cg_endo -85.4 -151.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.906 2.404 . . . . 0.0 112.872 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.433 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.0 p-80 -153.7 151.09 29.25 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.4 m -97.28 129.85 44.54 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.766 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -108.78 135.4 50.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.027 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.84 140.2 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.982 -179.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.855 0.359 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.434 ' HB1' ' H ' ' A' ' 94' ' ' GLU . . . -64.09 -141.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.517 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.434 ' H ' ' HB1' ' A' ' 93' ' ' ALA . 50.5 mt-10 58.56 47.64 13.04 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.04 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -59.91 136.07 57.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.796 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.4 p -174.89 139.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.261 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.684 ' HB2' ' H ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -169.28 61.05 0.05 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.754 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 1.9 pp -142.19 153.44 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.983 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.508 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 38.0 m -64.58 147.22 53.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.791 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 102' ' ' SER . 80.4 p -40.12 118.0 0.84 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 110.699 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -70.94 9.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.514 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 100' ' ' SER . 59.2 m -68.96 -39.2 79.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.189 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.902 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.8 m-85 -52.18 -37.84 55.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.984 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.618 HD13 ' H ' ' A' ' 104' ' ' LEU . 6.3 mp -50.22 142.48 9.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 0.0 111.03 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 31.9 p 61.84 132.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.673 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.1 tp -145.4 136.14 24.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.613 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.407 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 88.7 tt0 -57.12 132.3 52.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.389 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.493 ' HB3' ' OD1' ' A' ' 131' ' ' ASP . 76.4 m-20 57.52 42.81 23.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.617 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.76 172.82 45.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.517 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -141.66 146.37 36.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 0.0 110.476 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 60.6 t -118.12 127.44 75.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.424 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.498 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.7 m-85 -88.22 119.06 28.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.849 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 61.4 tp -83.53 146.73 28.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.266 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 33.2 m -162.16 66.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.65 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -160.82 -42.35 0.02 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.848 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.02 -119.5 5.4 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.655 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -137.78 47.88 2.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.162 0.506 . . . . 0.0 111.042 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 71.7 mt -75.72 158.46 82.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.125 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.427 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 74.5 Cg_exo -47.03 120.46 4.22 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.159 1.906 . . . . 0.0 111.625 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.684 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 51.98 31.32 8.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.2 0.524 . . . . 0.0 110.155 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.754 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 13.9 tp 42.44 37.42 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.712 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -70.63 141.06 51.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.907 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.56 -24.62 9.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.78 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.721 ' HB2' ' HB2' ' A' ' 144' ' ' CYS . . . -57.25 152.89 13.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.761 0.315 . . . . 0.0 111.092 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.772 ' HD2' HH21 ' A' ' 141' ' ' ARG . 23.0 ptt-85 -165.45 133.19 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.679 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 33.9 m -120.54 143.5 32.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.039 0.447 . . . . 0.0 111.798 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.458 ' HB2' ' NH1' ' A' ' 141' ' ' ARG . 40.7 tp10 -108.48 121.86 45.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.057 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.418 ' CE1' HG22 ' A' ' 126' ' ' VAL . 2.8 m-85 -83.7 154.48 23.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.602 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 5.1 tpm_? -157.57 127.28 6.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.23 143.84 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.905 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.493 ' OD1' ' HB3' ' A' ' 108' ' ' ASN . 12.8 p-10 -54.07 148.96 19.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.48 77.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.015 2.477 . . . . 0.0 112.862 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 131' ' ' ASP . 64.4 t0 179.02 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.72 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -108.84 142.84 38.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.876 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.463 ' H ' ' HD1' ' A' ' 135' ' ' HIS . 13.1 p-80 -101.88 130.8 48.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.176 0.512 . . . . 0.0 110.961 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.659 HD22 ' HA ' ' A' ' 140' ' ' SER . 32.6 tp -70.25 126.82 30.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.964 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.446 HG22 ' C ' ' A' ' 136' ' ' LEU . 41.7 t -137.89 71.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.937 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.49 -135.67 2.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.846 -1.169 . . . . 0.0 113.102 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.724 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 67.0 m -75.94 52.79 0.72 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.92 0.391 . . . . 0.0 110.601 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.659 ' HA ' HD22 ' A' ' 136' ' ' LEU . 47.2 t -46.25 -39.85 10.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.071 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.772 HH21 ' HD2' ' A' ' 125' ' ' ARG . 23.9 tpt180 -104.11 137.46 42.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.589 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.8 t -143.05 101.69 3.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.346 . . . . 0.0 110.597 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.643 HG13 ' HB2' ' A' ' 150' ' ' SER . 7.7 p -96.8 129.89 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.065 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.721 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 1.8 m -74.62 146.99 42.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.395 0.617 . . . . 0.0 112.111 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.443 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 48.0 t -163.94 124.67 2.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.358 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 62.9 38.35 11.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.114 0.483 . . . . 0.0 110.419 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 63.12 25.73 68.46 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.562 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 145' ' ' SER . 23.6 pt20 -143.72 138.24 28.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.059 0.43 . . . . 0.0 111.262 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.508 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 59.4 m95 -65.04 138.02 58.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.466 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.643 ' HB2' HG13 ' A' ' 143' ' ' VAL . 47.5 t -57.43 -48.54 78.86 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.057 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.513 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 82.6 p -135.14 136.86 25.56 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.816 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.97 156.35 49.87 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.04 2.494 . . . . 0.0 112.438 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.902 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 28.5 mtpp -52.42 129.17 42.81 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.428 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.724 ' HB3' ' H ' ' A' ' 139' ' ' SER . 60.7 Cg_endo -72.89 -143.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.728 2.285 . . . . 0.0 112.246 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.45 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 23.0 p-80 -153.71 145.25 23.23 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.986 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 81.7 m -96.23 125.87 41.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.509 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -109.06 142.99 38.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.385 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 159' ' ' ASN . 61.9 t -61.83 139.96 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.044 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.427 ' N ' HG12 ' A' ' 158' ' ' VAL . 22.1 p30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.026 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.846 0.355 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.51 -42.62 88.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.995 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -173.22 -139.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.58 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -170.93 -134.09 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.64 126.1 32.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.956 0.408 . . . . 0.0 111.272 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.94 ' HG2' HG12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -88.82 -158.47 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.893 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.94 HG12 ' HG2' ' A' ' 97' ' ' ARG . 46.7 mm 64.74 143.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.342 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.564 ' N ' HG22 ' A' ' 98' ' ' ILE . 1.5 p -59.99 161.21 6.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.196 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -39.78 131.8 1.79 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.109 0.48 . . . . 0.0 111.453 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 21.8 pttp -96.48 78.56 3.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.674 0.749 . . . . 0.0 110.009 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.9 t -164.13 -34.9 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.076 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.631 ' HH ' ' HA ' ' A' ' 152' ' ' PRO . 2.7 m-85 -56.8 -26.33 57.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.192 0.52 . . . . 0.0 109.63 178.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.478 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 53.5 mt -50.23 -44.11 53.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.671 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.2 p -92.66 139.66 30.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.647 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 46.6 tp -143.07 133.72 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.389 . . . . 0.0 111.163 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.472 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 39.6 tt0 -67.8 129.98 41.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.333 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.472 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 76.1 m-80 56.6 37.09 28.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.964 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 130' ' ' CYS . . . -176.44 149.5 9.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.998 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -108.25 139.26 43.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.845 0.355 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 94.9 t -106.54 121.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.815 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -82.74 124.99 30.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.239 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.733 HD11 ' H ' ' A' ' 115' ' ' GLY . 3.4 tm? -85.84 145.04 27.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.475 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.571 ' H ' HD23 ' A' ' 113' ' ' LEU . 28.7 m -155.75 63.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 110.854 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.733 ' H ' HD11 ' A' ' 113' ' ' LEU . . . -161.04 -104.44 0.19 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.178 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 166.99 -129.64 1.96 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.739 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.708 ' HA ' HD13 ' A' ' 98' ' ' ILE . 58.7 m-20 -150.27 46.79 0.9 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 111.044 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.1 mp -97.9 154.27 37.87 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.823 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.546 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 76.1 Cg_exo -46.78 122.13 5.68 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.466 2.111 . . . . 0.0 112.112 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.715 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 72.77 -40.74 0.48 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.528 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 121' ' ' LEU . 14.8 tp 59.51 51.18 6.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.956 0.408 . . . . 0.0 110.943 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -73.26 66.25 0.89 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.247 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.31 -36.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.623 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.792 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -51.39 153.9 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.954 0.407 . . . . 0.0 111.483 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.497 ' O ' ' HB ' ' A' ' 114' ' ' THR . 50.8 ttp85 -158.94 126.07 4.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.176 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.544 HG22 ' CZ3' ' A' ' 149' ' ' TRP . 24.6 m -108.17 136.67 42.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.022 0.439 . . . . 0.0 111.648 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -100.29 115.98 31.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.686 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -80.09 143.04 34.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 129' ' ' ARG . 37.7 ttt85 -167.22 118.82 0.9 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.423 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 51.3 m -89.18 154.13 20.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.981 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -52.77 158.34 2.25 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.305 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.518 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 82.0 Cg_exo -47.49 162.81 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.829 2.353 . . . . 0.0 112.245 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.5 m-20 77.93 -35.07 0.19 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.791 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.421 ' H ' ' C ' ' A' ' 132' ' ' PRO . 11.6 m-85 -106.32 127.14 53.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -108.34 131.1 55.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.034 0.445 . . . . 0.0 111.375 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.537 ' C ' HD13 ' A' ' 136' ' ' LEU . 3.2 tm? -74.79 132.86 41.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.292 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.0 t -133.07 71.53 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.785 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.92 -132.5 1.82 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.057 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.603 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 61.2 p -72.83 61.56 0.55 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 110.648 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.532 ' HB3' HD11 ' A' ' 136' ' ' LEU . 97.0 p -55.6 -15.59 3.09 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.775 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -140.64 139.89 34.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.716 0.293 . . . . 0.0 111.266 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 96.6 p -139.54 117.01 11.35 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.255 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.493 ' HB ' ' HG ' ' A' ' 150' ' ' SER . 73.7 t -84.18 125.01 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 111.52 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.792 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 42.1 t -79.3 131.03 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.306 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.4 t -173.25 137.53 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 0.0 111.156 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 56.35 37.93 29.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.505 ' C ' ' HA ' ' A' ' 99' ' ' CYS . . . 56.78 24.66 49.62 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.644 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -143.07 134.55 26.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.657 0.265 . . . . 0.0 111.087 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.544 ' CZ3' HG22 ' A' ' 126' ' ' VAL . 66.0 m95 -77.76 140.03 39.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.255 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.493 ' HG ' ' HB ' ' A' ' 143' ' ' VAL . 63.1 m -57.4 -47.61 81.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.661 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.565 ' HG1' ' HB2' ' A' ' 139' ' ' SER . 67.4 p -127.46 138.9 33.79 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.631 ' HA ' ' HH ' ' A' ' 103' ' ' TYR . 34.8 Cg_endo -64.86 -162.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.471 2.114 . . . . 0.0 112.566 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 14.4 mmmm -83.86 131.65 51.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.974 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.603 ' HB3' ' H ' ' A' ' 139' ' ' SER . 89.5 Cg_endo -81.75 -149.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.675 2.25 . . . . 0.0 112.483 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -153.71 134.1 13.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.945 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.486 ' SG ' HD22 ' A' ' 136' ' ' LEU . 92.4 m -104.93 142.43 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.235 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -135.21 137.59 42.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.881 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 159' ' ' ASN . 8.7 p -67.15 139.08 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.4 ' N ' HG23 ' A' ' 158' ' ' VAL . 74.5 m-80 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.913 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.613 0.244 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.0 -47.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.48 135.19 55.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.647 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -78.33 44.81 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.983 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 p -59.71 125.83 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.912 0.387 . . . . 0.0 111.106 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.731 ' HD3' ' H ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -85.51 -148.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.851 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 21.3 pt 52.75 137.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.969 0.908 . . . . 0.0 112.72 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.513 ' HB2' HD21 ' A' ' 121' ' ' LEU . 92.2 m -57.36 167.41 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.767 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.6 p -40.17 143.77 0.26 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.751 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.622 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 4.6 ttmp? -99.68 78.45 2.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.227 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.2 t -166.24 -36.2 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.062 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -56.94 -32.4 65.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 110.389 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.411 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 64.5 mt -52.87 -46.18 67.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.568 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.2 p -92.63 137.69 32.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 0.0 111.194 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.516 ' HB2' ' HZ2' ' A' ' 153' ' ' LYS . 29.2 tp -145.38 136.36 24.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.382 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.418 ' HG3' ' ND2' ' A' ' 108' ' ' ASN . 42.2 tp10 -69.53 138.1 53.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.9 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.418 ' ND2' ' HG3' ' A' ' 107' ' ' GLU . 76.2 m-20 58.01 36.3 25.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.283 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 179.94 176.88 47.68 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.755 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -139.78 136.46 34.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.717 HG22 ' HA ' ' A' ' 128' ' ' PHE . 94.9 t -106.11 123.86 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.8 m-85 -76.6 122.5 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.29 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.702 HD22 ' N ' ' A' ' 114' ' ' THR . 2.8 tt -95.35 140.6 30.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.711 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.702 ' N ' HD22 ' A' ' 113' ' ' LEU . 30.1 m -158.49 62.65 0.43 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.085 0.469 . . . . 0.0 110.739 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.424 ' C ' HD13 ' A' ' 121' ' ' LEU . . . -172.44 -16.28 0.02 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.716 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -49.77 147.59 6.75 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.372 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 1.5 m-20 73.31 41.98 0.45 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 122.714 0.406 . . . . 0.0 111.753 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -141.82 149.4 53.02 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.59 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -50.28 116.94 2.77 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.481 2.121 . . . . 0.0 111.822 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.713 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 50.06 36.17 11.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.544 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.851 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 14.3 tp 52.22 42.24 30.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.491 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.89 142.27 57.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.589 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.76 33.93 84.78 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.425 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' A' ' 144' ' ' CYS . . . -93.44 144.09 25.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.892 0.377 . . . . 0.0 111.452 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -145.53 128.45 16.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.804 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 34.4 m -136.11 142.15 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.751 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 41.4 tt0 -108.69 121.39 44.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.435 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.717 ' HA ' HG22 ' A' ' 111' ' ' VAL . 2.3 m-85 -86.86 44.11 1.14 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.841 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.632 ' HD3' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -67.16 133.5 49.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 110.667 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.443 ' SG ' HD23 ' A' ' 106' ' ' LEU . 69.5 m -105.16 155.85 18.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.638 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -53.7 156.84 4.34 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.116 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 86.6 Cg_exo -47.66 162.94 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.808 2.339 . . . . 0.0 112.466 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.559 ' HB3' ' ND2' ' A' ' 159' ' ' ASN . 57.3 m-20 78.31 -31.4 0.16 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.151 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.41 ' H ' ' C ' ' A' ' 132' ' ' PRO . 2.6 m-85 -105.0 130.17 53.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.719 0.295 . . . . 0.0 110.393 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -111.39 130.58 55.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 111.516 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.79 HD23 ' HA ' ' A' ' 140' ' ' SER . 36.2 tp -78.05 136.4 37.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.419 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.0 66.06 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.14 -135.66 2.34 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.206 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.485 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 82.8 p -72.62 63.91 0.61 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.991 0.425 . . . . 0.0 110.78 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.79 ' HA ' HD23 ' A' ' 136' ' ' LEU . 88.0 p -56.08 -11.49 1.13 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.452 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 141' ' ' ARG . 69.3 mtt-85 -140.54 136.87 33.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 57.9 m -137.05 126.66 25.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.368 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 5.9 p -116.71 130.15 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.922 0.391 . . . . 0.0 111.262 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.816 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 33.2 m -96.83 147.92 23.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.852 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.1 p -171.31 27.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.299 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.49 ' O ' ' HG3' ' A' ' 146' ' ' GLN . 70.7 tp60 -176.26 37.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.06 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.505 ' N ' ' HB3' ' A' ' 120' ' ' ALA . . . 60.0 10.49 14.58 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.769 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -141.52 134.25 28.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.688 0.28 . . . . 0.0 110.92 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.496 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 38.7 m95 -64.86 134.97 55.18 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.564 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.2 m -57.42 -57.07 14.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.224 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 68.6 p -103.69 131.75 21.72 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.26 140.57 89.38 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.81 2.34 . . . . 0.0 111.895 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.516 ' HZ2' ' HB2' ' A' ' 106' ' ' LEU . 61.2 tttp -47.09 132.93 9.1 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.276 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.485 ' HB3' ' H ' ' A' ' 139' ' ' SER . 65.1 Cg_endo -89.26 -151.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.024 2.483 . . . . 0.0 113.004 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.446 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 20.8 p-80 -153.76 138.09 16.65 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.06 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.465 ' SG ' HD12 ' A' ' 136' ' ' LEU . 85.7 m -98.69 133.27 43.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.855 0.36 . . . . 0.0 110.83 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -103.02 136.93 41.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.727 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.68 142.42 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.901 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.559 ' ND2' ' HB3' ' A' ' 133' ' ' ASP . 23.4 p30 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.992 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.867 0.365 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.62 -46.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.011 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.73 137.13 57.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.428 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 2.0 m-85 -59.98 134.48 57.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.8 m -154.36 139.93 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.038 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HD2' ' HA ' ' A' ' 119' ' ' PRO . 3.2 ptp85 -161.04 126.8 3.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.96 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 98' ' ' ILE . 2.6 pp -156.23 148.36 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.239 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.473 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 0.1 OUTLIER -63.8 151.55 41.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.964 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.0 t -39.89 111.18 0.18 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.015 0.436 . . . . 0.0 111.125 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -63.6 -22.37 66.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.984 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 t -53.5 -32.17 49.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.653 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -76.23 45.28 0.36 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.608 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.508 HD23 HD21 ' A' ' 113' ' ' LEU . 93.9 mt -132.82 -37.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 0.0 110.677 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 t -92.54 132.77 36.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.964 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.4 HD13 ' HZ1' ' A' ' 153' ' ' LYS . 37.6 tp -145.44 125.06 13.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.54 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -82.83 45.15 0.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.066 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 p30 179.55 36.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.363 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.63 -155.39 26.37 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.959 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -142.06 150.55 41.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.818 0.342 . . . . 0.0 110.7 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.419 HG11 ' HB ' ' A' ' 126' ' ' VAL . 98.1 t -106.56 125.19 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.496 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.0 m-85 -85.38 76.83 10.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.58 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.736 HD13 ' H ' ' A' ' 115' ' ' GLY . 3.4 tm? -54.96 141.52 33.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.339 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 23.6 m -157.46 61.33 0.49 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.657 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.736 ' H ' HD13 ' A' ' 113' ' ' LEU . . . 173.38 41.94 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.732 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.82 123.42 6.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.186 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 66.25 52.27 1.15 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.475 HD12 ' C ' ' A' ' 115' ' ' GLY . 10.7 mp -119.29 148.42 45.26 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.532 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.466 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 41.7 Cg_exo -54.73 82.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.031 2.487 . . . . 0.0 111.748 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 62.12 13.45 5.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.576 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.669 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 7.3 mp 47.92 59.54 4.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.782 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.0 46.02 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.049 0.452 . . . . 0.0 110.567 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 171.64 -26.16 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.281 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.613 ' HB1' ' HA3' ' A' ' 115' ' ' GLY . . . -50.52 155.21 1.12 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 111.298 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 114' ' ' THR . 39.0 ptt180 -160.65 130.48 5.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.281 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.568 HG13 ' HA ' ' A' ' 113' ' ' LEU . 34.8 m -107.62 134.12 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.163 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 96.3 mt-10 -95.03 122.05 37.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.704 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.475 ' CE1' HG21 ' A' ' 126' ' ' VAL . 30.3 m-85 -88.28 149.08 24.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.654 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.405 HH11 ' HG3' ' A' ' 129' ' ' ARG . 40.1 ttt85 -153.62 126.97 8.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.739 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 16.6 t -89.24 151.28 22.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.016 0.436 . . . . 0.0 111.505 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -52.75 151.63 7.94 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.486 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.8 73.63 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.186 2.591 . . . . 0.0 112.747 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -176.31 -42.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.699 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.612 ' HB2' ' SG ' ' A' ' 130' ' ' CYS . 4.5 m-85 -109.51 143.53 39.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.545 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -99.44 135.05 41.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.304 0.574 . . . . 0.0 111.514 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.454 ' CD2' ' HA ' ' A' ' 140' ' ' SER . 35.5 tp -70.9 124.06 23.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.928 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.15 63.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.379 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -171.21 -128.63 1.05 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.921 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.654 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 60.1 m -73.54 57.14 0.54 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.878 0.371 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.454 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 38.9 t -51.66 -25.47 7.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.269 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 12.9 mtp-105 -137.82 129.71 28.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.572 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.452 ' HA ' ' HG1' ' A' ' 151' ' ' THR . 49.9 m -127.21 120.2 28.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.874 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.8 p -104.99 124.6 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.413 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 38.9 t -72.79 151.74 41.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.169 0.509 . . . . 0.0 111.587 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.5 m -161.44 121.71 2.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.563 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 57.92 43.17 21.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.315 0.578 . . . . 0.0 109.848 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 61.0 28.2 68.4 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.444 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -142.92 130.29 21.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.691 0.282 . . . . 0.0 110.61 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.514 ' CZ3' HG12 ' A' ' 126' ' ' VAL . 35.9 m95 -72.11 132.07 43.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.59 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.9 m -57.51 -60.64 3.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.452 ' HG1' ' HA ' ' A' ' 142' ' ' SER . 70.9 p -99.78 133.32 21.82 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.245 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 23.1 Cg_exo -64.9 -158.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.684 2.256 . . . . 0.0 112.326 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.467 ' HE3' ' HE2' ' A' ' 128' ' ' PHE . 14.2 mmmm -87.51 129.49 50.91 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.767 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.654 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.4 Cg_endo -75.26 -156.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.401 2.067 . . . . 0.0 112.803 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.72 148.77 26.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.938 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.43 ' HB3' ' CB ' ' A' ' 134' ' ' PHE . 97.1 m -97.07 130.54 44.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -108.72 135.11 50.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.692 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 158' ' ' VAL . 7.4 p -72.12 128.81 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.935 -179.876 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.788 0.328 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.75 41.96 31.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.156 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -175.88 54.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.388 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -162.98 137.93 6.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.91 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.536 ' O ' HG13 ' A' ' 98' ' ' ILE . 90.7 t -145.68 135.51 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.846 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.589 ' CG ' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -62.83 126.74 28.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.541 HG22 ' HA ' ' A' ' 117' ' ' ASP . 1.5 pp -171.75 32.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.482 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 6.1 t 59.38 150.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.576 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.694 ' HB2' ' HD1' ' A' ' 149' ' ' TRP . 57.4 m -39.86 125.55 1.9 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.976 0.417 . . . . 0.0 111.301 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.526 ' HD3' HD21 ' A' ' 104' ' ' LEU . 16.8 tppt? -86.31 -36.43 19.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.537 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.9 p -69.0 40.3 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.456 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 5.5 m-85 -128.41 -47.97 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.605 HD11 ' N ' ' A' ' 105' ' ' THR . 0.4 OUTLIER -54.8 -30.0 55.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.995 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.605 ' N ' HD11 ' A' ' 104' ' ' LEU . 6.8 t -92.48 132.43 36.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.775 0.321 . . . . 0.0 111.138 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.723 ' HB2' ' HZ3' ' A' ' 153' ' ' LYS . 34.5 tp -145.39 128.59 16.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.467 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -74.1 130.28 39.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.961 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.506 ' N ' HD21 ' A' ' 108' ' ' ASN . 2.0 m120 60.23 38.88 19.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.621 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.75 151.86 13.1 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.845 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -110.68 137.0 48.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.49 126.74 62.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -79.35 60.39 3.13 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.006 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.429 HD22 ' HB3' ' A' ' 104' ' ' LEU . 60.2 tp -58.5 140.96 53.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.546 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 31.3 m -155.62 55.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.492 0.663 . . . . 0.0 109.85 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.645 ' HA3' ' HB3' ' A' ' 124' ' ' ALA . . . 168.46 99.98 0.13 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.843 -179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 117' ' ' ASP . . . -165.32 151.34 20.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.774 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.541 ' HA ' HG22 ' A' ' 98' ' ' ILE . 38.8 t70 77.23 41.21 0.15 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.037 0.446 . . . . 0.0 110.975 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.431 ' O ' ' N ' ' A' ' 120' ' ' ALA . 3.2 mm? -144.14 150.9 50.49 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.589 ' HA ' ' CG ' ' A' ' 97' ' ' ARG . 12.0 Cg_endo -55.47 81.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.841 2.361 . . . . 0.0 112.187 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 73.69 -38.07 0.39 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.271 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.448 ' H ' ' C ' ' A' ' 119' ' ' PRO . 17.6 tp 55.2 80.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.89 0.376 . . . . 0.0 110.746 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.02 48.69 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.139 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -178.26 26.12 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.36 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.645 ' HB3' ' HA3' ' A' ' 115' ' ' GLY . . . -80.52 142.3 34.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.616 0.246 . . . . 0.0 110.669 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.546 ' O ' ' HB ' ' A' ' 114' ' ' THR . 45.7 mtp85 -131.73 150.48 52.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 111.278 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.622 HG21 ' H ' ' A' ' 127' ' ' GLU . 7.6 p -154.49 158.27 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.279 0.562 . . . . 0.0 111.252 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.622 ' H ' HG21 ' A' ' 126' ' ' VAL . 43.6 tt0 -136.94 89.71 2.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.106 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.456 ' CE1' HG12 ' A' ' 126' ' ' VAL . 4.2 m-85 -59.11 148.57 30.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.714 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.8 tpt85 -159.52 128.36 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 35.4 t -89.22 150.23 22.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.301 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -53.67 156.61 4.52 Favored Pre-proline 0 N--CA 1.462 0.149 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.34 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 80.0 Cg_exo -45.64 162.02 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.978 2.452 . . . . 0.0 112.718 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 28.1 m-20 77.83 -36.57 0.22 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.61 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.432 ' H ' ' C ' ' A' ' 132' ' ' PRO . 1.9 m-85 -107.49 128.65 54.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.919 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.469 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -102.86 137.16 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.077 0.465 . . . . 0.0 111.409 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.496 HD22 ' H ' ' A' ' 138' ' ' GLY . 6.9 tt -78.89 127.24 31.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.339 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.438 ' N ' HD22 ' A' ' 136' ' ' LEU . 26.3 t -130.07 65.66 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.496 ' H ' HD22 ' A' ' 136' ' ' LEU . . . -170.54 -125.38 0.8 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.636 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.813 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 29.2 t -73.37 59.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 111.295 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.3 t -58.29 -24.77 60.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.603 ' HD2' ' N ' ' A' ' 142' ' ' SER . 4.0 tmm_? -140.55 131.29 25.76 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.421 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.621 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 50.7 m -132.23 153.32 50.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.499 ' H ' ' HG ' ' A' ' 150' ' ' SER . 77.3 t -142.78 125.3 13.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.278 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.533 ' SG ' ' HB1' ' A' ' 124' ' ' ALA . 61.3 m -68.18 153.86 42.89 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -157.45 -23.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.285 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 146' ' ' GLN . 4.2 tp-100 -159.2 58.16 0.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.031 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 73.57 -8.08 11.28 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.914 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.74 136.17 33.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 111.023 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.694 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 60.2 m95 -60.57 150.32 32.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.752 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.499 ' HG ' ' H ' ' A' ' 143' ' ' VAL . 79.9 p -54.21 -58.77 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 t -104.25 144.88 29.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.378 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.456 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 17.7 Cg_endo -59.25 -147.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.993 2.462 . . . . 0.0 113.034 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.723 ' HZ3' ' HB2' ' A' ' 106' ' ' LEU . 55.0 tttp -108.92 135.32 20.15 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.604 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.813 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 73.4 Cg_endo -76.68 -155.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.492 2.128 . . . . 0.0 113.037 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -153.77 161.24 42.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 88.1 m -96.11 131.62 42.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.787 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.469 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 4.2 tp-100 -118.84 138.14 52.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.917 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.65 136.56 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.237 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 24.1 p30 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.04 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.818 0.342 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -176.92 45.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.892 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.25 147.72 20.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -161.63 141.81 10.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.043 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.3 m -150.68 138.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.618 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.798 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -167.2 58.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.054 0.454 . . . . 0.0 111.585 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 98' ' ' ILE . 1.7 pp -150.27 149.56 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.243 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.599 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 72.8 m -59.89 140.37 56.7 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.8 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.4 p -37.93 113.36 0.27 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.087 0.47 . . . . 0.0 111.62 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.554 ' HB3' HD13 ' A' ' 104' ' ' LEU . 98.3 mttt -69.43 1.95 3.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.316 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.2 p -59.63 -37.52 78.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.879 0.371 . . . . 0.0 110.569 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.5 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 1.4 m-85 -54.38 -35.43 62.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.851 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 101' ' ' LYS . 79.3 mt -53.53 139.45 31.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.33 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 30.9 p 60.52 130.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.497 0.498 . . . . 0.0 111.106 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.72 HD12 ' HE2' ' A' ' 153' ' ' LYS . 30.9 tp -145.37 134.88 23.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.305 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pm0 -63.62 133.03 52.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.323 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 58.42 42.99 20.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.41 -177.58 43.66 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.563 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -142.03 151.89 42.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.607 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 86.5 t -129.14 123.98 59.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.349 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.5 m-85 -89.79 119.42 30.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.748 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 54.9 tp -80.92 145.3 31.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.858 0.361 . . . . 0.0 110.932 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 23.7 m -158.88 56.16 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.733 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.572 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . -159.0 -108.88 0.25 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.818 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 158.68 -124.67 1.4 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.863 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -151.4 53.03 0.84 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.189 0.519 . . . . 0.0 110.228 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 97.3 mt -99.35 156.89 34.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.879 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.798 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 80.6 Cg_exo -44.32 111.24 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.45 2.1 . . . . 0.0 112.182 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.598 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 72.66 -38.99 0.44 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.593 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.463 ' HA ' HD12 ' A' ' 121' ' ' LEU . 16.5 tp 58.23 51.94 7.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.968 0.413 . . . . 0.0 111.122 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.3 60.4 1.52 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.008 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.29 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.396 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.572 ' HB1' ' HA3' ' A' ' 115' ' ' GLY . . . -49.92 152.27 1.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.486 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.498 ' O ' ' HB ' ' A' ' 114' ' ' THR . 79.1 ttt180 -155.63 122.05 5.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.409 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 26.8 m -111.82 134.71 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.159 0.504 . . . . 0.0 111.772 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -87.34 141.84 28.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.226 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.584 ' CE1' HG23 ' A' ' 126' ' ' VAL . 14.4 m-85 -117.09 140.23 49.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.491 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -162.36 131.02 4.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.661 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 7.1 t -89.22 155.11 19.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.909 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 133' ' ' ASP . 45.9 m-20 -52.75 151.62 7.95 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.496 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.03 76.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.284 2.656 . . . . 0.0 113.133 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 131' ' ' ASP . 33.4 t70 -178.68 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.702 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.534 ' HB2' ' SG ' ' A' ' 130' ' ' CYS . 5.0 m-85 -108.93 145.83 34.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.55 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -101.08 140.03 35.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.32 0.581 . . . . 0.0 111.287 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.537 HD13 ' N ' ' A' ' 137' ' ' VAL . 2.4 tm? -79.61 127.09 31.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.971 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.537 ' N ' HD13 ' A' ' 136' ' ' LEU . 44.6 t -132.38 71.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.549 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.98 -130.25 1.56 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.879 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.771 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 31.4 t -73.53 58.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 111.268 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.444 ' HB3' HD11 ' A' ' 136' ' ' LEU . 96.5 p -51.71 -26.29 9.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.122 0.487 . . . . 0.0 109.885 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 34.2 ptt85 -140.62 128.95 22.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.272 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 99.8 p -125.74 128.27 47.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 111.038 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 89.1 t -103.13 117.56 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 42.6 t -64.54 136.69 57.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.455 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.1 t -164.47 130.29 2.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 111.201 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 39.5 tt0 56.75 43.16 25.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.28 0.562 . . . . 0.0 110.538 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 60.53 17.4 47.95 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.94 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -143.52 135.03 26.2 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.886 0.343 . . . . 0.0 111.128 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.599 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 95.5 m95 -68.97 135.19 50.57 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.838 0.352 . . . . 0.0 111.126 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -57.46 -55.16 38.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.3 p -103.97 132.11 21.33 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.63 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 54.3 Cg_endo -69.37 136.49 34.15 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.797 2.331 . . . . 0.0 112.473 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.72 ' HE2' HD12 ' A' ' 106' ' ' LEU . 85.9 tttt -40.01 129.03 1.6 Allowed Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.459 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 95.2 Cg_endo -79.2 -154.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.906 2.404 . . . . 0.0 113.221 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.418 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 20.6 p-80 -153.74 169.42 23.38 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.902 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 92.3 m -98.72 136.79 38.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.418 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -131.25 131.14 43.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 110.857 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.43 132.08 29.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.322 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.904 179.862 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.849 0.357 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.86 -44.34 73.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 57.5 45.92 18.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.322 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -173.87 135.53 0.5 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.333 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.456 HG21 ' N ' ' A' ' 97' ' ' ARG . 8.8 p -66.54 146.54 13.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.042 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.575 ' CG ' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -145.61 136.1 24.15 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.422 0.629 . . . . 0.0 111.18 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.417 HD13 ' OD1' ' A' ' 117' ' ' ASP . 6.7 tt 175.21 144.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.042 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 14.4 m -48.85 138.41 11.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.376 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.7 m -39.86 128.45 2.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.416 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.409 ' HE3' HD12 ' A' ' 98' ' ' ILE . 33.1 mmtp -82.0 -15.95 51.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.923 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.7 m -53.11 -42.41 65.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.085 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -57.5 -41.48 80.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.014 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.503 HD11 ' N ' ' A' ' 104' ' ' LEU . 3.6 mp -77.88 40.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.8 m -147.39 62.68 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.653 ' HA ' ' HZ3' ' A' ' 153' ' ' LYS . 49.9 tp -94.55 124.97 38.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.849 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.421 ' OE1' ' ND2' ' A' ' 108' ' ' ASN . 0.0 OUTLIER -90.58 41.0 1.04 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.017 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.421 ' ND2' ' OE1' ' A' ' 107' ' ' GLU . 78.4 m-20 -160.12 27.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.697 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 161.07 -146.48 12.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.997 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.65 ' HB3' ' HZ1' ' A' ' 110' ' ' LYS . 7.9 mtpm? -141.94 143.37 33.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.296 -0.452 . . . . 0.0 110.663 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.71 119.84 54.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.831 0.348 . . . . 0.0 110.519 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.437 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 1.7 m-85 -71.71 123.02 21.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.907 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.656 HD12 ' H ' ' A' ' 115' ' ' GLY . 3.4 tm? -89.17 141.34 28.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.494 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.2 m -157.95 54.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.868 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.656 ' H ' HD12 ' A' ' 113' ' ' LEU . . . -146.96 -105.57 0.43 Allowed Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.934 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.659 ' H ' HD23 ' A' ' 121' ' ' LEU . . . 165.82 -126.46 1.48 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.42 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.417 ' OD1' HD13 ' A' ' 98' ' ' ILE . 32.3 t70 -167.32 67.17 0.09 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.157 0.504 . . . . 0.0 109.984 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.683 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 71.5 mt -127.97 168.76 14.32 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.116 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.683 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 76.3 Cg_exo -38.18 97.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.635 2.224 . . . . 0.0 112.125 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 70.68 -20.05 0.21 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.847 -179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.659 HD23 ' H ' ' A' ' 116' ' ' GLY . 19.8 tp 62.31 54.01 2.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.93 0.395 . . . . 0.0 110.76 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.678 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 33.1 t70 -56.83 129.51 41.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.182 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.74 26.31 38.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.988 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.836 ' HB2' ' HB3' ' A' ' 144' ' ' CYS . . . -79.64 156.91 27.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.494 ' O ' ' HB ' ' A' ' 114' ' ' THR . 56.4 ttp85 -154.34 145.27 22.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.407 . . . . 0.0 111.405 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.579 HG21 ' CZ3' ' A' ' 149' ' ' TRP . 26.7 m -148.35 138.23 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.582 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.442 ' HG3' ' NH1' ' A' ' 141' ' ' ARG . 43.3 tt0 -110.79 115.83 30.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.582 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.558 ' HE2' ' HG3' ' A' ' 153' ' ' LYS . 2.0 m-85 -73.95 143.0 45.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -156.3 117.84 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.704 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.528 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 95.2 m -92.32 156.25 17.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.571 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -52.7 153.11 6.01 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.476 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.37 78.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.128 2.552 . . . . 0.0 112.668 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -177.46 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.646 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.638 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 0.6 OUTLIER -108.61 134.52 51.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.924 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.479 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 20.3 p-80 -102.66 127.33 49.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.122 0.486 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.725 HD21 ' HA ' ' A' ' 140' ' ' SER . 26.6 tp -70.21 126.61 30.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.131 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.7 67.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.638 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -174.74 -135.31 2.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.072 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.743 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 65.0 m -74.74 55.04 0.66 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.725 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.8 t -48.42 -43.53 34.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.09 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.57 ' HD2' ' N ' ' A' ' 141' ' ' ARG . 0.4 OUTLIER -102.02 133.63 46.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.9 m -133.91 130.0 37.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.713 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.61 123.97 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.299 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.836 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 41.1 t -100.7 145.21 28.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.687 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.678 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 81.1 p -168.14 35.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 175.8 39.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.276 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 61.71 10.98 27.52 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.112 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.15 134.81 28.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.562 0.22 . . . . 0.0 110.592 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.579 ' CZ3' HG21 ' A' ' 126' ' ' VAL . 56.1 m95 -73.42 137.11 44.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.366 . . . . 0.0 111.13 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.2 t -57.49 -59.66 4.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.35 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.64 ' HG1' ' HB3' ' A' ' 139' ' ' SER . 82.7 p -96.44 134.52 23.32 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 15.9 Cg_exo -67.53 146.28 73.5 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.935 2.423 . . . . 0.0 111.949 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.653 ' HZ3' ' HA ' ' A' ' 106' ' ' LEU . 88.2 tttt -51.17 122.93 19.24 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.858 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.743 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.2 Cg_endo -75.25 -150.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.734 2.289 . . . . 0.0 112.953 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.465 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.5 p-80 -153.74 139.88 18.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.638 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 67.5 m -98.79 139.28 34.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.003 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.479 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 39.3 tt0 -102.93 132.53 49.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.11 126.91 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.338 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.395 179.667 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.835 0.35 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -176.82 -43.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -59.05 135.14 57.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.989 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.462 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 1.1 m-85 -64.66 129.23 39.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.796 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 p 177.77 141.32 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.173 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.597 ' NE ' ' N ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -168.66 109.51 0.51 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.465 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.542 ' HA ' HD13 ' A' ' 121' ' ' LEU . 1.4 pt -175.87 135.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.94 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.51 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 99.7 m -64.16 136.18 57.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.418 ' C ' ' H ' ' A' ' 102' ' ' SER . 54.4 m -41.42 131.12 2.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.275 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.529 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -76.63 15.56 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.177 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 100' ' ' SER . 50.4 m -68.93 -39.81 79.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 111.433 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.533 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 1.8 m-85 -64.59 -70.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.559 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -46.98 156.97 0.18 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.97 0.414 . . . . 0.0 111.484 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.6 m 64.67 73.13 0.43 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.34 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.564 HD12 ' HZ1' ' A' ' 153' ' ' LYS . 49.3 tp -93.14 136.52 33.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.333 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.83 135.06 57.58 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 58.97 40.93 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.075 0.464 . . . . 0.0 110.186 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.37 169.58 41.81 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.934 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -136.93 129.66 30.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.958 0.409 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 58.4 t -111.15 126.53 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.227 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.5 m-85 -70.87 111.33 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.19 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.585 ' HA ' HG11 ' A' ' 126' ' ' VAL . 58.5 tp -80.84 145.26 31.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.931 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.4 m -161.88 54.42 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.849 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.629 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -174.76 61.26 0.11 Allowed Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.697 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.46 -53.37 45.52 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 114.634 0.613 . . . . 0.0 114.634 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -164.08 54.7 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.425 0.613 . . . . 0.0 111.821 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.654 ' N ' HD13 ' A' ' 118' ' ' LEU . 7.1 mp -87.74 159.19 49.75 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.355 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.437 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 75.4 Cg_exo -47.52 83.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.541 2.16 . . . . 0.0 111.638 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 59.83 23.12 12.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.902 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.674 ' N ' HD11 ' A' ' 121' ' ' LEU . 7.8 mp 52.22 53.26 12.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.62 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 38.6 t70 -76.79 44.93 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.211 0.529 . . . . 0.0 110.329 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.429 ' O ' ' HG3' ' A' ' 125' ' ' ARG . . . 172.5 -27.65 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.536 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.629 ' HB2' ' HA3' ' A' ' 115' ' ' GLY . . . -51.8 144.55 11.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.783 0.325 . . . . 0.0 111.251 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.498 ' O ' ' HB ' ' A' ' 114' ' ' THR . 84.2 mtm180 -147.84 136.98 22.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.003 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 113' ' ' LEU . 31.6 m -121.91 131.98 71.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.004 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.16 124.2 39.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.606 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.452 ' N ' ' CD1' ' A' ' 128' ' ' PHE . 0.8 OUTLIER -87.09 138.17 31.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.98 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -145.92 127.47 15.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.491 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.517 ' SG ' HD13 ' A' ' 136' ' ' LEU . 96.5 m -89.29 145.32 25.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.692 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 134' ' ' PHE . 3.2 t70 -55.63 146.79 43.58 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.616 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 131' ' ' ASP . 88.4 Cg_exo -36.82 137.0 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.863 2.376 . . . . 0.0 112.593 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.449 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 51.5 m-20 75.0 22.21 1.85 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.512 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.51 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 16.9 m-85 -134.97 131.54 37.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.562 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -106.03 135.23 47.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.926 0.393 . . . . 0.0 110.836 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.763 HD21 ' HA ' ' A' ' 140' ' ' SER . 17.5 tp -78.15 143.07 37.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.406 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 155' ' ' HIS . 14.5 p -134.92 59.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.834 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 169.28 -126.15 1.34 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 119.013 -1.565 . . . . 0.0 113.764 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.933 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 29.9 t -65.66 65.8 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.796 0.332 . . . . 0.0 111.258 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.763 ' HA ' HD21 ' A' ' 136' ' ' LEU . 95.6 p -61.88 -26.55 68.22 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.331 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -140.68 125.23 17.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.502 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m -116.35 137.33 52.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.793 0.33 . . . . 0.0 110.736 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 92.3 t -131.32 115.45 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.038 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 69.7 m -80.31 153.19 28.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.832 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.588 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 40.8 t -152.43 -23.01 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.661 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -146.58 46.18 1.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.15 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.502 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 64.74 24.18 69.58 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.882 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -141.7 132.74 26.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.293 0.237 . . . . 0.0 110.483 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.51 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 72.4 m95 -66.41 145.22 55.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 110.864 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.3 t -56.27 -48.61 76.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.294 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.484 HG23 ' HA ' ' A' ' 139' ' ' SER . 1.0 OUTLIER -135.52 139.24 30.59 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-O 120.847 0.356 . . . . 0.0 111.765 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.533 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 17.8 Cg_endo -59.76 137.7 78.44 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.444 2.763 . . . . 0.0 113.842 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.793 ' HD3' ' HD2' ' A' ' 154' ' ' PRO . 2.7 tppp? -50.42 126.75 22.72 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.77 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.933 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 96.1 Cg_endo -85.03 -140.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.096 2.531 . . . . 0.0 112.278 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.44 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.69 149.31 27.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.876 0.369 . . . . 0.0 111.077 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.3 m -95.32 132.74 40.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.363 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -123.58 139.4 54.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.359 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.23 133.73 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.779 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.934 179.942 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.701 0.286 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.37 45.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.1 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -60.71 137.18 58.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.003 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.451 ' O ' HG13 ' A' ' 96' ' ' VAL . 1.3 p90 -58.33 145.11 39.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 95' ' ' PHE . 28.4 m -151.1 137.42 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.329 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.844 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -171.82 -161.89 0.2 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.817 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.836 HG13 ' HG2' ' A' ' 97' ' ' ARG . 91.1 mt 64.44 129.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.771 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.7 m -63.43 153.1 36.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.635 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.458 ' C ' ' H ' ' A' ' 102' ' ' SER . 47.7 t -39.44 104.02 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.167 0.508 . . . . 0.0 110.879 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.636 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -66.46 3.95 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.328 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.458 ' H ' ' C ' ' A' ' 100' ' ' SER . 47.7 t -68.11 -38.62 82.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.49 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.49 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 2.3 m-85 -51.5 -38.4 53.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.13 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 83.1 mt -53.77 -43.51 69.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.725 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.2 t -92.61 136.59 33.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.641 ' HB2' ' HZ2' ' A' ' 153' ' ' LYS . 34.8 tp -145.42 128.94 17.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.909 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.92 42.24 0.62 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.284 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -154.08 -31.31 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.801 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.541 ' HA2' ' OD1' ' A' ' 131' ' ' ASP . . . -153.9 -148.37 4.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.174 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -131.15 137.42 49.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.779 0.323 . . . . 0.0 110.827 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.501 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 60.1 t -108.72 121.82 62.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.864 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -69.17 124.32 23.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.513 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.724 HD12 ' H ' ' A' ' 115' ' ' GLY . 3.1 tm? -99.7 142.16 31.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.395 0.617 . . . . 0.0 111.804 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.575 ' H ' HD22 ' A' ' 113' ' ' LEU . 22.6 m -157.47 42.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.861 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.724 ' H ' HD12 ' A' ' 113' ' ' LEU . . . 162.0 95.81 0.11 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.629 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.32 43.28 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.354 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.513 ' O ' HD23 ' A' ' 118' ' ' LEU . 53.1 p-10 -173.13 33.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 0.0 110.647 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.62 ' HB2' HD22 ' A' ' 121' ' ' LEU . 86.1 mt -141.13 140.76 21.71 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.526 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.844 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 51.0 Cg_exo -52.54 117.36 3.58 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.579 2.186 . . . . 0.0 112.813 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.6 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 71.18 -38.03 0.41 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.63 HD23 ' HB1' ' A' ' 124' ' ' ALA . 46.5 mt 63.04 55.23 1.99 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.799 0.333 . . . . 0.0 110.789 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -76.54 48.97 0.58 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.617 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.16 -20.11 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.789 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.828 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.97 143.02 4.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 111.672 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.584 ' HD2' HH22 ' A' ' 141' ' ' ARG . 84.9 mtm180 -136.57 141.6 43.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.414 ' O ' HG21 ' A' ' 126' ' ' VAL . 33.8 m -138.13 136.2 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -114.27 113.4 24.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.49 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 3.0 m-85 -77.99 147.03 35.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.148 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 129' ' ' ARG . 38.1 ttt85 -158.07 129.34 6.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.078 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 31.1 m -89.07 139.52 30.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.02 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.541 ' OD1' ' HA2' ' A' ' 109' ' ' GLY . 82.3 m-20 -52.63 151.44 7.92 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.232 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.69 77.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.023 2.482 . . . . 0.0 112.422 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 131' ' ' ASP . 65.1 t0 -179.44 -41.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.432 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 2.9 m-85 -110.09 140.93 43.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.229 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -102.72 127.8 49.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.863 0.364 . . . . 0.0 110.573 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.444 HD21 ' HG2' ' A' ' 154' ' ' PRO . 2.7 tm? -77.35 129.34 35.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.07 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.4 t -136.82 72.46 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.24 -135.89 2.41 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.632 -1.271 . . . . 0.0 113.318 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 152' ' ' PRO . 68.6 m -76.37 54.54 0.92 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.708 0.29 . . . . 0.0 110.94 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 88.8 p -47.07 -37.46 9.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.541 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.584 HH22 ' HD2' ' A' ' 125' ' ' ARG . 40.6 ttt85 -99.4 138.27 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.505 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.1 t -150.37 132.0 14.88 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.726 0.298 . . . . 0.0 110.655 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.472 ' HB ' ' HG ' ' A' ' 150' ' ' SER . 83.5 t -117.66 127.41 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.298 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.828 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 49.9 t -71.43 140.17 49.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -169.19 129.35 1.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.592 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 56.76 40.28 29.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 59.12 22.54 55.75 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.407 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.18 132.51 24.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.648 0.261 . . . . 0.0 110.687 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -69.5 141.29 53.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.839 0.352 . . . . 0.0 111.034 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.472 ' HG ' ' HB ' ' A' ' 143' ' ' VAL . 70.0 m -57.4 -54.41 47.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.05 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.463 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 65.0 p -115.71 137.34 23.17 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.399 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.47 ' O ' ' HB2' ' A' ' 139' ' ' SER . 31.7 Cg_exo -58.76 142.2 98.54 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.817 2.345 . . . . 0.0 112.227 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.641 ' HZ2' ' HB2' ' A' ' 106' ' ' LEU . 62.6 tttp -50.42 130.93 25.89 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.247 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.444 ' HG2' HD21 ' A' ' 136' ' ' LEU . 59.4 Cg_endo -72.39 -152.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.649 2.232 . . . . 0.0 112.555 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.422 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.63 143.7 22.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.133 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 81.1 m -98.15 129.68 44.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.37 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -119.28 140.82 49.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.937 0.398 . . . . 0.0 111.516 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.07 135.92 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.786 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.888 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.629 0.252 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 64.57 134.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.457 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.89 133.84 55.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.403 ' HB2' ' H ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -70.14 -145.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.686 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.403 ' H ' ' HB2' ' A' ' 95' ' ' PHE . 35.5 m -63.96 140.13 20.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.764 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.712 ' HG2' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -66.79 -156.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.033 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 1.043 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 94.5 mt 67.19 127.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.368 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.8 m -62.48 150.52 39.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.717 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 102' ' ' SER . 57.5 m -40.68 105.07 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.543 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -69.13 15.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.719 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.495 ' H ' ' C ' ' A' ' 100' ' ' SER . 46.9 t -68.92 -35.38 76.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.061 0.458 . . . . 0.0 110.029 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -51.65 -35.19 41.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.241 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.4 mt -53.47 -43.93 68.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.211 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.4 m -92.56 128.61 38.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 34.9 tp -145.45 132.91 20.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.366 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.41 132.91 47.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.492 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 56.24 43.98 25.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.545 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.81 163.82 32.99 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.519 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.653 ' HZ1' ' HB2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -138.89 134.39 33.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.775 0.322 . . . . 0.0 110.684 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.49 HG12 ' HB ' ' A' ' 126' ' ' VAL . 57.7 t -114.13 126.96 71.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.647 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -73.34 124.82 26.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.211 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 52.9 tp -89.54 143.35 26.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.225 0.535 . . . . 0.0 112.088 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.562 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.2 m -162.37 52.4 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.395 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 161.95 103.39 0.18 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.709 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.86 47.84 0.22 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.113 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.515 ' C ' HD22 ' A' ' 118' ' ' LEU . 2.7 p30 -174.5 36.43 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.35 . . . . 0.0 111.156 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.582 HD22 ' N ' ' A' ' 118' ' ' LEU . 2.2 mm? -134.98 151.85 76.22 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.582 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.4 124.26 11.64 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.345 2.03 . . . . 0.0 111.424 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.564 ' HA ' ' HB2' ' A' ' 97' ' ' ARG . . . 53.16 32.0 12.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.069 0.461 . . . . 0.0 110.279 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 1.043 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 14.7 tp 50.58 46.73 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.927 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -66.68 141.08 57.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.122 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.8 31.36 80.65 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.469 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.678 ' CB ' ' HG ' ' A' ' 121' ' ' LEU . . . -85.65 145.17 27.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.737 0.303 . . . . 0.0 110.976 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.562 ' O ' ' HB ' ' A' ' 114' ' ' THR . 53.4 ttt-85 -160.4 127.07 4.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.692 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.49 ' HB ' HG12 ' A' ' 111' ' ' VAL . 28.3 m -137.54 136.96 46.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.68 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -102.38 122.71 44.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.123 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.565 ' HE2' ' HG3' ' A' ' 153' ' ' LYS . 5.7 m-85 -83.61 150.21 26.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.134 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -157.04 126.13 5.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.588 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 73.4 m -89.91 136.91 32.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.218 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -57.78 159.33 10.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.965 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.52 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 88.3 Cg_exo -40.89 152.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.96 2.44 . . . . 0.0 112.721 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.52 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 57.8 m-20 78.03 -34.38 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.039 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.401 ' H ' ' C ' ' A' ' 132' ' ' PRO . 2.7 m-85 -106.02 128.21 53.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.3 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -106.27 140.08 39.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.14 0.495 . . . . 0.0 111.878 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.817 HD23 ' HA ' ' A' ' 140' ' ' SER . 36.5 tp -78.11 128.44 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.704 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.42 64.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.577 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.73 -135.83 2.05 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.219 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.667 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 63.8 m -72.04 63.92 0.51 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.114 0.483 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.817 ' HA ' HD23 ' A' ' 136' ' ' LEU . 38.1 t -55.31 -16.96 3.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.467 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -140.64 136.03 32.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.89 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 79.2 p -135.57 141.87 45.23 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.436 ' H ' ' HB3' ' A' ' 150' ' ' SER . 95.5 t -135.82 126.18 42.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.066 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.449 ' HB2' ' CB ' ' A' ' 124' ' ' ALA . 57.2 m -92.95 148.46 21.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.039 0.447 . . . . 0.0 111.735 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.6 t -163.15 26.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.148 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 175.86 39.51 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.275 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 62.66 19.37 60.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.495 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -142.38 132.77 24.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.664 0.268 . . . . 0.0 110.641 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -64.56 143.01 58.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.967 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.436 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 48.5 t -57.14 -47.43 81.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.714 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.472 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 59.8 p -127.68 133.57 25.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.342 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.25 142.99 77.61 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.879 2.386 . . . . 0.0 112.619 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.565 ' HG3' ' HE2' ' A' ' 128' ' ' PHE . 87.4 tttt -48.86 128.24 14.39 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.28 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.667 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.0 Cg_endo -75.91 -150.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.704 2.269 . . . . 0.0 112.672 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.434 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.6 p-80 -153.69 151.51 29.74 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.08 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 90.2 m -98.61 137.09 37.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.727 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -120.4 135.83 54.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.362 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.65 143.63 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.973 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.4 HD21 ' HA ' ' A' ' 133' ' ' ASP . 23.5 p30 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.09 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.824 0.345 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -178.21 46.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.843 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -56.95 135.23 56.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -60.63 141.61 56.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.88 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.3 m -134.12 45.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.062 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.965 ' HG3' HG13 ' A' ' 98' ' ' ILE . 31.8 ptt180 -172.2 -164.63 0.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.984 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.965 HG13 ' HG3' ' A' ' 97' ' ' ARG . 12.8 mt 51.42 32.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.755 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.522 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 72.9 m 58.77 149.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.876 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -40.41 100.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.404 ' HG3' HD11 ' A' ' 104' ' ' LEU . 27.7 ttpp -59.9 -20.61 58.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.861 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.8 p -53.24 -33.51 53.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.292 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -56.95 -44.87 82.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.662 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.417 HD22 HG11 ' A' ' 126' ' ' VAL . 92.7 mt -49.61 -39.98 37.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.7 p -92.55 131.87 37.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.652 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.724 ' HB2' ' HZ3' ' A' ' 153' ' ' LYS . 55.4 tp -145.36 130.68 18.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.18 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.57 132.3 47.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.433 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.77 43.89 24.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.566 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.19 164.4 34.92 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.472 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -136.7 134.35 37.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.736 0.303 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 127' ' ' GLU . 86.9 t -106.48 126.07 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.391 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.58 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.5 m-85 -74.71 127.43 33.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.634 HD11 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -81.6 140.97 34.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.076 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.634 ' N ' HD11 ' A' ' 113' ' ' LEU . 28.2 m -158.1 56.11 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.083 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.422 ' H ' HD11 ' A' ' 113' ' ' LEU . . . -153.99 -101.87 0.2 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.012 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -179.97 -131.55 1.66 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.225 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.566 ' HA ' HD12 ' A' ' 98' ' ' ILE . 39.0 t70 -165.8 58.38 0.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.974 0.416 . . . . 0.0 110.34 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.582 ' N ' HD13 ' A' ' 118' ' ' LEU . 8.0 mp -131.38 156.98 79.39 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.515 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.808 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 95.6 Cg_exo -42.89 119.89 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.445 2.097 . . . . 0.0 112.468 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.675 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 72.99 -40.24 0.47 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.672 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 119' ' ' PRO . 21.2 tp 55.23 57.21 5.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.949 0.404 . . . . 0.0 110.857 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -51.19 137.1 23.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.15 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.22 33.52 64.78 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.895 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.6 ' HB2' ' HB2' ' A' ' 144' ' ' CYS . . . -84.35 148.53 26.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.523 0.201 . . . . 0.0 110.595 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.407 ' O ' ' HB ' ' A' ' 114' ' ' THR . 66.1 mtm-85 -144.87 141.96 29.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.985 0.421 . . . . 0.0 111.338 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.577 HG22 ' CE1' ' A' ' 128' ' ' PHE . 23.9 m -147.8 132.08 9.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.715 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.58 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.7 mt-10 -93.05 131.43 38.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.292 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.577 ' CE1' HG22 ' A' ' 126' ' ' VAL . 4.3 m-85 -103.47 145.84 29.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.029 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.5 ' HG2' HH11 ' A' ' 129' ' ' ARG . 2.9 ptp85 -168.89 129.98 1.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.651 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 26.2 t -89.22 150.5 22.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.235 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -52.68 155.8 3.68 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.32 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 84.9 Cg_exo -46.28 159.21 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.68 2.254 . . . . 0.0 112.149 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.511 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 25.3 m-20 78.27 -37.53 0.22 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.61 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.41 ' H ' ' C ' ' A' ' 132' ' ' PRO . 20.7 m-85 -108.05 128.96 55.13 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -108.66 133.52 52.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 111.596 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 138' ' ' GLY . 7.9 tt -71.42 137.53 48.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.02 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.663 HG21 HE21 ' A' ' 157' ' ' GLN . 42.8 t -131.37 73.08 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.769 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.5 ' N ' HD23 ' A' ' 136' ' ' LEU . . . 177.46 -133.43 2.22 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.081 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.777 ' HB2' ' HG1' ' A' ' 151' ' ' THR . 43.6 p -73.72 62.6 0.81 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 99.8 p -56.27 -14.93 3.19 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.801 -179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.638 ' HD2' ' O ' ' A' ' 141' ' ' ARG . 7.6 ppt_? -140.62 140.52 35.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.599 0.237 . . . . 0.0 110.964 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 56.1 m -136.55 148.93 47.84 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.855 0.359 . . . . 0.0 111.278 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 124' ' ' ALA . 6.7 p -143.21 129.87 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.374 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.6 ' HB2' ' HB2' ' A' ' 124' ' ' ALA . 98.3 m -75.06 174.93 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.509 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.7 t -172.21 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.452 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -150.8 49.5 0.86 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.59 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 65.68 19.35 67.08 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.259 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -142.82 132.19 23.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.548 0.213 . . . . 0.0 110.731 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.522 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 97.7 m95 -65.15 135.83 55.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.647 0.261 . . . . 0.0 110.941 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.8 t -57.48 -52.76 64.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.483 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.777 ' HG1' ' HB2' ' A' ' 139' ' ' SER . 72.7 p -104.3 146.15 32.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.971 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.403 ' HB2' ' H ' ' A' ' 153' ' ' LYS . 32.7 Cg_endo -63.83 -152.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.622 2.215 . . . . 0.0 112.739 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.763 ' HD2' ' HD2' ' A' ' 154' ' ' PRO . 59.0 tptt -121.77 123.62 27.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.262 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.763 ' HD2' ' HD2' ' A' ' 153' ' ' LYS . 98.3 Cg_endo -85.45 -146.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.66 2.24 . . . . 0.0 113.214 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -153.72 -149.28 0.28 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.912 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 85.6 m -133.07 134.83 44.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.663 HE21 HG21 ' A' ' 137' ' ' VAL . 8.3 tt0 -116.85 130.03 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.456 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.0 p -62.14 137.99 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.125 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.6 p30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.954 -179.846 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.848 0.356 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.491 ' HB2' ' H ' ' A' ' 94' ' ' GLU . . . -173.52 -135.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.713 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.491 ' H ' ' HB2' ' A' ' 93' ' ' ALA . 0.5 OUTLIER -59.95 130.22 45.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.68 0.276 . . . . 0.0 110.859 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 63.93 138.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.49 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p -172.03 134.9 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.756 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.799 ' HG2' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -65.84 -152.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.694 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.799 HG23 ' HG2' ' A' ' 97' ' ' ARG . 11.4 pt 52.63 127.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.409 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.612 ' SG ' HD22 ' A' ' 121' ' ' LEU . 3.2 p -60.7 136.04 57.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.726 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.424 ' C ' ' H ' ' A' ' 102' ' ' SER . 80.4 p -39.89 130.31 2.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.592 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -75.11 16.12 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.345 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 100' ' ' SER . 79.6 p -68.96 -44.8 72.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.866 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.574 ' HH ' ' HA ' ' A' ' 152' ' ' PRO . 3.0 m-85 -59.07 -36.83 75.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.412 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.55 HD23 HD21 ' A' ' 113' ' ' LEU . 94.9 mt -50.55 149.39 3.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.747 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.441 ' OG1' ' O ' ' A' ' 104' ' ' LEU . 30.3 p 62.66 137.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.115 -179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.634 HD11 ' HE2' ' A' ' 153' ' ' LYS . 36.1 tp -145.41 139.66 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.26 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -68.04 130.0 41.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.235 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 57.37 41.74 25.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.713 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.49 152.82 10.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.636 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.48 132.01 56.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.724 0.297 . . . . 0.0 110.685 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.563 HG22 ' HA ' ' A' ' 128' ' ' PHE . 98.5 t -108.32 121.96 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.288 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.51 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.7 m-85 -74.82 126.08 30.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.152 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -108.58 142.06 39.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.411 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.589 ' N ' HD13 ' A' ' 113' ' ' LEU . 94.7 m -163.58 97.66 0.88 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.608 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.561 ' O ' HD21 ' A' ' 118' ' ' LEU . . . 163.08 -30.26 0.27 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.883 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -41.58 150.14 0.26 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.528 -0.368 . . . . 0.0 113.901 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.596 ' O ' HD22 ' A' ' 118' ' ' LEU . 32.5 m-20 72.23 37.11 0.99 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.826 0.45 . . . . 0.0 111.704 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.596 HD22 ' O ' ' A' ' 117' ' ' ASP . 3.3 mm? -142.44 148.67 48.2 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.953 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.86 97.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.797 2.332 . . . . 0.0 112.616 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.747 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 55.64 17.06 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.574 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.857 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 10.4 mp 46.11 62.44 2.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.25 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.53 46.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.169 0.509 . . . . 0.0 110.376 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 121' ' ' LEU . . . 166.86 27.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.029 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.857 ' HB2' ' HB3' ' A' ' 121' ' ' LEU . . . -81.46 142.08 33.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.754 0.311 . . . . 0.0 111.397 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.56 130.29 34.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.621 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.657 HG21 ' HZ3' ' A' ' 149' ' ' TRP . 19.0 m -136.1 144.13 34.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.468 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.533 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 87.2 tt0 -119.09 122.05 41.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.229 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.563 ' HA ' HG22 ' A' ' 111' ' ' VAL . 9.4 m-85 -85.65 53.51 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.965 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.48 ' HB3' ' NH1' ' A' ' 129' ' ' ARG . 12.8 mtp-105 -58.88 128.62 38.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 0.0 111.001 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 61.3 m -89.55 147.21 24.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.891 179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 133' ' ' ASP . 52.6 p-10 -52.81 153.0 6.27 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.031 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.36 75.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.001 2.468 . . . . 0.0 112.755 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.5 t70 179.93 -40.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 3.5 m-85 -108.63 139.65 43.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.259 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -102.86 131.45 49.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.053 0.454 . . . . 0.0 110.757 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.722 HD21 ' HA ' ' A' ' 140' ' ' SER . 23.2 tp -69.91 131.9 45.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.982 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.1 t -136.25 67.8 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.94 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.59 -136.5 2.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.47 -1.348 . . . . 0.0 113.376 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.588 ' HG ' ' HB ' ' A' ' 151' ' ' THR . 62.2 m -74.62 58.12 0.77 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.997 0.427 . . . . 0.0 110.565 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.722 ' HA ' HD21 ' A' ' 136' ' ' LEU . 39.3 t -47.63 -44.03 26.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.416 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -102.62 133.03 48.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.968 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.411 ' HG ' ' HE3' ' A' ' 149' ' ' TRP . 45.7 t -138.32 125.23 21.18 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.64 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 96.8 t -111.89 125.62 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.086 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.62 ' HB2' ' HB1' ' A' ' 124' ' ' ALA . 73.9 m -72.83 143.35 47.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.017 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.5 p -163.51 128.69 3.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.097 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 1.5 mp0 55.79 38.21 29.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.451 . . . . 0.0 109.917 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 62.29 28.21 70.53 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.351 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -143.23 131.53 22.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.576 0.227 . . . . 0.0 110.593 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.657 ' HZ3' HG21 ' A' ' 126' ' ' VAL . 46.9 m95 -69.85 137.43 51.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 111.117 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.2 t -57.49 -56.46 21.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.644 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.588 ' HB ' ' HG ' ' A' ' 139' ' ' SER . 82.0 p -111.75 137.64 21.32 Favored Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.574 ' HA ' ' HH ' ' A' ' 103' ' ' TYR . 32.2 Cg_exo -58.41 147.17 86.96 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.879 2.386 . . . . 0.0 112.268 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.634 ' HE2' HD11 ' A' ' 106' ' ' LEU . 85.9 tttt -52.79 125.65 39.16 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.499 ' HB2' HD11 ' A' ' 136' ' ' LEU . 74.8 Cg_endo -76.78 -154.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.76 2.306 . . . . 0.0 112.655 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -153.67 150.67 28.82 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.229 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 76.5 m -97.33 134.91 39.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.228 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.461 HE22 HG12 ' A' ' 158' ' ' VAL . 2.7 tm0? -124.47 131.42 53.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.715 0.293 . . . . 0.0 110.721 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.461 HG12 HE22 ' A' ' 157' ' ' GLN . 7.3 p -74.09 129.27 36.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 111.641 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.184 -0.913 . . . . 0.0 111.091 179.758 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.639 ' H2 ' ' HD2' ' A' ' 97' ' ' ARG . 5.6 tp10 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.798 0.332 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.15 -141.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.27 -42.19 84.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.045 0.45 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.534 ' O ' ' HD3' ' A' ' 97' ' ' ARG . 1.5 m-85 -59.88 129.53 42.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.66 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.7 m -63.28 144.55 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.557 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.65 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -165.59 62.71 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.54 0.685 . . . . 0.0 111.021 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.612 ' HA ' HD11 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -145.25 133.59 16.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.104 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.566 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 39.1 m -57.1 143.77 37.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.866 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.6 t -39.88 128.56 2.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.075 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.647 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -72.73 -14.27 61.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.364 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.5 p -53.1 -47.06 68.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.53 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -59.44 -41.27 89.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.252 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.48 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 86.8 mt -51.86 -36.89 49.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.23 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.5 p -92.49 141.42 28.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.608 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.435 HD21 ' H ' ' A' ' 108' ' ' ASN . 1.9 tt -140.84 120.93 13.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.532 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 108' ' ' ASN . 3.8 mm-40 -82.64 30.05 0.43 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.435 ' H ' HD21 ' A' ' 106' ' ' LEU . 72.3 m-80 -166.14 25.68 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.54 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.15 -156.67 23.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.656 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -141.96 134.01 27.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.632 0.253 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 94.0 t -106.59 121.18 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.023 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.526 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.2 m-85 -74.78 116.35 15.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.437 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.426 HD13 HD23 ' A' ' 104' ' ' LEU . 51.2 tp -83.28 142.77 30.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.393 . . . . 0.0 111.422 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.3 m -163.28 61.17 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.393 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.767 ' HA3' ' HB3' ' A' ' 124' ' ' ALA . . . -152.39 -39.35 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.839 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.06 -125.74 7.35 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.885 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.435 ' HA ' HD13 ' A' ' 121' ' ' LEU . 52.0 p-10 -147.47 48.3 1.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.999 0.428 . . . . 0.0 111.163 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.656 ' N ' HD13 ' A' ' 118' ' ' LEU . 6.7 mp -80.77 161.38 63.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.402 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.65 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 83.6 Cg_exo -43.82 94.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.459 2.106 . . . . 0.0 112.343 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.453 ' H ' ' CG ' ' A' ' 97' ' ' ARG . . . 69.25 -9.03 0.65 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.961 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.945 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 7.6 mp 61.46 57.68 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.593 0.235 . . . . 0.0 110.883 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -75.12 49.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 110.587 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 178.99 -13.68 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.905 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.945 ' HB2' ' HB3' ' A' ' 121' ' ' LEU . . . -50.75 147.54 4.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.928 0.394 . . . . 0.0 111.335 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 143' ' ' VAL . 43.8 mmm-85 -146.25 133.57 20.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.657 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.448 HG21 ' CE1' ' A' ' 128' ' ' PHE . 35.7 m -127.03 132.13 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 111.584 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 52.4 mm-40 -103.32 138.63 39.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.839 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.448 ' CE1' HG21 ' A' ' 126' ' ' VAL . 9.6 m-85 -105.58 145.06 31.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.043 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -148.52 122.53 9.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.355 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 59.3 m -89.22 143.89 26.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.052 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 133' ' ' ASP . 1.4 m-20 -52.8 151.94 7.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.883 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.28 75.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.13 2.553 . . . . 0.0 112.722 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' ASP . 38.9 t70 178.89 -36.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.646 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -108.8 136.67 47.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.068 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -102.84 130.13 49.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 0.0 110.532 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.508 HD22 ' HA ' ' A' ' 140' ' ' SER . 35.8 tp -71.46 130.32 41.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.056 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.33 68.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.785 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 174.61 -129.21 1.55 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 119.512 -1.327 . . . . 0.0 113.347 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.723 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 30.1 t -68.86 63.63 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.89 0.376 . . . . 0.0 111.259 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.508 ' HA ' HD22 ' A' ' 136' ' ' LEU . 93.4 p -57.77 -23.99 54.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.526 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -140.61 136.17 32.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.79 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.587 ' HG ' ' HB3' ' A' ' 149' ' ' TRP . 46.7 t -127.92 125.48 39.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.559 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.438 ' H ' ' HB3' ' A' ' 150' ' ' SER . 46.3 t -97.72 120.24 46.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.244 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 52.7 t -77.94 122.94 26.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.506 ' HG ' ' H ' ' A' ' 146' ' ' GLN . 88.4 p -104.65 -123.72 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.703 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.506 ' H ' ' HG ' ' A' ' 145' ' ' SER . 52.3 tt0 -75.88 55.89 0.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.68 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.03 21.13 66.13 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.776 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -143.09 137.07 28.91 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.65 0.262 . . . . 0.0 111.239 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.587 ' HB3' ' HG ' ' A' ' 142' ' ' SER . 83.3 m95 -67.24 139.79 57.37 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.875 0.369 . . . . 0.0 111.51 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.438 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 46.7 t -57.49 -53.86 53.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.978 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.4 t -127.06 141.41 40.59 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.698 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.3 145.32 98.19 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.174 2.583 . . . . 0.0 112.979 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -49.91 134.76 21.24 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.381 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.723 ' HB3' ' H ' ' A' ' 139' ' ' SER . 97.0 Cg_endo -79.48 -149.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.749 2.299 . . . . 0.0 112.759 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.417 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.2 p-80 -153.72 145.71 23.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 75.2 m -96.81 127.52 42.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.544 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -111.09 129.48 55.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.064 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.22 136.29 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.826 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.886 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 54.1 mt-10 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.704 0.288 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.77 42.53 31.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 15.9 pt-20 -174.24 135.69 0.46 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.757 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -172.65 131.56 0.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.027 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.24 141.35 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.286 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.637 ' HD3' ' N ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -167.29 110.19 0.67 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.278 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.496 HD11 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -161.38 141.5 3.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.693 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.525 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 61.2 m -55.88 135.7 51.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.509 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.4 p -42.15 127.27 3.49 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -77.86 16.23 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.5 m -68.26 -42.25 79.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 110.359 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.503 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.2 m-85 -62.03 -46.28 89.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.728 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.711 HD11 HD12 ' A' ' 113' ' ' LEU . 92.4 mt -64.64 -30.63 71.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.979 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.2 p -92.46 72.63 5.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.633 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.639 HD22 ' H ' ' A' ' 109' ' ' GLY . 1.3 tt -94.54 124.27 38.46 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.525 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 38.5 tt0 -81.84 34.99 0.41 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.082 0.468 . . . . 0.0 111.38 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.536 ' N ' HD22 ' A' ' 106' ' ' LEU . 7.3 m120 -160.75 -49.17 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.4 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.639 ' H ' HD22 ' A' ' 106' ' ' LEU . . . -86.68 -151.96 20.51 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.964 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.481 ' O ' HG13 ' A' ' 111' ' ' VAL . 86.0 tttt -142.04 -42.33 0.34 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.811 0.339 . . . . 0.0 110.602 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 104' ' ' LEU . 10.5 p 48.55 115.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.947 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -75.17 127.48 33.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.111 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.711 HD12 HD11 ' A' ' 104' ' ' LEU . 56.3 tp -90.84 146.23 24.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.065 179.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 24.8 m -157.11 53.97 0.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.398 0.618 . . . . 0.0 109.912 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.96 107.68 0.2 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.702 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.53 140.67 7.72 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.862 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 9.4 t70 73.87 53.38 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.137 0.494 . . . . 0.0 111.073 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.3 mp -140.27 152.4 66.89 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.657 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.515 ' HA ' ' CG ' ' A' ' 97' ' ' ARG . 14.3 Cg_endo -57.24 113.75 1.63 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.228 1.952 . . . . 0.0 110.999 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.408 ' H ' ' CG ' ' A' ' 97' ' ' ARG . . . 56.55 18.27 3.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.143 0.497 . . . . 0.0 109.887 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.569 ' HG ' ' CB ' ' A' ' 124' ' ' ALA . 14.9 tp 45.54 42.94 8.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.069 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -62.78 137.39 58.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.63 37.53 61.8 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.979 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.785 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -98.73 142.76 29.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.685 0.279 . . . . 0.0 110.867 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.506 ' O ' ' HB ' ' A' ' 114' ' ' THR . 66.2 mtm-85 -131.49 138.54 49.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.94 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 126' ' ' VAL . 28.6 m -144.53 134.75 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.273 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -113.68 105.93 13.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.39 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.521 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 66.3 m-85 -68.78 146.49 52.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.102 0.477 . . . . 0.0 111.625 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' A' ' 129' ' ' ARG . 41.3 ttt85 -153.16 125.42 8.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.657 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.603 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 56.5 m -89.26 139.97 29.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.558 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.508 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 47.4 p-10 -54.26 161.09 2.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.703 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.542 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 1.8 Cg_endo -45.04 152.44 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.835 2.357 . . . . 0.0 111.899 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.542 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 35.0 t70 79.62 -29.57 0.14 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -106.45 132.43 52.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.711 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -112.28 136.02 52.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.992 0.425 . . . . 0.0 111.191 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.468 HD21 ' CB ' ' A' ' 140' ' ' SER . 29.6 tp -77.3 129.77 36.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.3 t -136.2 68.91 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.861 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 176.82 -129.99 1.57 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.267 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.733 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 31.3 t -70.06 62.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.035 0.445 . . . . 0.0 111.206 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.468 ' CB ' HD21 ' A' ' 136' ' ' LEU . 36.2 t -58.13 -23.13 53.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.81 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -127.28 139.71 52.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.654 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.449 ' HG ' ' HB3' ' A' ' 149' ' ' TRP . 47.6 t -144.48 134.82 24.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.687 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -122.54 125.56 72.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.785 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 7.5 m -64.46 148.46 50.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.331 0.586 . . . . 0.0 112.091 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.6 p -166.82 124.26 1.29 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.32 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 59.3 39.02 22.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.082 0.468 . . . . 0.0 110.079 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 62.11 24.1 64.74 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.659 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -142.42 135.93 29.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.505 0.193 . . . . 0.0 110.81 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.449 ' HB3' ' HG ' ' A' ' 142' ' ' SER . 59.5 m95 -64.33 133.03 51.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.741 0.305 . . . . 0.0 110.546 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -57.44 -59.43 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.009 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.9 p -94.11 135.48 24.54 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.778 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.16 142.91 82.37 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.726 2.284 . . . . 0.0 111.915 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.493 ' HZ2' ' HA ' ' A' ' 106' ' ' LEU . 88.0 tttt -50.72 129.29 27.41 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.302 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.733 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.8 Cg_endo -75.69 -148.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.692 2.261 . . . . 0.0 112.47 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.438 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 15.5 p-80 -153.69 143.32 21.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.172 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 88.3 m -97.63 130.85 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.031 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -124.02 143.36 50.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.184 0.516 . . . . 0.0 111.794 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 4.5 t -66.0 137.27 25.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.982 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.2 p30 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.173 -0.917 . . . . 0.0 111.002 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.498 0.19 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.91 49.65 0.01 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.758 0.313 . . . . 0.0 111.243 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -170.88 138.46 1.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.021 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.435 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 2.1 m-85 -61.25 130.7 47.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.393 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.36 126.9 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.611 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.862 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 13.0 ttp-105 -175.97 -155.98 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.269 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.862 ' H ' ' HG2' ' A' ' 97' ' ' ARG . 4.4 pt -56.96 140.24 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.029 0.443 . . . . 0.0 111.82 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.68 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 2.4 p -53.5 136.55 38.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.698 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.485 ' C ' ' H ' ' A' ' 102' ' ' SER . 46.8 t -40.4 128.83 2.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.973 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -74.46 23.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.528 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 100' ' ' SER . 77.7 p -68.87 -41.16 78.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.029 0.442 . . . . 0.0 110.506 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.488 ' C ' ' H ' ' A' ' 105' ' ' THR . 1.7 m-85 -67.92 -25.29 65.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.449 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.44 HD21 ' HA ' ' A' ' 104' ' ' LEU . 79.0 mt -68.86 23.9 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.488 ' H ' ' C ' ' A' ' 103' ' ' TYR . 9.2 t -148.36 129.55 14.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.504 HD23 ' SG ' ' A' ' 130' ' ' CYS . 43.5 tp -145.44 127.37 15.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 107' ' ' GLU . 41.9 tp10 -82.36 46.15 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.095 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -158.89 -30.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.215 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.617 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -158.33 -150.77 5.86 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.386 -0.912 . . . . 0.0 113.349 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -130.23 152.07 50.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.816 0.341 . . . . 0.0 111.005 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.43 HG23 ' CE2' ' A' ' 128' ' ' PHE . 61.0 t -105.79 126.4 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -80.17 69.18 6.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.973 ' HA ' HG11 ' A' ' 126' ' ' VAL . 3.3 tm? -63.73 145.12 56.35 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.558 ' N ' HD12 ' A' ' 113' ' ' LEU . 56.4 m -149.06 81.74 1.43 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.022 0.439 . . . . 0.0 111.391 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 177.03 -103.01 0.17 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.216 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.627 ' H ' HD23 ' A' ' 121' ' ' LEU . . . 59.58 144.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.073 0.389 . . . . 0.0 114.073 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.44 ' HB2' ' O ' ' A' ' 116' ' ' GLY . 57.6 m-20 71.86 49.84 0.25 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.465 ' C ' ' H ' ' A' ' 120' ' ' ALA . 3.4 mm? -142.23 138.68 16.88 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.883 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.807 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 70.1 Cg_endo -74.55 33.94 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.376 2.051 . . . . 0.0 112.192 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.465 ' H ' ' C ' ' A' ' 118' ' ' LEU . . . 172.19 -44.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.732 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.845 ' HB2' HG23 ' A' ' 98' ' ' ILE . 15.2 tp 59.7 43.9 14.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 64.4 t0 -79.97 58.49 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.822 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.37 -27.09 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.738 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.714 ' HB1' ' HB3' ' A' ' 144' ' ' CYS . . . -48.83 153.53 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.063 0.458 . . . . 0.0 111.707 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -139.5 136.67 34.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.369 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.973 HG11 ' HA ' ' A' ' 113' ' ' LEU . 29.1 m -125.66 139.26 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.07 0.462 . . . . 0.0 111.942 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -120.71 98.24 5.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.397 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.467 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 4.6 m-85 -64.65 147.45 52.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.347 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -159.95 115.52 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.409 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.617 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 91.7 m -89.17 149.16 23.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.456 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.454 ' OD1' ' HA2' ' A' ' 109' ' ' GLY . 1.3 m-20 -52.7 158.35 2.2 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.083 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.519 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 99.3 Cg_exo -43.04 159.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.906 2.404 . . . . 0.0 112.564 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 49.8 m-20 80.76 -31.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.79 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.86 143.97 33.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.414 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -133.99 131.31 38.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.973 0.416 . . . . 0.0 111.015 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' A' ' 154' ' ' PRO . 24.4 tp -78.32 133.77 37.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.668 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.99 71.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.66 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.67 -133.61 2.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.955 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.586 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 58.7 m -76.05 54.82 0.88 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.739 0.304 . . . . 0.0 110.958 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.426 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 95.7 p -50.0 -41.31 46.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -99.38 130.23 45.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.482 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.456 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 44.0 t -134.9 127.27 30.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.902 0.382 . . . . 0.0 110.74 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.5 t -93.81 128.67 45.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.357 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.714 ' HB3' ' HB1' ' A' ' 124' ' ' ALA . 48.9 t -83.03 134.43 35.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.887 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 79.3 p -175.04 132.95 0.32 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.972 0.415 . . . . 0.0 111.853 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 53.53 46.29 26.42 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.881 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.68 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . 52.76 23.35 14.52 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.961 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -142.49 130.22 21.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.66 0.267 . . . . 0.0 110.824 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.456 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 65.3 m95 -75.98 135.18 40.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 111.03 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 m -57.52 -53.98 51.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.036 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 80.8 p -107.5 129.53 24.11 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.477 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 139' ' ' SER . 38.8 Cg_exo -60.74 142.87 98.97 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.745 2.296 . . . . 0.0 111.866 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 57.1 tttm -51.76 125.87 30.74 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.305 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.586 ' HB3' ' H ' ' A' ' 139' ' ' SER . 80.8 Cg_endo -79.26 -149.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.666 2.244 . . . . 0.0 112.433 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.462 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 15.2 p-80 -153.95 141.47 19.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.741 0.305 . . . . 0.0 111.446 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 95.1 m -98.58 132.76 43.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.602 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -103.03 133.92 47.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.426 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.86 138.67 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.738 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 133' ' ' ASP . 24.6 p30 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.029 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.599 0.238 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.07 134.26 56.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.939 0.4 . . . . 0.0 111.271 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -66.25 135.73 54.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.043 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -60.62 -44.45 96.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.769 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -172.38 129.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.82 ' HD3' ' H ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -68.68 -176.31 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.455 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.634 HD13 ' N ' ' A' ' 98' ' ' ILE . 1.6 mp 68.94 135.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.943 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.4 ' O ' ' C ' ' A' ' 100' ' ' SER . 69.4 m -57.44 146.54 29.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.518 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 99' ' ' CYS . 52.8 m -35.85 120.98 0.63 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.017 0.437 . . . . 0.0 111.491 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.595 ' HB3' ' HZ3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -72.82 3.22 5.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.883 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.6 p -66.48 -41.95 88.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.353 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.553 ' HD2' ' HZ ' ' A' ' 128' ' ' PHE . 2.1 m-85 -54.23 -42.28 69.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.307 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.25 -35.89 74.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 111.079 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -92.55 69.39 4.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.41 HD11 ' CE ' ' A' ' 153' ' ' LYS . 28.7 tp -94.61 130.99 40.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.187 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -67.57 136.06 53.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.289 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.508 ' HB3' ' OD1' ' A' ' 131' ' ' ASP . 75.4 m-20 55.83 44.11 26.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.353 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.59 164.65 34.44 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.493 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -136.99 130.91 32.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 0.0 110.489 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.541 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 48.5 t -106.5 123.09 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.573 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.3 m-85 -78.4 125.84 29.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.019 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 60.8 tp -85.18 150.91 24.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.252 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.8 m -156.59 56.8 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.531 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -157.0 -105.15 0.22 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.21 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.57 -127.43 1.34 Allowed Glycine 0 CA--C 1.516 0.146 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.752 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -152.15 41.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.298 0.57 . . . . 0.0 110.466 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.5 mt -95.02 152.01 39.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.36 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.461 ' HA ' ' CB ' ' A' ' 97' ' ' ARG . 86.6 Cg_exo -42.96 123.11 3.01 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.369 2.046 . . . . 0.0 111.998 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.662 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 73.63 -37.44 0.37 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.401 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.481 ' HG ' ' HB1' ' A' ' 124' ' ' ALA . 22.9 tp 55.88 45.15 24.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 111.18 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.495 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 8.1 t70 -65.51 133.42 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.69 -28.54 13.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.477 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.78 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.15 143.3 3.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.742 0.306 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.45 HH11 ' HG3' ' A' ' 125' ' ' ARG . 40.6 mmm-85 -129.6 144.9 51.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.21 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.573 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 32.8 m -142.38 134.93 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.553 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -107.97 116.84 32.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.704 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.553 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.5 m-85 -80.16 147.68 31.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.993 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -156.19 124.91 5.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.974 0.416 . . . . 0.0 110.815 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 136' ' ' LEU . 68.7 m -89.52 146.42 24.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.119 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.508 ' OD1' ' HB3' ' A' ' 108' ' ' ASN . 12.1 p-10 -55.28 154.97 10.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.735 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.538 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 2.3 Cg_endo -45.08 155.38 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.935 2.423 . . . . 0.0 111.906 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.4 m-20 78.57 -34.72 0.17 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.776 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.605 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 10.7 m-85 -106.53 126.51 52.36 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -106.89 137.19 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 111.296 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.845 HD21 ' HA ' ' A' ' 140' ' ' SER . 33.6 tp -71.24 136.84 48.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.724 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.31 67.78 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.577 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.75 -136.06 2.32 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.295 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.551 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 92.9 p -74.13 59.74 0.76 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.873 0.368 . . . . 0.0 110.75 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.845 ' HA ' HD21 ' A' ' 136' ' ' LEU . 97.0 p -47.94 -34.72 9.53 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.179 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.426 HH11 ' HG3' ' A' ' 141' ' ' ARG . 21.2 mmt85 -109.55 138.79 45.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.706 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.407 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 45.3 t -143.57 127.03 16.84 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 24.0 t -103.91 117.8 50.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.775 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 50.7 t -71.82 140.43 49.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.936 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 43.8 t -169.43 131.97 1.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.819 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.433 ' HA ' ' HB2' ' A' ' 120' ' ' ALA . 26.1 mt-30 56.35 41.8 28.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.583 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.67 25.06 50.25 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -141.68 132.51 25.83 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.489 0.185 . . . . 0.0 110.662 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.407 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 72.6 m95 -71.26 138.95 49.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.074 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.9 t -57.44 -58.46 8.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.279 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 82.8 p -101.78 136.55 19.52 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.6 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 33.3 Cg_exo -60.44 138.83 83.1 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.736 2.291 . . . . 0.0 111.954 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 103' ' ' TYR . 84.5 tttt -47.99 131.48 12.01 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.341 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.551 ' HB3' ' H ' ' A' ' 139' ' ' SER . 88.4 Cg_endo -84.37 -148.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.873 2.382 . . . . 0.0 113.029 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.425 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.6 p-80 -153.66 149.69 27.81 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.965 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 91.4 m -97.91 136.16 38.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.01 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -136.93 133.98 36.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 134' ' ' PHE . 8.7 p -65.6 142.55 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.277 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.491 ' N ' HG22 ' A' ' 158' ' ' VAL . 74.6 m-20 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.748 0.309 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.16 44.81 15.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.212 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -174.83 -50.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.106 0.479 . . . . 0.0 110.686 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -81.45 55.52 2.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.874 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.504 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 97.1 t -140.12 140.68 34.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.257 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.774 ' HD2' ' HA ' ' A' ' 119' ' ' PRO . 37.9 ptt180 44.01 -147.61 0.07 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.411 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.771 HG22 ' HG3' ' A' ' 97' ' ' ARG . 14.7 pt 48.27 30.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.52 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.495 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 36.1 m 55.97 142.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.3 p -44.08 130.67 6.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.944 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.413 ' HA ' ' HG ' ' A' ' 104' ' ' LEU . 18.0 ptpt -77.45 10.75 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.513 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.2 m -68.93 -44.76 72.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 110.693 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 103' ' ' TYR . 1.2 m-85 -62.63 -33.1 74.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.253 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.486 HD22 HD21 ' A' ' 113' ' ' LEU . 65.8 mt -49.8 -45.45 49.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.1 t -92.51 138.65 31.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.109 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.47 HD22 ' HA3' ' A' ' 109' ' ' GLY . 28.6 tp -143.75 126.41 16.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.023 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.483 ' HG3' ' ND2' ' A' ' 108' ' ' ASN . 17.0 tp10 -73.45 124.59 26.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.018 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.483 ' ND2' ' HG3' ' A' ' 107' ' ' GLU . 74.4 m-20 56.3 49.15 15.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.524 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.47 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -170.74 148.42 11.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.891 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.702 ' HB2' ' HD2' ' A' ' 129' ' ' ARG . 55.1 mtpt -102.53 138.84 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.417 ' CG1' HG22 ' A' ' 126' ' ' VAL . 59.5 t -111.74 119.22 59.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.541 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.523 ' C ' HG23 ' A' ' 126' ' ' VAL . 2.6 m-85 -83.14 60.43 5.51 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.268 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.486 HD21 HD22 ' A' ' 104' ' ' LEU . 63.2 tp -59.52 145.99 42.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.15 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.638 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 27.1 m -158.86 53.31 0.41 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.587 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.667 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . 177.14 105.08 0.19 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.147 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.547 ' N ' HD22 ' A' ' 121' ' ' LEU . . . -163.12 138.16 5.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.784 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.466 ' O ' HD12 ' A' ' 118' ' ' LEU . 8.2 t70 73.2 42.21 0.45 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.98 0.419 . . . . 0.0 111.055 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.78 ' HB2' HD23 ' A' ' 121' ' ' LEU . 9.5 mp -137.38 150.1 67.63 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.774 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 92.7 Cg_exo -44.87 89.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.987 2.458 . . . . 0.0 112.818 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 56.0 13.58 1.18 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.734 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.781 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 58.7 mt 50.09 60.32 3.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.538 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.799 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 9.1 t70 -76.11 45.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.229 0.538 . . . . 0.0 110.412 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.59 25.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.127 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.781 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -84.13 153.19 23.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.719 0.295 . . . . 0.0 111.002 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.638 ' O ' ' HB ' ' A' ' 114' ' ' THR . 4.4 tmm_? -151.48 140.67 21.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.441 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.523 HG23 ' C ' ' A' ' 112' ' ' PHE . 1.6 p -151.35 148.28 14.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.493 0.663 . . . . 0.0 112.107 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -113.3 118.11 33.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.689 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.499 ' HE1' HG12 ' A' ' 126' ' ' VAL . 6.3 m-85 -89.0 145.58 25.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.097 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.702 ' HD2' ' HB2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -159.57 138.94 11.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.437 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.445 ' SG ' HD22 ' A' ' 136' ' ' LEU . 66.0 m -89.24 144.21 26.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.681 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.538 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 9.0 p-10 -54.02 160.68 2.15 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 131' ' ' ASP . 2.8 Cg_endo -44.98 149.72 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.86 2.374 . . . . 0.0 111.692 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.538 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 36.1 t70 80.64 -31.37 0.12 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.578 -178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -108.86 132.44 54.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.191 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -108.94 148.09 31.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.169 0.509 . . . . 0.0 111.925 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.5 ' CD1' ' HB2' ' A' ' 140' ' ' SER . 1.1 tm? -79.2 128.73 33.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.701 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.63 60.31 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.66 0.266 . . . . 0.0 111.602 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.65 -133.85 1.87 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.206 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.576 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 63.9 m -73.4 59.64 0.6 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.392 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.5 ' HB2' ' CD1' ' A' ' 136' ' ' LEU . 38.9 t -62.49 -2.48 1.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.432 ' H ' ' C ' ' A' ' 139' ' ' SER . 79.2 ttt180 -140.65 133.96 29.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.517 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 61.2 m -147.41 134.02 19.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.52 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.488 HG11 ' O ' ' A' ' 124' ' ' ALA . 94.3 t -128.73 122.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 111.316 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.679 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 55.4 m -85.16 140.87 30.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.497 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.799 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 79.7 p -169.65 31.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.063 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 177.47 34.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.061 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 59.6 14.97 31.02 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.465 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -142.63 133.73 25.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.536 0.208 . . . . 0.0 110.686 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.495 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 74.2 m95 -66.89 137.61 56.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.699 0.285 . . . . 0.0 110.761 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.0 m -57.39 -56.22 24.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.552 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 66.9 p -106.23 136.69 19.31 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.764 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 53.2 Cg_exo -55.89 151.58 40.31 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.865 2.377 . . . . 0.0 112.187 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.451 ' HE3' HD12 ' A' ' 106' ' ' LEU . 4.8 tmtm? -51.21 121.74 16.96 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.575 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.576 ' HB3' ' N ' ' A' ' 139' ' ' SER . 47.7 Cg_endo -69.71 -160.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.676 2.25 . . . . 0.0 112.975 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.74 148.98 27.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.72 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 97.1 m -97.88 139.6 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 0.0 111.408 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -130.98 129.77 42.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.1 p -63.7 143.31 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.189 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.429 ' N ' HD21 ' A' ' 159' ' ' ASN . 2.6 m120 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.973 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.808 0.337 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.3 39.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.8 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -66.8 140.91 57.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.021 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -56.81 146.28 26.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.435 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.7 136.3 26.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.371 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.556 ' HG2' ' HA ' ' A' ' 119' ' ' PRO . 25.2 ttm-85 -91.59 104.06 16.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.584 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.663 ' N ' HD12 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -162.27 42.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.497 178.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 149' ' ' TRP . 80.4 m 64.27 133.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.243 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.514 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 37.3 t -41.56 127.69 3.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.905 0.383 . . . . 0.0 111.245 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -75.5 -37.42 60.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.503 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 105' ' ' THR . 47.9 t -53.21 -43.38 67.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.664 -179.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.782 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.4 m-85 -59.38 -34.89 72.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.514 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 104' ' ' LEU . 89.3 mt -55.22 -43.87 74.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.988 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 102' ' ' SER . 6.9 t -92.55 145.98 24.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.975 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 tp -144.36 130.1 19.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.342 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.15 132.95 42.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.392 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.406 ' N ' HD21 ' A' ' 108' ' ' ASN . 2.6 m120 57.49 41.01 26.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.614 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.97 152.0 10.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.057 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -104.78 154.02 20.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.58 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.465 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 99.1 t -131.17 118.52 41.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.298 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.591 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.2 m-85 -73.08 80.08 1.23 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.513 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.703 ' HA ' HG13 ' A' ' 126' ' ' VAL . 7.7 tt -51.88 140.25 20.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.155 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.629 ' N ' HD22 ' A' ' 113' ' ' LEU . 20.6 m -153.33 53.73 0.74 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.267 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.744 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . 128.0 110.24 1.55 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.869 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -171.31 50.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.024 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.611 ' HA ' ' HB ' ' A' ' 98' ' ' ILE . 12.3 p-10 -171.29 39.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 110.821 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.588 ' HB2' ' HB2' ' A' ' 121' ' ' LEU . 3.2 mm? -145.36 153.68 52.39 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.248 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.556 ' HA ' ' HG2' ' A' ' 97' ' ' ARG . 5.0 Cg_endo -48.41 81.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.959 2.439 . . . . 0.0 111.873 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 75.2 -40.81 0.44 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.035 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.635 HD23 ' HB1' ' A' ' 124' ' ' ALA . 19.2 tp 53.07 58.98 4.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.06 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.35 84.5 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.588 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 121' ' ' LEU . . . 163.9 -35.8 0.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.912 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.744 ' HB1' ' HA3' ' A' ' 115' ' ' GLY . . . -49.81 150.67 2.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.725 0.298 . . . . 0.0 111.171 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.549 ' O ' ' HB ' ' A' ' 114' ' ' THR . 58.6 ttp180 -157.67 118.02 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.232 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.703 HG13 ' HA ' ' A' ' 113' ' ' LEU . 30.4 m -97.89 133.65 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.591 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.2 mt-10 -92.56 115.99 28.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -76.33 150.88 36.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.996 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.465 ' HG2' HH11 ' A' ' 129' ' ' ARG . 11.3 tpt180 -158.65 131.78 7.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 83.6 m -90.28 155.71 18.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.155 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -52.6 158.03 2.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.223 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.55 62.97 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.178 2.585 . . . . 0.0 112.737 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -177.12 -29.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.781 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.457 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 4.1 m-85 -108.66 139.91 42.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.335 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.412 ' H ' ' ND1' ' A' ' 135' ' ' HIS . 16.5 p-80 -102.85 133.37 48.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.179 -179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.68 HD22 ' HA ' ' A' ' 140' ' ' SER . 37.1 tp -76.17 131.16 39.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.871 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.3 t -135.92 68.04 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.789 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.54 -131.94 1.76 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.151 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.539 ' HG ' ' HD3' ' A' ' 154' ' ' PRO . 62.5 p -71.39 63.29 0.38 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 110.661 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.68 ' HA ' HD22 ' A' ' 136' ' ' LEU . 93.0 p -55.67 -20.28 13.61 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.911 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -140.59 136.58 32.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 111.141 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.574 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 60.5 m -129.58 136.22 49.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.708 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.487 HG11 ' O ' ' A' ' 124' ' ' ALA . 82.2 t -117.85 132.82 66.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.274 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 75.4 m -60.19 142.74 53.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.299 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.7 t -173.02 120.01 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 58.15 42.68 21.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.902 0.382 . . . . 0.0 110.782 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 64.48 11.57 48.38 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.667 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -142.84 135.66 27.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.271 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 54.4 m95 -67.22 142.23 57.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.669 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.4 m -55.08 -57.48 11.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.8 p -98.91 133.78 22.02 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.807 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.08 -160.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.315 2.01 . . . . 0.0 112.255 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.782 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 4.5 mmmp? -84.95 130.23 53.25 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.831 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.675 ' HD2' ' HZ1' ' A' ' 153' ' ' LYS . 90.1 Cg_endo -81.1 -151.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.636 2.224 . . . . 0.0 112.545 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.4 p-80 -153.73 139.94 18.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 78.6 m -98.71 127.72 44.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.541 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -105.17 141.03 37.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.337 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.407 HG21 ' N ' ' A' ' 159' ' ' ASN . 7.5 p -60.31 140.22 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.078 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.407 ' N ' HG21 ' A' ' 158' ' ' VAL . 24.3 p30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.971 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.508 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 8.9 mp0 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.712 0.291 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 58.04 45.78 17.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.508 ' HG2' ' HB3' ' A' ' 92' ' ' GLU . 66.4 mm-40 -81.53 47.29 1.04 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.75 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.429 ' CE1' HG13 ' A' ' 96' ' ' VAL . 21.4 t80 -69.71 134.85 49.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.734 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 98' ' ' ILE . 35.5 m 40.37 46.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.193 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.79 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -61.36 129.65 42.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.813 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.538 HG21 ' O ' ' A' ' 97' ' ' ARG . 1.5 pp -166.98 146.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.499 0.666 . . . . 0.0 112.003 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.637 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 3.6 m -83.36 146.09 28.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.144 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.4 m -40.21 121.21 1.32 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 111.029 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -70.73 -24.06 62.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.154 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.5 t -53.05 -42.15 65.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.722 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -62.93 -42.96 99.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.545 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.421 ' O ' HG21 ' A' ' 111' ' ' VAL . 94.2 mt -57.07 -38.24 73.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.414 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 t -92.5 135.69 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 111.312 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.66 HD11 ' HZ3' ' A' ' 153' ' ' LYS . 21.3 tp -145.41 129.76 17.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.715 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -81.4 38.52 0.49 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.49 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.9 p30 177.21 26.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.388 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.582 ' O ' ' HB3' ' A' ' 106' ' ' LEU . . . 168.84 155.89 10.08 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.535 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.712 ' HZ1' ' HB2' ' A' ' 110' ' ' LYS . 9.8 mtmp? -101.32 146.01 28.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.116 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.421 HG21 ' O ' ' A' ' 104' ' ' LEU . 64.5 t -105.4 120.77 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 111.38 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.419 ' CE1' ' HD2' ' A' ' 129' ' ' ARG . 1.6 m-85 -84.59 68.26 10.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.841 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.863 ' HA ' HG13 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -62.56 147.52 48.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.02 0.438 . . . . 0.0 111.295 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.9 m -133.2 70.84 1.46 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.1 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.464 ' HA3' HD22 ' A' ' 121' ' ' LEU . . . -165.18 -98.25 0.12 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.94 -179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 61.06 127.6 0.01 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.391 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 62.1 t0 60.31 49.48 7.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.973 0.416 . . . . 0.0 111.369 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.642 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 68.8 mt -131.83 143.3 48.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.732 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.79 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 50.6 Cg_exo -52.5 85.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.667 2.245 . . . . 0.0 111.581 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.427 ' H ' ' CG ' ' A' ' 97' ' ' ARG . . . 61.79 17.11 8.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.202 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.642 ' HG ' ' HB2' ' A' ' 118' ' ' LEU . 7.4 mp 40.72 53.84 3.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.844 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.43 45.59 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.228 0.537 . . . . 0.0 110.234 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 121' ' ' LEU . . . -176.2 -25.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.779 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -57.51 147.4 26.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.875 0.369 . . . . 0.0 111.211 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.468 ' HG2' HH11 ' A' ' 125' ' ' ARG . 50.5 ttp85 -133.36 137.81 46.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.629 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.863 HG13 ' HA ' ' A' ' 113' ' ' LEU . 32.8 m -120.12 135.76 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.017 0.437 . . . . 0.0 111.643 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -112.89 113.58 25.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.095 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -76.01 141.86 42.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 111.654 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.419 ' HD2' ' CE1' ' A' ' 112' ' ' PHE . 71.1 mtt-85 -148.91 108.88 4.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.117 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 95.6 m -89.54 160.75 16.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.957 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -52.69 156.6 3.12 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.448 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.5 56.07 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.06 2.507 . . . . 0.0 112.588 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -153.07 -37.45 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.648 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -108.8 134.18 51.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.636 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -101.22 132.92 46.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.171 0.51 . . . . 0.0 111.176 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.677 HD23 ' HA ' ' A' ' 140' ' ' SER . 23.0 tp -76.39 129.99 37.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.693 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.5 t -136.3 61.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.697 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.14 -138.01 2.41 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.503 -1.332 . . . . 0.0 113.406 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.641 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.4 m -74.6 57.8 0.75 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 110.975 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.677 ' HA ' HD23 ' A' ' 136' ' ' LEU . 38.0 t -49.94 -38.36 36.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.001 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.04 136.18 44.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 53.4 m -146.42 125.99 13.31 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.811 0.339 . . . . 0.0 111.304 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 76.5 t -104.95 125.39 59.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.669 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 48.1 t -71.42 151.86 43.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.099 0.476 . . . . 0.0 111.587 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -168.72 122.97 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.892 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.6 tt0 54.48 43.23 30.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.263 0.554 . . . . 0.0 109.634 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 58.01 29.2 61.95 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.858 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -139.69 131.34 27.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.641 0.258 . . . . 0.0 110.408 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.455 ' HZ3' HG12 ' A' ' 126' ' ' VAL . 73.0 m95 -75.45 139.34 42.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 111.625 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.1 t -57.42 -58.48 8.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.199 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.589 ' HB ' ' HG ' ' A' ' 139' ' ' SER . 77.3 p -106.93 134.64 19.77 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.514 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 139' ' ' SER . 35.5 Cg_exo -57.8 142.41 96.16 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.668 2.246 . . . . 0.0 112.041 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.66 ' HZ3' HD11 ' A' ' 106' ' ' LEU . 87.2 tttt -51.62 125.86 29.43 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.131 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.641 ' HB3' ' N ' ' A' ' 139' ' ' SER . 61.1 Cg_endo -73.21 -152.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.595 2.197 . . . . 0.0 112.427 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.437 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.7 p-80 -153.68 133.67 13.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.905 0.383 . . . . 0.0 111.295 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 16.6 m -98.83 132.46 44.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.912 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -124.38 139.66 53.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.051 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.97 134.52 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.3 p30 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.984 -179.858 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.715 0.293 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.34 -42.4 98.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.94 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 57.06 44.27 22.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.016 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.5 t80 64.42 132.4 0.02 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.219 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 96' ' ' VAL . 36.0 m -64.76 135.84 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.662 ' HD3' ' H ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -65.41 -155.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.18 -179.675 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.59 HG12 ' O ' ' A' ' 97' ' ' ARG . 15.3 pt 51.81 134.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.856 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.56 ' HB2' ' NE1' ' A' ' 149' ' ' TRP . 2.4 p -62.01 136.84 58.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.563 178.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -40.02 127.54 2.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.253 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -77.43 14.94 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.434 -179.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -68.9 -39.01 79.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.027 0.442 . . . . 0.0 110.432 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.774 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.6 m-85 -56.3 -34.08 66.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.523 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.592 HD11 HD22 ' A' ' 113' ' ' LEU . 86.3 mt -74.71 38.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.685 -179.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.402 ' H ' ' C ' ' A' ' 103' ' ' TYR . 74.2 m -147.46 114.48 6.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 111.0 179.626 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.5 mt -145.5 128.21 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -82.58 43.13 0.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -177.02 -43.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.017 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 130' ' ' CYS . . . -79.11 -162.37 23.19 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.732 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.536 ' O ' HG11 ' A' ' 111' ' ' VAL . 22.7 tptm -142.12 -43.81 0.34 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.723 0.297 . . . . 0.0 110.805 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.692 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 11.9 p 49.1 120.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.015 179.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.48 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.3 m-85 -84.38 117.92 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.579 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.592 HD22 HD11 ' A' ' 104' ' ' LEU . 55.1 tp -83.52 145.51 28.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 111.447 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.0 m -158.51 53.06 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.803 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.988 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . 165.33 105.48 0.19 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.825 -179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.64 140.02 6.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.634 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.455 ' O ' HD21 ' A' ' 118' ' ' LEU . 57.2 m-20 62.52 43.98 7.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.86 0.362 . . . . 0.0 111.216 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.553 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 84.5 mt -134.82 144.68 51.54 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.428 ' C ' ' H ' ' A' ' 121' ' ' LEU . 82.3 Cg_exo -46.18 96.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.965 2.443 . . . . 0.0 113.796 -179.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 121' ' ' LEU . . . 68.62 -29.83 0.17 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.589 ' HB3' ' HB1' ' A' ' 124' ' ' ALA . 32.0 mt 65.11 51.27 1.7 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.829 0.347 . . . . 0.0 111.019 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -77.17 51.42 0.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.548 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.64 -21.03 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.205 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.988 ' HB2' ' HA3' ' A' ' 115' ' ' GLY . . . -47.94 148.45 1.67 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.735 0.302 . . . . 0.0 111.418 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.525 ' O ' ' HB ' ' A' ' 114' ' ' THR . 70.1 mtt-85 -141.73 141.07 33.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.525 HG12 ' HZ3' ' A' ' 149' ' ' TRP . 34.5 m -133.59 137.02 53.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 111.14 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -116.17 99.25 7.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.692 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 46.3 m-85 -68.06 139.39 56.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.42 . . . . 0.0 111.106 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -142.71 133.17 24.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.243 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 136' ' ' LEU . 60.7 m -89.19 148.7 23.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 133' ' ' ASP . 45.7 p-10 -52.67 153.93 5.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.31 72.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.235 2.623 . . . . 0.0 113.204 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 131' ' ' ASP . 38.9 t70 178.66 -39.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.048 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -107.0 139.18 41.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.904 179.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -102.83 134.26 46.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 111.151 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' A' ' 154' ' ' PRO . 19.8 tp -76.54 131.92 39.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.923 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.58 66.23 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.861 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -171.98 -136.91 2.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.149 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.617 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 45.4 p -76.55 53.98 0.91 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.989 0.423 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.476 ' HA ' HD23 ' A' ' 136' ' ' LEU . 47.6 t -49.07 -43.91 41.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.246 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -99.48 133.24 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.657 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.406 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.5 t -141.23 125.08 17.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.684 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 90.5 t -100.19 123.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.385 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.585 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 47.2 t -76.7 136.12 39.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.621 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.2 t -172.68 134.01 0.61 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.774 0.321 . . . . 0.0 111.183 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.427 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 0.5 OUTLIER 57.4 41.44 26.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.85 18.55 25.89 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.998 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -141.09 131.09 24.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 110.619 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.56 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 33.6 m95 -73.03 138.29 45.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.173 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 54.0 m -57.45 -52.99 63.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.004 179.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 78.8 p -114.4 136.95 22.38 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.481 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 30.0 Cg_exo -62.03 -159.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.512 2.141 . . . . 0.0 112.428 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.774 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 60.8 mtpt -96.66 125.77 45.68 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.965 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.671 ' HB2' HD11 ' A' ' 136' ' ' LEU . 68.1 Cg_endo -74.36 -148.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.282 1.988 . . . . 0.0 111.939 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.439 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 20.6 p-80 -153.74 143.11 21.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.902 0.382 . . . . 0.0 111.283 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 79.3 m -96.72 132.99 41.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.168 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -131.31 140.26 49.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.398 . . . . 0.0 111.481 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.7 p -64.34 137.72 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.01 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.881 179.975 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.739 0.304 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 55.97 49.61 15.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.188 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -168.15 -40.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.086 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.429 ' HB3' HH21 ' A' ' 97' ' ' ARG . 2.8 m-85 57.93 54.0 6.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.783 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.5 m -49.74 144.5 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.702 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.645 HH11 ' HA ' ' A' ' 119' ' ' PRO . 13.2 ptp180 -165.24 129.18 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.765 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.448 HG23 ' C ' ' A' ' 97' ' ' ARG . 0.2 OUTLIER -152.66 137.18 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.236 0.541 . . . . 0.0 111.463 179.935 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.652 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 3.2 m -63.58 173.4 1.68 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.55 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.411 ' HB2' ' CD1' ' A' ' 149' ' ' TRP . 52.0 m -42.4 129.22 3.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 111.195 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.612 ' HD2' HD11 ' A' ' 104' ' ' LEU . 24.0 tptm -76.89 -31.43 56.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.432 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.8 p -53.08 -43.86 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.945 -179.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.822 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.3 m-85 -56.9 -41.45 78.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.694 0.283 . . . . 0.0 111.065 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.612 HD11 ' HD2' ' A' ' 101' ' ' LYS . 90.9 mt -58.65 139.95 55.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.3 m 65.35 137.72 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.168 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.492 HD21 ' SG ' ' A' ' 130' ' ' CYS . 46.2 tp -145.43 133.68 21.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.417 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.76 140.51 56.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.22 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 65.19 30.82 11.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.394 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.514 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 175.7 -168.26 40.52 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.042 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.688 ' HD3' ' N ' ' A' ' 111' ' ' VAL . 1.5 tmtp? -141.95 143.29 33.17 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.688 ' N ' ' HD3' ' A' ' 110' ' ' LYS . 71.2 t -106.39 120.73 57.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.929 0.395 . . . . 0.0 111.458 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.55 ' HE1' ' HB3' ' A' ' 129' ' ' ARG . 3.3 m-85 -70.22 125.99 28.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.045 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.618 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -105.78 141.64 36.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.939 0.4 . . . . 0.0 110.94 -179.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.618 ' N ' HD13 ' A' ' 113' ' ' LEU . 35.6 m -158.89 65.61 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.619 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.784 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -156.83 -43.53 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.649 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.76 -132.46 19.91 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.886 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -115.7 34.78 4.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.987 0.422 . . . . 0.0 111.225 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 120' ' ' ALA . 96.5 mt -64.19 162.91 27.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.911 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.645 ' HA ' HH11 ' A' ' 97' ' ' ARG . 81.9 Cg_exo -43.57 80.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.772 2.315 . . . . 0.0 112.01 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.603 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 59.19 22.96 11.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.405 -178.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.879 ' HB3' ' HB1' ' A' ' 124' ' ' ALA . 6.8 mp 44.41 62.7 1.92 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.228 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.686 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 38.7 t70 -74.97 42.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.096 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 121' ' ' LEU . . . 161.89 28.72 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.394 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.879 ' HB1' ' HB3' ' A' ' 121' ' ' LEU . . . -77.58 122.17 24.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.706 0.288 . . . . 0.0 111.1 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -90.88 134.79 34.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.655 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.509 HG12 ' CH2' ' A' ' 149' ' ' TRP . 30.1 m -145.78 140.59 21.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.669 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -121.25 120.43 35.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.415 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.436 ' O ' HD21 ' A' ' 136' ' ' LEU . 2.0 m-85 -84.38 47.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 110.992 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.55 ' HB3' ' HE1' ' A' ' 112' ' ' PHE . 21.2 tpp180 -64.33 126.77 28.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.509 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.514 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 65.3 m -98.47 158.95 15.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.324 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 133' ' ' ASP . 55.6 m-20 -52.69 148.28 13.43 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.831 -179.516 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.18 79.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.204 2.602 . . . . 0.0 112.717 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 131' ' ' ASP . 9.1 t0 -179.14 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.599 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -108.78 130.85 55.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.199 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -102.75 130.64 49.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.904 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 140' ' ' SER . 22.8 tp -75.48 133.82 40.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.412 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.86 70.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.688 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.46 -132.65 1.96 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.819 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.568 ' HG ' ' HB ' ' A' ' 151' ' ' THR . 70.8 m -76.12 55.13 0.92 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.708 0.29 . . . . 0.0 111.028 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.545 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 90.0 p -49.25 -43.11 42.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.671 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -100.46 133.93 44.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.229 178.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 126' ' ' VAL . 47.4 t -144.02 136.22 26.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.389 . . . . 0.0 110.953 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 57.5 t -122.46 117.05 50.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.343 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.676 ' HA ' ' HA ' ' A' ' 149' ' ' TRP . 46.1 t -65.8 155.31 36.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.109 0.481 . . . . 0.0 111.502 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.686 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 46.5 t -166.44 122.01 1.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.838 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 57.68 44.13 21.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.081 0.467 . . . . 0.0 110.62 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.563 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 64.72 20.65 66.45 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.636 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -141.4 127.03 18.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.64 0.257 . . . . 0.0 110.749 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.676 ' HA ' ' HA ' ' A' ' 144' ' ' CYS . 58.0 m95 -71.94 139.36 48.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.934 0.397 . . . . 0.0 111.372 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.4 t -57.53 -62.46 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.378 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.568 ' HB ' ' HG ' ' A' ' 139' ' ' SER . 71.1 p -95.38 137.08 22.12 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.755 -179.392 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.461 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 45.1 Cg_endo -67.69 140.38 51.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.882 2.388 . . . . 0.0 112.418 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.822 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 64.4 tttm -53.87 121.2 27.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.264 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.503 ' HB3' ' H ' ' A' ' 139' ' ' SER . 86.5 Cg_endo -81.32 -147.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.832 2.355 . . . . 0.0 112.932 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.487 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 19.5 p-80 -153.61 144.72 22.89 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 64.8 m -98.47 142.64 29.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -133.7 139.24 46.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.829 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.59 138.41 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.507 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.889 179.935 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.841 0.353 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -170.72 131.3 0.86 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.8 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.577 ' HG3' ' H ' ' A' ' 95' ' ' PHE . 4.5 tp10 -173.42 -129.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.526 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.577 ' H ' ' HG3' ' A' ' 94' ' ' GLU . 19.3 t80 -177.76 132.52 0.16 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.66 0.267 . . . . 0.0 110.689 -179.606 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.5 141.14 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.532 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.865 ' HD2' ' HA ' ' A' ' 119' ' ' PRO . 39.0 ptt180 -163.64 49.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.543 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.766 HD13 ' HA ' ' A' ' 117' ' ' ASP . 4.9 pt -158.82 41.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.861 0.362 . . . . 0.0 110.839 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.587 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 74.6 m 62.31 134.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.971 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.3 m -40.32 119.97 1.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.716 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -74.83 -9.72 58.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.869 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.6 t -58.75 -19.93 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.837 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.54 ' HA ' ' HZ3' ' A' ' 153' ' ' LYS . 4.7 m-85 -64.62 -46.28 83.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.166 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.606 HD13 ' C ' ' A' ' 104' ' ' LEU . 1.7 pp -76.98 33.3 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.893 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.436 ' H ' ' C ' ' A' ' 103' ' ' TYR . 61.6 p -147.54 58.54 1.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.36 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.407 ' HA ' HD11 ' A' ' 106' ' ' LEU . 44.4 tp -94.49 135.75 35.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.5 -178.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.527 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 87.9 tt0 -66.59 138.48 57.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.352 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.527 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 75.1 m-20 56.56 40.13 29.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.304 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.28 168.46 41.53 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.214 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.429 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 28.9 mtpp -141.68 139.52 32.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.733 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.591 ' HB ' ' HA ' ' A' ' 104' ' ' LEU . 35.7 t -118.76 126.13 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -80.25 121.4 25.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.141 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.783 ' HA ' HG12 ' A' ' 126' ' ' VAL . 3.1 tm? -85.04 143.5 28.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.917 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.582 ' N ' HD12 ' A' ' 113' ' ' LEU . 43.4 m -152.96 65.96 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.574 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.521 ' H ' HD12 ' A' ' 113' ' ' LEU . . . -158.1 -107.4 0.24 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.886 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.15 -124.29 1.3 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.848 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.766 ' HA ' HD13 ' A' ' 98' ' ' ILE . 37.6 t70 -148.68 47.84 1.02 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.237 0.541 . . . . 0.0 110.644 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.535 ' HB2' HD12 ' A' ' 121' ' ' LEU . 2.9 mm? -94.19 150.89 39.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.505 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.865 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 88.9 Cg_exo -43.47 105.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.37 2.047 . . . . 0.0 111.985 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 97' ' ' ARG . . . 72.45 -37.95 0.4 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.357 -179.224 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.76 HD23 ' HB1' ' A' ' 124' ' ' ALA . 14.1 tp 58.06 56.24 4.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 0.0 111.16 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -70.14 69.29 0.34 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 179.59 -30.48 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.237 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.76 ' HB1' HD23 ' A' ' 121' ' ' LEU . . . -49.05 153.04 0.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.972 0.415 . . . . 0.0 111.398 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.503 ' HD2' ' NH2' ' A' ' 141' ' ' ARG . 53.9 ttp180 -153.56 135.86 14.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.714 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.783 HG12 ' HA ' ' A' ' 113' ' ' LEU . 34.4 m -127.52 137.16 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.108 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -100.94 121.15 41.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.37 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.474 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.3 m-85 -86.03 150.77 24.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 15.8 ptm180 -163.96 134.86 4.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.759 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 68.0 m -89.2 155.11 19.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.496 -179.304 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -52.71 163.27 0.82 Allowed Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.383 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.73 52.07 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.205 2.603 . . . . 0.0 112.708 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -155.59 -39.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.5 m-85 -108.9 141.02 41.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.651 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -102.1 134.11 45.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.123 0.487 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.474 HD13 ' H ' ' A' ' 138' ' ' GLY . 3.4 tm? -72.97 130.86 41.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.622 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.418 ' N ' HD13 ' A' ' 136' ' ' LEU . 26.6 t -134.57 66.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.573 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . 0.474 ' H ' HD13 ' A' ' 136' ' ' LEU . . . 177.03 -129.68 1.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 119.71 -1.233 . . . . 0.0 113.212 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.679 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 31.3 t -68.75 65.41 0.12 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.979 0.419 . . . . 0.0 111.384 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 94.5 p -63.12 -18.35 63.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.874 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.503 ' NH2' ' HD2' ' A' ' 125' ' ' ARG . 50.2 mtp85 -140.66 137.31 33.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.768 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.474 ' HG ' HG23 ' A' ' 126' ' ' VAL . 90.0 p -135.21 128.17 31.46 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.758 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.91 126.63 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.96 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.36 139.21 45.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.016 179.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -170.57 131.41 0.9 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.552 179.799 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 58.76 38.58 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.57 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 60.9 19.14 55.69 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.998 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -144.7 133.11 21.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.619 0.247 . . . . 0.0 111.239 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.587 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 94.1 m95 -70.34 135.58 48.97 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.83 0.348 . . . . 0.0 110.995 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.0 t -57.42 -56.26 24.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.372 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.484 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 55.4 p -97.08 133.14 24.49 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 8.2 Cg_exo -71.97 149.11 52.55 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.22 2.613 . . . . 0.0 111.941 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.54 ' HZ3' ' HA ' ' A' ' 103' ' ' TYR . 29.2 mtpp -47.42 125.57 9.64 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-O 120.64 0.257 . . . . 0.0 111.216 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.679 ' HB3' ' H ' ' A' ' 139' ' ' SER . 58.0 Cg_endo -71.49 -146.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.63 2.22 . . . . 0.0 112.401 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.482 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.7 145.41 23.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.451 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 70.8 m -96.66 133.64 40.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.82 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -124.76 136.29 53.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 p -64.67 137.15 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.035 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.958 179.937 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.784 0.326 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 63.66 127.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.396 179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -83.45 40.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.399 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -82.58 45.36 0.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.21 179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t 65.19 139.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.473 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.825 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -172.44 121.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.896 -179.928 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 97' ' ' ARG . 1.5 pp -173.45 39.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.953 179.315 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.1 m 61.18 160.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.197 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.9 t -39.82 128.67 2.08 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.662 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.59 ' HA ' HD22 ' A' ' 104' ' ' LEU . 17.5 tppt? -76.6 -27.94 55.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.362 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.2 m -53.14 -38.33 62.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.317 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.454 ' O ' HG23 ' A' ' 111' ' ' VAL . 2.8 m-85 -60.85 -39.23 88.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.278 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.59 HD22 ' HA ' ' A' ' 101' ' ' LYS . 2.1 mm? -53.37 -42.45 66.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.222 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.435 HG23 ' N ' ' A' ' 106' ' ' LEU . 68.7 m -92.54 141.26 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.533 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 107' ' ' GLU . 5.3 tt -142.57 127.05 17.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.611 -179.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.573 ' N ' HD23 ' A' ' 106' ' ' LEU . 17.3 tp10 -67.14 128.08 35.01 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 60.36 36.51 20.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.753 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.487 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -177.02 -177.96 46.37 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.06 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -142.8 144.84 32.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.624 0.25 . . . . 0.0 110.779 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 103' ' ' TYR . 65.3 t -105.21 124.98 60.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.862 0.363 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.2 m-85 -75.53 127.52 33.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.056 -179.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.59 ' C ' HD12 ' A' ' 113' ' ' LEU . 3.4 tm? -90.97 143.3 26.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.541 ' N ' HD12 ' A' ' 113' ' ' LEU . 33.7 m -156.19 62.17 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.235 0.54 . . . . 0.0 110.573 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -159.62 -102.26 0.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.017 -179.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.528 ' H ' HD23 ' A' ' 121' ' ' LEU . . . 174.59 -128.4 1.44 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.008 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.411 ' HA ' ' CG2' ' A' ' 98' ' ' ILE . 52.7 p-10 -159.27 48.19 0.31 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.931 0.396 . . . . 0.0 111.004 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.516 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 6.1 mp -98.99 163.57 18.49 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.221 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.825 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 81.2 Cg_exo -39.63 106.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.433 2.088 . . . . 0.0 112.193 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . 0.467 ' H ' ' CG ' ' A' ' 97' ' ' ARG . . . 72.54 -32.29 0.24 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.716 -179.453 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.528 HD23 ' H ' ' A' ' 116' ' ' GLY . 27.5 tp 56.12 47.59 19.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.114 0.483 . . . . 0.0 110.228 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.81 136.18 46.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.968 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 76.74 31.96 51.94 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.168 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.72 ' H ' ' HB2' ' A' ' 144' ' ' CYS . . . -80.33 119.87 23.63 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.507 ' HB2' ' HB ' ' A' ' 114' ' ' THR . 67.0 mtt-85 -84.58 134.59 34.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.496 HG21 ' HE1' ' A' ' 128' ' ' PHE . 28.0 m -149.7 134.14 9.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.422 179.036 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -114.45 112.96 23.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.964 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.496 ' HE1' HG21 ' A' ' 126' ' ' VAL . 1.9 m-85 -80.29 136.5 36.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.635 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -165.04 131.79 2.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.343 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' CYS . . . . . 0.487 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 40.9 m -89.3 157.17 18.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.33 0.586 . . . . 0.0 112.497 -179.069 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.454 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 58.2 m-20 -52.67 159.24 1.79 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.997 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 21.1 Cg_endo -59.9 75.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.17 2.58 . . . . 0.0 112.43 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 131' ' ' ASP . 64.5 t0 -174.63 -40.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.048 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -116.08 132.33 56.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.182 178.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -102.74 127.45 49.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.138 0.494 . . . . 0.0 111.288 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.773 HD12 ' HB3' ' A' ' 140' ' ' SER . 3.4 tm? -69.98 132.88 46.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.262 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 36.6 t -134.82 76.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.816 -179.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.44 -133.96 2.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.247 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.714 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 40.9 t -74.61 56.42 0.69 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.773 ' HB3' HD12 ' A' ' 136' ' ' LEU . 95.7 p -53.86 -30.33 45.14 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.825 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.563 ' HD2' ' OG ' ' A' ' 140' ' ' SER . 7.9 mpt_? -99.41 137.06 38.45 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.496 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.46 ' O ' HG22 ' A' ' 126' ' ' VAL . 51.5 m -150.63 137.73 19.31 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.256 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 13.8 p -134.05 131.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 111.036 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.72 ' HB2' ' H ' ' A' ' 124' ' ' ALA . 4.1 m -58.14 154.93 12.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.332 0.587 . . . . 0.0 112.226 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.4 p -173.28 113.64 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.759 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 146' ' ' GLN . 8.0 tt0 60.92 48.46 6.68 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.096 0.474 . . . . 0.0 110.544 -179.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 58.22 18.08 33.76 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.355 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -141.63 138.22 32.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 110.639 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' TRP . . . . . 0.407 ' CZ3' HG23 ' A' ' 126' ' ' VAL . 60.9 m95 -68.1 135.29 51.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.219 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -57.48 -60.18 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.176 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.488 ' HB ' ' OG ' ' A' ' 139' ' ' SER . 33.3 p -99.79 132.69 22.55 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.799 0.333 . . . . 0.0 111.889 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.414 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 37.2 Cg_exo -60.6 150.75 80.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.977 2.452 . . . . 0.0 112.442 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.461 ' HG3' ' CE2' ' A' ' 128' ' ' PHE . 57.5 tttp -55.91 129.81 72.41 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.714 ' HB3' ' N ' ' A' ' 139' ' ' SER . 59.4 Cg_endo -72.37 -152.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.729 2.286 . . . . 0.0 112.996 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' HIS . . . . . 0.416 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.4 p-80 -153.72 139.61 18.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 86.4 m -98.72 143.31 29.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.494 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -128.2 136.44 51.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.576 179.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.67 135.65 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.305 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.917 179.814 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.601 HD12 HD22 ' A' ' 121' ' ' LEU . 40.6 mm . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 121.209 0.528 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.562 ' HB2' ' NE1' ' A' ' 149' ' ' TRP . 1.3 p -57.3 149.32 20.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.138 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.9 t -38.25 113.53 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.768 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.529 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -67.23 -14.26 62.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.767 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.1 t -53.5 -38.91 64.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.209 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.58 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.5 m-85 -53.34 -37.89 62.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.178 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.4 mt -50.92 -45.45 60.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.332 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.0 t -92.52 131.28 37.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 111.202 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.647 HD13 ' HE2' ' A' ' 153' ' ' LYS . 38.0 tp -145.34 132.28 20.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -63.02 127.02 29.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.18 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.6 m120 55.14 45.73 25.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.885 0.374 . . . . 0.0 110.415 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.0 157.44 26.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -130.62 139.7 50.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.746 0.308 . . . . 0.0 110.831 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 103' ' ' TYR . 96.1 t -106.51 132.95 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.576 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 3.7 m-85 -94.78 73.44 3.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 1.01 ' HA ' HG12 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -60.95 157.03 16.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 111.228 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 40.9 m -158.53 69.47 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.778 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.674 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -162.98 -44.92 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.642 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.44 -121.84 6.51 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.297 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.471 ' HA ' ' CD1' ' A' ' 98' ' ' ILE . 2.1 p30 -144.76 52.0 1.24 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.051 0.453 . . . . 0.0 111.474 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 118' ' ' LEU . 7.0 mp -88.08 158.13 50.21 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.909 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 121' ' ' LEU . 85.1 Cg_exo -44.05 111.02 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.621 2.214 . . . . 0.0 112.601 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 70.77 -33.55 0.27 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.828 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.601 HD22 HD12 ' A' ' 98' ' ' ILE . 17.0 tp 64.28 43.9 4.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.05 0.452 . . . . 0.0 110.624 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.918 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 64.5 t0 -79.4 59.06 2.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.013 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.29 -29.48 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.375 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -49.68 147.53 3.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 111.923 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.561 ' NH2' ' HD3' ' A' ' 141' ' ' ARG . 51.6 mtp85 -138.72 126.78 22.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 1.01 HG12 ' HA ' ' A' ' 113' ' ' LEU . 33.7 m -116.72 130.3 71.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.029 0.442 . . . . 0.0 111.674 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.9 mt-10 -102.5 109.79 21.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.586 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' ' 140' ' ' SER . 21.2 m-85 -75.52 147.12 39.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.514 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 5.6 tpm_? -162.28 125.94 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.472 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.421 ' H ' ' HE ' ' A' ' 129' ' ' ARG . 56.6 m -89.29 149.14 23.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.074 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.57 163.31 0.79 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.634 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.63 57.3 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.43 2.753 . . . . 0.0 113.131 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -158.06 -43.3 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.3 m-85 -108.91 138.76 44.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.665 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.411 ' O ' HG23 ' A' ' 137' ' ' VAL . 18.7 p-80 -101.6 127.51 48.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.091 0.472 . . . . 0.0 110.993 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 137' ' ' VAL . 4.9 tt -65.04 131.23 46.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.184 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.629 ' N ' HD23 ' A' ' 136' ' ' LEU . 21.8 t -133.39 65.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.25 -135.63 2.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.396 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.51 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 80.6 p -73.37 62.08 0.69 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.532 ' HB3' HD22 ' A' ' 136' ' ' LEU . 98.5 p -57.61 -7.02 0.57 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.288 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.561 ' HD3' ' NH2' ' A' ' 125' ' ' ARG . 39.7 ttm180 -140.65 134.37 30.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.672 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 126' ' ' VAL . 47.6 t -146.39 119.5 8.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.569 HG13 ' OG ' ' A' ' 150' ' ' SER . 3.2 p -95.98 121.56 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 0.0 111.223 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.769 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 49.7 t -69.22 138.3 53.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.601 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.918 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 80.6 p -164.51 133.11 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.165 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 57.38 40.76 27.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.849 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 63.9 18.25 61.84 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.126 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -145.27 139.79 27.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 117.099 0.449 . . . . 0.0 111.45 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.562 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 32.7 m95 -72.12 139.0 48.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.195 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.569 ' OG ' HG13 ' A' ' 143' ' ' VAL . 75.4 m -57.49 -57.74 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.005 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 t -109.42 143.11 27.1 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-O 120.862 0.363 . . . . 0.0 111.87 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.0 148.14 93.79 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.125 2.55 . . . . 0.0 112.693 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.647 ' HE2' HD13 ' A' ' 106' ' ' LEU . 87.5 tttt -53.34 135.64 51.36 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.527 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.51 ' HB3' ' H ' ' A' ' 139' ' ' SER . 97.5 Cg_endo -85.4 -151.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.906 2.404 . . . . 0.0 112.872 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -153.7 151.09 29.25 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.4 m -97.28 129.85 44.54 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.766 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -108.78 135.4 50.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.027 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.84 140.2 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.982 -179.899 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.769 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 1.9 pp . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.182 0.515 . . . . 0.0 111.983 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 38.0 m -64.58 147.22 53.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.791 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 102' ' ' SER . 80.4 p -40.12 118.0 0.84 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 110.699 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.4 ' HA ' HD13 ' A' ' 104' ' ' LEU . 68.7 mttm -70.94 9.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.514 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 100' ' ' SER . 59.2 m -68.96 -39.2 79.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.189 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.916 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.8 m-85 -52.18 -37.84 55.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.984 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.552 ' H ' HD12 ' A' ' 104' ' ' LEU . 6.3 mp -50.22 142.48 9.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 0.0 111.03 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.9 p 61.84 132.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.673 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.1 tp -145.4 136.14 24.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.613 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.12 132.3 52.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.389 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.497 ' HB3' ' OD1' ' A' ' 131' ' ' ASP . 33.9 m120 57.52 42.81 23.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.617 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.76 172.82 45.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.517 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -141.66 146.37 36.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 0.0 110.476 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 60.6 t -118.12 127.44 75.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.424 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.7 m-85 -88.22 119.06 28.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.849 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.64 ' HA ' HG12 ' A' ' 126' ' ' VAL . 61.4 tp -83.53 146.73 28.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.266 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 33.2 m -162.16 66.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.65 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . -160.82 -42.35 0.02 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.848 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.02 -119.5 5.4 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.655 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -137.78 47.88 2.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.162 0.506 . . . . 0.0 111.042 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 71.7 mt -75.72 158.46 82.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.125 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.03 120.46 4.22 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.159 1.906 . . . . 0.0 111.625 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 51.98 31.32 8.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.2 0.524 . . . . 0.0 110.155 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.769 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 13.9 tp 42.44 37.42 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.712 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -70.63 141.06 51.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.907 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.56 -24.62 9.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.78 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.715 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -57.25 152.89 13.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.761 0.315 . . . . 0.0 111.092 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.788 ' HD2' HH21 ' A' ' 141' ' ' ARG . 23.0 ptt-85 -165.45 133.19 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.679 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 113' ' ' LEU . 33.9 m -120.54 143.5 32.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.039 0.447 . . . . 0.0 111.798 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.462 ' HB2' ' NH1' ' A' ' 141' ' ' ARG . 40.7 tp10 -108.48 121.86 45.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.057 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.418 ' CD2' ' HD2' ' A' ' 154' ' ' PRO . 2.8 m-85 -83.7 154.48 23.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.624 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 5.1 tpm_? -157.57 127.28 6.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.23 143.84 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.905 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.497 ' OD1' ' HB3' ' A' ' 108' ' ' ASN . 12.8 p-10 -54.07 148.96 19.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.48 77.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.015 2.477 . . . . 0.0 112.862 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 131' ' ' ASP . 64.4 t0 179.02 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.72 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.497 ' CE2' HG22 ' A' ' 158' ' ' VAL . 3.6 m-85 -108.84 142.84 38.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.876 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -101.88 130.8 48.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.176 0.512 . . . . 0.0 110.961 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.623 HD21 ' HA ' ' A' ' 140' ' ' SER . 32.6 tp -70.25 126.82 30.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.964 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 41.7 t -137.89 71.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.937 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.49 -135.67 2.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.846 -1.169 . . . . 0.0 113.102 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.729 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.0 m -75.94 52.79 0.72 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.92 0.391 . . . . 0.0 110.601 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.623 ' HA ' HD21 ' A' ' 136' ' ' LEU . 47.2 t -46.25 -39.85 10.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.071 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.788 HH21 ' HD2' ' A' ' 125' ' ' ARG . 23.9 tpt180 -104.11 137.46 42.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.589 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.8 t -143.05 101.69 3.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.346 . . . . 0.0 110.597 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 150' ' ' SER . 7.7 p -96.8 129.89 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.065 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.715 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 1.8 m -74.62 146.99 42.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.395 0.617 . . . . 0.0 112.111 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.469 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 48.0 t -163.94 124.67 2.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.358 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 62.9 38.35 11.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.114 0.483 . . . . 0.0 110.419 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 63.12 25.73 68.46 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.562 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 145' ' ' SER . 23.6 pt20 -143.72 138.24 28.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.059 0.43 . . . . 0.0 111.262 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.526 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 59.4 m95 -65.04 138.02 58.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.466 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 47.5 t -57.43 -48.54 78.86 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.057 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.518 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 82.6 p -135.14 136.86 25.56 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.816 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 31.4 Cg_exo -61.97 156.35 49.87 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.04 2.494 . . . . 0.0 112.438 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.916 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 28.5 mtpp -52.42 129.17 42.81 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.428 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.729 ' HB3' ' N ' ' A' ' 139' ' ' SER . 60.7 Cg_endo -72.89 -143.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.728 2.285 . . . . 0.0 112.246 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.451 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 23.0 p-80 -153.71 145.25 23.23 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.986 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 81.7 m -96.23 125.87 41.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.509 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -109.06 142.99 38.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.385 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.497 HG22 ' CE2' ' A' ' 134' ' ' PHE . 61.9 t -61.83 139.96 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.044 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 22.1 p30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.026 179.808 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.637 HD12 HD22 ' A' ' 121' ' ' LEU . 46.7 mm . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.377 0.608 . . . . 0.0 112.342 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.51 ' HA ' ' C ' ' A' ' 147' ' ' GLY . 1.5 p -59.99 161.21 6.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.196 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -39.78 131.8 1.79 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.109 0.48 . . . . 0.0 111.453 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 21.8 pttp -96.48 78.56 3.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.674 0.749 . . . . 0.0 110.009 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.9 t -164.13 -34.9 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.076 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.7 m-85 -56.8 -26.33 57.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.192 0.52 . . . . 0.0 109.63 178.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.483 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 53.5 mt -50.23 -44.11 53.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.671 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.2 p -92.66 139.66 30.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.647 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.464 HD13 ' CE ' ' A' ' 153' ' ' LYS . 46.6 tp -143.07 133.72 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.389 . . . . 0.0 111.163 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.8 129.98 41.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.333 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.8 m120 56.6 37.09 28.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.964 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 130' ' ' CYS . . . -176.44 149.5 9.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.998 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -108.25 139.26 43.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.845 0.355 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.485 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 94.9 t -106.54 121.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.815 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -82.74 124.99 30.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.239 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.699 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -85.84 145.04 27.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.475 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.699 ' N ' HD13 ' A' ' 113' ' ' LEU . 28.7 m -155.75 63.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 110.854 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -161.04 -104.44 0.19 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.178 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 166.99 -129.64 1.96 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.739 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.453 ' HA ' HD11 ' A' ' 98' ' ' ILE . 58.7 m-20 -150.27 46.79 0.9 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 111.044 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 118' ' ' LEU . 7.1 mp -97.9 154.27 37.87 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.823 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.445 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 76.1 Cg_exo -46.78 122.13 5.68 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.466 2.111 . . . . 0.0 112.112 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 72.77 -40.74 0.48 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.528 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.637 HD22 HD12 ' A' ' 98' ' ' ILE . 14.8 tp 59.51 51.18 6.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.956 0.408 . . . . 0.0 110.943 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -73.26 66.25 0.89 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.247 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.31 -36.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.623 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.809 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -51.39 153.9 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.954 0.407 . . . . 0.0 111.483 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.501 ' O ' ' HB ' ' A' ' 114' ' ' THR . 50.8 ttp85 -158.94 126.07 4.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.176 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.485 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 24.6 m -108.17 136.67 42.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.022 0.439 . . . . 0.0 111.648 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -100.29 115.98 31.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.686 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -80.09 143.04 34.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.433 HH11 ' HG3' ' A' ' 129' ' ' ARG . 37.7 ttt85 -167.22 118.82 0.9 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.456 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 51.3 m -89.18 154.13 20.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.981 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -52.77 158.34 2.25 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.305 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.507 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 82.0 Cg_exo -47.49 162.81 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.829 2.353 . . . . 0.0 112.245 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.5 m-20 77.93 -35.07 0.19 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.791 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -106.32 127.14 53.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -108.34 131.1 55.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.034 0.445 . . . . 0.0 111.375 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.579 HD23 ' SG ' ' A' ' 156' ' ' CYS . 3.2 tm? -74.79 132.86 41.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.292 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.0 t -133.07 71.53 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.785 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.92 -132.5 1.82 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.057 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.604 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 61.2 p -72.83 61.56 0.55 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 110.648 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.559 ' HB3' HD12 ' A' ' 136' ' ' LEU . 97.0 p -55.6 -15.59 3.09 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.775 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -140.64 139.89 34.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.716 0.293 . . . . 0.0 111.266 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 96.6 p -139.54 117.01 11.35 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.255 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.413 ' HB ' ' OG ' ' A' ' 150' ' ' SER . 73.7 t -84.18 125.01 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 111.52 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.809 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 42.1 t -79.3 131.03 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.306 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.4 t -173.25 137.53 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 0.0 111.156 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 56.35 37.93 29.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.51 ' C ' ' HA ' ' A' ' 99' ' ' CYS . . . 56.78 24.66 49.62 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.644 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -143.07 134.55 26.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.657 0.265 . . . . 0.0 111.087 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -77.76 140.03 39.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 143' ' ' VAL . 63.1 m -57.4 -47.61 81.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.661 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 67.4 p -127.46 138.9 33.79 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 34.8 Cg_endo -64.86 -162.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.471 2.114 . . . . 0.0 112.566 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.464 ' CE ' HD13 ' A' ' 106' ' ' LEU . 14.4 mmmm -83.86 131.65 51.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.974 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.604 ' HB3' ' H ' ' A' ' 139' ' ' SER . 89.5 Cg_endo -81.75 -149.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.675 2.25 . . . . 0.0 112.483 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.455 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 27.5 p-80 -153.71 134.1 13.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.945 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.579 ' SG ' HD23 ' A' ' 136' ' ' LEU . 92.4 m -104.93 142.43 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.235 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -135.21 137.59 42.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.881 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.15 139.08 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.913 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.845 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 21.3 pt . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.597 0.713 . . . . 0.0 112.72 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.519 ' HB2' HD23 ' A' ' 121' ' ' LEU . 92.2 m -57.36 167.41 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.767 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.6 p -40.17 143.77 0.26 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.751 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.626 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 4.6 ttmp? -99.68 78.45 2.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.227 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.2 t -166.24 -36.2 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.062 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -56.94 -32.4 65.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 110.389 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.419 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 64.5 mt -52.87 -46.18 67.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.568 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.2 p -92.63 137.69 32.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 0.0 111.194 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.738 HD13 ' HE3' ' A' ' 153' ' ' LYS . 29.2 tp -145.38 136.36 24.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.382 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.463 ' H ' HD12 ' A' ' 106' ' ' LEU . 42.2 tp10 -69.53 138.1 53.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.9 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.0 m120 58.01 36.3 25.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.283 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 179.94 176.88 47.68 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.755 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -139.78 136.46 34.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 128' ' ' PHE . 94.9 t -106.11 123.86 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.8 m-85 -76.6 122.5 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.29 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.767 ' HA ' HG12 ' A' ' 126' ' ' VAL . 2.8 tt -95.35 140.6 30.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.711 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.759 ' N ' HD23 ' A' ' 113' ' ' LEU . 30.1 m -158.49 62.65 0.43 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.085 0.469 . . . . 0.0 110.739 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 118' ' ' LEU . . . -172.44 -16.28 0.02 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.716 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -49.77 147.59 6.75 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.372 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.713 ' C ' HD22 ' A' ' 118' ' ' LEU . 1.5 m-20 73.31 41.98 0.45 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 122.714 0.406 . . . . 0.0 111.753 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.713 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.7 mm? -141.82 149.4 53.02 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.59 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -50.28 116.94 2.77 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.481 2.121 . . . . 0.0 111.822 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.51 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 50.06 36.17 11.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.544 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.845 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 14.3 tp 52.22 42.24 30.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.491 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.89 142.27 57.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.589 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.76 33.93 84.78 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.425 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.873 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -93.44 144.09 25.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.892 0.377 . . . . 0.0 111.452 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -145.53 128.45 16.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.804 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 113' ' ' LEU . 34.4 m -136.11 142.15 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.751 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 41.4 tt0 -108.69 121.39 44.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.435 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.755 ' HA ' HG22 ' A' ' 111' ' ' VAL . 2.3 m-85 -86.86 44.11 1.14 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.841 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.631 ' HD3' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -67.16 133.5 49.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 110.667 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 69.5 m -105.16 155.85 18.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.638 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -53.7 156.84 4.34 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.116 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.519 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 86.6 Cg_exo -47.66 162.94 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.808 2.339 . . . . 0.0 112.466 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.557 ' HB3' ' ND2' ' A' ' 159' ' ' ASN . 57.3 m-20 78.31 -31.4 0.16 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.151 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -105.0 130.17 53.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.719 0.295 . . . . 0.0 110.393 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -111.39 130.58 55.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 111.516 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.594 HD22 ' O ' ' A' ' 128' ' ' PHE . 36.2 tp -78.05 136.4 37.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.419 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.0 66.06 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.14 -135.66 2.34 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.206 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.509 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 82.8 p -72.62 63.91 0.61 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.991 0.425 . . . . 0.0 110.78 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.552 ' HA ' HD21 ' A' ' 136' ' ' LEU . 88.0 p -56.08 -11.49 1.13 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.452 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 141' ' ' ARG . 69.3 mtt-85 -140.54 136.87 33.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 57.9 m -137.05 126.66 25.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.368 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 124' ' ' ALA . 5.9 p -116.71 130.15 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.922 0.391 . . . . 0.0 111.262 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.873 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 33.2 m -96.83 147.92 23.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.852 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.1 p -171.31 27.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.299 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.483 ' O ' ' HG3' ' A' ' 146' ' ' GLN . 70.7 tp60 -176.26 37.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.06 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.51 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 60.0 10.49 14.58 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.769 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -141.52 134.25 28.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.688 0.28 . . . . 0.0 110.92 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.519 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 38.7 m95 -64.86 134.97 55.18 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.564 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.2 m -57.42 -57.07 14.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.224 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 68.6 p -103.69 131.75 21.72 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.26 140.57 89.38 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.81 2.34 . . . . 0.0 111.895 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.738 ' HE3' HD13 ' A' ' 106' ' ' LEU . 61.2 tttp -47.09 132.93 9.1 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.276 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.509 ' HB3' ' H ' ' A' ' 139' ' ' SER . 65.1 Cg_endo -89.26 -151.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.024 2.483 . . . . 0.0 113.004 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -153.76 138.09 16.65 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.06 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.496 ' SG ' HD13 ' A' ' 136' ' ' LEU . 85.7 m -98.69 133.27 43.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.855 0.36 . . . . 0.0 110.83 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -103.02 136.93 41.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.727 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.68 142.42 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.901 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' A' ' 133' ' ' ASP . 23.4 p30 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.992 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.717 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.6 pp . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 121.143 0.497 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.724 ' HB2' HD22 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -63.8 151.55 41.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.964 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.0 t -39.89 111.18 0.18 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.015 0.436 . . . . 0.0 111.125 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.523 ' HG3' HD13 ' A' ' 98' ' ' ILE . 55.1 mtmt -63.6 -22.37 66.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.984 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 t -53.5 -32.17 49.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.653 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 3.4 m-85 -76.23 45.28 0.36 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.608 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.576 HD21 HD23 ' A' ' 113' ' ' LEU . 93.9 mt -132.82 -37.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 0.0 110.677 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 t -92.54 132.77 36.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.964 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.6 tp -145.44 125.06 13.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.54 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -82.83 45.15 0.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.066 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 p30 179.55 36.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.363 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.63 -155.39 26.37 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.959 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -142.06 150.55 41.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.818 0.342 . . . . 0.0 110.7 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.1 t -106.56 125.19 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.496 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.0 m-85 -85.38 76.83 10.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.58 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.945 ' HA ' HG12 ' A' ' 126' ' ' VAL . 3.4 tm? -54.96 141.52 33.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.339 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.722 ' N ' HD13 ' A' ' 113' ' ' LEU . 23.6 m -157.46 61.33 0.49 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.657 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.563 ' C ' HD13 ' A' ' 118' ' ' LEU . . . 173.38 41.94 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.732 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.82 123.42 6.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.186 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.408 ' C ' HD12 ' A' ' 118' ' ' LEU . 1.5 m-20 66.25 52.27 1.15 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.563 HD13 ' C ' ' A' ' 115' ' ' GLY . 10.7 mp -119.29 148.42 45.26 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.532 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -54.73 82.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.031 2.487 . . . . 0.0 111.748 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.613 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 62.12 13.45 5.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.576 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.724 HD22 ' HB2' ' A' ' 99' ' ' CYS . 7.3 mp 47.92 59.54 4.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.782 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.0 46.02 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.049 0.452 . . . . 0.0 110.567 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 171.64 -26.16 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.281 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -50.52 155.21 1.12 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 111.298 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.513 ' O ' ' HB ' ' A' ' 114' ' ' THR . 39.0 ptt180 -160.65 130.48 5.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.281 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.945 HG12 ' HA ' ' A' ' 113' ' ' LEU . 34.8 m -107.62 134.12 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.163 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 96.3 mt-10 -95.03 122.05 37.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.704 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.481 ' HE2' ' HE3' ' A' ' 153' ' ' LYS . 30.3 m-85 -88.28 149.08 24.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.654 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.412 HH11 ' HG3' ' A' ' 129' ' ' ARG . 40.1 ttt85 -153.62 126.97 8.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.739 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 16.6 t -89.24 151.28 22.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.016 0.436 . . . . 0.0 111.505 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -52.75 151.63 7.94 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.486 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.8 73.63 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.186 2.591 . . . . 0.0 112.747 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -176.31 -42.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.699 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.631 ' HB2' ' SG ' ' A' ' 130' ' ' CYS . 4.5 m-85 -109.51 143.53 39.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.545 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.447 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -99.44 135.05 41.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.304 0.574 . . . . 0.0 111.514 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.915 HD21 ' HA ' ' A' ' 140' ' ' SER . 35.5 tp -70.9 124.06 23.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.928 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.15 63.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.379 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -171.21 -128.63 1.05 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.921 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.661 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 60.1 m -73.54 57.14 0.54 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.878 0.371 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.915 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.9 t -51.66 -25.47 7.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.269 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 12.9 mtp-105 -137.82 129.71 28.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.572 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.9 m -127.21 120.2 28.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.426 HG13 ' OG ' ' A' ' 150' ' ' SER . 3.8 p -104.99 124.6 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.413 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 38.9 t -72.79 151.74 41.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.169 0.509 . . . . 0.0 111.587 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.5 m -161.44 121.71 2.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.563 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 57.92 43.17 21.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.315 0.578 . . . . 0.0 109.848 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.613 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 61.0 28.2 68.4 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.444 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -142.92 130.29 21.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.691 0.282 . . . . 0.0 110.61 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.465 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 35.9 m95 -72.11 132.07 43.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.59 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.426 ' OG ' HG13 ' A' ' 143' ' ' VAL . 70.9 m -57.51 -60.64 3.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 70.9 p -99.78 133.32 21.82 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.245 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.447 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 23.1 Cg_exo -64.9 -158.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.684 2.256 . . . . 0.0 112.326 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.481 ' HE3' ' HE2' ' A' ' 128' ' ' PHE . 14.2 mmmm -87.51 129.49 50.91 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.767 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.661 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.4 Cg_endo -75.26 -156.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.401 2.067 . . . . 0.0 112.803 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.72 148.77 26.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.938 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 134' ' ' PHE . 97.1 m -97.07 130.54 44.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.447 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 4.3 tp-100 -108.72 135.11 50.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.692 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.12 128.81 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.935 -179.876 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.575 0.226 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 6.1 t 59.38 150.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.576 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.706 ' HB2' ' HD1' ' A' ' 149' ' ' TRP . 57.4 m -39.86 125.55 1.9 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.976 0.417 . . . . 0.0 111.301 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.484 ' HD3' HD21 ' A' ' 104' ' ' LEU . 16.8 tppt? -86.31 -36.43 19.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.537 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.9 p -69.0 40.3 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.475 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 5.5 m-85 -128.41 -47.97 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.774 HD12 ' H ' ' A' ' 105' ' ' THR . 0.4 OUTLIER -54.8 -30.0 55.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.995 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.774 ' H ' HD12 ' A' ' 104' ' ' LEU . 6.8 t -92.48 132.43 36.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.775 0.321 . . . . 0.0 111.138 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.89 HD13 ' HE3' ' A' ' 153' ' ' LYS . 34.5 tp -145.39 128.59 16.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.467 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -74.1 130.28 39.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.961 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 60.23 38.88 19.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.621 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.75 151.86 13.1 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.845 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -110.68 137.0 48.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.49 126.74 62.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.541 ' C ' HG23 ' A' ' 126' ' ' VAL . 3.0 m-85 -79.35 60.39 3.13 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.006 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.564 HD22 ' HB3' ' A' ' 104' ' ' LEU . 60.2 tp -58.5 140.96 53.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.559 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 31.3 m -155.62 55.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.492 0.663 . . . . 0.0 109.85 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 168.46 99.98 0.13 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.843 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 117' ' ' ASP . . . -165.32 151.34 20.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.774 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.735 ' C ' HD22 ' A' ' 118' ' ' LEU . 38.8 t70 77.23 41.21 0.15 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.037 0.446 . . . . 0.0 110.975 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.735 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.2 mm? -144.14 150.9 50.49 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 12.0 Cg_endo -55.47 81.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.841 2.361 . . . . 0.0 112.187 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 73.69 -38.07 0.39 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.271 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.657 HD23 ' HB2' ' A' ' 124' ' ' ALA . 17.6 tp 55.2 80.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.89 0.376 . . . . 0.0 110.746 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.02 48.69 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.139 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -178.26 26.12 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.36 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.657 ' HB2' HD23 ' A' ' 121' ' ' LEU . . . -80.52 142.3 34.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.616 0.246 . . . . 0.0 110.669 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.559 ' O ' ' HB ' ' A' ' 114' ' ' THR . 45.7 mtp85 -131.73 150.48 52.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 111.278 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.541 HG23 ' C ' ' A' ' 112' ' ' PHE . 7.6 p -154.49 158.27 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.279 0.562 . . . . 0.0 111.252 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.536 ' N ' HG22 ' A' ' 126' ' ' VAL . 43.6 tt0 -136.94 89.71 2.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.106 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.481 ' H ' ' HD1' ' A' ' 128' ' ' PHE . 4.2 m-85 -59.11 148.57 30.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.714 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.8 tpt85 -159.52 128.36 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 35.4 t -89.22 150.23 22.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.301 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -53.67 156.61 4.52 Favored Pre-proline 0 N--CA 1.462 0.149 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.34 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 80.0 Cg_exo -45.64 162.02 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.978 2.452 . . . . 0.0 112.718 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 28.1 m-20 77.83 -36.57 0.22 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.61 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.403 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.9 m-85 -107.49 128.65 54.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.919 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.86 137.16 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.077 0.465 . . . . 0.0 111.409 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 154' ' ' PRO . 6.9 tt -78.89 127.24 31.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.339 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.469 ' N ' HD23 ' A' ' 136' ' ' LEU . 26.3 t -130.07 65.66 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.476 ' H ' HD23 ' A' ' 136' ' ' LEU . . . -170.54 -125.38 0.8 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.636 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.792 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 29.2 t -73.37 59.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 111.295 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.409 ' HB2' HD22 ' A' ' 136' ' ' LEU . 35.3 t -58.29 -24.77 60.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.604 ' HD2' ' N ' ' A' ' 142' ' ' SER . 4.0 tmm_? -140.55 131.29 25.76 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.421 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.643 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 50.7 m -132.23 153.32 50.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 124' ' ' ALA . 77.3 t -142.78 125.3 13.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.278 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 61.3 m -68.18 153.86 42.89 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -157.45 -23.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.285 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 146' ' ' GLN . 4.2 tp-100 -159.2 58.16 0.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.031 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 73.57 -8.08 11.28 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.914 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -139.74 136.17 33.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 111.023 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.706 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 60.2 m95 -60.57 150.32 32.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.752 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.9 p -54.21 -58.77 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.536 HG23 ' OG ' ' A' ' 139' ' ' SER . 2.7 t -104.25 144.88 29.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.378 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 17.7 Cg_endo -59.25 -147.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.993 2.462 . . . . 0.0 113.034 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.89 ' HE3' HD13 ' A' ' 106' ' ' LEU . 55.0 tttp -108.92 135.32 20.15 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.604 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 73.4 Cg_endo -76.68 -155.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.492 2.128 . . . . 0.0 113.037 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -153.77 161.24 42.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 88.1 m -96.11 131.62 42.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.787 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -118.84 138.14 52.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.65 136.56 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.237 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 24.1 p30 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.04 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 98' ' ' ILE . 1.7 pp . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.185 0.517 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.622 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 72.8 m -59.89 140.37 56.7 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.8 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.4 p -37.93 113.36 0.27 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.087 0.47 . . . . 0.0 111.62 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.418 ' HB3' HD12 ' A' ' 104' ' ' LEU . 98.3 mttt -69.43 1.95 3.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.316 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.2 p -59.63 -37.52 78.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.879 0.371 . . . . 0.0 110.569 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.526 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 1.4 m-85 -54.38 -35.43 62.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.851 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 101' ' ' LYS . 79.3 mt -53.53 139.45 31.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.33 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.9 p 60.52 130.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.497 0.498 . . . . 0.0 111.106 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.823 HD13 ' HE2' ' A' ' 153' ' ' LYS . 30.9 tp -145.37 134.88 23.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.305 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pm0 -63.62 133.03 52.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.323 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 58.42 42.99 20.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.41 -177.58 43.66 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.563 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -142.03 151.89 42.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.607 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 86.5 t -129.14 123.98 59.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.349 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.594 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.5 m-85 -89.79 119.42 30.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.748 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HA ' HG12 ' A' ' 126' ' ' VAL . 54.9 tp -80.92 145.3 31.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.858 0.361 . . . . 0.0 110.932 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 23.7 m -158.88 56.16 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.733 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -159.0 -108.88 0.25 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.818 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 158.68 -124.67 1.4 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.863 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -151.4 53.03 0.84 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.189 0.519 . . . . 0.0 110.228 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 97.3 mt -99.35 156.89 34.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.879 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 80.6 Cg_exo -44.32 111.24 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.45 2.1 . . . . 0.0 112.182 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 72.66 -38.99 0.44 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.593 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 119' ' ' PRO . 16.5 tp 58.23 51.94 7.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.968 0.413 . . . . 0.0 111.122 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.3 60.4 1.52 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.008 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.29 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.396 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -49.92 152.27 1.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.486 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.502 ' O ' ' HB ' ' A' ' 114' ' ' THR . 79.1 ttt180 -155.63 122.05 5.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.409 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.593 HG23 ' CE1' ' A' ' 128' ' ' PHE . 26.8 m -111.82 134.71 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.159 0.504 . . . . 0.0 111.772 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -87.34 141.84 28.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.226 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.593 ' CE1' HG23 ' A' ' 126' ' ' VAL . 14.4 m-85 -117.09 140.23 49.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.491 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -162.36 131.02 4.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.661 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 7.1 t -89.22 155.11 19.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.909 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 133' ' ' ASP . 45.9 m-20 -52.75 151.62 7.95 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.496 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.03 76.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.284 2.656 . . . . 0.0 113.133 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 131' ' ' ASP . 33.4 t70 -178.68 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.702 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.549 ' HB2' ' SG ' ' A' ' 130' ' ' CYS . 5.0 m-85 -108.93 145.83 34.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.55 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -101.08 140.03 35.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.32 0.581 . . . . 0.0 111.287 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.558 HD13 ' N ' ' A' ' 137' ' ' VAL . 2.4 tm? -79.61 127.09 31.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.971 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.558 ' N ' HD13 ' A' ' 136' ' ' LEU . 44.6 t -132.38 71.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.549 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.98 -130.25 1.56 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.879 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.743 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 31.4 t -73.53 58.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 111.268 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.477 ' HB3' HD12 ' A' ' 136' ' ' LEU . 96.5 p -51.71 -26.29 9.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.122 0.487 . . . . 0.0 109.885 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.407 ' HD2' ' NH2' ' A' ' 125' ' ' ARG . 34.2 ptt85 -140.62 128.95 22.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.272 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 99.8 p -125.74 128.27 47.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 111.038 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 89.1 t -103.13 117.56 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 42.6 t -64.54 136.69 57.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.455 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.1 t -164.47 130.29 2.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 111.201 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 17.5 tt0 56.75 43.16 25.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.28 0.562 . . . . 0.0 110.538 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 60.53 17.4 47.95 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.94 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -143.52 135.03 26.2 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.886 0.343 . . . . 0.0 111.128 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.622 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 95.5 m95 -68.97 135.19 50.57 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.838 0.352 . . . . 0.0 111.126 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -57.46 -55.16 38.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.3 p -103.97 132.11 21.33 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.63 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.526 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 54.3 Cg_endo -69.37 136.49 34.15 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.797 2.331 . . . . 0.0 112.473 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.823 ' HE2' HD13 ' A' ' 106' ' ' LEU . 85.9 tttt -40.01 129.03 1.6 Allowed Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.459 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 95.2 Cg_endo -79.2 -154.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.906 2.404 . . . . 0.0 113.221 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -153.74 169.42 23.38 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 92.3 m -98.72 136.79 38.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.418 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -131.25 131.14 43.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 110.857 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.43 132.08 29.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.322 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.904 179.862 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.441 -0.91 0 CA-C-O 120.919 0.39 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 14.4 m -48.85 138.41 11.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.376 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.7 m -39.86 128.45 2.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.416 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.406 ' HA ' HD13 ' A' ' 104' ' ' LEU . 33.1 mmtp -82.0 -15.95 51.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.923 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.7 m -53.11 -42.41 65.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.085 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -57.5 -41.48 80.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.014 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.605 ' N ' HD12 ' A' ' 104' ' ' LEU . 3.6 mp -77.88 40.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.8 m -147.39 62.68 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.481 HD21 ' SG ' ' A' ' 130' ' ' CYS . 49.9 tp -94.55 124.97 38.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.849 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.58 41.0 1.04 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.017 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -160.12 27.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.697 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 161.07 -146.48 12.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.997 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 7.9 mtpm? -141.94 143.37 33.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.296 -0.452 . . . . 0.0 110.663 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.71 119.84 54.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.831 0.348 . . . . 0.0 110.519 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.432 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 1.7 m-85 -71.71 123.02 21.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.907 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.591 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -89.17 141.34 28.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.625 HG21 ' NH2' ' A' ' 125' ' ' ARG . 25.2 m -157.95 54.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.868 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.96 -105.57 0.43 Allowed Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.934 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.628 ' H ' HD21 ' A' ' 121' ' ' LEU . . . 165.82 -126.46 1.48 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.42 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -167.32 67.17 0.09 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.157 0.504 . . . . 0.0 109.984 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.698 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 71.5 mt -127.97 168.76 14.32 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.116 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.698 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 76.3 Cg_exo -38.18 97.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.635 2.224 . . . . 0.0 112.125 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 70.68 -20.05 0.21 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.847 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.673 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 19.8 tp 62.31 54.01 2.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.93 0.395 . . . . 0.0 110.76 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.699 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 33.1 t70 -56.83 129.51 41.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.182 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.74 26.31 38.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.988 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 1.086 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -79.64 156.91 27.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.625 ' NH2' HG21 ' A' ' 114' ' ' THR . 56.4 ttp85 -154.34 145.27 22.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.407 . . . . 0.0 111.405 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.7 m -148.35 138.23 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.582 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.449 ' HG3' ' NH1' ' A' ' 141' ' ' ARG . 43.3 tt0 -110.79 115.83 30.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.582 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.558 ' HE2' ' HG3' ' A' ' 153' ' ' LYS . 2.0 m-85 -73.95 143.0 45.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -156.3 117.84 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.704 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.558 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 95.2 m -92.32 156.25 17.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.571 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -52.7 153.11 6.01 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.476 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.37 78.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.128 2.552 . . . . 0.0 112.668 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -177.46 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.646 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.675 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 0.6 OUTLIER -108.61 134.52 51.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.924 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' HIS . . . . . 0.474 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 20.3 p-80 -102.66 127.33 49.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.122 0.486 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.75 HD21 ' HA ' ' A' ' 140' ' ' SER . 26.6 tp -70.21 126.61 30.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.131 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.7 67.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.638 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -174.74 -135.31 2.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.072 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.73 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 65.0 m -74.74 55.04 0.66 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.75 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.8 t -48.42 -43.53 34.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.09 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.574 ' HD2' ' N ' ' A' ' 141' ' ' ARG . 0.4 OUTLIER -102.02 133.63 46.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.9 m -133.91 130.0 37.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.713 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.61 123.97 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.299 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 1.086 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 41.1 t -100.7 145.21 28.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.687 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.699 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 81.1 p -168.14 35.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 175.8 39.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.276 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 61.71 10.98 27.52 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.112 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.15 134.81 28.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.562 0.22 . . . . 0.0 110.592 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -73.42 137.11 44.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.366 . . . . 0.0 111.13 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.2 t -57.49 -59.66 4.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.35 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 82.7 p -96.44 134.52 23.32 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 15.9 Cg_exo -67.53 146.28 73.5 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.935 2.423 . . . . 0.0 111.949 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.558 ' HG3' ' HE2' ' A' ' 128' ' ' PHE . 88.2 tttt -51.17 122.93 19.24 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.858 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.73 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.2 Cg_endo -75.25 -150.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.734 2.289 . . . . 0.0 112.953 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -153.74 139.88 18.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 67.5 m -98.79 139.28 34.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.003 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.474 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 39.3 tt0 -102.93 132.53 49.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.11 126.91 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.338 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.395 179.667 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.625 HG22 HD11 ' A' ' 121' ' ' LEU . 1.4 pt . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 120.745 0.307 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.528 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 99.7 m -64.16 136.18 57.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.4 m -41.42 131.12 2.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.275 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.575 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -76.63 15.56 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.177 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.4 m -68.93 -39.81 79.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 111.433 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.496 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 1.8 m-85 -64.59 -70.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.599 HD23 HD13 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -46.98 156.97 0.18 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.97 0.414 . . . . 0.0 111.484 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.6 m 64.67 73.13 0.43 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.34 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.689 ' HB2' ' HZ3' ' A' ' 153' ' ' LYS . 49.3 tp -93.14 136.52 33.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.333 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.83 135.06 57.58 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.0 m120 58.97 40.93 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.075 0.464 . . . . 0.0 110.186 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.37 169.58 41.81 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.934 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -136.93 129.66 30.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.958 0.409 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.489 HG12 ' HB ' ' A' ' 126' ' ' VAL . 58.4 t -111.15 126.53 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.227 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.5 m-85 -70.87 111.33 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.19 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.599 HD13 HD23 ' A' ' 104' ' ' LEU . 58.5 tp -80.84 145.26 31.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.931 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.4 m -161.88 54.42 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.849 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.506 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . -174.76 61.26 0.11 Allowed Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.697 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.46 -53.37 45.52 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 114.634 0.613 . . . . 0.0 114.634 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -164.08 54.7 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.425 0.613 . . . . 0.0 111.821 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 120' ' ' ALA . 7.1 mp -87.74 159.19 49.75 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.355 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -47.52 83.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.541 2.16 . . . . 0.0 111.638 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 59.83 23.12 12.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.902 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 7.8 mp 52.22 53.26 12.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.62 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 38.6 t70 -76.79 44.93 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.211 0.529 . . . . 0.0 110.329 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 125' ' ' ARG . . . 172.5 -27.65 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.536 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -51.8 144.55 11.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.783 0.325 . . . . 0.0 111.251 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.567 ' HG2' HG22 ' A' ' 143' ' ' VAL . 84.2 mtm180 -147.84 136.98 22.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.003 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' A' ' 113' ' ' LEU . 31.6 m -121.91 131.98 71.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.004 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.16 124.2 39.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.606 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.483 ' CE1' HG23 ' A' ' 126' ' ' VAL . 0.8 OUTLIER -87.09 138.17 31.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.98 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -145.92 127.47 15.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.491 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 96.5 m -89.29 145.32 25.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.692 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 134' ' ' PHE . 3.2 t70 -55.63 146.79 43.58 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.616 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 131' ' ' ASP . 88.4 Cg_exo -36.82 137.0 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.863 2.376 . . . . 0.0 112.593 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 51.5 m-20 75.0 22.21 1.85 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.512 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 16.9 m-85 -134.97 131.54 37.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.562 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -106.03 135.23 47.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.926 0.393 . . . . 0.0 110.836 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.823 HD11 ' HG2' ' A' ' 154' ' ' PRO . 17.5 tp -78.15 143.07 37.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.406 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 137' ' ' VAL . 14.5 p -134.92 59.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.87 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 169.28 -126.15 1.34 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 119.013 -1.565 . . . . 0.0 113.764 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.941 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 29.9 t -65.66 65.8 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.796 0.332 . . . . 0.0 111.258 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.649 ' HA ' HD21 ' A' ' 136' ' ' LEU . 95.6 p -61.88 -26.55 68.22 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.331 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -140.68 125.23 17.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.502 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m -116.35 137.33 52.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.793 0.33 . . . . 0.0 110.736 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.567 HG22 ' HG2' ' A' ' 125' ' ' ARG . 92.3 t -131.32 115.45 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.038 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 69.7 m -80.31 153.19 28.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.832 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 40.8 t -152.43 -23.01 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.661 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -146.58 46.18 1.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.15 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 64.74 24.18 69.58 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.882 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -141.7 132.74 26.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.293 0.237 . . . . 0.0 110.483 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.528 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 72.4 m95 -66.41 145.22 55.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 110.864 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.414 ' CB ' ' H ' ' A' ' 143' ' ' VAL . 47.3 t -56.27 -48.61 76.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.294 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.75 HG23 ' OG ' ' A' ' 139' ' ' SER . 1.0 OUTLIER -135.52 139.24 30.59 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-O 120.847 0.356 . . . . 0.0 111.765 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 17.8 Cg_endo -59.76 137.7 78.44 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.444 2.763 . . . . 0.0 113.842 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.838 ' HD3' ' HD2' ' A' ' 154' ' ' PRO . 2.7 tppp? -50.42 126.75 22.72 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.77 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 96.1 Cg_endo -85.03 -140.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.096 2.531 . . . . 0.0 112.278 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.505 ' O ' HG12 ' A' ' 137' ' ' VAL . 18.4 p-80 -153.69 149.31 27.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.876 0.369 . . . . 0.0 111.077 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.3 m -95.32 132.74 40.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.363 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -123.58 139.4 54.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.359 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.23 133.73 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.779 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.934 179.942 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 121.053 0.454 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.7 m -63.43 153.1 36.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.635 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 102' ' ' SER . 47.7 t -39.44 104.02 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.167 0.508 . . . . 0.0 110.879 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.639 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -66.46 3.95 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.328 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 100' ' ' SER . 47.7 t -68.11 -38.62 82.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.49 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.637 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.3 m-85 -51.5 -38.4 53.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.13 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.543 HD21 HD23 ' A' ' 113' ' ' LEU . 83.1 mt -53.77 -43.51 69.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.725 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.2 t -92.61 136.59 33.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.592 HD13 ' CE ' ' A' ' 153' ' ' LYS . 34.8 tp -145.42 128.94 17.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.909 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.92 42.24 0.62 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.284 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -154.08 -31.31 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.801 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.552 ' HA2' ' OD1' ' A' ' 131' ' ' ASP . . . -153.9 -148.37 4.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.174 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -131.15 137.42 49.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.779 0.323 . . . . 0.0 110.827 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.637 HG21 ' O ' ' A' ' 103' ' ' TYR . 60.1 t -108.72 121.82 62.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.864 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -69.17 124.32 23.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.513 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.705 HD22 ' H ' ' A' ' 114' ' ' THR . 3.1 tm? -99.7 142.16 31.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.395 0.617 . . . . 0.0 111.804 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.705 ' H ' HD22 ' A' ' 113' ' ' LEU . 22.6 m -157.47 42.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.861 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.553 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . 162.0 95.81 0.11 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.629 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.32 43.28 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.354 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.531 ' O ' HD23 ' A' ' 118' ' ' LEU . 53.1 p-10 -173.13 33.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 0.0 110.647 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.617 ' HB2' HD23 ' A' ' 121' ' ' LEU . 86.1 mt -141.13 140.76 21.71 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.526 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 51.0 Cg_exo -52.54 117.36 3.58 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.579 2.186 . . . . 0.0 112.813 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 71.18 -38.03 0.41 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.686 HD22 ' HB2' ' A' ' 124' ' ' ALA . 46.5 mt 63.04 55.23 1.99 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.799 0.333 . . . . 0.0 110.789 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -76.54 48.97 0.58 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.617 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.16 -20.11 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.789 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.848 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.97 143.02 4.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 111.672 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.621 ' HD2' HH22 ' A' ' 141' ' ' ARG . 84.9 mtm180 -136.57 141.6 43.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.13 136.2 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -114.27 113.4 24.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 3.0 m-85 -77.99 147.03 35.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.148 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 129' ' ' ARG . 38.1 ttt85 -158.07 129.34 6.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.078 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 31.1 m -89.07 139.52 30.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.02 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' ' HA2' ' A' ' 109' ' ' GLY . 82.3 m-20 -52.63 151.44 7.92 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.232 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.69 77.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.023 2.482 . . . . 0.0 112.422 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 131' ' ' ASP . 65.1 t0 -179.44 -41.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.432 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 2.9 m-85 -110.09 140.93 43.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.229 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -102.72 127.8 49.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.863 0.364 . . . . 0.0 110.573 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' A' ' 140' ' ' SER . 2.7 tm? -77.35 129.34 35.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.07 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.553 ' N ' HD13 ' A' ' 136' ' ' LEU . 39.4 t -136.82 72.46 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.24 -135.89 2.41 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.632 -1.271 . . . . 0.0 113.318 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.477 ' HB3' ' OG1' ' A' ' 151' ' ' THR . 68.6 m -76.37 54.54 0.92 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.708 0.29 . . . . 0.0 110.94 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.572 ' HB3' HD12 ' A' ' 136' ' ' LEU . 88.8 p -47.07 -37.46 9.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.541 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.621 HH22 ' HD2' ' A' ' 125' ' ' ARG . 40.6 ttt85 -99.4 138.27 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.505 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.1 t -150.37 132.0 14.88 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.726 0.298 . . . . 0.0 110.655 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 125' ' ' ARG . 83.5 t -117.66 127.41 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.298 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.848 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 49.9 t -71.43 140.17 49.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -169.19 129.35 1.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.592 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 56.76 40.28 29.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 59.12 22.54 55.75 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.407 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.18 132.51 24.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.648 0.261 . . . . 0.0 110.687 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -69.5 141.29 53.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.839 0.352 . . . . 0.0 111.034 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.0 m -57.4 -54.41 47.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.05 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.477 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 65.0 p -115.71 137.34 23.17 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.399 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 139' ' ' SER . 31.7 Cg_exo -58.76 142.2 98.54 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.817 2.345 . . . . 0.0 112.227 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.592 ' CE ' HD13 ' A' ' 106' ' ' LEU . 62.6 tttp -50.42 130.93 25.89 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.247 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.475 ' HG2' HD21 ' A' ' 136' ' ' LEU . 59.4 Cg_endo -72.39 -152.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.649 2.232 . . . . 0.0 112.555 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -153.63 143.7 22.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.133 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 81.1 m -98.15 129.68 44.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.37 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -119.28 140.82 49.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.937 0.398 . . . . 0.0 111.516 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.07 135.92 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.786 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 32.2 m120 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.888 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 1.058 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 94.5 mt . . . . . 0 N--CA 1.457 -0.094 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.8 m -62.48 150.52 39.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.717 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 102' ' ' SER . 57.5 m -40.68 105.07 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.603 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -69.13 15.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.719 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 100' ' ' SER . 46.9 t -68.92 -35.38 76.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.061 0.458 . . . . 0.0 110.029 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -51.65 -35.19 41.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.241 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.731 HD21 HD13 ' A' ' 113' ' ' LEU . 91.4 mt -53.47 -43.93 68.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.211 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.4 m -92.56 128.61 38.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.541 HD13 ' CE ' ' A' ' 153' ' ' LYS . 34.9 tp -145.45 132.91 20.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.366 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.41 132.91 47.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.492 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 56.24 43.98 25.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.545 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.81 163.82 32.99 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.519 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.58 ' NZ ' ' HB2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -138.89 134.39 33.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.775 0.322 . . . . 0.0 110.684 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' A' ' 126' ' ' VAL . 57.7 t -114.13 126.96 71.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.647 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -73.34 124.82 26.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.211 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.731 HD13 HD21 ' A' ' 104' ' ' LEU . 52.9 tp -89.54 143.35 26.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.225 0.535 . . . . 0.0 112.088 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.577 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.2 m -162.37 52.4 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.395 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.641 ' O ' HD11 ' A' ' 121' ' ' LEU . . . 161.95 103.39 0.18 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.709 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.86 47.84 0.22 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.113 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.643 ' O ' HD13 ' A' ' 118' ' ' LEU . 2.7 p30 -174.5 36.43 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.35 . . . . 0.0 111.156 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 117' ' ' ASP . 2.2 mm? -134.98 151.85 76.22 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.582 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.4 124.26 11.64 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.345 2.03 . . . . 0.0 111.424 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 53.16 32.0 12.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.069 0.461 . . . . 0.0 110.279 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 1.058 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 14.7 tp 50.58 46.73 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.927 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -66.68 141.08 57.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.122 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.8 31.36 80.65 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.469 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.919 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . . . -85.65 145.17 27.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.737 0.303 . . . . 0.0 110.976 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.577 ' O ' ' HB ' ' A' ' 114' ' ' THR . 53.4 ttt-85 -160.4 127.07 4.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.692 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 113' ' ' LEU . 28.3 m -137.54 136.96 46.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.68 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -102.38 122.71 44.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.123 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.569 ' HE2' ' HG3' ' A' ' 153' ' ' LYS . 5.7 m-85 -83.61 150.21 26.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.134 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -157.04 126.13 5.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.588 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 73.4 m -89.91 136.91 32.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.218 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -57.78 159.33 10.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.965 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 88.3 Cg_exo -40.89 152.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.96 2.44 . . . . 0.0 112.721 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 57.8 m-20 78.03 -34.38 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.039 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -106.02 128.21 53.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.3 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.27 140.08 39.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.14 0.495 . . . . 0.0 111.878 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.817 HD21 ' HA ' ' A' ' 140' ' ' SER . 36.5 tp -78.11 128.44 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.704 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.42 64.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.577 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.73 -135.83 2.05 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.219 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.678 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 63.8 m -72.04 63.92 0.51 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.114 0.483 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.817 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.1 t -55.31 -16.96 3.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.467 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -140.64 136.03 32.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.89 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 79.2 p -135.57 141.87 45.23 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.49 ' H ' ' HB3' ' A' ' 150' ' ' SER . 95.5 t -135.82 126.18 42.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.066 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.867 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 57.2 m -92.95 148.46 21.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.039 0.447 . . . . 0.0 111.735 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.6 t -163.15 26.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.148 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 175.86 39.51 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.275 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 62.66 19.37 60.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.495 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -142.38 132.77 24.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.664 0.268 . . . . 0.0 110.641 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -64.56 143.01 58.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.967 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 48.5 t -57.14 -47.43 81.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.714 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 59.8 p -127.68 133.57 25.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.342 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.25 142.99 77.61 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.879 2.386 . . . . 0.0 112.619 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.569 ' HG3' ' HE2' ' A' ' 128' ' ' PHE . 87.4 tttt -48.86 128.24 14.39 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.28 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.678 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.0 Cg_endo -75.91 -150.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.704 2.269 . . . . 0.0 112.672 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.405 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.6 p-80 -153.69 151.51 29.74 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.08 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 90.2 m -98.61 137.09 37.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.727 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -120.4 135.83 54.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.362 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.65 143.63 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.973 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 133' ' ' ASP . 23.5 p30 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.09 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.629 HD13 ' HA ' ' A' ' 117' ' ' ASP . 12.8 mt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.923 0.392 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.539 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 72.9 m 58.77 149.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.876 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -40.41 100.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.549 ' HG3' HD12 ' A' ' 104' ' ' LEU . 27.7 ttpp -59.9 -20.61 58.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.861 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.8 p -53.24 -33.51 53.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.292 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -56.95 -44.87 82.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.662 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.549 HD12 ' HG3' ' A' ' 101' ' ' LYS . 92.7 mt -49.61 -39.98 37.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.7 p -92.55 131.87 37.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.652 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.859 HD13 ' HE3' ' A' ' 153' ' ' LYS . 55.4 tp -145.36 130.68 18.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.18 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.57 132.3 47.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.433 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 56.77 43.89 24.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.566 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.19 164.4 34.92 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.472 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -136.7 134.35 37.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.736 0.303 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 86.9 t -106.48 126.07 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.391 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.585 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.5 m-85 -74.71 127.43 33.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -81.6 140.97 34.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.076 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.649 ' N ' HD13 ' A' ' 113' ' ' LEU . 28.2 m -158.1 56.11 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.083 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.99 -101.87 0.2 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.012 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.651 ' H ' HD21 ' A' ' 121' ' ' LEU . . . -179.97 -131.55 1.66 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.225 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.699 ' C ' HD12 ' A' ' 118' ' ' LEU . 39.0 t70 -165.8 58.38 0.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.974 0.416 . . . . 0.0 110.34 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.699 HD12 ' C ' ' A' ' 117' ' ' ASP . 8.0 mp -131.38 156.98 79.39 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.515 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.439 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 95.6 Cg_exo -42.89 119.89 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.445 2.097 . . . . 0.0 112.468 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 72.99 -40.24 0.47 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.672 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.651 HD21 ' H ' ' A' ' 116' ' ' GLY . 21.2 tp 55.23 57.21 5.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.949 0.404 . . . . 0.0 110.857 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -51.19 137.1 23.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.15 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.22 33.52 64.78 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.895 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.586 ' HB3' ' SG ' ' A' ' 144' ' ' CYS . . . -84.35 148.53 26.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.523 0.201 . . . . 0.0 110.595 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.422 ' O ' ' HB ' ' A' ' 114' ' ' THR . 66.1 mtm-85 -144.87 141.96 29.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.985 0.421 . . . . 0.0 111.338 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.58 HG23 ' CE1' ' A' ' 128' ' ' PHE . 23.9 m -147.8 132.08 9.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.715 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.7 mt-10 -93.05 131.43 38.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.292 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.58 ' CE1' HG23 ' A' ' 126' ' ' VAL . 4.3 m-85 -103.47 145.84 29.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.029 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.508 ' HG2' HH11 ' A' ' 129' ' ' ARG . 2.9 ptp85 -168.89 129.98 1.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.651 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 26.2 t -89.22 150.5 22.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.235 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -52.68 155.8 3.68 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.32 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 84.9 Cg_exo -46.28 159.21 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.68 2.254 . . . . 0.0 112.149 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 25.3 m-20 78.27 -37.53 0.22 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.61 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -108.05 128.96 55.13 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -108.66 133.52 52.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 111.596 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 137' ' ' VAL . 7.9 tt -71.42 137.53 48.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.02 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.551 ' N ' HD23 ' A' ' 136' ' ' LEU . 42.8 t -131.37 73.08 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.769 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.46 -133.43 2.22 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.081 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.58 ' OG ' ' HD3' ' A' ' 154' ' ' PRO . 43.6 p -73.72 62.6 0.81 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.528 ' HB3' HD22 ' A' ' 136' ' ' LEU . 99.8 p -56.27 -14.93 3.19 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.801 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.647 ' HD2' ' O ' ' A' ' 141' ' ' ARG . 7.6 ppt_? -140.62 140.52 35.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.599 0.237 . . . . 0.0 110.964 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 56.1 m -136.55 148.93 47.84 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.855 0.359 . . . . 0.0 111.278 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.21 129.87 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.374 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.586 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 98.3 m -75.06 174.93 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.509 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.7 t -172.21 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.452 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -150.8 49.5 0.86 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.59 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 65.68 19.35 67.08 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.259 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -142.82 132.19 23.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.548 0.213 . . . . 0.0 110.731 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.539 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 97.7 m95 -65.15 135.83 55.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.647 0.261 . . . . 0.0 110.941 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.8 t -57.48 -52.76 64.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.483 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.7 p -104.3 146.15 32.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.971 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.83 -152.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.622 2.215 . . . . 0.0 112.739 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.859 ' HE3' HD13 ' A' ' 106' ' ' LEU . 59.0 tptt -121.77 123.62 27.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.262 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.782 ' HD2' ' HD2' ' A' ' 153' ' ' LYS . 98.3 Cg_endo -85.45 -146.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.66 2.24 . . . . 0.0 113.214 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.445 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.7 p-80 -153.72 -149.28 0.28 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 85.6 m -133.07 134.83 44.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -116.85 130.03 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.456 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.0 p -62.14 137.99 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.125 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.6 p30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.954 -179.846 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.777 ' HA ' HD13 ' A' ' 121' ' ' LEU . 11.4 pt . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.527 0.679 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.609 ' SG ' HD22 ' A' ' 121' ' ' LEU . 3.2 p -60.7 136.04 57.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.726 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 102' ' ' SER . 80.4 p -39.89 130.31 2.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.592 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.581 ' NZ ' HD12 ' A' ' 98' ' ' ILE . 60.5 mttp -75.11 16.12 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.345 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 100' ' ' SER . 79.6 p -68.96 -44.8 72.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.866 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -59.07 -36.83 75.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.412 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.412 HD21 HD23 ' A' ' 113' ' ' LEU . 94.9 mt -50.55 149.39 3.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.747 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.3 p 62.66 137.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.115 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.796 HD13 ' HE2' ' A' ' 153' ' ' LYS . 36.1 tp -145.41 139.66 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.26 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -68.04 130.0 41.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.235 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 57.37 41.74 25.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.713 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.49 152.82 10.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.636 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.48 132.01 56.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.724 0.297 . . . . 0.0 110.685 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.757 HG22 ' HA ' ' A' ' 128' ' ' PHE . 98.5 t -108.32 121.96 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.288 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.7 m-85 -74.82 126.08 30.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.152 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.681 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -108.58 142.06 39.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.411 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.681 ' N ' HD13 ' A' ' 113' ' ' LEU . 94.7 m -163.58 97.66 0.88 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.608 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.493 ' O ' ' HG ' ' A' ' 121' ' ' LEU . . . 163.08 -30.26 0.27 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.883 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -41.58 150.14 0.26 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.528 -0.368 . . . . 0.0 113.901 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.672 ' C ' HD22 ' A' ' 118' ' ' LEU . 32.5 m-20 72.23 37.11 0.99 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.826 0.45 . . . . 0.0 111.704 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.672 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.3 mm? -142.44 148.67 48.2 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.953 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.86 97.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.797 2.332 . . . . 0.0 112.616 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.402 ' HB1' ' H ' ' A' ' 147' ' ' GLY . . . 55.64 17.06 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.574 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.777 HD13 ' HA ' ' A' ' 98' ' ' ILE . 10.4 mp 46.11 62.44 2.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.25 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.53 46.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.169 0.509 . . . . 0.0 110.376 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.86 27.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.029 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.784 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -81.46 142.08 33.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.754 0.311 . . . . 0.0 111.397 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.56 130.29 34.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.621 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 113' ' ' LEU . 19.0 m -136.1 144.13 34.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.468 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 87.2 tt0 -119.09 122.05 41.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.229 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.757 ' HA ' HG22 ' A' ' 111' ' ' VAL . 9.4 m-85 -85.65 53.51 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.965 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.499 ' HB3' ' NH1' ' A' ' 129' ' ' ARG . 12.8 mtp-105 -58.88 128.62 38.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 0.0 111.001 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 61.3 m -89.55 147.21 24.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.891 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 133' ' ' ASP . 52.6 p-10 -52.81 153.0 6.27 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.031 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.36 75.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.001 2.468 . . . . 0.0 112.755 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.5 t70 179.93 -40.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.435 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 3.5 m-85 -108.63 139.65 43.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.259 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -102.86 131.45 49.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.053 0.454 . . . . 0.0 110.757 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.852 HD21 ' HA ' ' A' ' 140' ' ' SER . 23.2 tp -69.91 131.9 45.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.982 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.1 t -136.25 67.8 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.94 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.59 -136.5 2.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.47 -1.348 . . . . 0.0 113.376 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.495 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 62.2 m -74.62 58.12 0.77 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.997 0.427 . . . . 0.0 110.565 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.852 ' HA ' HD21 ' A' ' 136' ' ' LEU . 39.3 t -47.63 -44.03 26.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.416 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -102.62 133.03 48.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.968 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.7 t -138.32 125.23 21.18 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.64 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 96.8 t -111.89 125.62 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.086 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.784 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 73.9 m -72.83 143.35 47.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.017 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.5 p -163.51 128.69 3.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.097 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 1.5 mp0 55.79 38.21 29.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.451 . . . . 0.0 109.917 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.402 ' H ' ' HB1' ' A' ' 120' ' ' ALA . . . 62.29 28.21 70.53 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.351 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -143.23 131.53 22.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.576 0.227 . . . . 0.0 110.593 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -69.85 137.43 51.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.2 t -57.49 -56.46 21.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.644 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 82.0 p -111.75 137.64 21.32 Favored Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 32.2 Cg_exo -58.41 147.17 86.96 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.879 2.386 . . . . 0.0 112.268 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.796 ' HE2' HD13 ' A' ' 106' ' ' LEU . 85.9 tttt -52.79 125.65 39.16 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.495 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.8 Cg_endo -76.78 -154.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.76 2.306 . . . . 0.0 112.655 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -153.67 150.67 28.82 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.229 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 76.5 m -97.33 134.91 39.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.228 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 158' ' ' VAL . 0.7 OUTLIER -124.47 131.42 53.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.715 0.293 . . . . 0.0 110.721 -179.359 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 7.3 p -74.09 129.27 36.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 111.641 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.184 -0.913 . . . . 0.0 111.091 179.758 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.679 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 120.872 0.367 . . . . 0.0 111.104 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 39.1 m -57.1 143.77 37.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.866 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.6 t -39.88 128.56 2.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.075 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.69 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -72.73 -14.27 61.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.364 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.5 p -53.1 -47.06 68.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.53 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -59.44 -41.27 89.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.252 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 86.8 mt -51.86 -36.89 49.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.23 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.5 p -92.49 141.42 28.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.608 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.498 HD22 ' H ' ' A' ' 108' ' ' ASN . 1.9 tt -140.84 120.93 13.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.532 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 108' ' ' ASN . 3.8 mm-40 -82.64 30.05 0.43 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.498 ' H ' HD22 ' A' ' 106' ' ' LEU . 72.3 m-80 -166.14 25.68 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.54 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.15 -156.67 23.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.656 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -141.96 134.01 27.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.632 0.253 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 94.0 t -106.59 121.18 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.023 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.2 m-85 -74.78 116.35 15.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.437 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.2 tp -83.28 142.77 30.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.393 . . . . 0.0 111.422 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 114' ' ' THR . 32.3 m -163.28 61.17 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.393 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.486 ' O ' HD13 ' A' ' 118' ' ' LEU . . . -152.39 -39.35 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.839 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.06 -125.74 7.35 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.885 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.457 ' HA ' HD11 ' A' ' 121' ' ' LEU . 52.0 p-10 -147.47 48.3 1.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.999 0.428 . . . . 0.0 111.163 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 121' ' ' LEU . 6.7 mp -80.77 161.38 63.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.402 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 83.6 Cg_exo -43.82 94.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.459 2.106 . . . . 0.0 112.343 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.25 -9.03 0.65 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.961 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 118' ' ' LEU . 7.6 mp 61.46 57.68 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.593 0.235 . . . . 0.0 110.883 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -75.12 49.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 110.587 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 178.99 -13.68 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.905 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.993 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -50.75 147.54 4.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.928 0.394 . . . . 0.0 111.335 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.684 ' CD ' HG22 ' A' ' 143' ' ' VAL . 43.8 mmm-85 -146.25 133.57 20.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.657 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.415 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 35.7 m -127.03 132.13 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 111.584 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 52.4 mm-40 -103.32 138.63 39.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.839 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -105.58 145.06 31.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.043 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -148.52 122.53 9.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.355 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 59.3 m -89.22 143.89 26.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.052 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 133' ' ' ASP . 1.4 m-20 -52.8 151.94 7.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.883 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.28 75.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.13 2.553 . . . . 0.0 112.722 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' ASP . 38.9 t70 178.89 -36.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.646 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 1.6 m-85 -108.8 136.67 47.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.068 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -102.84 130.13 49.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 0.0 110.532 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 140' ' ' SER . 35.8 tp -71.46 130.32 41.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.056 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.33 68.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.785 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 174.61 -129.21 1.55 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 119.512 -1.327 . . . . 0.0 113.347 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.736 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 30.1 t -68.86 63.63 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.89 0.376 . . . . 0.0 111.259 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.812 ' HA ' HD21 ' A' ' 136' ' ' LEU . 93.4 p -57.77 -23.99 54.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.526 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -140.61 136.17 32.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.79 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.548 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 46.7 t -127.92 125.48 39.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.559 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.684 HG22 ' CD ' ' A' ' 125' ' ' ARG . 46.3 t -97.72 120.24 46.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.244 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.993 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 52.7 t -77.94 122.94 26.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.4 p -104.65 -123.72 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.703 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -75.88 55.89 0.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.68 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.03 21.13 66.13 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.776 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -143.09 137.07 28.91 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.65 0.262 . . . . 0.0 111.239 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 83.3 m95 -67.24 139.79 57.37 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.875 0.369 . . . . 0.0 111.51 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.508 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 46.7 t -57.49 -53.86 53.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.978 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.587 HG23 ' OG ' ' A' ' 139' ' ' SER . 2.4 t -127.06 141.41 40.59 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.698 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.3 145.32 98.19 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.174 2.583 . . . . 0.0 112.979 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -49.91 134.76 21.24 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.381 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.736 ' HB3' ' H ' ' A' ' 139' ' ' SER . 97.0 Cg_endo -79.48 -149.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.749 2.299 . . . . 0.0 112.759 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.421 ' CD2' HE21 ' A' ' 157' ' ' GLN . 18.2 p-80 -153.72 145.71 23.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 75.2 m -96.81 127.52 42.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.544 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.421 HE21 ' CD2' ' A' ' 155' ' ' HIS . 82.5 mt-30 -111.09 129.48 55.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.064 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.22 136.29 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.826 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 33.6 m120 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.886 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.633 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.675 0.274 . . . . 0.0 110.693 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 61.2 m -55.88 135.7 51.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.509 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.4 p -42.15 127.27 3.49 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -77.86 16.23 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.5 m -68.26 -42.25 79.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 110.359 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.503 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.2 m-85 -62.03 -46.28 89.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.728 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.423 ' HA ' HG11 ' A' ' 111' ' ' VAL . 92.4 mt -64.64 -30.63 71.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.979 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.2 p -92.46 72.63 5.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.633 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.796 HD22 ' H ' ' A' ' 109' ' ' GLY . 1.3 tt -94.54 124.27 38.46 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 38.5 tt0 -81.84 34.99 0.41 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.082 0.468 . . . . 0.0 111.38 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.417 ' N ' HD22 ' A' ' 106' ' ' LEU . 7.3 m120 -160.75 -49.17 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.4 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.796 ' H ' HD22 ' A' ' 106' ' ' LEU . . . -86.68 -151.96 20.51 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.964 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 111' ' ' VAL . 86.0 tttt -142.04 -42.33 0.34 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.811 0.339 . . . . 0.0 110.602 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 10.5 p 48.55 115.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.947 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -75.17 127.48 33.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.111 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.3 tp -90.84 146.23 24.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.065 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 24.8 m -157.11 53.97 0.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.398 0.618 . . . . 0.0 109.912 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.664 ' C ' HD11 ' A' ' 121' ' ' LEU . . . 164.96 107.68 0.2 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.702 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.53 140.67 7.72 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.862 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.726 ' C ' HD12 ' A' ' 118' ' ' LEU . 9.4 t70 73.87 53.38 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.137 0.494 . . . . 0.0 111.073 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.726 HD12 ' C ' ' A' ' 117' ' ' ASP . 9.3 mp -140.27 152.4 66.89 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.657 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -57.24 113.75 1.63 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.228 1.952 . . . . 0.0 110.999 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.573 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 56.55 18.27 3.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.143 0.497 . . . . 0.0 109.887 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.778 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 14.9 tp 45.54 42.94 8.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.069 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -62.78 137.39 58.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.63 37.53 61.8 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.979 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.822 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -98.73 142.76 29.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.685 0.279 . . . . 0.0 110.867 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.512 ' O ' ' HB ' ' A' ' 114' ' ' THR . 66.2 mtm-85 -131.49 138.54 49.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.94 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.6 m -144.53 134.75 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.273 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -113.68 105.93 13.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.39 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 66.3 m-85 -68.78 146.49 52.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.102 0.477 . . . . 0.0 111.625 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' ' 129' ' ' ARG . 41.3 ttt85 -153.16 125.42 8.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.657 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.637 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 56.5 m -89.26 139.97 29.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.558 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 47.4 p-10 -54.26 161.09 2.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.703 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.559 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 1.8 Cg_endo -45.04 152.44 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.835 2.357 . . . . 0.0 111.899 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.559 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 35.0 t70 79.62 -29.57 0.14 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.485 ' CE2' HG22 ' A' ' 158' ' ' VAL . 35.6 m-85 -106.45 132.43 52.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.711 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -112.28 136.02 52.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.992 0.425 . . . . 0.0 111.191 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.896 HD21 ' HA ' ' A' ' 140' ' ' SER . 29.6 tp -77.3 129.77 36.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.3 t -136.2 68.91 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.861 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 176.82 -129.99 1.57 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.267 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.741 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 31.3 t -70.06 62.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.035 0.445 . . . . 0.0 111.206 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.896 ' HA ' HD21 ' A' ' 136' ' ' LEU . 36.2 t -58.13 -23.13 53.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.81 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -127.28 139.71 52.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.654 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.6 t -144.48 134.82 24.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.687 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -122.54 125.56 72.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.822 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 7.5 m -64.46 148.46 50.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.331 0.586 . . . . 0.0 112.091 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.6 p -166.82 124.26 1.29 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.32 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 59.3 39.02 22.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.082 0.468 . . . . 0.0 110.079 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.573 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 62.11 24.1 64.74 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.659 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -142.42 135.93 29.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.505 0.193 . . . . 0.0 110.81 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.457 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 59.5 m95 -64.33 133.03 51.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.741 0.305 . . . . 0.0 110.546 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -57.44 -59.43 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.009 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.9 p -94.11 135.48 24.54 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.778 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.16 142.91 82.37 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.726 2.284 . . . . 0.0 111.915 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -50.72 129.29 27.41 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.302 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.741 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.8 Cg_endo -75.69 -148.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.692 2.261 . . . . 0.0 112.47 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.422 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 3.6 p80 -153.69 143.32 21.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.172 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 88.3 m -97.63 130.85 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.031 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -124.02 143.36 50.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.184 0.516 . . . . 0.0 111.794 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.485 HG22 ' CE2' ' A' ' 134' ' ' PHE . 4.5 t -66.0 137.27 25.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.982 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.2 p30 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.173 -0.917 . . . . 0.0 111.002 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.96 HG22 ' HB2' ' A' ' 121' ' ' LEU . 4.4 pt . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.029 0.443 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.673 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 2.4 p -53.5 136.55 38.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.698 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 102' ' ' SER . 46.8 t -40.4 128.83 2.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.973 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -74.46 23.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.528 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.571 ' O ' HG22 ' A' ' 105' ' ' THR . 77.7 p -68.87 -41.16 78.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.029 0.442 . . . . 0.0 110.506 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.476 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.7 m-85 -67.92 -25.29 65.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.449 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.409 HD21 HD23 ' A' ' 113' ' ' LEU . 79.0 mt -68.86 23.9 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 102' ' ' SER . 9.2 t -148.36 129.55 14.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.56 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 43.5 tp -145.44 127.37 15.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 107' ' ' GLU . 41.9 tp10 -82.36 46.15 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.095 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -158.89 -30.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.215 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.643 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -158.33 -150.77 5.86 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.386 -0.912 . . . . 0.0 113.349 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -130.23 152.07 50.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.816 0.341 . . . . 0.0 111.005 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 103' ' ' TYR . 61.0 t -105.79 126.4 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -80.17 69.18 6.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.977 ' HA ' HG12 ' A' ' 126' ' ' VAL . 3.3 tm? -63.73 145.12 56.35 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.705 ' N ' HD13 ' A' ' 113' ' ' LEU . 56.4 m -149.06 81.74 1.43 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.022 0.439 . . . . 0.0 111.391 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.613 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . 177.03 -103.01 0.17 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.216 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . 59.58 144.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.073 0.389 . . . . 0.0 114.073 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.705 ' C ' HD22 ' A' ' 118' ' ' LEU . 57.6 m-20 71.86 49.84 0.25 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.705 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.4 mm? -142.23 138.68 16.88 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.883 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 70.1 Cg_endo -74.55 33.94 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.376 2.051 . . . . 0.0 112.192 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 119' ' ' PRO . . . 172.19 -44.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.732 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.96 ' HB2' HG22 ' A' ' 98' ' ' ILE . 15.2 tp 59.7 43.9 14.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 64.4 t0 -79.97 58.49 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.822 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.37 -27.09 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.738 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -48.83 153.53 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.063 0.458 . . . . 0.0 111.707 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -139.5 136.67 34.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.369 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.977 HG12 ' HA ' ' A' ' 113' ' ' LEU . 29.1 m -125.66 139.26 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.07 0.462 . . . . 0.0 111.942 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -120.71 98.24 5.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.397 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.476 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 4.6 m-85 -64.65 147.45 52.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.347 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -159.95 115.52 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.409 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.643 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 91.7 m -89.17 149.16 23.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.456 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.469 ' OD1' ' HA2' ' A' ' 109' ' ' GLY . 1.3 m-20 -52.7 158.35 2.2 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.083 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.509 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 99.3 Cg_exo -43.04 159.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.906 2.404 . . . . 0.0 112.564 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 49.8 m-20 80.76 -31.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.79 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.86 143.97 33.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.414 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -133.99 131.31 38.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.973 0.416 . . . . 0.0 111.015 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.768 HD11 ' HG2' ' A' ' 154' ' ' PRO . 24.4 tp -78.32 133.77 37.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.668 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.99 71.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.66 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.67 -133.61 2.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.955 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.597 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 58.7 m -76.05 54.82 0.88 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.739 0.304 . . . . 0.0 110.958 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.424 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 95.7 p -50.0 -41.31 46.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -99.38 130.23 45.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.482 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 126' ' ' VAL . 44.0 t -134.9 127.27 30.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.902 0.382 . . . . 0.0 110.74 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.5 t -93.81 128.67 45.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.357 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.735 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 48.9 t -83.03 134.43 35.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.887 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 79.3 p -175.04 132.95 0.32 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.972 0.415 . . . . 0.0 111.853 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 53.53 46.29 26.42 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.881 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.673 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . 52.76 23.35 14.52 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.961 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -142.49 130.22 21.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.66 0.267 . . . . 0.0 110.824 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.466 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 65.3 m95 -75.98 135.18 40.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 111.03 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 m -57.52 -53.98 51.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.036 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 80.8 p -107.5 129.53 24.11 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.477 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 139' ' ' SER . 38.8 Cg_exo -60.74 142.87 98.97 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.745 2.296 . . . . 0.0 111.866 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.56 ' NZ ' HD13 ' A' ' 106' ' ' LEU . 57.1 tttm -51.76 125.87 30.74 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.305 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.768 ' HG2' HD11 ' A' ' 136' ' ' LEU . 80.8 Cg_endo -79.26 -149.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.666 2.244 . . . . 0.0 112.433 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -153.95 141.47 19.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.741 0.305 . . . . 0.0 111.446 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 95.1 m -98.58 132.76 43.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.602 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -103.03 133.92 47.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.426 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.86 138.67 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.738 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . 0.421 HD21 ' C ' ' A' ' 159' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.029 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.494 HD11 ' C ' ' A' ' 117' ' ' ASP . 1.6 mp . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.966 0.412 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.47 ' O ' HG22 ' A' ' 98' ' ' ILE . 69.4 m -57.44 146.54 29.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.518 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 99' ' ' CYS . 52.8 m -35.85 120.98 0.63 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.017 0.437 . . . . 0.0 111.491 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.566 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -72.82 3.22 5.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.883 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.6 p -66.48 -41.95 88.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.353 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.554 ' HD2' ' HZ ' ' A' ' 128' ' ' PHE . 2.1 m-85 -54.23 -42.28 69.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.307 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 84.8 mt -59.25 -35.89 74.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -92.55 69.39 4.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.648 HD13 ' HE2' ' A' ' 153' ' ' LYS . 28.7 tp -94.61 130.99 40.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.187 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -67.57 136.06 53.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.289 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.522 ' HB3' ' OD1' ' A' ' 131' ' ' ASP . 75.4 m-20 55.83 44.11 26.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.353 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.59 164.65 34.44 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.493 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -136.99 130.91 32.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 0.0 110.489 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 48.5 t -106.5 123.09 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.3 m-85 -78.4 125.84 29.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.019 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.473 HD12 ' H ' ' A' ' 114' ' ' THR . 60.8 tp -85.18 150.91 24.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.252 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.473 ' H ' HD12 ' A' ' 113' ' ' LEU . 27.8 m -156.59 56.8 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.531 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -157.0 -105.15 0.22 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.21 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.57 -127.43 1.34 Allowed Glycine 0 CA--C 1.516 0.146 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.752 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.494 ' C ' HD11 ' A' ' 98' ' ' ILE . 38.8 t70 -152.15 41.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.298 0.57 . . . . 0.0 110.466 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.5 mt -95.02 152.01 39.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.36 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 86.6 Cg_exo -42.96 123.11 3.01 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.369 2.046 . . . . 0.0 111.998 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 73.63 -37.44 0.37 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.401 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.808 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 22.9 tp 55.88 45.15 24.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 111.18 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 8.1 t70 -65.51 133.42 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.69 -28.54 13.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.477 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 1.044 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.15 143.3 3.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.742 0.306 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.595 ' CD ' HG22 ' A' ' 143' ' ' VAL . 40.6 mmm-85 -129.6 144.9 51.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.21 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 32.8 m -142.38 134.93 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.553 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -107.97 116.84 32.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.704 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.554 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.5 m-85 -80.16 147.68 31.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.993 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -156.19 124.91 5.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.974 0.416 . . . . 0.0 110.815 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 136' ' ' LEU . 68.7 m -89.52 146.42 24.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.119 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' HB3' ' A' ' 108' ' ' ASN . 12.1 p-10 -55.28 154.97 10.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.735 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 2.3 Cg_endo -45.08 155.38 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.935 2.423 . . . . 0.0 111.906 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.4 m-20 78.57 -34.72 0.17 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.776 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 10.7 m-85 -106.53 126.51 52.36 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -106.89 137.19 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 111.296 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' A' ' 140' ' ' SER . 33.6 tp -71.24 136.84 48.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.724 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.31 67.78 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.577 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.75 -136.06 2.32 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.295 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.57 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 92.9 p -74.13 59.74 0.76 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.873 0.368 . . . . 0.0 110.75 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.631 ' HA ' HD21 ' A' ' 136' ' ' LEU . 97.0 p -47.94 -34.72 9.53 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.179 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 141' ' ' ARG . 21.2 mmt85 -109.55 138.79 45.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.706 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 45.3 t -143.57 127.03 16.84 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.595 HG22 ' CD ' ' A' ' 125' ' ' ARG . 24.0 t -103.91 117.8 50.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.775 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 1.044 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 50.7 t -71.82 140.43 49.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.936 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 43.8 t -169.43 131.97 1.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.819 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 56.35 41.8 28.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.583 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.67 25.06 50.25 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -141.68 132.51 25.83 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.489 0.185 . . . . 0.0 110.662 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.411 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 72.6 m95 -71.26 138.95 49.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.074 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.9 t -57.44 -58.46 8.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.279 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 82.8 p -101.78 136.55 19.52 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.6 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 33.3 Cg_exo -60.44 138.83 83.1 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.736 2.291 . . . . 0.0 111.954 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.648 ' HE2' HD13 ' A' ' 106' ' ' LEU . 84.5 tttt -47.99 131.48 12.01 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.341 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.57 ' HB3' ' H ' ' A' ' 139' ' ' SER . 88.4 Cg_endo -84.37 -148.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.873 2.382 . . . . 0.0 113.029 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.439 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.6 p-80 -153.66 149.69 27.81 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.965 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 91.4 m -97.91 136.16 38.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.01 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -136.93 133.98 36.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 134' ' ' PHE . 8.7 p -65.6 142.55 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.277 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.884 -179.946 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.756 HG22 ' H ' ' A' ' 118' ' ' LEU . 14.7 pt . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.503 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 36.1 m 55.97 142.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.3 p -44.08 130.67 6.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.944 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.544 ' HB2' HD12 ' A' ' 104' ' ' LEU . 18.0 ptpt -77.45 10.75 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.513 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.2 m -68.93 -44.76 72.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 110.693 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 103' ' ' TYR . 1.2 m-85 -62.63 -33.1 74.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.253 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.759 HD22 HD22 ' A' ' 113' ' ' LEU . 65.8 mt -49.8 -45.45 49.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.1 t -92.51 138.65 31.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.109 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.803 HD13 ' HE3' ' A' ' 153' ' ' LYS . 28.6 tp -143.75 126.41 16.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.023 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -73.45 124.59 26.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.018 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.8 m120 56.3 49.15 15.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.524 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.74 148.42 11.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.891 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.722 ' HB2' ' HD2' ' A' ' 129' ' ' ARG . 55.1 mtpt -102.53 138.84 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.74 119.22 59.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.541 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.615 ' C ' HG23 ' A' ' 126' ' ' VAL . 2.6 m-85 -83.14 60.43 5.51 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.268 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.759 HD22 HD22 ' A' ' 104' ' ' LEU . 63.2 tp -59.52 145.99 42.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.15 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 27.1 m -158.86 53.31 0.41 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.587 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.467 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . 177.14 105.08 0.19 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.147 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.503 ' N ' HD21 ' A' ' 121' ' ' LEU . . . -163.12 138.16 5.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.784 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.687 ' C ' HD12 ' A' ' 118' ' ' LEU . 8.2 t70 73.2 42.21 0.45 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.98 0.419 . . . . 0.0 111.055 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.756 ' H ' HG22 ' A' ' 98' ' ' ILE . 9.5 mp -137.38 150.1 67.63 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -44.87 89.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.987 2.458 . . . . 0.0 112.818 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 56.0 13.58 1.18 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.734 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 118' ' ' LEU . 58.7 mt 50.09 60.32 3.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.538 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.817 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 9.1 t70 -76.11 45.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.229 0.538 . . . . 0.0 110.412 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.59 25.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.127 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.946 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -84.13 153.19 23.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.719 0.295 . . . . 0.0 111.002 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.649 ' O ' ' HB ' ' A' ' 114' ' ' THR . 4.4 tmm_? -151.48 140.67 21.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.441 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.615 HG23 ' C ' ' A' ' 112' ' ' PHE . 1.6 p -151.35 148.28 14.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.493 0.663 . . . . 0.0 112.107 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -113.3 118.11 33.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.689 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.527 ' HB2' ' HA ' ' A' ' 140' ' ' SER . 6.3 m-85 -89.0 145.58 25.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.097 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.722 ' HD2' ' HB2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -159.57 138.94 11.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.437 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 66.0 m -89.24 144.21 26.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.681 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.537 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 9.0 p-10 -54.02 160.68 2.15 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.556 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 2.8 Cg_endo -44.98 149.72 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.86 2.374 . . . . 0.0 111.692 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.556 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 36.1 t70 80.64 -31.37 0.12 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.578 -178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -108.86 132.44 54.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.191 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -108.94 148.09 31.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.169 0.509 . . . . 0.0 111.925 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 140' ' ' SER . 1.1 tm? -79.2 128.73 33.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.701 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.668 ' N ' HD13 ' A' ' 136' ' ' LEU . 21.7 t -132.63 60.31 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.66 0.266 . . . . 0.0 111.602 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . 0.402 ' H ' ' CD1' ' A' ' 136' ' ' LEU . . . -176.65 -133.85 1.87 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.206 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.585 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 63.9 m -73.4 59.64 0.6 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.392 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.686 ' HB2' HD12 ' A' ' 136' ' ' LEU . 38.9 t -62.49 -2.48 1.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 139' ' ' SER . 79.2 ttt180 -140.65 133.96 29.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.517 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 61.2 m -147.41 134.02 19.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.52 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 124' ' ' ALA . 94.3 t -128.73 122.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 111.316 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.946 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 55.4 m -85.16 140.87 30.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.497 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.817 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 79.7 p -169.65 31.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.063 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 177.47 34.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.061 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 59.6 14.97 31.02 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.465 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -142.63 133.73 25.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.536 0.208 . . . . 0.0 110.686 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.503 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 74.2 m95 -66.89 137.61 56.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.699 0.285 . . . . 0.0 110.761 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.0 m -57.39 -56.22 24.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.556 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 66.9 p -106.23 136.69 19.31 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.764 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 53.2 Cg_exo -55.89 151.58 40.31 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.865 2.377 . . . . 0.0 112.187 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.803 ' HE3' HD13 ' A' ' 106' ' ' LEU . 4.8 tmtm? -51.21 121.74 16.96 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.575 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.585 ' HB3' ' N ' ' A' ' 139' ' ' SER . 47.7 Cg_endo -69.71 -160.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.676 2.25 . . . . 0.0 112.975 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.74 148.98 27.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.72 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 97.1 m -97.88 139.6 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 0.0 111.408 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -130.98 129.77 42.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.1 p -63.7 143.31 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.189 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.973 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' A' ' 117' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 120.731 0.3 . . . . 0.0 110.497 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.464 ' HB3' ' CZ2' ' A' ' 149' ' ' TRP . 80.4 m 64.27 133.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.243 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.536 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 37.3 t -41.56 127.69 3.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.905 0.383 . . . . 0.0 111.245 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -75.5 -37.42 60.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.503 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.9 t -53.21 -43.38 67.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.664 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.797 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.4 m-85 -59.38 -34.89 72.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.514 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.22 -43.87 74.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.988 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.9 t -92.55 145.98 24.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.975 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.618 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 22.0 tp -144.36 130.1 19.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.342 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.15 132.95 42.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.392 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 57.49 41.01 26.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.614 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.97 152.0 10.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.057 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -104.78 154.02 20.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.58 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.476 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 99.1 t -131.17 118.52 41.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.298 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.2 m-85 -73.08 80.08 1.23 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.513 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.877 ' HA ' HG12 ' A' ' 126' ' ' VAL . 7.7 tt -51.88 140.25 20.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.155 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.622 ' N ' HD23 ' A' ' 113' ' ' LEU . 20.6 m -153.33 53.73 0.74 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.267 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . 128.0 110.24 1.55 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.869 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -171.31 50.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.024 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.768 ' C ' HD22 ' A' ' 118' ' ' LEU . 12.3 p-10 -171.29 39.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 110.821 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.768 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.2 mm? -145.36 153.68 52.39 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.248 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 5.0 Cg_endo -48.41 81.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.959 2.439 . . . . 0.0 111.873 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 75.2 -40.81 0.44 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.035 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 118' ' ' LEU . 19.2 tp 53.07 58.98 4.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.06 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.35 84.5 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.588 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 121' ' ' LEU . . . 163.9 -35.8 0.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.912 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.545 ' HB2' HD23 ' A' ' 121' ' ' LEU . . . -49.81 150.67 2.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.725 0.298 . . . . 0.0 111.171 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.55 ' O ' ' HB ' ' A' ' 114' ' ' THR . 58.6 ttp180 -157.67 118.02 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.232 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.877 HG12 ' HA ' ' A' ' 113' ' ' LEU . 30.4 m -97.89 133.65 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.2 mt-10 -92.56 115.99 28.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -76.33 150.88 36.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.996 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 129' ' ' ARG . 11.3 tpt180 -158.65 131.78 7.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 83.6 m -90.28 155.71 18.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.155 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -52.6 158.03 2.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.223 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.55 62.97 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.178 2.585 . . . . 0.0 112.737 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -177.12 -29.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.781 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 4.1 m-85 -108.66 139.91 42.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.335 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -102.85 133.37 48.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.179 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' A' ' 140' ' ' SER . 37.1 tp -76.17 131.16 39.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.871 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.3 t -135.92 68.04 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.789 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.54 -131.94 1.76 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.151 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.5 p -71.39 63.29 0.38 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 110.661 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.768 ' HA ' HD21 ' A' ' 136' ' ' LEU . 93.0 p -55.67 -20.28 13.61 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.911 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -140.59 136.58 32.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 111.141 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.596 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 60.5 m -129.58 136.22 49.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.708 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 82.2 t -117.85 132.82 66.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.274 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 75.4 m -60.19 142.74 53.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.299 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.7 t -173.02 120.01 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 58.15 42.68 21.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.902 0.382 . . . . 0.0 110.782 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 64.48 11.57 48.38 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.667 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -142.84 135.66 27.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.271 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 54.4 m95 -67.22 142.23 57.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.669 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.4 m -55.08 -57.48 11.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.8 p -98.91 133.78 22.02 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.807 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.455 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 40.1 Cg_endo -67.08 -160.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.315 2.01 . . . . 0.0 112.255 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.797 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 4.5 mmmp? -84.95 130.23 53.25 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.831 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.551 ' HD2' ' HZ2' ' A' ' 153' ' ' LYS . 90.1 Cg_endo -81.1 -151.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.636 2.224 . . . . 0.0 112.545 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.432 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.4 p-80 -153.73 139.94 18.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 78.6 m -98.71 127.72 44.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.541 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -105.17 141.03 37.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.337 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.31 140.22 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.078 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.3 p30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.971 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.525 ' O ' HD12 ' A' ' 98' ' ' ILE . 1.5 pp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.499 0.666 . . . . 0.0 112.003 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.652 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 3.6 m -83.36 146.09 28.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.144 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.4 m -40.21 121.21 1.32 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 111.029 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -70.73 -24.06 62.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.154 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.5 t -53.05 -42.15 65.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.722 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.521 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.0 m-85 -62.93 -42.96 99.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.545 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.07 -38.24 73.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.414 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 t -92.5 135.69 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 111.312 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.589 ' HB3' ' O ' ' A' ' 109' ' ' GLY . 21.3 tp -145.41 129.76 17.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.715 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -81.4 38.52 0.49 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.49 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.9 p30 177.21 26.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.388 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 106' ' ' LEU . . . 168.84 155.89 10.08 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.535 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.589 ' NZ ' ' HB2' ' A' ' 110' ' ' LYS . 9.8 mtmp? -101.32 146.01 28.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.116 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 103' ' ' TYR . 64.5 t -105.4 120.77 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 111.38 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.432 ' CE1' ' HD2' ' A' ' 129' ' ' ARG . 1.6 m-85 -84.59 68.26 10.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.841 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.965 ' HA ' HG12 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -62.56 147.52 48.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.02 0.438 . . . . 0.0 111.295 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.9 m -133.2 70.84 1.46 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.1 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -165.18 -98.25 0.12 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.94 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.601 ' H ' HD21 ' A' ' 121' ' ' LEU . . . 61.06 127.6 0.01 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.391 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.561 ' O ' HD23 ' A' ' 118' ' ' LEU . 62.1 t0 60.31 49.48 7.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.973 0.416 . . . . 0.0 111.369 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.657 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 68.8 mt -131.83 143.3 48.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.732 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.5 85.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.667 2.245 . . . . 0.0 111.581 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.533 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 61.79 17.11 8.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.202 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.657 ' HG ' ' HB2' ' A' ' 118' ' ' LEU . 7.4 mp 40.72 53.84 3.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.844 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.43 45.59 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.228 0.537 . . . . 0.0 110.234 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.2 -25.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.779 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -57.51 147.4 26.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.875 0.369 . . . . 0.0 111.211 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' ' 125' ' ' ARG . 50.5 ttp85 -133.36 137.81 46.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.629 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.965 HG12 ' HA ' ' A' ' 113' ' ' LEU . 32.8 m -120.12 135.76 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.017 0.437 . . . . 0.0 111.643 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -112.89 113.58 25.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.095 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -76.01 141.86 42.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 111.654 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.432 ' HD2' ' CE1' ' A' ' 112' ' ' PHE . 71.1 mtt-85 -148.91 108.88 4.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.117 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 95.6 m -89.54 160.75 16.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.957 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -52.69 156.6 3.12 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.448 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.5 56.07 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.06 2.507 . . . . 0.0 112.588 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -153.07 -37.45 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.648 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -108.8 134.18 51.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.636 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -101.22 132.92 46.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.171 0.51 . . . . 0.0 111.176 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.696 HD21 ' HA ' ' A' ' 140' ' ' SER . 23.0 tp -76.39 129.99 37.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.693 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.5 t -136.3 61.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.697 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.14 -138.01 2.41 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.503 -1.332 . . . . 0.0 113.406 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.66 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.4 m -74.6 57.8 0.75 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 110.975 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.696 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.0 t -49.94 -38.36 36.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.001 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.04 136.18 44.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.434 ' O ' HG22 ' A' ' 126' ' ' VAL . 53.4 m -146.42 125.99 13.31 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.811 0.339 . . . . 0.0 111.304 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 76.5 t -104.95 125.39 59.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.669 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 48.1 t -71.42 151.86 43.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.099 0.476 . . . . 0.0 111.587 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -168.72 122.97 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.892 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.6 tt0 54.48 43.23 30.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.263 0.554 . . . . 0.0 109.634 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.533 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 58.01 29.2 61.95 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.858 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -139.69 131.34 27.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.641 0.258 . . . . 0.0 110.408 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -75.45 139.34 42.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 111.625 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.1 t -57.42 -58.48 8.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.199 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 77.3 p -106.93 134.64 19.77 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.514 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 139' ' ' SER . 35.5 Cg_exo -57.8 142.41 96.16 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.668 2.246 . . . . 0.0 112.041 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.517 ' CE ' HD13 ' A' ' 106' ' ' LEU . 87.2 tttt -51.62 125.86 29.43 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.131 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.66 ' HB3' ' N ' ' A' ' 139' ' ' SER . 61.1 Cg_endo -73.21 -152.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.595 2.197 . . . . 0.0 112.427 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -153.68 133.67 13.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.905 0.383 . . . . 0.0 111.295 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 16.6 m -98.83 132.46 44.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.912 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -124.38 139.66 53.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.051 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.97 134.52 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.3 p30 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.984 -179.858 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.496 HD12 ' HE2' ' A' ' 101' ' ' LYS . 15.3 pt . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 121.675 0.75 . . . . 0.0 112.856 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.557 ' HB2' ' NE1' ' A' ' 149' ' ' TRP . 2.4 p -62.01 136.84 58.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.563 178.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -40.02 127.54 2.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.253 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.496 ' HE2' HD12 ' A' ' 98' ' ' ILE . 68.5 mttm -77.43 14.94 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.434 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -68.9 -39.01 79.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.027 0.442 . . . . 0.0 110.432 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.769 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.6 m-85 -56.3 -34.08 66.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.523 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.559 HD11 HD13 ' A' ' 113' ' ' LEU . 86.3 mt -74.71 38.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.685 -179.464 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 74.2 m -147.46 114.48 6.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 111.0 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.5 mt -145.5 128.21 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -82.58 43.13 0.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -177.02 -43.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.017 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 130' ' ' CYS . . . -79.11 -162.37 23.19 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.732 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 111' ' ' VAL . 22.7 tptm -142.12 -43.81 0.34 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.723 0.297 . . . . 0.0 110.805 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 11.9 p 49.1 120.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.015 179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.3 m-85 -84.38 117.92 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.579 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.559 HD13 HD11 ' A' ' 104' ' ' LEU . 55.1 tp -83.52 145.51 28.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 111.447 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.0 m -158.51 53.06 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.803 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . 165.33 105.48 0.19 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.825 -179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.64 140.02 6.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.634 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.494 ' O ' HD23 ' A' ' 118' ' ' LEU . 57.2 m-20 62.52 43.98 7.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.86 0.362 . . . . 0.0 111.216 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 84.5 mt -134.82 144.68 51.54 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.18 96.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.965 2.443 . . . . 0.0 113.796 -179.203 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 121' ' ' LEU . . . 68.62 -29.83 0.17 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.715 HD22 ' HB2' ' A' ' 124' ' ' ALA . 32.0 mt 65.11 51.27 1.7 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.829 0.347 . . . . 0.0 111.019 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -77.17 51.42 0.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.548 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.64 -21.03 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.205 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.962 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.94 148.45 1.67 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.735 0.302 . . . . 0.0 111.418 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.533 ' O ' ' HB ' ' A' ' 114' ' ' THR . 70.1 mtt-85 -141.73 141.07 33.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 34.5 m -133.59 137.02 53.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 111.14 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -116.17 99.25 7.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 46.3 m-85 -68.06 139.39 56.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.42 . . . . 0.0 111.106 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -142.71 133.17 24.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.243 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.529 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 60.7 m -89.19 148.7 23.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 133' ' ' ASP . 45.7 p-10 -52.67 153.93 5.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.31 72.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.235 2.623 . . . . 0.0 113.204 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 131' ' ' ASP . 38.9 t70 178.66 -39.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.048 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 5.6 m-85 -107.0 139.18 41.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.904 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -102.83 134.26 46.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 111.151 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 140' ' ' SER . 19.8 tp -76.54 131.92 39.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.923 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.58 66.23 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.861 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -171.98 -136.91 2.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.149 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.632 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 45.4 p -76.55 53.98 0.91 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.989 0.423 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.634 ' HA ' HD21 ' A' ' 136' ' ' LEU . 47.6 t -49.07 -43.91 41.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.246 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -99.48 133.24 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.657 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.5 t -141.23 125.08 17.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.684 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 90.5 t -100.19 123.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.385 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.962 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 47.2 t -76.7 136.12 39.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.621 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.2 t -172.68 134.01 0.61 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.774 0.321 . . . . 0.0 111.183 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.427 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 0.5 OUTLIER 57.4 41.44 26.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.85 18.55 25.89 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.998 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -141.09 131.09 24.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 110.619 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.557 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 33.6 m95 -73.03 138.29 45.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.173 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 54.0 m -57.45 -52.99 63.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.004 179.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 78.8 p -114.4 136.95 22.38 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.481 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 30.0 Cg_exo -62.03 -159.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.512 2.141 . . . . 0.0 112.428 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.769 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 60.8 mtpt -96.66 125.77 45.68 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.965 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.632 ' HB2' HD11 ' A' ' 136' ' ' LEU . 68.1 Cg_endo -74.36 -148.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.282 1.988 . . . . 0.0 111.939 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -153.74 143.11 21.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.902 0.382 . . . . 0.0 111.283 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 79.3 m -96.72 132.99 41.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.168 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -131.31 140.26 49.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.398 . . . . 0.0 111.481 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.7 p -64.34 137.72 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.01 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.881 179.975 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.599 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.236 0.541 . . . . 0.0 111.463 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.671 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 3.2 m -63.58 173.4 1.68 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.55 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.404 ' HB2' ' CD1' ' A' ' 149' ' ' TRP . 52.0 m -42.4 129.22 3.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 111.195 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.759 ' HD2' HD12 ' A' ' 104' ' ' LEU . 24.0 tptm -76.89 -31.43 56.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.432 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.8 p -53.08 -43.86 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.945 -179.063 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.845 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.3 m-85 -56.9 -41.45 78.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.694 0.283 . . . . 0.0 111.065 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.759 HD12 ' HD2' ' A' ' 101' ' ' LYS . 90.9 mt -58.65 139.95 55.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.3 m 65.35 137.72 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.168 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.542 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 46.2 tp -145.43 133.68 21.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.417 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.76 140.51 56.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.22 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 65.19 30.82 11.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.394 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 175.7 -168.26 40.52 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.042 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.694 ' HD3' ' N ' ' A' ' 111' ' ' VAL . 1.5 tmtp? -141.95 143.29 33.17 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.694 ' N ' ' HD3' ' A' ' 110' ' ' LYS . 71.2 t -106.39 120.73 57.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.929 0.395 . . . . 0.0 111.458 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.558 ' HE1' ' HB3' ' A' ' 129' ' ' ARG . 3.3 m-85 -70.22 125.99 28.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.045 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.648 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -105.78 141.64 36.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.939 0.4 . . . . 0.0 110.94 -179.695 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.648 ' N ' HD13 ' A' ' 113' ' ' LEU . 35.6 m -158.89 65.61 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.619 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.527 ' O ' ' HG ' ' A' ' 118' ' ' LEU . . . -156.83 -43.53 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.649 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.464 ' O ' HD11 ' A' ' 121' ' ' LEU . . . 71.76 -132.46 19.91 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.886 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -115.7 34.78 4.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.987 0.422 . . . . 0.0 111.225 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 120' ' ' ALA . 96.5 mt -64.19 162.91 27.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.911 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 81.9 Cg_exo -43.57 80.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.772 2.315 . . . . 0.0 112.01 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.774 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 59.19 22.96 11.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.405 -178.606 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 6.8 mp 44.41 62.7 1.92 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.228 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.705 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 38.7 t70 -74.97 42.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.096 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.89 28.72 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.394 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 121' ' ' LEU . . . -77.58 122.17 24.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.706 0.288 . . . . 0.0 111.1 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -90.88 134.79 34.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.655 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 113' ' ' LEU . 30.1 m -145.78 140.59 21.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.669 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -121.25 120.43 35.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.415 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.445 ' O ' HD22 ' A' ' 136' ' ' LEU . 2.0 m-85 -84.38 47.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 110.992 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.558 ' HB3' ' HE1' ' A' ' 112' ' ' PHE . 21.2 tpp180 -64.33 126.77 28.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.509 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.544 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 65.3 m -98.47 158.95 15.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.324 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 133' ' ' ASP . 55.6 m-20 -52.69 148.28 13.43 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.831 -179.516 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.18 79.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.204 2.602 . . . . 0.0 112.717 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 131' ' ' ASP . 9.1 t0 -179.14 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.599 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.406 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 2.5 m-85 -108.78 130.85 55.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.199 179.41 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -102.75 130.64 49.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.904 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.766 HD11 ' HG2' ' A' ' 154' ' ' PRO . 22.8 tp -75.48 133.82 40.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.412 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.86 70.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.688 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.46 -132.65 1.96 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.819 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.507 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 70.8 m -76.12 55.13 0.92 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.708 0.29 . . . . 0.0 111.028 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.549 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 90.0 p -49.25 -43.11 42.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.671 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -100.46 133.93 44.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.229 178.844 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 126' ' ' VAL . 47.4 t -144.02 136.22 26.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.389 . . . . 0.0 110.953 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 57.5 t -122.46 117.05 50.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.343 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 149' ' ' TRP . 46.1 t -65.8 155.31 36.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.109 0.481 . . . . 0.0 111.502 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.705 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 46.5 t -166.44 122.01 1.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.838 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 57.68 44.13 21.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.081 0.467 . . . . 0.0 110.62 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.774 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 64.72 20.65 66.45 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.636 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -141.4 127.03 18.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.64 0.257 . . . . 0.0 110.749 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.696 ' HA ' ' HA ' ' A' ' 144' ' ' CYS . 58.0 m95 -71.94 139.36 48.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.934 0.397 . . . . 0.0 111.372 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.4 t -57.53 -62.46 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.378 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 71.1 p -95.38 137.08 22.12 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.755 -179.392 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 45.1 Cg_endo -67.69 140.38 51.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.882 2.388 . . . . 0.0 112.418 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.845 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 64.4 tttm -53.87 121.2 27.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.264 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.766 ' HG2' HD11 ' A' ' 136' ' ' LEU . 86.5 Cg_endo -81.32 -147.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.832 2.355 . . . . 0.0 112.932 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.423 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 19.5 p-80 -153.61 144.72 22.89 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' CYS . . . . . 0.473 ' SG ' HD13 ' A' ' 136' ' ' LEU . 64.8 m -98.47 142.64 29.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -133.7 139.24 46.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.829 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.59 138.41 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.507 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.889 179.935 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.8 HG21 ' HA ' ' A' ' 117' ' ' ASP . 4.9 pt . . . . . 0 CA--C 1.519 -0.239 0 CA-C-O 120.861 0.362 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.599 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 74.6 m 62.31 134.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.971 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.3 m -40.32 119.97 1.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.716 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -74.83 -9.72 58.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.869 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.6 t -58.75 -19.93 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.837 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.472 ' HD2' ' HZ ' ' A' ' 128' ' ' PHE . 4.7 m-85 -64.62 -46.28 83.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.166 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.794 HD12 HG23 ' A' ' 105' ' ' THR . 1.7 pp -76.98 33.3 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.893 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.794 HG23 HD12 ' A' ' 104' ' ' LEU . 61.6 p -147.54 58.54 1.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.36 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.4 tp -94.49 135.75 35.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.5 -178.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -66.59 138.48 57.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.352 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.6 m120 56.56 40.13 29.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.304 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.28 168.46 41.53 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.214 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 28.9 mtpp -141.68 139.52 32.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.733 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.681 HG12 ' HB ' ' A' ' 126' ' ' VAL . 35.7 t -118.76 126.13 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -80.25 121.4 25.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.141 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.774 ' HA ' HG12 ' A' ' 126' ' ' VAL . 3.1 tm? -85.04 143.5 28.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.917 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.657 ' H ' HD22 ' A' ' 113' ' ' LEU . 43.4 m -152.96 65.96 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.574 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.409 ' HA3' HD21 ' A' ' 121' ' ' LEU . . . -158.1 -107.4 0.24 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.886 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.15 -124.29 1.3 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.848 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.8 ' HA ' HG21 ' A' ' 98' ' ' ILE . 37.6 t70 -148.68 47.84 1.02 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.237 0.541 . . . . 0.0 110.644 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.585 ' HB2' HD13 ' A' ' 121' ' ' LEU . 2.9 mm? -94.19 150.89 39.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.505 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 121' ' ' LEU . 88.9 Cg_exo -43.47 105.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.37 2.047 . . . . 0.0 111.985 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 72.45 -37.95 0.4 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.357 -179.224 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.725 ' HB2' HG22 ' A' ' 98' ' ' ILE . 14.1 tp 58.06 56.24 4.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 0.0 111.16 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -70.14 69.29 0.34 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 179.59 -30.48 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.237 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.54 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . . . -49.05 153.04 0.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.972 0.415 . . . . 0.0 111.398 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.505 ' HD2' ' NH2' ' A' ' 141' ' ' ARG . 53.9 ttp180 -153.56 135.86 14.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.714 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.774 HG12 ' HA ' ' A' ' 113' ' ' LEU . 34.4 m -127.52 137.16 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.108 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -100.94 121.15 41.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.37 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.472 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.3 m-85 -86.03 150.77 24.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 15.8 ptm180 -163.96 134.86 4.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.759 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 68.0 m -89.2 155.11 19.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.496 -179.304 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -52.71 163.27 0.82 Allowed Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.383 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.73 52.07 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.205 2.603 . . . . 0.0 112.708 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -155.59 -39.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.5 m-85 -108.9 141.02 41.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.651 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -102.1 134.11 45.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.123 0.487 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.551 HD21 ' CG ' ' A' ' 154' ' ' PRO . 3.4 tm? -72.97 130.86 41.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.622 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.534 ' N ' HD13 ' A' ' 136' ' ' LEU . 26.6 t -134.57 66.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.573 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.03 -129.68 1.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 119.71 -1.233 . . . . 0.0 113.212 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.691 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 31.3 t -68.75 65.41 0.12 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.979 0.419 . . . . 0.0 111.384 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.476 ' HB3' HD12 ' A' ' 136' ' ' LEU . 94.5 p -63.12 -18.35 63.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.874 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.505 ' NH2' ' HD2' ' A' ' 125' ' ' ARG . 50.2 mtp85 -140.66 137.31 33.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.768 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 90.0 p -135.21 128.17 31.46 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.758 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.91 126.63 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.96 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 41.9 t -73.36 139.21 45.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.016 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -170.57 131.41 0.9 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.552 179.799 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 58.76 38.58 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.57 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 60.9 19.14 55.69 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.998 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -144.7 133.11 21.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.619 0.247 . . . . 0.0 111.239 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' TRP . . . . . 0.599 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 94.1 m95 -70.34 135.58 48.97 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.83 0.348 . . . . 0.0 110.995 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.0 t -57.42 -56.26 24.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.372 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.499 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 55.4 p -97.08 133.14 24.49 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 8.2 Cg_exo -71.97 149.11 52.55 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.22 2.613 . . . . 0.0 111.941 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -47.42 125.57 9.64 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-O 120.64 0.257 . . . . 0.0 111.216 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.691 ' HB3' ' H ' ' A' ' 139' ' ' SER . 58.0 Cg_endo -71.49 -146.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.63 2.22 . . . . 0.0 112.401 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' HIS . . . . . 0.426 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.7 145.41 23.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.451 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 70.8 m -96.66 133.64 40.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.82 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -124.76 136.29 53.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 p -64.67 137.15 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.035 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.958 179.937 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.422 ' CG2' ' HA ' ' A' ' 117' ' ' ASP . 1.5 pp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.803 0.335 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.1 m 61.18 160.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.197 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.9 t -39.82 128.67 2.08 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.662 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.684 ' HA ' HD23 ' A' ' 104' ' ' LEU . 17.5 tppt? -76.6 -27.94 55.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.362 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.2 m -53.14 -38.33 62.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.317 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.472 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.8 m-85 -60.85 -39.23 88.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.278 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.684 HD23 ' HA ' ' A' ' 101' ' ' LYS . 2.1 mm? -53.37 -42.45 66.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.222 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.7 m -92.54 141.26 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.533 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 107' ' ' GLU . 5.3 tt -142.57 127.05 17.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.611 -179.239 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.528 ' N ' HD23 ' A' ' 106' ' ' LEU . 17.3 tp10 -67.14 128.08 35.01 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.1 m120 60.36 36.51 20.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.753 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -177.02 -177.96 46.37 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.06 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -142.8 144.84 32.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.624 0.25 . . . . 0.0 110.779 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 103' ' ' TYR . 65.3 t -105.21 124.98 60.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.862 0.363 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -75.53 127.52 33.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.056 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -90.97 143.3 26.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.682 ' N ' HD13 ' A' ' 113' ' ' LEU . 33.7 m -156.19 62.17 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.235 0.54 . . . . 0.0 110.573 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -159.62 -102.26 0.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.017 -179.683 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.768 ' H ' HD21 ' A' ' 121' ' ' LEU . . . 174.59 -128.4 1.44 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.008 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.422 ' HA ' ' CG2' ' A' ' 98' ' ' ILE . 52.7 p-10 -159.27 48.19 0.31 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.931 0.396 . . . . 0.0 111.004 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 118' ' ' LEU . 6.1 mp -98.99 163.57 18.49 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.221 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 81.2 Cg_exo -39.63 106.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.433 2.088 . . . . 0.0 112.193 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 72.54 -32.29 0.24 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.716 -179.453 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.768 HD21 ' H ' ' A' ' 116' ' ' GLY . 27.5 tp 56.12 47.59 19.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.114 0.483 . . . . 0.0 110.228 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.81 136.18 46.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.968 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.456 ' HA2' HG22 ' A' ' 143' ' ' VAL . . . 76.74 31.96 51.94 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.168 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.815 ' H ' ' HB2' ' A' ' 144' ' ' CYS . . . -80.33 119.87 23.63 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.533 ' HB2' ' HB ' ' A' ' 114' ' ' THR . 67.0 mtt-85 -84.58 134.59 34.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.7 134.14 9.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.422 179.036 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -114.45 112.96 23.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.964 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.467 ' CE2' ' HG3' ' A' ' 153' ' ' LYS . 1.9 m-85 -80.29 136.5 36.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.635 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -165.04 131.79 2.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.343 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' CYS . . . . . 0.504 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 40.9 m -89.3 157.17 18.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.33 0.586 . . . . 0.0 112.497 -179.069 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 58.2 m-20 -52.67 159.24 1.79 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.997 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 21.1 Cg_endo -59.9 75.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.17 2.58 . . . . 0.0 112.43 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 131' ' ' ASP . 64.5 t0 -174.63 -40.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.048 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -116.08 132.33 56.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.182 178.61 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -102.74 127.45 49.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.138 0.494 . . . . 0.0 111.288 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 140' ' ' SER . 3.4 tm? -69.98 132.88 46.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.262 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.509 ' N ' HD13 ' A' ' 136' ' ' LEU . 36.6 t -134.82 76.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.816 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.44 -133.96 2.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.247 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.729 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 40.9 t -74.61 56.42 0.69 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' SER . . . . . 0.675 ' HB3' HD12 ' A' ' 136' ' ' LEU . 95.7 p -53.86 -30.33 45.14 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.825 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.578 ' HD2' ' OG ' ' A' ' 140' ' ' SER . 7.9 mpt_? -99.41 137.06 38.45 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.496 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.5 m -150.63 137.73 19.31 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.256 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 13.8 p -134.05 131.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 111.036 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.815 ' HB2' ' H ' ' A' ' 124' ' ' ALA . 4.1 m -58.14 154.93 12.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.332 0.587 . . . . 0.0 112.226 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.4 p -173.28 113.64 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.759 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 146' ' ' GLN . 62.6 tt0 60.92 48.46 6.68 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.096 0.474 . . . . 0.0 110.544 -179.411 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 58.22 18.08 33.76 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.355 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -141.63 138.22 32.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 110.639 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -68.1 135.29 51.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.219 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -57.48 -60.18 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.176 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.486 ' HB ' ' OG ' ' A' ' 139' ' ' SER . 33.3 p -99.79 132.69 22.55 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.799 0.333 . . . . 0.0 111.889 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.424 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 37.2 Cg_exo -60.6 150.75 80.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.977 2.452 . . . . 0.0 112.442 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 128' ' ' PHE . 57.5 tttp -55.91 129.81 72.41 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.729 ' HB3' ' N ' ' A' ' 139' ' ' SER . 59.4 Cg_endo -72.37 -152.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.729 2.286 . . . . 0.0 112.996 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -153.72 139.61 18.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 86.4 m -98.72 143.31 29.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.494 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -128.2 136.44 51.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.576 179.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.67 135.65 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.305 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.917 179.814 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.486 ' OE1' ' N ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.555 0.217 . . . . 0.0 111.078 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.437 ' N ' ' HG2' ' A' ' 92' ' ' GLU . . . 55.75 -139.78 0.94 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.131 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -173.8 133.72 0.46 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.775 0.321 . . . . 0.0 110.75 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.0 t80 57.72 -129.03 1.59 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.369 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.4 t -71.13 128.87 34.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.83 0.348 . . . . 0.0 111.13 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.944 ' HD3' ' HA ' ' A' ' 119' ' ' PRO . 2.1 ptp85 -80.7 47.6 0.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.306 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.601 HD12 HD22 ' A' ' 121' ' ' LEU . 40.6 mm -145.34 141.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.209 0.528 . . . . 0.0 111.659 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.562 ' HB2' ' NE1' ' A' ' 149' ' ' TRP . 1.3 p -57.3 149.32 20.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.138 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.9 t -38.25 113.53 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.768 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.529 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -67.23 -14.26 62.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.767 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.1 t -53.5 -38.91 64.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.209 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.58 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.5 m-85 -53.34 -37.89 62.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.178 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.4 mt -50.92 -45.45 60.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.332 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.0 t -92.52 131.28 37.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 111.202 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.647 HD13 ' HE2' ' A' ' 153' ' ' LYS . 38.0 tp -145.34 132.28 20.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -63.02 127.02 29.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.18 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.6 m120 55.14 45.73 25.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.885 0.374 . . . . 0.0 110.415 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.0 157.44 26.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -130.62 139.7 50.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.746 0.308 . . . . 0.0 110.831 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 103' ' ' TYR . 96.1 t -106.51 132.95 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.576 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 3.7 m-85 -94.78 73.44 3.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.01 ' HA ' HG12 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -60.95 157.03 16.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 111.228 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 40.9 m -158.53 69.47 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.778 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.674 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -162.98 -44.92 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.642 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.44 -121.84 6.51 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.297 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.471 ' HA ' ' CD1' ' A' ' 98' ' ' ILE . 2.1 p30 -144.76 52.0 1.24 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.051 0.453 . . . . 0.0 111.474 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 118' ' ' LEU . 7.0 mp -88.08 158.13 50.21 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.909 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.944 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 85.1 Cg_exo -44.05 111.02 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.621 2.214 . . . . 0.0 112.601 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.761 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 70.77 -33.55 0.27 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.828 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.601 HD22 HD12 ' A' ' 98' ' ' ILE . 17.0 tp 64.28 43.9 4.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.05 0.452 . . . . 0.0 110.624 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.918 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 64.5 t0 -79.4 59.06 2.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.013 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.29 -29.48 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.375 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -49.68 147.53 3.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 111.923 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.561 ' NH2' ' HD3' ' A' ' 141' ' ' ARG . 51.6 mtp85 -138.72 126.78 22.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 1.01 HG12 ' HA ' ' A' ' 113' ' ' LEU . 33.7 m -116.72 130.3 71.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.029 0.442 . . . . 0.0 111.674 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.9 mt-10 -102.5 109.79 21.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.586 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' ' 140' ' ' SER . 21.2 m-85 -75.52 147.12 39.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.514 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 5.6 tpm_? -162.28 125.94 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.472 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.421 ' H ' ' HE ' ' A' ' 129' ' ' ARG . 56.6 m -89.29 149.14 23.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.074 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.57 163.31 0.79 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.634 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.63 57.3 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.43 2.753 . . . . 0.0 113.131 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -158.06 -43.3 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.3 m-85 -108.91 138.76 44.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.665 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.411 ' O ' HG23 ' A' ' 137' ' ' VAL . 18.7 p-80 -101.6 127.51 48.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.091 0.472 . . . . 0.0 110.993 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 137' ' ' VAL . 4.9 tt -65.04 131.23 46.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.184 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.629 ' N ' HD23 ' A' ' 136' ' ' LEU . 21.8 t -133.39 65.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.25 -135.63 2.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.396 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.51 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 80.6 p -73.37 62.08 0.69 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.532 ' HB3' HD22 ' A' ' 136' ' ' LEU . 98.5 p -57.61 -7.02 0.57 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.288 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.561 ' HD3' ' NH2' ' A' ' 125' ' ' ARG . 39.7 ttm180 -140.65 134.37 30.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.672 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 126' ' ' VAL . 47.6 t -146.39 119.5 8.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.569 HG13 ' OG ' ' A' ' 150' ' ' SER . 3.2 p -95.98 121.56 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 0.0 111.223 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.769 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 49.7 t -69.22 138.3 53.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.601 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.918 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 80.6 p -164.51 133.11 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.165 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 57.38 40.76 27.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.849 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 63.9 18.25 61.84 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.126 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -145.27 139.79 27.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 117.099 0.449 . . . . 0.0 111.45 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.562 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 32.7 m95 -72.12 139.0 48.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.195 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.569 ' OG ' HG13 ' A' ' 143' ' ' VAL . 75.4 m -57.49 -57.74 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.005 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 t -109.42 143.11 27.1 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-O 120.862 0.363 . . . . 0.0 111.87 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.0 148.14 93.79 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.125 2.55 . . . . 0.0 112.693 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.647 ' HE2' HD13 ' A' ' 106' ' ' LEU . 87.5 tttt -53.34 135.64 51.36 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.527 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.51 ' HB3' ' H ' ' A' ' 139' ' ' SER . 97.5 Cg_endo -85.4 -151.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.906 2.404 . . . . 0.0 112.872 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -153.7 151.09 29.25 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.4 m -97.28 129.85 44.54 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.766 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -108.78 135.4 50.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.027 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.84 140.2 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.982 -179.899 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.855 0.359 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.09 -141.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.517 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 58.56 47.64 13.04 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.04 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.434 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 4.1 m-85 -59.91 136.07 57.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.796 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.4 p -174.89 139.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.261 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.771 ' HB2' ' H ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -169.28 61.05 0.05 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.769 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 1.9 pp -142.19 153.44 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.983 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 38.0 m -64.58 147.22 53.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.791 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 102' ' ' SER . 80.4 p -40.12 118.0 0.84 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 110.699 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.4 ' HA ' HD13 ' A' ' 104' ' ' LEU . 68.7 mttm -70.94 9.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.514 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 100' ' ' SER . 59.2 m -68.96 -39.2 79.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.189 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.916 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.8 m-85 -52.18 -37.84 55.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.984 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.552 ' H ' HD12 ' A' ' 104' ' ' LEU . 6.3 mp -50.22 142.48 9.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 0.0 111.03 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.9 p 61.84 132.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.673 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.1 tp -145.4 136.14 24.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.613 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -57.12 132.3 52.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.389 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.497 ' HB3' ' OD1' ' A' ' 131' ' ' ASP . 33.9 m120 57.52 42.81 23.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.617 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.76 172.82 45.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.517 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -141.66 146.37 36.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 0.0 110.476 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 60.6 t -118.12 127.44 75.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.424 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.7 m-85 -88.22 119.06 28.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.849 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.64 ' HA ' HG12 ' A' ' 126' ' ' VAL . 61.4 tp -83.53 146.73 28.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.266 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 33.2 m -162.16 66.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.65 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . -160.82 -42.35 0.02 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.848 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.02 -119.5 5.4 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.655 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -137.78 47.88 2.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.162 0.506 . . . . 0.0 111.042 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 71.7 mt -75.72 158.46 82.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.125 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.486 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 74.5 Cg_exo -47.03 120.46 4.22 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.159 1.906 . . . . 0.0 111.625 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.771 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 51.98 31.32 8.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.2 0.524 . . . . 0.0 110.155 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.769 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 13.9 tp 42.44 37.42 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.712 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -70.63 141.06 51.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.907 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.56 -24.62 9.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.78 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.715 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -57.25 152.89 13.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.761 0.315 . . . . 0.0 111.092 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.788 ' HD2' HH21 ' A' ' 141' ' ' ARG . 23.0 ptt-85 -165.45 133.19 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.679 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 113' ' ' LEU . 33.9 m -120.54 143.5 32.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.039 0.447 . . . . 0.0 111.798 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.462 ' HB2' ' NH1' ' A' ' 141' ' ' ARG . 40.7 tp10 -108.48 121.86 45.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.057 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.418 ' CD2' ' HD2' ' A' ' 154' ' ' PRO . 2.8 m-85 -83.7 154.48 23.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.624 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 5.1 tpm_? -157.57 127.28 6.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.23 143.84 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.905 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.497 ' OD1' ' HB3' ' A' ' 108' ' ' ASN . 12.8 p-10 -54.07 148.96 19.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.48 77.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.015 2.477 . . . . 0.0 112.862 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 131' ' ' ASP . 64.4 t0 179.02 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.72 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.497 ' CE2' HG22 ' A' ' 158' ' ' VAL . 3.6 m-85 -108.84 142.84 38.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.876 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -101.88 130.8 48.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.176 0.512 . . . . 0.0 110.961 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.623 HD21 ' HA ' ' A' ' 140' ' ' SER . 32.6 tp -70.25 126.82 30.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.964 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 41.7 t -137.89 71.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.937 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.49 -135.67 2.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.846 -1.169 . . . . 0.0 113.102 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.729 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.0 m -75.94 52.79 0.72 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.92 0.391 . . . . 0.0 110.601 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.623 ' HA ' HD21 ' A' ' 136' ' ' LEU . 47.2 t -46.25 -39.85 10.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.071 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.788 HH21 ' HD2' ' A' ' 125' ' ' ARG . 23.9 tpt180 -104.11 137.46 42.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.589 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.8 t -143.05 101.69 3.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.346 . . . . 0.0 110.597 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 150' ' ' SER . 7.7 p -96.8 129.89 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.065 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.715 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 1.8 m -74.62 146.99 42.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.395 0.617 . . . . 0.0 112.111 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.469 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 48.0 t -163.94 124.67 2.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.358 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 62.9 38.35 11.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.114 0.483 . . . . 0.0 110.419 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 63.12 25.73 68.46 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.562 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 145' ' ' SER . 23.6 pt20 -143.72 138.24 28.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.059 0.43 . . . . 0.0 111.262 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.526 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 59.4 m95 -65.04 138.02 58.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.466 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 47.5 t -57.43 -48.54 78.86 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.057 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.518 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 82.6 p -135.14 136.86 25.56 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.816 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 31.4 Cg_exo -61.97 156.35 49.87 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.04 2.494 . . . . 0.0 112.438 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.916 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 28.5 mtpp -52.42 129.17 42.81 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.428 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.729 ' HB3' ' N ' ' A' ' 139' ' ' SER . 60.7 Cg_endo -72.89 -143.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.728 2.285 . . . . 0.0 112.246 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.451 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 23.0 p-80 -153.71 145.25 23.23 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.986 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 81.7 m -96.23 125.87 41.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.509 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -109.06 142.99 38.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.385 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.497 HG22 ' CE2' ' A' ' 134' ' ' PHE . 61.9 t -61.83 139.96 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.044 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 22.1 p30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.026 179.808 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.846 0.355 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.51 -42.62 88.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.995 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -173.22 -139.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.58 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -170.93 -134.09 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.64 126.1 32.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.956 0.408 . . . . 0.0 111.272 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.957 ' HG2' HG12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -88.82 -158.47 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.893 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.957 HG12 ' HG2' ' A' ' 97' ' ' ARG . 46.7 mm 64.74 143.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.342 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.51 ' HA ' ' C ' ' A' ' 147' ' ' GLY . 1.5 p -59.99 161.21 6.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.196 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -39.78 131.8 1.79 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.109 0.48 . . . . 0.0 111.453 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 21.8 pttp -96.48 78.56 3.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.674 0.749 . . . . 0.0 110.009 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.9 t -164.13 -34.9 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.076 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.7 m-85 -56.8 -26.33 57.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.192 0.52 . . . . 0.0 109.63 178.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.483 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 53.5 mt -50.23 -44.11 53.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.671 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.2 p -92.66 139.66 30.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.647 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.464 HD13 ' CE ' ' A' ' 153' ' ' LYS . 46.6 tp -143.07 133.72 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.389 . . . . 0.0 111.163 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -67.8 129.98 41.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.333 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.8 m120 56.6 37.09 28.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.964 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 130' ' ' CYS . . . -176.44 149.5 9.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.998 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -108.25 139.26 43.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.845 0.355 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.485 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 94.9 t -106.54 121.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.815 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -82.74 124.99 30.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.239 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.699 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -85.84 145.04 27.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.475 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.699 ' N ' HD13 ' A' ' 113' ' ' LEU . 28.7 m -155.75 63.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 110.854 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -161.04 -104.44 0.19 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.178 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 166.99 -129.64 1.96 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.739 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.453 ' HA ' HD11 ' A' ' 98' ' ' ILE . 58.7 m-20 -150.27 46.79 0.9 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 111.044 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 118' ' ' LEU . 7.1 mp -97.9 154.27 37.87 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.823 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.568 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 76.1 Cg_exo -46.78 122.13 5.68 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.466 2.111 . . . . 0.0 112.112 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.784 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 72.77 -40.74 0.48 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.528 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.637 HD22 HD12 ' A' ' 98' ' ' ILE . 14.8 tp 59.51 51.18 6.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.956 0.408 . . . . 0.0 110.943 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -73.26 66.25 0.89 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.247 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.31 -36.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.623 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.809 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -51.39 153.9 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.954 0.407 . . . . 0.0 111.483 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.501 ' O ' ' HB ' ' A' ' 114' ' ' THR . 50.8 ttp85 -158.94 126.07 4.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.176 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.485 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 24.6 m -108.17 136.67 42.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.022 0.439 . . . . 0.0 111.648 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -100.29 115.98 31.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.686 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -80.09 143.04 34.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.433 HH11 ' HG3' ' A' ' 129' ' ' ARG . 37.7 ttt85 -167.22 118.82 0.9 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.456 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 51.3 m -89.18 154.13 20.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.981 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -52.77 158.34 2.25 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.305 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.507 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 82.0 Cg_exo -47.49 162.81 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.829 2.353 . . . . 0.0 112.245 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.5 m-20 77.93 -35.07 0.19 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.791 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -106.32 127.14 53.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -108.34 131.1 55.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.034 0.445 . . . . 0.0 111.375 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.579 HD23 ' SG ' ' A' ' 156' ' ' CYS . 3.2 tm? -74.79 132.86 41.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.292 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.0 t -133.07 71.53 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.785 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.92 -132.5 1.82 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.057 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.604 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 61.2 p -72.83 61.56 0.55 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 110.648 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.559 ' HB3' HD12 ' A' ' 136' ' ' LEU . 97.0 p -55.6 -15.59 3.09 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.775 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -140.64 139.89 34.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.716 0.293 . . . . 0.0 111.266 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 96.6 p -139.54 117.01 11.35 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.255 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.413 ' HB ' ' OG ' ' A' ' 150' ' ' SER . 73.7 t -84.18 125.01 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 111.52 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.809 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 42.1 t -79.3 131.03 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.306 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.4 t -173.25 137.53 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 0.0 111.156 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 56.35 37.93 29.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.51 ' C ' ' HA ' ' A' ' 99' ' ' CYS . . . 56.78 24.66 49.62 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.644 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -143.07 134.55 26.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.657 0.265 . . . . 0.0 111.087 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -77.76 140.03 39.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 143' ' ' VAL . 63.1 m -57.4 -47.61 81.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.661 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 67.4 p -127.46 138.9 33.79 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 34.8 Cg_endo -64.86 -162.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.471 2.114 . . . . 0.0 112.566 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.464 ' CE ' HD13 ' A' ' 106' ' ' LEU . 14.4 mmmm -83.86 131.65 51.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.974 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.604 ' HB3' ' H ' ' A' ' 139' ' ' SER . 89.5 Cg_endo -81.75 -149.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.675 2.25 . . . . 0.0 112.483 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.455 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 27.5 p-80 -153.71 134.1 13.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.945 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.579 ' SG ' HD23 ' A' ' 136' ' ' LEU . 92.4 m -104.93 142.43 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.235 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -135.21 137.59 42.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.881 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.15 139.08 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.913 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.613 0.244 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.0 -47.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.48 135.19 55.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.647 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -78.33 44.81 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.983 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 p -59.71 125.83 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.912 0.387 . . . . 0.0 111.106 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.862 ' HG2' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -85.51 -148.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.862 HG23 ' HG2' ' A' ' 97' ' ' ARG . 21.3 pt 52.75 137.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.969 0.908 . . . . 0.0 112.72 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.519 ' HB2' HD23 ' A' ' 121' ' ' LEU . 92.2 m -57.36 167.41 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.767 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.6 p -40.17 143.77 0.26 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.751 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.626 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 4.6 ttmp? -99.68 78.45 2.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.227 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.2 t -166.24 -36.2 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.062 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -56.94 -32.4 65.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 110.389 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.419 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 64.5 mt -52.87 -46.18 67.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.568 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.2 p -92.63 137.69 32.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 0.0 111.194 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.738 HD13 ' HE3' ' A' ' 153' ' ' LYS . 29.2 tp -145.38 136.36 24.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.382 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.463 ' H ' HD12 ' A' ' 106' ' ' LEU . 42.2 tp10 -69.53 138.1 53.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.9 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.0 m120 58.01 36.3 25.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.283 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 179.94 176.88 47.68 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.755 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -139.78 136.46 34.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 128' ' ' PHE . 94.9 t -106.11 123.86 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.8 m-85 -76.6 122.5 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.29 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.767 ' HA ' HG12 ' A' ' 126' ' ' VAL . 2.8 tt -95.35 140.6 30.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.711 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.759 ' N ' HD23 ' A' ' 113' ' ' LEU . 30.1 m -158.49 62.65 0.43 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.085 0.469 . . . . 0.0 110.739 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 118' ' ' LEU . . . -172.44 -16.28 0.02 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.716 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -49.77 147.59 6.75 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.372 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.713 ' C ' HD22 ' A' ' 118' ' ' LEU . 1.5 m-20 73.31 41.98 0.45 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 122.714 0.406 . . . . 0.0 111.753 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.713 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.7 mm? -141.82 149.4 53.02 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.59 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -50.28 116.94 2.77 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.481 2.121 . . . . 0.0 111.822 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.807 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 50.06 36.17 11.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.544 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.845 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 14.3 tp 52.22 42.24 30.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.491 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.89 142.27 57.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.589 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.76 33.93 84.78 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.425 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.873 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -93.44 144.09 25.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.892 0.377 . . . . 0.0 111.452 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -145.53 128.45 16.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.804 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 113' ' ' LEU . 34.4 m -136.11 142.15 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.751 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 41.4 tt0 -108.69 121.39 44.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.435 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.755 ' HA ' HG22 ' A' ' 111' ' ' VAL . 2.3 m-85 -86.86 44.11 1.14 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.841 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.631 ' HD3' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -67.16 133.5 49.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 110.667 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 69.5 m -105.16 155.85 18.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.638 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -53.7 156.84 4.34 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.116 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.519 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 86.6 Cg_exo -47.66 162.94 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.808 2.339 . . . . 0.0 112.466 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.557 ' HB3' ' ND2' ' A' ' 159' ' ' ASN . 57.3 m-20 78.31 -31.4 0.16 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.151 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -105.0 130.17 53.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.719 0.295 . . . . 0.0 110.393 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -111.39 130.58 55.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 111.516 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.594 HD22 ' O ' ' A' ' 128' ' ' PHE . 36.2 tp -78.05 136.4 37.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.419 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.0 66.06 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.14 -135.66 2.34 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.206 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.509 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 82.8 p -72.62 63.91 0.61 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.991 0.425 . . . . 0.0 110.78 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.552 ' HA ' HD21 ' A' ' 136' ' ' LEU . 88.0 p -56.08 -11.49 1.13 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.452 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 141' ' ' ARG . 69.3 mtt-85 -140.54 136.87 33.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 57.9 m -137.05 126.66 25.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.368 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 124' ' ' ALA . 5.9 p -116.71 130.15 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.922 0.391 . . . . 0.0 111.262 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.873 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 33.2 m -96.83 147.92 23.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.852 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.1 p -171.31 27.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.299 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.483 ' O ' ' HG3' ' A' ' 146' ' ' GLN . 70.7 tp60 -176.26 37.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.06 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.51 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 60.0 10.49 14.58 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.769 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -141.52 134.25 28.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.688 0.28 . . . . 0.0 110.92 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.519 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 38.7 m95 -64.86 134.97 55.18 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.564 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.2 m -57.42 -57.07 14.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.224 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 68.6 p -103.69 131.75 21.72 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.26 140.57 89.38 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.81 2.34 . . . . 0.0 111.895 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.738 ' HE3' HD13 ' A' ' 106' ' ' LEU . 61.2 tttp -47.09 132.93 9.1 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.276 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.509 ' HB3' ' H ' ' A' ' 139' ' ' SER . 65.1 Cg_endo -89.26 -151.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.024 2.483 . . . . 0.0 113.004 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -153.76 138.09 16.65 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.06 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.496 ' SG ' HD13 ' A' ' 136' ' ' LEU . 85.7 m -98.69 133.27 43.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.855 0.36 . . . . 0.0 110.83 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -103.02 136.93 41.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.727 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.68 142.42 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.901 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' A' ' 133' ' ' ASP . 23.4 p30 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.992 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.867 0.365 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.62 -46.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.011 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.73 137.13 57.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.473 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 2.0 m-85 -59.98 134.48 57.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.8 m -154.36 139.93 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.038 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.494 ' CD ' ' HA ' ' A' ' 119' ' ' PRO . 3.2 ptp85 -161.04 126.8 3.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.96 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.717 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.6 pp -156.23 148.36 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.239 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.724 ' HB2' HD22 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -63.8 151.55 41.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.964 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.0 t -39.89 111.18 0.18 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.015 0.436 . . . . 0.0 111.125 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.523 ' HG3' HD13 ' A' ' 98' ' ' ILE . 55.1 mtmt -63.6 -22.37 66.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.984 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 t -53.5 -32.17 49.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.653 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 3.4 m-85 -76.23 45.28 0.36 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.608 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.576 HD21 HD23 ' A' ' 113' ' ' LEU . 93.9 mt -132.82 -37.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 0.0 110.677 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 t -92.54 132.77 36.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.964 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.6 tp -145.44 125.06 13.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.54 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -82.83 45.15 0.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.066 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 p30 179.55 36.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.363 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.63 -155.39 26.37 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.959 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -142.06 150.55 41.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.818 0.342 . . . . 0.0 110.7 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.1 t -106.56 125.19 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.496 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.0 m-85 -85.38 76.83 10.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.58 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.945 ' HA ' HG12 ' A' ' 126' ' ' VAL . 3.4 tm? -54.96 141.52 33.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.339 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.722 ' N ' HD13 ' A' ' 113' ' ' LEU . 23.6 m -157.46 61.33 0.49 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.657 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.563 ' C ' HD13 ' A' ' 118' ' ' LEU . . . 173.38 41.94 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.732 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.82 123.42 6.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.186 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.408 ' C ' HD12 ' A' ' 118' ' ' LEU . 1.5 m-20 66.25 52.27 1.15 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.563 HD13 ' C ' ' A' ' 115' ' ' GLY . 10.7 mp -119.29 148.42 45.26 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.532 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.494 ' HA ' ' CD ' ' A' ' 97' ' ' ARG . 41.7 Cg_exo -54.73 82.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.031 2.487 . . . . 0.0 111.748 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.613 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 62.12 13.45 5.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.576 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.724 HD22 ' HB2' ' A' ' 99' ' ' CYS . 7.3 mp 47.92 59.54 4.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.782 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.0 46.02 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.049 0.452 . . . . 0.0 110.567 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 171.64 -26.16 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.281 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -50.52 155.21 1.12 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 111.298 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.513 ' O ' ' HB ' ' A' ' 114' ' ' THR . 39.0 ptt180 -160.65 130.48 5.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.281 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.945 HG12 ' HA ' ' A' ' 113' ' ' LEU . 34.8 m -107.62 134.12 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.163 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 96.3 mt-10 -95.03 122.05 37.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.704 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.481 ' HE2' ' HE3' ' A' ' 153' ' ' LYS . 30.3 m-85 -88.28 149.08 24.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.654 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.412 HH11 ' HG3' ' A' ' 129' ' ' ARG . 40.1 ttt85 -153.62 126.97 8.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.739 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 16.6 t -89.24 151.28 22.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.016 0.436 . . . . 0.0 111.505 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -52.75 151.63 7.94 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.486 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.8 73.63 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.186 2.591 . . . . 0.0 112.747 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -176.31 -42.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.699 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.631 ' HB2' ' SG ' ' A' ' 130' ' ' CYS . 4.5 m-85 -109.51 143.53 39.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.545 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.447 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 0.0 OUTLIER -99.44 135.05 41.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.304 0.574 . . . . 0.0 111.514 -179.581 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.915 HD21 ' HA ' ' A' ' 140' ' ' SER . 35.5 tp -70.9 124.06 23.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.928 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.15 63.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.379 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -171.21 -128.63 1.05 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.921 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.661 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 60.1 m -73.54 57.14 0.54 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.878 0.371 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.915 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.9 t -51.66 -25.47 7.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.269 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 12.9 mtp-105 -137.82 129.71 28.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.572 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.9 m -127.21 120.2 28.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.426 HG13 ' OG ' ' A' ' 150' ' ' SER . 3.8 p -104.99 124.6 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.413 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 38.9 t -72.79 151.74 41.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.169 0.509 . . . . 0.0 111.587 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.5 m -161.44 121.71 2.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.563 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 57.92 43.17 21.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.315 0.578 . . . . 0.0 109.848 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.613 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 61.0 28.2 68.4 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.444 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -142.92 130.29 21.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.691 0.282 . . . . 0.0 110.61 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.465 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 35.9 m95 -72.11 132.07 43.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.59 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.426 ' OG ' HG13 ' A' ' 143' ' ' VAL . 70.9 m -57.51 -60.64 3.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 70.9 p -99.78 133.32 21.82 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.245 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.447 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 23.1 Cg_exo -64.9 -158.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.684 2.256 . . . . 0.0 112.326 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.481 ' HE3' ' HE2' ' A' ' 128' ' ' PHE . 14.2 mmmm -87.51 129.49 50.91 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.767 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.661 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.4 Cg_endo -75.26 -156.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.401 2.067 . . . . 0.0 112.803 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.72 148.77 26.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.938 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 134' ' ' PHE . 97.1 m -97.07 130.54 44.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.447 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 4.3 tp-100 -108.72 135.11 50.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.692 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.12 128.81 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.935 -179.876 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.788 0.328 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.75 41.96 31.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.156 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -175.88 54.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.388 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -162.98 137.93 6.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.91 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 98' ' ' ILE . 90.7 t -145.68 135.51 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.846 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.753 ' O ' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -62.83 126.74 28.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 97' ' ' ARG . 1.5 pp -171.75 32.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.482 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 6.1 t 59.38 150.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.576 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.706 ' HB2' ' HD1' ' A' ' 149' ' ' TRP . 57.4 m -39.86 125.55 1.9 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.976 0.417 . . . . 0.0 111.301 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.484 ' HD3' HD21 ' A' ' 104' ' ' LEU . 16.8 tppt? -86.31 -36.43 19.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.537 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.9 p -69.0 40.3 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.475 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 5.5 m-85 -128.41 -47.97 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.774 HD12 ' H ' ' A' ' 105' ' ' THR . 0.4 OUTLIER -54.8 -30.0 55.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.995 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.774 ' H ' HD12 ' A' ' 104' ' ' LEU . 6.8 t -92.48 132.43 36.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.775 0.321 . . . . 0.0 111.138 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.89 HD13 ' HE3' ' A' ' 153' ' ' LYS . 34.5 tp -145.39 128.59 16.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.467 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -74.1 130.28 39.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.961 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 60.23 38.88 19.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.621 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.75 151.86 13.1 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.845 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -110.68 137.0 48.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.49 126.74 62.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.541 ' C ' HG23 ' A' ' 126' ' ' VAL . 3.0 m-85 -79.35 60.39 3.13 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.006 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.564 HD22 ' HB3' ' A' ' 104' ' ' LEU . 60.2 tp -58.5 140.96 53.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.559 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 31.3 m -155.62 55.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.492 0.663 . . . . 0.0 109.85 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 168.46 99.98 0.13 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.843 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 117' ' ' ASP . . . -165.32 151.34 20.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.774 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.735 ' C ' HD22 ' A' ' 118' ' ' LEU . 38.8 t70 77.23 41.21 0.15 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.037 0.446 . . . . 0.0 110.975 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.735 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.2 mm? -144.14 150.9 50.49 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.632 ' HA ' ' HG2' ' A' ' 97' ' ' ARG . 12.0 Cg_endo -55.47 81.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.841 2.361 . . . . 0.0 112.187 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 73.69 -38.07 0.39 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.271 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.657 HD23 ' HB2' ' A' ' 124' ' ' ALA . 17.6 tp 55.2 80.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.89 0.376 . . . . 0.0 110.746 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.02 48.69 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.139 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -178.26 26.12 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.36 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.657 ' HB2' HD23 ' A' ' 121' ' ' LEU . . . -80.52 142.3 34.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.616 0.246 . . . . 0.0 110.669 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.559 ' O ' ' HB ' ' A' ' 114' ' ' THR . 45.7 mtp85 -131.73 150.48 52.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 111.278 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.541 HG23 ' C ' ' A' ' 112' ' ' PHE . 7.6 p -154.49 158.27 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.279 0.562 . . . . 0.0 111.252 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.536 ' N ' HG22 ' A' ' 126' ' ' VAL . 43.6 tt0 -136.94 89.71 2.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.106 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.481 ' H ' ' HD1' ' A' ' 128' ' ' PHE . 4.2 m-85 -59.11 148.57 30.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.714 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.8 tpt85 -159.52 128.36 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 35.4 t -89.22 150.23 22.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.301 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -53.67 156.61 4.52 Favored Pre-proline 0 N--CA 1.462 0.149 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.34 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 80.0 Cg_exo -45.64 162.02 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.978 2.452 . . . . 0.0 112.718 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 28.1 m-20 77.83 -36.57 0.22 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.61 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.403 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.9 m-85 -107.49 128.65 54.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.919 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.86 137.16 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.077 0.465 . . . . 0.0 111.409 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 154' ' ' PRO . 6.9 tt -78.89 127.24 31.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.339 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.469 ' N ' HD23 ' A' ' 136' ' ' LEU . 26.3 t -130.07 65.66 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.476 ' H ' HD23 ' A' ' 136' ' ' LEU . . . -170.54 -125.38 0.8 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.636 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.792 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 29.2 t -73.37 59.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 111.295 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.409 ' HB2' HD22 ' A' ' 136' ' ' LEU . 35.3 t -58.29 -24.77 60.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.604 ' HD2' ' N ' ' A' ' 142' ' ' SER . 4.0 tmm_? -140.55 131.29 25.76 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.421 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.643 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 50.7 m -132.23 153.32 50.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 124' ' ' ALA . 77.3 t -142.78 125.3 13.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.278 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 61.3 m -68.18 153.86 42.89 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -157.45 -23.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.285 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 146' ' ' GLN . 4.2 tp-100 -159.2 58.16 0.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.031 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 73.57 -8.08 11.28 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.914 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -139.74 136.17 33.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 111.023 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.706 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 60.2 m95 -60.57 150.32 32.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.752 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.9 p -54.21 -58.77 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.536 HG23 ' OG ' ' A' ' 139' ' ' SER . 2.7 t -104.25 144.88 29.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.378 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 17.7 Cg_endo -59.25 -147.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.993 2.462 . . . . 0.0 113.034 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.89 ' HE3' HD13 ' A' ' 106' ' ' LEU . 55.0 tttp -108.92 135.32 20.15 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.604 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 73.4 Cg_endo -76.68 -155.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.492 2.128 . . . . 0.0 113.037 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -153.77 161.24 42.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 88.1 m -96.11 131.62 42.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.787 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -118.84 138.14 52.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.917 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.65 136.56 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.237 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 24.1 p30 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.04 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.818 0.342 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -176.92 45.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.892 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.25 147.72 20.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -161.63 141.81 10.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.043 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.3 m -150.68 138.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.618 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.794 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -167.2 58.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.054 0.454 . . . . 0.0 111.585 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 98' ' ' ILE . 1.7 pp -150.27 149.56 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.243 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.622 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 72.8 m -59.89 140.37 56.7 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.8 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.4 p -37.93 113.36 0.27 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.087 0.47 . . . . 0.0 111.62 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.418 ' HB3' HD12 ' A' ' 104' ' ' LEU . 98.3 mttt -69.43 1.95 3.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.316 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.2 p -59.63 -37.52 78.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.879 0.371 . . . . 0.0 110.569 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.526 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 1.4 m-85 -54.38 -35.43 62.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.851 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 101' ' ' LYS . 79.3 mt -53.53 139.45 31.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.33 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.9 p 60.52 130.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.497 0.498 . . . . 0.0 111.106 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.823 HD13 ' HE2' ' A' ' 153' ' ' LYS . 30.9 tp -145.37 134.88 23.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.305 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pm0 -63.62 133.03 52.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.323 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 58.42 42.99 20.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.41 -177.58 43.66 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.563 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -142.03 151.89 42.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.607 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 86.5 t -129.14 123.98 59.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.349 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.594 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.5 m-85 -89.79 119.42 30.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.748 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HA ' HG12 ' A' ' 126' ' ' VAL . 54.9 tp -80.92 145.3 31.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.858 0.361 . . . . 0.0 110.932 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 23.7 m -158.88 56.16 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.733 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -159.0 -108.88 0.25 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.818 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 158.68 -124.67 1.4 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.863 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -151.4 53.03 0.84 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.189 0.519 . . . . 0.0 110.228 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 97.3 mt -99.35 156.89 34.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.879 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.794 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 80.6 Cg_exo -44.32 111.24 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.45 2.1 . . . . 0.0 112.182 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.629 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 72.66 -38.99 0.44 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.593 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 119' ' ' PRO . 16.5 tp 58.23 51.94 7.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.968 0.413 . . . . 0.0 111.122 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.3 60.4 1.52 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.008 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.29 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.396 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -49.92 152.27 1.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.486 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.502 ' O ' ' HB ' ' A' ' 114' ' ' THR . 79.1 ttt180 -155.63 122.05 5.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.409 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.593 HG23 ' CE1' ' A' ' 128' ' ' PHE . 26.8 m -111.82 134.71 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.159 0.504 . . . . 0.0 111.772 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -87.34 141.84 28.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.226 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.593 ' CE1' HG23 ' A' ' 126' ' ' VAL . 14.4 m-85 -117.09 140.23 49.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.491 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -162.36 131.02 4.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.661 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 7.1 t -89.22 155.11 19.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.909 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 133' ' ' ASP . 45.9 m-20 -52.75 151.62 7.95 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.496 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.03 76.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.284 2.656 . . . . 0.0 113.133 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 131' ' ' ASP . 33.4 t70 -178.68 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.702 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.549 ' HB2' ' SG ' ' A' ' 130' ' ' CYS . 5.0 m-85 -108.93 145.83 34.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.55 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -101.08 140.03 35.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.32 0.581 . . . . 0.0 111.287 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.558 HD13 ' N ' ' A' ' 137' ' ' VAL . 2.4 tm? -79.61 127.09 31.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.971 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.558 ' N ' HD13 ' A' ' 136' ' ' LEU . 44.6 t -132.38 71.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.549 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.98 -130.25 1.56 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.879 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.743 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 31.4 t -73.53 58.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 111.268 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.477 ' HB3' HD12 ' A' ' 136' ' ' LEU . 96.5 p -51.71 -26.29 9.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.122 0.487 . . . . 0.0 109.885 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.407 ' HD2' ' NH2' ' A' ' 125' ' ' ARG . 34.2 ptt85 -140.62 128.95 22.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.272 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 99.8 p -125.74 128.27 47.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 111.038 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 89.1 t -103.13 117.56 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 42.6 t -64.54 136.69 57.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.455 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.1 t -164.47 130.29 2.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 111.201 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 17.5 tt0 56.75 43.16 25.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.28 0.562 . . . . 0.0 110.538 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 60.53 17.4 47.95 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.94 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -143.52 135.03 26.2 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.886 0.343 . . . . 0.0 111.128 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.622 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 95.5 m95 -68.97 135.19 50.57 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.838 0.352 . . . . 0.0 111.126 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -57.46 -55.16 38.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.3 p -103.97 132.11 21.33 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.63 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.526 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 54.3 Cg_endo -69.37 136.49 34.15 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.797 2.331 . . . . 0.0 112.473 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.823 ' HE2' HD13 ' A' ' 106' ' ' LEU . 85.9 tttt -40.01 129.03 1.6 Allowed Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.459 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 95.2 Cg_endo -79.2 -154.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.906 2.404 . . . . 0.0 113.221 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -153.74 169.42 23.38 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 92.3 m -98.72 136.79 38.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.418 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -131.25 131.14 43.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 110.857 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.43 132.08 29.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.322 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.904 179.862 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.849 0.357 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.86 -44.34 73.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 57.5 45.92 18.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.322 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -173.87 135.53 0.5 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.333 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.8 p -66.54 146.54 13.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.042 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.621 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -145.61 136.1 24.15 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.422 0.629 . . . . 0.0 111.18 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 tt 175.21 144.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.042 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 14.4 m -48.85 138.41 11.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.376 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.7 m -39.86 128.45 2.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.416 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.406 ' HA ' HD13 ' A' ' 104' ' ' LEU . 33.1 mmtp -82.0 -15.95 51.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.923 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.7 m -53.11 -42.41 65.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.085 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -57.5 -41.48 80.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.014 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.605 ' N ' HD12 ' A' ' 104' ' ' LEU . 3.6 mp -77.88 40.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.8 m -147.39 62.68 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.481 HD21 ' SG ' ' A' ' 130' ' ' CYS . 49.9 tp -94.55 124.97 38.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.849 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.58 41.0 1.04 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.017 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.6 m120 -160.12 27.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.697 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 161.07 -146.48 12.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.997 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 7.9 mtpm? -141.94 143.37 33.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.296 -0.452 . . . . 0.0 110.663 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.71 119.84 54.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.831 0.348 . . . . 0.0 110.519 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.432 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 1.7 m-85 -71.71 123.02 21.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.907 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.591 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -89.17 141.34 28.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.625 HG21 ' NH2' ' A' ' 125' ' ' ARG . 25.2 m -157.95 54.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.868 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.96 -105.57 0.43 Allowed Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.934 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.628 ' H ' HD21 ' A' ' 121' ' ' LEU . . . 165.82 -126.46 1.48 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.42 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -167.32 67.17 0.09 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.157 0.504 . . . . 0.0 109.984 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.698 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 71.5 mt -127.97 168.76 14.32 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.116 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.698 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 76.3 Cg_exo -38.18 97.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.635 2.224 . . . . 0.0 112.125 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 70.68 -20.05 0.21 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.847 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.673 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 19.8 tp 62.31 54.01 2.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.93 0.395 . . . . 0.0 110.76 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.699 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 33.1 t70 -56.83 129.51 41.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.182 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.74 26.31 38.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.988 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 1.086 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -79.64 156.91 27.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.625 ' NH2' HG21 ' A' ' 114' ' ' THR . 56.4 ttp85 -154.34 145.27 22.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.407 . . . . 0.0 111.405 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.7 m -148.35 138.23 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.582 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.449 ' HG3' ' NH1' ' A' ' 141' ' ' ARG . 43.3 tt0 -110.79 115.83 30.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.582 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.558 ' HE2' ' HG3' ' A' ' 153' ' ' LYS . 2.0 m-85 -73.95 143.0 45.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -156.3 117.84 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.704 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.558 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 95.2 m -92.32 156.25 17.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.571 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -52.7 153.11 6.01 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.476 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.37 78.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.128 2.552 . . . . 0.0 112.668 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -177.46 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.646 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.675 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 0.6 OUTLIER -108.61 134.52 51.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.924 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.474 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 20.3 p-80 -102.66 127.33 49.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.122 0.486 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.75 HD21 ' HA ' ' A' ' 140' ' ' SER . 26.6 tp -70.21 126.61 30.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.131 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.7 67.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.638 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -174.74 -135.31 2.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.072 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.73 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 65.0 m -74.74 55.04 0.66 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.75 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.8 t -48.42 -43.53 34.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.09 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.574 ' HD2' ' N ' ' A' ' 141' ' ' ARG . 0.4 OUTLIER -102.02 133.63 46.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.9 m -133.91 130.0 37.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.713 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.61 123.97 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.299 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 1.086 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 41.1 t -100.7 145.21 28.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.687 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.699 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 81.1 p -168.14 35.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 175.8 39.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.276 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 61.71 10.98 27.52 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.112 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.15 134.81 28.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.562 0.22 . . . . 0.0 110.592 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -73.42 137.11 44.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.366 . . . . 0.0 111.13 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.2 t -57.49 -59.66 4.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.35 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 82.7 p -96.44 134.52 23.32 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 15.9 Cg_exo -67.53 146.28 73.5 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.935 2.423 . . . . 0.0 111.949 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.558 ' HG3' ' HE2' ' A' ' 128' ' ' PHE . 88.2 tttt -51.17 122.93 19.24 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.858 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.73 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.2 Cg_endo -75.25 -150.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.734 2.289 . . . . 0.0 112.953 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -153.74 139.88 18.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 67.5 m -98.79 139.28 34.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.003 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.474 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 39.3 tt0 -102.93 132.53 49.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.11 126.91 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.338 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.395 179.667 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.835 0.35 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -176.82 -43.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -59.05 135.14 57.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.989 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.507 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 1.1 m-85 -64.66 129.23 39.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.796 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 p 177.77 141.32 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.173 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.82 ' O ' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -168.66 109.51 0.51 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.465 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.82 HG23 ' O ' ' A' ' 97' ' ' ARG . 1.4 pt -175.87 135.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.94 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.528 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 99.7 m -64.16 136.18 57.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.4 m -41.42 131.12 2.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.275 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.575 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -76.63 15.56 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.177 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.4 m -68.93 -39.81 79.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 111.433 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.496 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 1.8 m-85 -64.59 -70.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.599 HD23 HD13 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -46.98 156.97 0.18 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.97 0.414 . . . . 0.0 111.484 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.6 m 64.67 73.13 0.43 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.34 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.689 ' HB2' ' HZ3' ' A' ' 153' ' ' LYS . 49.3 tp -93.14 136.52 33.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.333 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.83 135.06 57.58 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.0 m120 58.97 40.93 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.075 0.464 . . . . 0.0 110.186 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.37 169.58 41.81 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.934 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -136.93 129.66 30.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.958 0.409 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.489 HG12 ' HB ' ' A' ' 126' ' ' VAL . 58.4 t -111.15 126.53 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.227 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.5 m-85 -70.87 111.33 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.19 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.599 HD13 HD23 ' A' ' 104' ' ' LEU . 58.5 tp -80.84 145.26 31.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.931 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.4 m -161.88 54.42 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.849 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.506 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . -174.76 61.26 0.11 Allowed Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.697 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.46 -53.37 45.52 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 114.634 0.613 . . . . 0.0 114.634 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -164.08 54.7 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.425 0.613 . . . . 0.0 111.821 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 120' ' ' ALA . 7.1 mp -87.74 159.19 49.75 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.355 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.521 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 75.4 Cg_exo -47.52 83.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.541 2.16 . . . . 0.0 111.638 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 59.83 23.12 12.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.902 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 7.8 mp 52.22 53.26 12.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.62 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 38.6 t70 -76.79 44.93 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.211 0.529 . . . . 0.0 110.329 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 125' ' ' ARG . . . 172.5 -27.65 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.536 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -51.8 144.55 11.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.783 0.325 . . . . 0.0 111.251 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.567 ' HG2' HG22 ' A' ' 143' ' ' VAL . 84.2 mtm180 -147.84 136.98 22.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.003 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' A' ' 113' ' ' LEU . 31.6 m -121.91 131.98 71.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.004 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.16 124.2 39.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.606 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.483 ' CE1' HG23 ' A' ' 126' ' ' VAL . 0.8 OUTLIER -87.09 138.17 31.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.98 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -145.92 127.47 15.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.491 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 96.5 m -89.29 145.32 25.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.692 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 134' ' ' PHE . 3.2 t70 -55.63 146.79 43.58 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.616 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 131' ' ' ASP . 88.4 Cg_exo -36.82 137.0 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.863 2.376 . . . . 0.0 112.593 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 51.5 m-20 75.0 22.21 1.85 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.512 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 16.9 m-85 -134.97 131.54 37.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.562 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -106.03 135.23 47.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.926 0.393 . . . . 0.0 110.836 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.823 HD11 ' HG2' ' A' ' 154' ' ' PRO . 17.5 tp -78.15 143.07 37.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.406 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 137' ' ' VAL . 14.5 p -134.92 59.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.87 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 169.28 -126.15 1.34 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 119.013 -1.565 . . . . 0.0 113.764 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.941 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 29.9 t -65.66 65.8 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.796 0.332 . . . . 0.0 111.258 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.649 ' HA ' HD21 ' A' ' 136' ' ' LEU . 95.6 p -61.88 -26.55 68.22 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.331 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -140.68 125.23 17.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.502 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m -116.35 137.33 52.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.793 0.33 . . . . 0.0 110.736 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.567 HG22 ' HG2' ' A' ' 125' ' ' ARG . 92.3 t -131.32 115.45 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.038 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 69.7 m -80.31 153.19 28.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.832 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 40.8 t -152.43 -23.01 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.661 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -146.58 46.18 1.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.15 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 64.74 24.18 69.58 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.882 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -141.7 132.74 26.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.293 0.237 . . . . 0.0 110.483 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.528 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 72.4 m95 -66.41 145.22 55.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 110.864 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.414 ' CB ' ' H ' ' A' ' 143' ' ' VAL . 47.3 t -56.27 -48.61 76.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.294 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.75 HG23 ' OG ' ' A' ' 139' ' ' SER . 1.0 OUTLIER -135.52 139.24 30.59 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-O 120.847 0.356 . . . . 0.0 111.765 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 17.8 Cg_endo -59.76 137.7 78.44 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.444 2.763 . . . . 0.0 113.842 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.838 ' HD3' ' HD2' ' A' ' 154' ' ' PRO . 2.7 tppp? -50.42 126.75 22.72 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.77 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 96.1 Cg_endo -85.03 -140.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.096 2.531 . . . . 0.0 112.278 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.505 ' O ' HG12 ' A' ' 137' ' ' VAL . 18.4 p-80 -153.69 149.31 27.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.876 0.369 . . . . 0.0 111.077 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.3 m -95.32 132.74 40.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.363 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -123.58 139.4 54.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.359 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.23 133.73 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.779 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.934 179.942 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.701 0.286 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.37 45.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.1 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -60.71 137.18 58.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.003 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -58.33 145.11 39.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.4 m -151.1 137.42 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.329 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.861 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -171.82 -161.89 0.2 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.817 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.858 HG13 ' HG2' ' A' ' 97' ' ' ARG . 91.1 mt 64.44 129.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.771 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.7 m -63.43 153.1 36.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.635 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 102' ' ' SER . 47.7 t -39.44 104.02 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.167 0.508 . . . . 0.0 110.879 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.639 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -66.46 3.95 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.328 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 100' ' ' SER . 47.7 t -68.11 -38.62 82.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.49 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.637 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.3 m-85 -51.5 -38.4 53.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.13 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.543 HD21 HD23 ' A' ' 113' ' ' LEU . 83.1 mt -53.77 -43.51 69.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.725 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.2 t -92.61 136.59 33.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.592 HD13 ' CE ' ' A' ' 153' ' ' LYS . 34.8 tp -145.42 128.94 17.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.909 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.92 42.24 0.62 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.284 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -154.08 -31.31 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.801 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.552 ' HA2' ' OD1' ' A' ' 131' ' ' ASP . . . -153.9 -148.37 4.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.174 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -131.15 137.42 49.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.779 0.323 . . . . 0.0 110.827 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.637 HG21 ' O ' ' A' ' 103' ' ' TYR . 60.1 t -108.72 121.82 62.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.864 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -69.17 124.32 23.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.513 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.705 HD22 ' H ' ' A' ' 114' ' ' THR . 3.1 tm? -99.7 142.16 31.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.395 0.617 . . . . 0.0 111.804 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.705 ' H ' HD22 ' A' ' 113' ' ' LEU . 22.6 m -157.47 42.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.861 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.553 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . 162.0 95.81 0.11 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.629 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.32 43.28 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.354 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.531 ' O ' HD23 ' A' ' 118' ' ' LEU . 53.1 p-10 -173.13 33.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 0.0 110.647 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.617 ' HB2' HD23 ' A' ' 121' ' ' LEU . 86.1 mt -141.13 140.76 21.71 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.526 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.861 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 51.0 Cg_exo -52.54 117.36 3.58 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.579 2.186 . . . . 0.0 112.813 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.651 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 71.18 -38.03 0.41 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.686 HD22 ' HB2' ' A' ' 124' ' ' ALA . 46.5 mt 63.04 55.23 1.99 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.799 0.333 . . . . 0.0 110.789 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -76.54 48.97 0.58 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.617 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.16 -20.11 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.789 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.848 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.97 143.02 4.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 111.672 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.621 ' HD2' HH22 ' A' ' 141' ' ' ARG . 84.9 mtm180 -136.57 141.6 43.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.13 136.2 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -114.27 113.4 24.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 3.0 m-85 -77.99 147.03 35.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.148 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 129' ' ' ARG . 38.1 ttt85 -158.07 129.34 6.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.078 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 31.1 m -89.07 139.52 30.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.02 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' ' HA2' ' A' ' 109' ' ' GLY . 82.3 m-20 -52.63 151.44 7.92 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.232 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.69 77.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.023 2.482 . . . . 0.0 112.422 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 131' ' ' ASP . 65.1 t0 -179.44 -41.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.432 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 2.9 m-85 -110.09 140.93 43.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.229 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -102.72 127.8 49.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.863 0.364 . . . . 0.0 110.573 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' A' ' 140' ' ' SER . 2.7 tm? -77.35 129.34 35.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.07 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.553 ' N ' HD13 ' A' ' 136' ' ' LEU . 39.4 t -136.82 72.46 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.24 -135.89 2.41 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.632 -1.271 . . . . 0.0 113.318 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.477 ' HB3' ' OG1' ' A' ' 151' ' ' THR . 68.6 m -76.37 54.54 0.92 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.708 0.29 . . . . 0.0 110.94 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.572 ' HB3' HD12 ' A' ' 136' ' ' LEU . 88.8 p -47.07 -37.46 9.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.541 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.621 HH22 ' HD2' ' A' ' 125' ' ' ARG . 40.6 ttt85 -99.4 138.27 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.505 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.1 t -150.37 132.0 14.88 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.726 0.298 . . . . 0.0 110.655 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 125' ' ' ARG . 83.5 t -117.66 127.41 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.298 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.848 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 49.9 t -71.43 140.17 49.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -169.19 129.35 1.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.592 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 56.76 40.28 29.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 59.12 22.54 55.75 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.407 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.18 132.51 24.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.648 0.261 . . . . 0.0 110.687 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -69.5 141.29 53.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.839 0.352 . . . . 0.0 111.034 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.0 m -57.4 -54.41 47.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.05 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.477 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 65.0 p -115.71 137.34 23.17 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.399 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 139' ' ' SER . 31.7 Cg_exo -58.76 142.2 98.54 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.817 2.345 . . . . 0.0 112.227 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.592 ' CE ' HD13 ' A' ' 106' ' ' LEU . 62.6 tttp -50.42 130.93 25.89 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.247 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.475 ' HG2' HD21 ' A' ' 136' ' ' LEU . 59.4 Cg_endo -72.39 -152.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.649 2.232 . . . . 0.0 112.555 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -153.63 143.7 22.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.133 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 81.1 m -98.15 129.68 44.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.37 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -119.28 140.82 49.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.937 0.398 . . . . 0.0 111.516 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.07 135.92 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.786 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 32.2 m120 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.888 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.629 0.252 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 64.57 134.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.457 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.89 133.84 55.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -145.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.686 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.5 m -63.96 140.13 20.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.764 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.738 ' HG2' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -66.79 -156.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.033 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.058 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 94.5 mt 67.19 127.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.368 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.8 m -62.48 150.52 39.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.717 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 102' ' ' SER . 57.5 m -40.68 105.07 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.603 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -69.13 15.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.719 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 100' ' ' SER . 46.9 t -68.92 -35.38 76.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.061 0.458 . . . . 0.0 110.029 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -51.65 -35.19 41.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.241 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.731 HD21 HD13 ' A' ' 113' ' ' LEU . 91.4 mt -53.47 -43.93 68.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.211 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.4 m -92.56 128.61 38.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.541 HD13 ' CE ' ' A' ' 153' ' ' LYS . 34.9 tp -145.45 132.91 20.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.366 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.41 132.91 47.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.492 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 56.24 43.98 25.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.545 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.81 163.82 32.99 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.519 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.58 ' NZ ' ' HB2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -138.89 134.39 33.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.775 0.322 . . . . 0.0 110.684 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' A' ' 126' ' ' VAL . 57.7 t -114.13 126.96 71.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.647 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -73.34 124.82 26.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.211 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.731 HD13 HD21 ' A' ' 104' ' ' LEU . 52.9 tp -89.54 143.35 26.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.225 0.535 . . . . 0.0 112.088 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.577 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.2 m -162.37 52.4 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.395 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.641 ' O ' HD11 ' A' ' 121' ' ' LEU . . . 161.95 103.39 0.18 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.709 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.86 47.84 0.22 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.113 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.643 ' O ' HD13 ' A' ' 118' ' ' LEU . 2.7 p30 -174.5 36.43 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.35 . . . . 0.0 111.156 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 117' ' ' ASP . 2.2 mm? -134.98 151.85 76.22 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.582 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.4 124.26 11.64 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.345 2.03 . . . . 0.0 111.424 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 97' ' ' ARG . . . 53.16 32.0 12.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.069 0.461 . . . . 0.0 110.279 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 1.058 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 14.7 tp 50.58 46.73 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.927 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -66.68 141.08 57.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.122 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.8 31.36 80.65 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.469 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.919 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . . . -85.65 145.17 27.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.737 0.303 . . . . 0.0 110.976 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.577 ' O ' ' HB ' ' A' ' 114' ' ' THR . 53.4 ttt-85 -160.4 127.07 4.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.692 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 113' ' ' LEU . 28.3 m -137.54 136.96 46.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.68 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -102.38 122.71 44.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.123 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.569 ' HE2' ' HG3' ' A' ' 153' ' ' LYS . 5.7 m-85 -83.61 150.21 26.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.134 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -157.04 126.13 5.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.588 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 73.4 m -89.91 136.91 32.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.218 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -57.78 159.33 10.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.965 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 88.3 Cg_exo -40.89 152.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.96 2.44 . . . . 0.0 112.721 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 57.8 m-20 78.03 -34.38 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.039 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -106.02 128.21 53.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.3 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -106.27 140.08 39.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.14 0.495 . . . . 0.0 111.878 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.817 HD21 ' HA ' ' A' ' 140' ' ' SER . 36.5 tp -78.11 128.44 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.704 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.42 64.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.577 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.73 -135.83 2.05 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.219 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.678 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 63.8 m -72.04 63.92 0.51 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.114 0.483 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.817 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.1 t -55.31 -16.96 3.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.467 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -140.64 136.03 32.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.89 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 79.2 p -135.57 141.87 45.23 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.49 ' H ' ' HB3' ' A' ' 150' ' ' SER . 95.5 t -135.82 126.18 42.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.066 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.867 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 57.2 m -92.95 148.46 21.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.039 0.447 . . . . 0.0 111.735 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.6 t -163.15 26.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.148 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 175.86 39.51 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.275 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 62.66 19.37 60.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.495 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -142.38 132.77 24.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.664 0.268 . . . . 0.0 110.641 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -64.56 143.01 58.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.967 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 48.5 t -57.14 -47.43 81.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.714 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 59.8 p -127.68 133.57 25.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.342 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.25 142.99 77.61 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.879 2.386 . . . . 0.0 112.619 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.569 ' HG3' ' HE2' ' A' ' 128' ' ' PHE . 87.4 tttt -48.86 128.24 14.39 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.28 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.678 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.0 Cg_endo -75.91 -150.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.704 2.269 . . . . 0.0 112.672 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.405 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.6 p-80 -153.69 151.51 29.74 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.08 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 90.2 m -98.61 137.09 37.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.727 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -120.4 135.83 54.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.362 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.65 143.63 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.973 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 133' ' ' ASP . 23.5 p30 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.09 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.824 0.345 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -178.21 46.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.843 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -56.95 135.23 56.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.432 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 2.5 m-85 -60.63 141.61 56.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.88 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.3 m -134.12 45.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.062 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 1.019 ' HG3' HG13 ' A' ' 98' ' ' ILE . 31.8 ptt180 -172.2 -164.63 0.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.984 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 1.019 HG13 ' HG3' ' A' ' 97' ' ' ARG . 12.8 mt 51.42 32.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.755 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.539 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 72.9 m 58.77 149.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.876 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -40.41 100.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.549 ' HG3' HD12 ' A' ' 104' ' ' LEU . 27.7 ttpp -59.9 -20.61 58.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.861 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.8 p -53.24 -33.51 53.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.292 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -56.95 -44.87 82.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.662 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.549 HD12 ' HG3' ' A' ' 101' ' ' LYS . 92.7 mt -49.61 -39.98 37.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.7 p -92.55 131.87 37.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.652 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.859 HD13 ' HE3' ' A' ' 153' ' ' LYS . 55.4 tp -145.36 130.68 18.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.18 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.57 132.3 47.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.433 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 56.77 43.89 24.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.566 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.19 164.4 34.92 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.472 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -136.7 134.35 37.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.736 0.303 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 86.9 t -106.48 126.07 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.391 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.585 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.5 m-85 -74.71 127.43 33.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -81.6 140.97 34.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.076 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.649 ' N ' HD13 ' A' ' 113' ' ' LEU . 28.2 m -158.1 56.11 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.083 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.99 -101.87 0.2 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.012 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.651 ' H ' HD21 ' A' ' 121' ' ' LEU . . . -179.97 -131.55 1.66 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.225 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.699 ' C ' HD12 ' A' ' 118' ' ' LEU . 39.0 t70 -165.8 58.38 0.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.974 0.416 . . . . 0.0 110.34 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.699 HD12 ' C ' ' A' ' 117' ' ' ASP . 8.0 mp -131.38 156.98 79.39 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.515 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.737 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 95.6 Cg_exo -42.89 119.89 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.445 2.097 . . . . 0.0 112.468 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.695 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 72.99 -40.24 0.47 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.672 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.651 HD21 ' H ' ' A' ' 116' ' ' GLY . 21.2 tp 55.23 57.21 5.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.949 0.404 . . . . 0.0 110.857 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -51.19 137.1 23.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.15 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.22 33.52 64.78 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.895 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.586 ' HB3' ' SG ' ' A' ' 144' ' ' CYS . . . -84.35 148.53 26.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.523 0.201 . . . . 0.0 110.595 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.422 ' O ' ' HB ' ' A' ' 114' ' ' THR . 66.1 mtm-85 -144.87 141.96 29.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.985 0.421 . . . . 0.0 111.338 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.58 HG23 ' CE1' ' A' ' 128' ' ' PHE . 23.9 m -147.8 132.08 9.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.715 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.7 mt-10 -93.05 131.43 38.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.292 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.58 ' CE1' HG23 ' A' ' 126' ' ' VAL . 4.3 m-85 -103.47 145.84 29.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.029 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.508 ' HG2' HH11 ' A' ' 129' ' ' ARG . 2.9 ptp85 -168.89 129.98 1.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.651 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 26.2 t -89.22 150.5 22.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.235 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -52.68 155.8 3.68 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.32 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 84.9 Cg_exo -46.28 159.21 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.68 2.254 . . . . 0.0 112.149 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 25.3 m-20 78.27 -37.53 0.22 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.61 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -108.05 128.96 55.13 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -108.66 133.52 52.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 111.596 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 137' ' ' VAL . 7.9 tt -71.42 137.53 48.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.02 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.551 ' N ' HD23 ' A' ' 136' ' ' LEU . 42.8 t -131.37 73.08 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.769 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.46 -133.43 2.22 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.081 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.58 ' OG ' ' HD3' ' A' ' 154' ' ' PRO . 43.6 p -73.72 62.6 0.81 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.528 ' HB3' HD22 ' A' ' 136' ' ' LEU . 99.8 p -56.27 -14.93 3.19 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.801 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.647 ' HD2' ' O ' ' A' ' 141' ' ' ARG . 7.6 ppt_? -140.62 140.52 35.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.599 0.237 . . . . 0.0 110.964 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 56.1 m -136.55 148.93 47.84 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.855 0.359 . . . . 0.0 111.278 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.21 129.87 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.374 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.586 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 98.3 m -75.06 174.93 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.509 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.7 t -172.21 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.452 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -150.8 49.5 0.86 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.59 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 65.68 19.35 67.08 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.259 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -142.82 132.19 23.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.548 0.213 . . . . 0.0 110.731 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.539 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 97.7 m95 -65.15 135.83 55.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.647 0.261 . . . . 0.0 110.941 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.8 t -57.48 -52.76 64.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.483 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.7 p -104.3 146.15 32.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.971 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.83 -152.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.622 2.215 . . . . 0.0 112.739 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.859 ' HE3' HD13 ' A' ' 106' ' ' LEU . 59.0 tptt -121.77 123.62 27.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.262 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.782 ' HD2' ' HD2' ' A' ' 153' ' ' LYS . 98.3 Cg_endo -85.45 -146.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.66 2.24 . . . . 0.0 113.214 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.445 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.7 p-80 -153.72 -149.28 0.28 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 85.6 m -133.07 134.83 44.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -116.85 130.03 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.456 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.0 p -62.14 137.99 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.125 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.6 p30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.954 -179.846 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.848 0.356 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.52 -135.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.713 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.468 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -59.95 130.22 45.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.68 0.276 . . . . 0.0 110.859 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 63.93 138.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.49 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p -172.03 134.9 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.756 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.854 ' HG2' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -65.84 -152.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.694 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.854 HG23 ' HG2' ' A' ' 97' ' ' ARG . 11.4 pt 52.63 127.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.409 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.609 ' SG ' HD22 ' A' ' 121' ' ' LEU . 3.2 p -60.7 136.04 57.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.726 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 102' ' ' SER . 80.4 p -39.89 130.31 2.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.592 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.581 ' NZ ' HD12 ' A' ' 98' ' ' ILE . 60.5 mttp -75.11 16.12 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.345 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 100' ' ' SER . 79.6 p -68.96 -44.8 72.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.866 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -59.07 -36.83 75.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.412 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.412 HD21 HD23 ' A' ' 113' ' ' LEU . 94.9 mt -50.55 149.39 3.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.747 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.3 p 62.66 137.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.115 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.796 HD13 ' HE2' ' A' ' 153' ' ' LYS . 36.1 tp -145.41 139.66 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.26 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -68.04 130.0 41.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.235 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 57.37 41.74 25.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.713 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.49 152.82 10.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.636 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.48 132.01 56.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.724 0.297 . . . . 0.0 110.685 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.757 HG22 ' HA ' ' A' ' 128' ' ' PHE . 98.5 t -108.32 121.96 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.288 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.7 m-85 -74.82 126.08 30.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.152 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.681 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -108.58 142.06 39.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.411 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.681 ' N ' HD13 ' A' ' 113' ' ' LEU . 94.7 m -163.58 97.66 0.88 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.608 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.493 ' O ' ' HG ' ' A' ' 121' ' ' LEU . . . 163.08 -30.26 0.27 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.883 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -41.58 150.14 0.26 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.528 -0.368 . . . . 0.0 113.901 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.672 ' C ' HD22 ' A' ' 118' ' ' LEU . 32.5 m-20 72.23 37.11 0.99 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.826 0.45 . . . . 0.0 111.704 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.672 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.3 mm? -142.44 148.67 48.2 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.953 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.86 97.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.797 2.332 . . . . 0.0 112.616 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.81 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 55.64 17.06 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.574 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.777 HD13 ' HA ' ' A' ' 98' ' ' ILE . 10.4 mp 46.11 62.44 2.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.25 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.53 46.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.169 0.509 . . . . 0.0 110.376 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.86 27.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.029 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.784 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -81.46 142.08 33.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.754 0.311 . . . . 0.0 111.397 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.56 130.29 34.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.621 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 113' ' ' LEU . 19.0 m -136.1 144.13 34.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.468 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 87.2 tt0 -119.09 122.05 41.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.229 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.757 ' HA ' HG22 ' A' ' 111' ' ' VAL . 9.4 m-85 -85.65 53.51 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.965 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.499 ' HB3' ' NH1' ' A' ' 129' ' ' ARG . 12.8 mtp-105 -58.88 128.62 38.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 0.0 111.001 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 61.3 m -89.55 147.21 24.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.891 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 133' ' ' ASP . 52.6 p-10 -52.81 153.0 6.27 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.031 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.36 75.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.001 2.468 . . . . 0.0 112.755 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.5 t70 179.93 -40.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.435 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 3.5 m-85 -108.63 139.65 43.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.259 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -102.86 131.45 49.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.053 0.454 . . . . 0.0 110.757 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.852 HD21 ' HA ' ' A' ' 140' ' ' SER . 23.2 tp -69.91 131.9 45.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.982 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.1 t -136.25 67.8 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.94 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.59 -136.5 2.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.47 -1.348 . . . . 0.0 113.376 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.495 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 62.2 m -74.62 58.12 0.77 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.997 0.427 . . . . 0.0 110.565 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.852 ' HA ' HD21 ' A' ' 136' ' ' LEU . 39.3 t -47.63 -44.03 26.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.416 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -102.62 133.03 48.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.968 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.7 t -138.32 125.23 21.18 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.64 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 96.8 t -111.89 125.62 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.086 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.784 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 73.9 m -72.83 143.35 47.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.017 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.5 p -163.51 128.69 3.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.097 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 1.5 mp0 55.79 38.21 29.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.451 . . . . 0.0 109.917 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.402 ' H ' ' HB1' ' A' ' 120' ' ' ALA . . . 62.29 28.21 70.53 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.351 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 -143.23 131.53 22.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.576 0.227 . . . . 0.0 110.593 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -69.85 137.43 51.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.2 t -57.49 -56.46 21.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.644 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 82.0 p -111.75 137.64 21.32 Favored Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 32.2 Cg_exo -58.41 147.17 86.96 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.879 2.386 . . . . 0.0 112.268 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.796 ' HE2' HD13 ' A' ' 106' ' ' LEU . 85.9 tttt -52.79 125.65 39.16 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.495 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.8 Cg_endo -76.78 -154.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.76 2.306 . . . . 0.0 112.655 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -153.67 150.67 28.82 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.229 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 76.5 m -97.33 134.91 39.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.228 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 158' ' ' VAL . 0.7 OUTLIER -124.47 131.42 53.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.715 0.293 . . . . 0.0 110.721 -179.359 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 7.3 p -74.09 129.27 36.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 111.641 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.184 -0.913 . . . . 0.0 111.091 179.758 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.798 0.332 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.15 -141.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.27 -42.19 84.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.045 0.45 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.547 ' O ' ' HD3' ' A' ' 97' ' ' ARG . 1.5 m-85 -59.88 129.53 42.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.66 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.7 m -63.28 144.55 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.557 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.764 HH21 HD12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -165.59 62.71 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.54 0.685 . . . . 0.0 111.021 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.764 HD12 HH21 ' A' ' 97' ' ' ARG . 0.2 OUTLIER -145.25 133.59 16.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.104 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 39.1 m -57.1 143.77 37.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.866 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.6 t -39.88 128.56 2.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.075 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.69 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -72.73 -14.27 61.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.364 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.5 p -53.1 -47.06 68.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.53 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -59.44 -41.27 89.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.252 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 86.8 mt -51.86 -36.89 49.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.23 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.5 p -92.49 141.42 28.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.608 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.498 HD22 ' H ' ' A' ' 108' ' ' ASN . 1.9 tt -140.84 120.93 13.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.532 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 108' ' ' ASN . 3.8 mm-40 -82.64 30.05 0.43 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.498 ' H ' HD22 ' A' ' 106' ' ' LEU . 72.3 m-80 -166.14 25.68 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.54 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.15 -156.67 23.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.656 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -141.96 134.01 27.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.632 0.253 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 94.0 t -106.59 121.18 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.023 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.2 m-85 -74.78 116.35 15.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.437 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.2 tp -83.28 142.77 30.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.393 . . . . 0.0 111.422 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 114' ' ' THR . 32.3 m -163.28 61.17 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.393 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.486 ' O ' HD13 ' A' ' 118' ' ' LEU . . . -152.39 -39.35 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.839 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.06 -125.74 7.35 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.885 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.457 ' HA ' HD11 ' A' ' 121' ' ' LEU . 52.0 p-10 -147.47 48.3 1.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.999 0.428 . . . . 0.0 111.163 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 121' ' ' LEU . 6.7 mp -80.77 161.38 63.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.402 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.705 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 83.6 Cg_exo -43.82 94.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.459 2.106 . . . . 0.0 112.343 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.471 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 69.25 -9.03 0.65 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.961 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 118' ' ' LEU . 7.6 mp 61.46 57.68 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.593 0.235 . . . . 0.0 110.883 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -75.12 49.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 110.587 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 178.99 -13.68 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.905 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.993 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -50.75 147.54 4.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.928 0.394 . . . . 0.0 111.335 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.684 ' CD ' HG22 ' A' ' 143' ' ' VAL . 43.8 mmm-85 -146.25 133.57 20.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.657 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.415 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 35.7 m -127.03 132.13 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 111.584 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 52.4 mm-40 -103.32 138.63 39.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.839 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -105.58 145.06 31.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.043 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -148.52 122.53 9.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.355 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 59.3 m -89.22 143.89 26.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.052 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 133' ' ' ASP . 1.4 m-20 -52.8 151.94 7.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.883 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.28 75.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.13 2.553 . . . . 0.0 112.722 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' ASP . 38.9 t70 178.89 -36.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.646 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 1.6 m-85 -108.8 136.67 47.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.068 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -102.84 130.13 49.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 0.0 110.532 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 140' ' ' SER . 35.8 tp -71.46 130.32 41.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.056 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.33 68.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.785 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 174.61 -129.21 1.55 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 119.512 -1.327 . . . . 0.0 113.347 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.736 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 30.1 t -68.86 63.63 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.89 0.376 . . . . 0.0 111.259 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.812 ' HA ' HD21 ' A' ' 136' ' ' LEU . 93.4 p -57.77 -23.99 54.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.526 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -140.61 136.17 32.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.79 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.548 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 46.7 t -127.92 125.48 39.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.559 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.684 HG22 ' CD ' ' A' ' 125' ' ' ARG . 46.3 t -97.72 120.24 46.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.244 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.993 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 52.7 t -77.94 122.94 26.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.4 p -104.65 -123.72 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.703 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -75.88 55.89 0.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.68 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.03 21.13 66.13 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.776 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -143.09 137.07 28.91 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.65 0.262 . . . . 0.0 111.239 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 83.3 m95 -67.24 139.79 57.37 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.875 0.369 . . . . 0.0 111.51 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.508 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 46.7 t -57.49 -53.86 53.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.978 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.587 HG23 ' OG ' ' A' ' 139' ' ' SER . 2.4 t -127.06 141.41 40.59 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.698 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.3 145.32 98.19 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.174 2.583 . . . . 0.0 112.979 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -49.91 134.76 21.24 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.381 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.736 ' HB3' ' H ' ' A' ' 139' ' ' SER . 97.0 Cg_endo -79.48 -149.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.749 2.299 . . . . 0.0 112.759 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.421 ' CD2' HE21 ' A' ' 157' ' ' GLN . 18.2 p-80 -153.72 145.71 23.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 75.2 m -96.81 127.52 42.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.544 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.421 HE21 ' CD2' ' A' ' 155' ' ' HIS . 82.5 mt-30 -111.09 129.48 55.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.064 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.22 136.29 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.826 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 33.6 m120 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.886 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 54.1 mt-10 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.704 0.288 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.77 42.53 31.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 15.9 pt-20 -174.24 135.69 0.46 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.757 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -172.65 131.56 0.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.027 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.24 141.35 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.286 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.644 ' HD3' ' N ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -167.29 110.19 0.67 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.278 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.633 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -161.38 141.5 3.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.693 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 61.2 m -55.88 135.7 51.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.509 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.4 p -42.15 127.27 3.49 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -77.86 16.23 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.5 m -68.26 -42.25 79.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 110.359 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.503 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.2 m-85 -62.03 -46.28 89.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.728 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.423 ' HA ' HG11 ' A' ' 111' ' ' VAL . 92.4 mt -64.64 -30.63 71.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.979 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.2 p -92.46 72.63 5.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.633 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.796 HD22 ' H ' ' A' ' 109' ' ' GLY . 1.3 tt -94.54 124.27 38.46 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 38.5 tt0 -81.84 34.99 0.41 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.082 0.468 . . . . 0.0 111.38 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.417 ' N ' HD22 ' A' ' 106' ' ' LEU . 7.3 m120 -160.75 -49.17 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.4 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.796 ' H ' HD22 ' A' ' 106' ' ' LEU . . . -86.68 -151.96 20.51 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.964 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 111' ' ' VAL . 86.0 tttt -142.04 -42.33 0.34 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.811 0.339 . . . . 0.0 110.602 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 10.5 p 48.55 115.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.947 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -75.17 127.48 33.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.111 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.3 tp -90.84 146.23 24.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.065 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 24.8 m -157.11 53.97 0.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.398 0.618 . . . . 0.0 109.912 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.664 ' C ' HD11 ' A' ' 121' ' ' LEU . . . 164.96 107.68 0.2 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.702 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.53 140.67 7.72 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.862 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.726 ' C ' HD12 ' A' ' 118' ' ' LEU . 9.4 t70 73.87 53.38 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.137 0.494 . . . . 0.0 111.073 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.726 HD12 ' C ' ' A' ' 117' ' ' ASP . 9.3 mp -140.27 152.4 66.89 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.657 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.544 ' HA ' ' CG ' ' A' ' 97' ' ' ARG . 14.3 Cg_endo -57.24 113.75 1.63 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.228 1.952 . . . . 0.0 110.999 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.573 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 56.55 18.27 3.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.143 0.497 . . . . 0.0 109.887 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.778 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 14.9 tp 45.54 42.94 8.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.069 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -62.78 137.39 58.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.63 37.53 61.8 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.979 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.822 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -98.73 142.76 29.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.685 0.279 . . . . 0.0 110.867 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.512 ' O ' ' HB ' ' A' ' 114' ' ' THR . 66.2 mtm-85 -131.49 138.54 49.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.94 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.6 m -144.53 134.75 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.273 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -113.68 105.93 13.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.39 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 66.3 m-85 -68.78 146.49 52.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.102 0.477 . . . . 0.0 111.625 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' ' 129' ' ' ARG . 41.3 ttt85 -153.16 125.42 8.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.657 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.637 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 56.5 m -89.26 139.97 29.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.558 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 47.4 p-10 -54.26 161.09 2.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.703 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.559 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 1.8 Cg_endo -45.04 152.44 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.835 2.357 . . . . 0.0 111.899 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.559 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 35.0 t70 79.62 -29.57 0.14 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.485 ' CE2' HG22 ' A' ' 158' ' ' VAL . 35.6 m-85 -106.45 132.43 52.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.711 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -112.28 136.02 52.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.992 0.425 . . . . 0.0 111.191 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.896 HD21 ' HA ' ' A' ' 140' ' ' SER . 29.6 tp -77.3 129.77 36.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.3 t -136.2 68.91 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.861 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 176.82 -129.99 1.57 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.267 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.741 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 31.3 t -70.06 62.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.035 0.445 . . . . 0.0 111.206 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.896 ' HA ' HD21 ' A' ' 136' ' ' LEU . 36.2 t -58.13 -23.13 53.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.81 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -127.28 139.71 52.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.654 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.6 t -144.48 134.82 24.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.687 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -122.54 125.56 72.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.822 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 7.5 m -64.46 148.46 50.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.331 0.586 . . . . 0.0 112.091 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.6 p -166.82 124.26 1.29 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.32 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 59.3 39.02 22.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.082 0.468 . . . . 0.0 110.079 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.573 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 62.11 24.1 64.74 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.659 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -142.42 135.93 29.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.505 0.193 . . . . 0.0 110.81 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.457 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 59.5 m95 -64.33 133.03 51.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.741 0.305 . . . . 0.0 110.546 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -57.44 -59.43 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.009 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.9 p -94.11 135.48 24.54 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.778 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.16 142.91 82.37 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.726 2.284 . . . . 0.0 111.915 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -50.72 129.29 27.41 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.302 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.741 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.8 Cg_endo -75.69 -148.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.692 2.261 . . . . 0.0 112.47 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.422 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 3.6 p80 -153.69 143.32 21.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.172 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 88.3 m -97.63 130.85 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.031 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 47.0 mm-40 -124.02 143.36 50.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.184 0.516 . . . . 0.0 111.794 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.485 HG22 ' CE2' ' A' ' 134' ' ' PHE . 4.5 t -66.0 137.27 25.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.982 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.2 p30 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.173 -0.917 . . . . 0.0 111.002 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.498 0.19 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.91 49.65 0.01 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.758 0.313 . . . . 0.0 111.243 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -170.88 138.46 1.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.021 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.488 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 2.1 m-85 -61.25 130.7 47.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.393 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.36 126.9 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.611 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.901 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 13.0 ttp-105 -175.97 -155.98 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.269 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.96 HG22 ' HB2' ' A' ' 121' ' ' LEU . 4.4 pt -56.96 140.24 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.029 0.443 . . . . 0.0 111.82 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.673 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 2.4 p -53.5 136.55 38.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.698 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 102' ' ' SER . 46.8 t -40.4 128.83 2.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.973 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -74.46 23.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.528 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.571 ' O ' HG22 ' A' ' 105' ' ' THR . 77.7 p -68.87 -41.16 78.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.029 0.442 . . . . 0.0 110.506 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.476 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.7 m-85 -67.92 -25.29 65.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.449 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.409 HD21 HD23 ' A' ' 113' ' ' LEU . 79.0 mt -68.86 23.9 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 102' ' ' SER . 9.2 t -148.36 129.55 14.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.56 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 43.5 tp -145.44 127.37 15.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 107' ' ' GLU . 41.9 tp10 -82.36 46.15 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.095 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -158.89 -30.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.215 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.643 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -158.33 -150.77 5.86 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.386 -0.912 . . . . 0.0 113.349 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -130.23 152.07 50.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.816 0.341 . . . . 0.0 111.005 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 103' ' ' TYR . 61.0 t -105.79 126.4 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -80.17 69.18 6.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.977 ' HA ' HG12 ' A' ' 126' ' ' VAL . 3.3 tm? -63.73 145.12 56.35 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.705 ' N ' HD13 ' A' ' 113' ' ' LEU . 56.4 m -149.06 81.74 1.43 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.022 0.439 . . . . 0.0 111.391 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.613 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . 177.03 -103.01 0.17 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.216 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . 59.58 144.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.073 0.389 . . . . 0.0 114.073 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.705 ' C ' HD22 ' A' ' 118' ' ' LEU . 57.6 m-20 71.86 49.84 0.25 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.705 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.4 mm? -142.23 138.68 16.88 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.883 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.869 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 70.1 Cg_endo -74.55 33.94 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.376 2.051 . . . . 0.0 112.192 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 119' ' ' PRO . . . 172.19 -44.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.732 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.96 ' HB2' HG22 ' A' ' 98' ' ' ILE . 15.2 tp 59.7 43.9 14.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 64.4 t0 -79.97 58.49 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.822 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.37 -27.09 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.738 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -48.83 153.53 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.063 0.458 . . . . 0.0 111.707 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -139.5 136.67 34.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.369 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.977 HG12 ' HA ' ' A' ' 113' ' ' LEU . 29.1 m -125.66 139.26 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.07 0.462 . . . . 0.0 111.942 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -120.71 98.24 5.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.397 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.476 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 4.6 m-85 -64.65 147.45 52.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.347 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -159.95 115.52 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.409 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.643 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 91.7 m -89.17 149.16 23.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.456 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.469 ' OD1' ' HA2' ' A' ' 109' ' ' GLY . 1.3 m-20 -52.7 158.35 2.2 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.083 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.509 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 99.3 Cg_exo -43.04 159.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.906 2.404 . . . . 0.0 112.564 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 49.8 m-20 80.76 -31.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.79 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.86 143.97 33.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.414 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -133.99 131.31 38.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.973 0.416 . . . . 0.0 111.015 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.768 HD11 ' HG2' ' A' ' 154' ' ' PRO . 24.4 tp -78.32 133.77 37.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.668 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.99 71.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.66 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.67 -133.61 2.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.955 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.597 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 58.7 m -76.05 54.82 0.88 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.739 0.304 . . . . 0.0 110.958 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.424 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 95.7 p -50.0 -41.31 46.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -99.38 130.23 45.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.482 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 126' ' ' VAL . 44.0 t -134.9 127.27 30.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.902 0.382 . . . . 0.0 110.74 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.5 t -93.81 128.67 45.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.357 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.735 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 48.9 t -83.03 134.43 35.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.887 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 79.3 p -175.04 132.95 0.32 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.972 0.415 . . . . 0.0 111.853 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 53.53 46.29 26.42 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.881 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.673 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . 52.76 23.35 14.52 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.961 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -142.49 130.22 21.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.66 0.267 . . . . 0.0 110.824 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.466 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 65.3 m95 -75.98 135.18 40.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 111.03 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 m -57.52 -53.98 51.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.036 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 80.8 p -107.5 129.53 24.11 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.477 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 139' ' ' SER . 38.8 Cg_exo -60.74 142.87 98.97 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.745 2.296 . . . . 0.0 111.866 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.56 ' NZ ' HD13 ' A' ' 106' ' ' LEU . 57.1 tttm -51.76 125.87 30.74 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.305 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.768 ' HG2' HD11 ' A' ' 136' ' ' LEU . 80.8 Cg_endo -79.26 -149.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.666 2.244 . . . . 0.0 112.433 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -153.95 141.47 19.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.741 0.305 . . . . 0.0 111.446 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 95.1 m -98.58 132.76 43.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.602 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -103.03 133.92 47.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.426 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.86 138.67 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.738 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.421 HD21 ' C ' ' A' ' 159' ' ' ASN . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.029 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.599 0.238 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.07 134.26 56.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.939 0.4 . . . . 0.0 111.271 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -66.25 135.73 54.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.043 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -60.62 -44.45 96.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.769 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -172.38 129.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.904 ' HD3' ' H ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -68.68 -176.31 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.455 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.764 HD13 ' HG2' ' A' ' 97' ' ' ARG . 1.6 mp 68.94 135.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.943 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.47 ' O ' HG22 ' A' ' 98' ' ' ILE . 69.4 m -57.44 146.54 29.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.518 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 99' ' ' CYS . 52.8 m -35.85 120.98 0.63 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.017 0.437 . . . . 0.0 111.491 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.566 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -72.82 3.22 5.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.883 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.6 p -66.48 -41.95 88.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.353 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.554 ' HD2' ' HZ ' ' A' ' 128' ' ' PHE . 2.1 m-85 -54.23 -42.28 69.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.307 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 84.8 mt -59.25 -35.89 74.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -92.55 69.39 4.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.648 HD13 ' HE2' ' A' ' 153' ' ' LYS . 28.7 tp -94.61 130.99 40.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.187 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -67.57 136.06 53.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.289 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.522 ' HB3' ' OD1' ' A' ' 131' ' ' ASP . 75.4 m-20 55.83 44.11 26.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.353 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.59 164.65 34.44 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.493 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -136.99 130.91 32.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 0.0 110.489 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 48.5 t -106.5 123.09 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.3 m-85 -78.4 125.84 29.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.019 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.473 HD12 ' H ' ' A' ' 114' ' ' THR . 60.8 tp -85.18 150.91 24.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.252 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.473 ' H ' HD12 ' A' ' 113' ' ' LEU . 27.8 m -156.59 56.8 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.531 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -157.0 -105.15 0.22 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.21 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.57 -127.43 1.34 Allowed Glycine 0 CA--C 1.516 0.146 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.752 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.494 ' C ' HD11 ' A' ' 98' ' ' ILE . 38.8 t70 -152.15 41.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.298 0.57 . . . . 0.0 110.466 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.5 mt -95.02 152.01 39.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.36 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.505 ' HA ' ' CB ' ' A' ' 97' ' ' ARG . 86.6 Cg_exo -42.96 123.11 3.01 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.369 2.046 . . . . 0.0 111.998 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.695 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 73.63 -37.44 0.37 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.401 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.808 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 22.9 tp 55.88 45.15 24.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 111.18 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 8.1 t70 -65.51 133.42 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.69 -28.54 13.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.477 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 1.044 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.15 143.3 3.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.742 0.306 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.595 ' CD ' HG22 ' A' ' 143' ' ' VAL . 40.6 mmm-85 -129.6 144.9 51.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.21 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 32.8 m -142.38 134.93 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.553 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -107.97 116.84 32.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.704 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.554 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.5 m-85 -80.16 147.68 31.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.993 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -156.19 124.91 5.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.974 0.416 . . . . 0.0 110.815 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 136' ' ' LEU . 68.7 m -89.52 146.42 24.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.119 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' HB3' ' A' ' 108' ' ' ASN . 12.1 p-10 -55.28 154.97 10.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.735 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 2.3 Cg_endo -45.08 155.38 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.935 2.423 . . . . 0.0 111.906 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.4 m-20 78.57 -34.72 0.17 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.776 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 10.7 m-85 -106.53 126.51 52.36 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -106.89 137.19 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 111.296 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' A' ' 140' ' ' SER . 33.6 tp -71.24 136.84 48.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.724 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.31 67.78 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.577 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.75 -136.06 2.32 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.295 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.57 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 92.9 p -74.13 59.74 0.76 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.873 0.368 . . . . 0.0 110.75 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.631 ' HA ' HD21 ' A' ' 136' ' ' LEU . 97.0 p -47.94 -34.72 9.53 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.179 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 141' ' ' ARG . 21.2 mmt85 -109.55 138.79 45.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.706 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 45.3 t -143.57 127.03 16.84 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.595 HG22 ' CD ' ' A' ' 125' ' ' ARG . 24.0 t -103.91 117.8 50.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.775 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 1.044 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 50.7 t -71.82 140.43 49.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.936 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 43.8 t -169.43 131.97 1.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.819 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 56.35 41.8 28.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.583 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.67 25.06 50.25 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -141.68 132.51 25.83 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.489 0.185 . . . . 0.0 110.662 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.411 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 72.6 m95 -71.26 138.95 49.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.074 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.9 t -57.44 -58.46 8.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.279 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 82.8 p -101.78 136.55 19.52 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.6 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 33.3 Cg_exo -60.44 138.83 83.1 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.736 2.291 . . . . 0.0 111.954 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.648 ' HE2' HD13 ' A' ' 106' ' ' LEU . 84.5 tttt -47.99 131.48 12.01 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.341 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.57 ' HB3' ' H ' ' A' ' 139' ' ' SER . 88.4 Cg_endo -84.37 -148.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.873 2.382 . . . . 0.0 113.029 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.439 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.6 p-80 -153.66 149.69 27.81 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.965 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 91.4 m -97.91 136.16 38.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.01 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -136.93 133.98 36.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 134' ' ' PHE . 8.7 p -65.6 142.55 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.277 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.884 -179.946 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.748 0.309 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.16 44.81 15.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.212 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -174.83 -50.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.106 0.479 . . . . 0.0 110.686 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -81.45 55.52 2.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.874 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 97.1 t -140.12 140.68 34.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.257 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.837 ' HD2' ' HA ' ' A' ' 119' ' ' PRO . 37.9 ptt180 44.01 -147.61 0.07 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.411 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.818 HG23 ' HG3' ' A' ' 97' ' ' ARG . 14.7 pt 48.27 30.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.52 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.503 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 36.1 m 55.97 142.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.3 p -44.08 130.67 6.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.944 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.544 ' HB2' HD12 ' A' ' 104' ' ' LEU . 18.0 ptpt -77.45 10.75 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.513 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.2 m -68.93 -44.76 72.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 110.693 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 103' ' ' TYR . 1.2 m-85 -62.63 -33.1 74.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.253 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.759 HD22 HD22 ' A' ' 113' ' ' LEU . 65.8 mt -49.8 -45.45 49.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.1 t -92.51 138.65 31.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.109 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.803 HD13 ' HE3' ' A' ' 153' ' ' LYS . 28.6 tp -143.75 126.41 16.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.023 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -73.45 124.59 26.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.018 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.8 m120 56.3 49.15 15.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.524 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.74 148.42 11.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.891 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.722 ' HB2' ' HD2' ' A' ' 129' ' ' ARG . 55.1 mtpt -102.53 138.84 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.74 119.22 59.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.541 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.615 ' C ' HG23 ' A' ' 126' ' ' VAL . 2.6 m-85 -83.14 60.43 5.51 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.268 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.759 HD22 HD22 ' A' ' 104' ' ' LEU . 63.2 tp -59.52 145.99 42.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.15 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 27.1 m -158.86 53.31 0.41 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.587 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.467 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . 177.14 105.08 0.19 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.147 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.503 ' N ' HD21 ' A' ' 121' ' ' LEU . . . -163.12 138.16 5.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.784 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.687 ' C ' HD12 ' A' ' 118' ' ' LEU . 8.2 t70 73.2 42.21 0.45 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.98 0.419 . . . . 0.0 111.055 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.756 ' H ' HG22 ' A' ' 98' ' ' ILE . 9.5 mp -137.38 150.1 67.63 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.837 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 92.7 Cg_exo -44.87 89.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.987 2.458 . . . . 0.0 112.818 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.458 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 56.0 13.58 1.18 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.734 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 118' ' ' LEU . 58.7 mt 50.09 60.32 3.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.538 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.817 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 9.1 t70 -76.11 45.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.229 0.538 . . . . 0.0 110.412 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.59 25.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.127 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.946 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -84.13 153.19 23.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.719 0.295 . . . . 0.0 111.002 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.649 ' O ' ' HB ' ' A' ' 114' ' ' THR . 4.4 tmm_? -151.48 140.67 21.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.441 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.615 HG23 ' C ' ' A' ' 112' ' ' PHE . 1.6 p -151.35 148.28 14.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.493 0.663 . . . . 0.0 112.107 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -113.3 118.11 33.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.689 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.527 ' HB2' ' HA ' ' A' ' 140' ' ' SER . 6.3 m-85 -89.0 145.58 25.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.097 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.722 ' HD2' ' HB2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -159.57 138.94 11.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.437 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 66.0 m -89.24 144.21 26.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.681 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.537 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 9.0 p-10 -54.02 160.68 2.15 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.556 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 2.8 Cg_endo -44.98 149.72 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.86 2.374 . . . . 0.0 111.692 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.556 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 36.1 t70 80.64 -31.37 0.12 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.578 -178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -108.86 132.44 54.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.191 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -108.94 148.09 31.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.169 0.509 . . . . 0.0 111.925 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 140' ' ' SER . 1.1 tm? -79.2 128.73 33.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.701 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.668 ' N ' HD13 ' A' ' 136' ' ' LEU . 21.7 t -132.63 60.31 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.66 0.266 . . . . 0.0 111.602 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . 0.402 ' H ' ' CD1' ' A' ' 136' ' ' LEU . . . -176.65 -133.85 1.87 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.206 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.585 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 63.9 m -73.4 59.64 0.6 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.392 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.686 ' HB2' HD12 ' A' ' 136' ' ' LEU . 38.9 t -62.49 -2.48 1.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 139' ' ' SER . 79.2 ttt180 -140.65 133.96 29.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.517 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 61.2 m -147.41 134.02 19.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.52 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 124' ' ' ALA . 94.3 t -128.73 122.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 111.316 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.946 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 55.4 m -85.16 140.87 30.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.497 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.817 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 79.7 p -169.65 31.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.063 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 177.47 34.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.061 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 59.6 14.97 31.02 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.465 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -142.63 133.73 25.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.536 0.208 . . . . 0.0 110.686 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.503 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 74.2 m95 -66.89 137.61 56.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.699 0.285 . . . . 0.0 110.761 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.0 m -57.39 -56.22 24.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.556 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 66.9 p -106.23 136.69 19.31 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.764 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 53.2 Cg_exo -55.89 151.58 40.31 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.865 2.377 . . . . 0.0 112.187 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.803 ' HE3' HD13 ' A' ' 106' ' ' LEU . 4.8 tmtm? -51.21 121.74 16.96 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.575 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.585 ' HB3' ' N ' ' A' ' 139' ' ' SER . 47.7 Cg_endo -69.71 -160.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.676 2.25 . . . . 0.0 112.975 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.74 148.98 27.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.72 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 97.1 m -97.88 139.6 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 0.0 111.408 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -130.98 129.77 42.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.1 p -63.7 143.31 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.189 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 31.6 m-20 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.973 -179.993 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.808 0.337 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.3 39.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.8 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -66.8 140.91 57.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.021 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -56.81 146.28 26.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.435 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.738 HG12 HD12 ' A' ' 98' ' ' ILE . 48.2 t -67.7 136.3 26.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.371 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.635 HH11 ' HB2' ' A' ' 120' ' ' ALA . 25.2 ttm-85 -91.59 104.06 16.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.584 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.738 HD12 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -162.27 42.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.497 178.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.464 ' HB3' ' CZ2' ' A' ' 149' ' ' TRP . 80.4 m 64.27 133.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.243 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.536 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 37.3 t -41.56 127.69 3.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.905 0.383 . . . . 0.0 111.245 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -75.5 -37.42 60.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.503 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.9 t -53.21 -43.38 67.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.664 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.797 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.4 m-85 -59.38 -34.89 72.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.514 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.22 -43.87 74.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.988 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.9 t -92.55 145.98 24.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.975 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.618 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 22.0 tp -144.36 130.1 19.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.342 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.15 132.95 42.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.392 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 57.49 41.01 26.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.614 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.97 152.0 10.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.057 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -104.78 154.02 20.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.58 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.476 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 99.1 t -131.17 118.52 41.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.298 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.2 m-85 -73.08 80.08 1.23 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.513 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.877 ' HA ' HG12 ' A' ' 126' ' ' VAL . 7.7 tt -51.88 140.25 20.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.155 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.622 ' N ' HD23 ' A' ' 113' ' ' LEU . 20.6 m -153.33 53.73 0.74 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.267 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . 128.0 110.24 1.55 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.869 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -171.31 50.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.024 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.768 ' C ' HD22 ' A' ' 118' ' ' LEU . 12.3 p-10 -171.29 39.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 110.821 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.768 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.2 mm? -145.36 153.68 52.39 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.248 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.606 ' HA ' ' HG2' ' A' ' 97' ' ' ARG . 5.0 Cg_endo -48.41 81.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.959 2.439 . . . . 0.0 111.873 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.635 ' HB2' HH11 ' A' ' 97' ' ' ARG . . . 75.2 -40.81 0.44 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.035 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 118' ' ' LEU . 19.2 tp 53.07 58.98 4.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.06 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.35 84.5 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.588 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 121' ' ' LEU . . . 163.9 -35.8 0.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.912 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.545 ' HB2' HD23 ' A' ' 121' ' ' LEU . . . -49.81 150.67 2.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.725 0.298 . . . . 0.0 111.171 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.55 ' O ' ' HB ' ' A' ' 114' ' ' THR . 58.6 ttp180 -157.67 118.02 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.232 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.877 HG12 ' HA ' ' A' ' 113' ' ' LEU . 30.4 m -97.89 133.65 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.2 mt-10 -92.56 115.99 28.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -76.33 150.88 36.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.996 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 129' ' ' ARG . 11.3 tpt180 -158.65 131.78 7.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 83.6 m -90.28 155.71 18.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.155 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -52.6 158.03 2.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.223 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.55 62.97 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.178 2.585 . . . . 0.0 112.737 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -177.12 -29.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.781 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 4.1 m-85 -108.66 139.91 42.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.335 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -102.85 133.37 48.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.179 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' A' ' 140' ' ' SER . 37.1 tp -76.17 131.16 39.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.871 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.3 t -135.92 68.04 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.789 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.54 -131.94 1.76 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.151 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.5 p -71.39 63.29 0.38 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 110.661 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.768 ' HA ' HD21 ' A' ' 136' ' ' LEU . 93.0 p -55.67 -20.28 13.61 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.911 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -140.59 136.58 32.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 111.141 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.596 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 60.5 m -129.58 136.22 49.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.708 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 82.2 t -117.85 132.82 66.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.274 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 75.4 m -60.19 142.74 53.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.299 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.7 t -173.02 120.01 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 58.15 42.68 21.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.902 0.382 . . . . 0.0 110.782 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 64.48 11.57 48.38 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.667 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -142.84 135.66 27.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.271 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 54.4 m95 -67.22 142.23 57.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.669 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.4 m -55.08 -57.48 11.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.8 p -98.91 133.78 22.02 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.807 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.455 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 40.1 Cg_endo -67.08 -160.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.315 2.01 . . . . 0.0 112.255 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.797 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 4.5 mmmp? -84.95 130.23 53.25 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.831 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.551 ' HD2' ' HZ2' ' A' ' 153' ' ' LYS . 90.1 Cg_endo -81.1 -151.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.636 2.224 . . . . 0.0 112.545 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.432 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.4 p-80 -153.73 139.94 18.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 78.6 m -98.71 127.72 44.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.541 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -105.17 141.03 37.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.337 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.31 140.22 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.078 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.3 p30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.971 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.544 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 8.9 mp0 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.712 0.291 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 58.04 45.78 17.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.544 ' HG2' ' HB3' ' A' ' 92' ' ' GLU . 66.4 mm-40 -81.53 47.29 1.04 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.75 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.493 ' CE1' HG13 ' A' ' 96' ' ' VAL . 21.4 t80 -69.71 134.85 49.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.734 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.543 ' O ' HG13 ' A' ' 98' ' ' ILE . 35.5 m 40.37 46.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.193 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.859 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -61.36 129.65 42.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.813 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 97' ' ' ARG . 1.5 pp -166.98 146.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.499 0.666 . . . . 0.0 112.003 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.652 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 3.6 m -83.36 146.09 28.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.144 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.4 m -40.21 121.21 1.32 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 111.029 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -70.73 -24.06 62.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.154 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.5 t -53.05 -42.15 65.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.722 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.521 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.0 m-85 -62.93 -42.96 99.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.545 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.07 -38.24 73.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.414 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 t -92.5 135.69 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 111.312 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.589 ' HB3' ' O ' ' A' ' 109' ' ' GLY . 21.3 tp -145.41 129.76 17.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.715 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -81.4 38.52 0.49 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.49 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.9 p30 177.21 26.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.388 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 106' ' ' LEU . . . 168.84 155.89 10.08 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.535 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.589 ' NZ ' ' HB2' ' A' ' 110' ' ' LYS . 9.8 mtmp? -101.32 146.01 28.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.116 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 103' ' ' TYR . 64.5 t -105.4 120.77 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 111.38 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.432 ' CE1' ' HD2' ' A' ' 129' ' ' ARG . 1.6 m-85 -84.59 68.26 10.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.841 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.965 ' HA ' HG12 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -62.56 147.52 48.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.02 0.438 . . . . 0.0 111.295 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.9 m -133.2 70.84 1.46 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.1 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -165.18 -98.25 0.12 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.94 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.601 ' H ' HD21 ' A' ' 121' ' ' LEU . . . 61.06 127.6 0.01 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.391 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.561 ' O ' HD23 ' A' ' 118' ' ' LEU . 62.1 t0 60.31 49.48 7.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.973 0.416 . . . . 0.0 111.369 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.657 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 68.8 mt -131.83 143.3 48.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.732 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.859 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 50.6 Cg_exo -52.5 85.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.667 2.245 . . . . 0.0 111.581 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.533 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 61.79 17.11 8.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.202 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.657 ' HG ' ' HB2' ' A' ' 118' ' ' LEU . 7.4 mp 40.72 53.84 3.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.844 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.43 45.59 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.228 0.537 . . . . 0.0 110.234 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.2 -25.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.779 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -57.51 147.4 26.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.875 0.369 . . . . 0.0 111.211 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' ' 125' ' ' ARG . 50.5 ttp85 -133.36 137.81 46.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.629 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.965 HG12 ' HA ' ' A' ' 113' ' ' LEU . 32.8 m -120.12 135.76 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.017 0.437 . . . . 0.0 111.643 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -112.89 113.58 25.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.095 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -76.01 141.86 42.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 111.654 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.432 ' HD2' ' CE1' ' A' ' 112' ' ' PHE . 71.1 mtt-85 -148.91 108.88 4.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.117 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 95.6 m -89.54 160.75 16.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.957 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -52.69 156.6 3.12 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.448 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.5 56.07 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.06 2.507 . . . . 0.0 112.588 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -153.07 -37.45 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.648 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -108.8 134.18 51.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.636 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -101.22 132.92 46.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.171 0.51 . . . . 0.0 111.176 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.696 HD21 ' HA ' ' A' ' 140' ' ' SER . 23.0 tp -76.39 129.99 37.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.693 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.5 t -136.3 61.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.697 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.14 -138.01 2.41 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.503 -1.332 . . . . 0.0 113.406 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.66 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.4 m -74.6 57.8 0.75 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 110.975 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.696 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.0 t -49.94 -38.36 36.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.001 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.04 136.18 44.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.434 ' O ' HG22 ' A' ' 126' ' ' VAL . 53.4 m -146.42 125.99 13.31 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.811 0.339 . . . . 0.0 111.304 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 76.5 t -104.95 125.39 59.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.669 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 48.1 t -71.42 151.86 43.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.099 0.476 . . . . 0.0 111.587 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -168.72 122.97 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.892 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.6 tt0 54.48 43.23 30.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.263 0.554 . . . . 0.0 109.634 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.533 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 58.01 29.2 61.95 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.858 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -139.69 131.34 27.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.641 0.258 . . . . 0.0 110.408 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -75.45 139.34 42.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 111.625 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.1 t -57.42 -58.48 8.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.199 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 77.3 p -106.93 134.64 19.77 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.514 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 139' ' ' SER . 35.5 Cg_exo -57.8 142.41 96.16 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.668 2.246 . . . . 0.0 112.041 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.517 ' CE ' HD13 ' A' ' 106' ' ' LEU . 87.2 tttt -51.62 125.86 29.43 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.131 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.66 ' HB3' ' N ' ' A' ' 139' ' ' SER . 61.1 Cg_endo -73.21 -152.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.595 2.197 . . . . 0.0 112.427 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -153.68 133.67 13.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.905 0.383 . . . . 0.0 111.295 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 16.6 m -98.83 132.46 44.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.912 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 33.8 tp60 -124.38 139.66 53.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.051 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.97 134.52 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.3 p30 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.984 -179.858 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.715 0.293 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.34 -42.4 98.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.94 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 57.06 44.27 22.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.016 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.5 t80 64.42 132.4 0.02 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.219 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.0 m -64.76 135.84 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.93 ' HG2' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -65.41 -155.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.18 -179.675 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.93 HG23 ' HG2' ' A' ' 97' ' ' ARG . 15.3 pt 51.81 134.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.856 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.557 ' HB2' ' NE1' ' A' ' 149' ' ' TRP . 2.4 p -62.01 136.84 58.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.563 178.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -40.02 127.54 2.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.253 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.496 ' HE2' HD12 ' A' ' 98' ' ' ILE . 68.5 mttm -77.43 14.94 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.434 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -68.9 -39.01 79.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.027 0.442 . . . . 0.0 110.432 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.769 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.6 m-85 -56.3 -34.08 66.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.523 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.559 HD11 HD13 ' A' ' 113' ' ' LEU . 86.3 mt -74.71 38.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.685 -179.464 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 74.2 m -147.46 114.48 6.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 111.0 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.5 mt -145.5 128.21 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -82.58 43.13 0.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -177.02 -43.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.017 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 130' ' ' CYS . . . -79.11 -162.37 23.19 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.732 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 111' ' ' VAL . 22.7 tptm -142.12 -43.81 0.34 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.723 0.297 . . . . 0.0 110.805 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 11.9 p 49.1 120.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.015 179.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.3 m-85 -84.38 117.92 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.579 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.559 HD13 HD11 ' A' ' 104' ' ' LEU . 55.1 tp -83.52 145.51 28.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 111.447 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.0 m -158.51 53.06 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.803 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . 165.33 105.48 0.19 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.825 -179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.64 140.02 6.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.634 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.494 ' O ' HD23 ' A' ' 118' ' ' LEU . 57.2 m-20 62.52 43.98 7.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.86 0.362 . . . . 0.0 111.216 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 84.5 mt -134.82 144.68 51.54 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.18 96.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.965 2.443 . . . . 0.0 113.796 -179.203 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.462 ' HA ' ' H ' ' A' ' 98' ' ' ILE . . . 68.62 -29.83 0.17 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.715 HD22 ' HB2' ' A' ' 124' ' ' ALA . 32.0 mt 65.11 51.27 1.7 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.829 0.347 . . . . 0.0 111.019 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -77.17 51.42 0.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.548 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.64 -21.03 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.205 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.962 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.94 148.45 1.67 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.735 0.302 . . . . 0.0 111.418 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.533 ' O ' ' HB ' ' A' ' 114' ' ' THR . 70.1 mtt-85 -141.73 141.07 33.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 34.5 m -133.59 137.02 53.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 111.14 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -116.17 99.25 7.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 46.3 m-85 -68.06 139.39 56.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.42 . . . . 0.0 111.106 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -142.71 133.17 24.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.243 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.529 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 60.7 m -89.19 148.7 23.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 133' ' ' ASP . 45.7 p-10 -52.67 153.93 5.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.31 72.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.235 2.623 . . . . 0.0 113.204 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 131' ' ' ASP . 38.9 t70 178.66 -39.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.048 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 5.6 m-85 -107.0 139.18 41.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.904 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -102.83 134.26 46.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 111.151 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 140' ' ' SER . 19.8 tp -76.54 131.92 39.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.923 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.58 66.23 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.861 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -171.98 -136.91 2.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.149 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.632 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 45.4 p -76.55 53.98 0.91 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.989 0.423 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.634 ' HA ' HD21 ' A' ' 136' ' ' LEU . 47.6 t -49.07 -43.91 41.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.246 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -99.48 133.24 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.657 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.5 t -141.23 125.08 17.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.684 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 90.5 t -100.19 123.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.385 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.962 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 47.2 t -76.7 136.12 39.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.621 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.2 t -172.68 134.01 0.61 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.774 0.321 . . . . 0.0 111.183 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.427 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 0.5 OUTLIER 57.4 41.44 26.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.85 18.55 25.89 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.998 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -141.09 131.09 24.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 110.619 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.557 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 33.6 m95 -73.03 138.29 45.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.173 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 54.0 m -57.45 -52.99 63.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.004 179.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 78.8 p -114.4 136.95 22.38 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.481 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 30.0 Cg_exo -62.03 -159.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.512 2.141 . . . . 0.0 112.428 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.769 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 60.8 mtpt -96.66 125.77 45.68 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.965 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.632 ' HB2' HD11 ' A' ' 136' ' ' LEU . 68.1 Cg_endo -74.36 -148.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.282 1.988 . . . . 0.0 111.939 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -153.74 143.11 21.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.902 0.382 . . . . 0.0 111.283 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 79.3 m -96.72 132.99 41.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.168 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -131.31 140.26 49.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.398 . . . . 0.0 111.481 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.7 p -64.34 137.72 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.01 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.881 179.975 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.739 0.304 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 55.97 49.61 15.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.188 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -168.15 -40.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.086 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.45 ' HB3' HH21 ' A' ' 97' ' ' ARG . 2.8 m-85 57.93 54.0 6.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.783 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.5 m -49.74 144.5 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.702 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.63 HH11 ' HA ' ' A' ' 119' ' ' PRO . 13.2 ptp180 -165.24 129.18 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.765 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.599 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -152.66 137.18 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.236 0.541 . . . . 0.0 111.463 179.935 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.671 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 3.2 m -63.58 173.4 1.68 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.55 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.404 ' HB2' ' CD1' ' A' ' 149' ' ' TRP . 52.0 m -42.4 129.22 3.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 111.195 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.759 ' HD2' HD12 ' A' ' 104' ' ' LEU . 24.0 tptm -76.89 -31.43 56.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.432 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.8 p -53.08 -43.86 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.945 -179.063 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.845 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.3 m-85 -56.9 -41.45 78.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.694 0.283 . . . . 0.0 111.065 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.759 HD12 ' HD2' ' A' ' 101' ' ' LYS . 90.9 mt -58.65 139.95 55.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.3 m 65.35 137.72 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.168 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.542 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 46.2 tp -145.43 133.68 21.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.417 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.76 140.51 56.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.22 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 65.19 30.82 11.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.394 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 175.7 -168.26 40.52 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.042 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.694 ' HD3' ' N ' ' A' ' 111' ' ' VAL . 1.5 tmtp? -141.95 143.29 33.17 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.694 ' N ' ' HD3' ' A' ' 110' ' ' LYS . 71.2 t -106.39 120.73 57.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.929 0.395 . . . . 0.0 111.458 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.558 ' HE1' ' HB3' ' A' ' 129' ' ' ARG . 3.3 m-85 -70.22 125.99 28.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.045 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.648 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -105.78 141.64 36.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.939 0.4 . . . . 0.0 110.94 -179.695 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.648 ' N ' HD13 ' A' ' 113' ' ' LEU . 35.6 m -158.89 65.61 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.619 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.527 ' O ' ' HG ' ' A' ' 118' ' ' LEU . . . -156.83 -43.53 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.649 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.464 ' O ' HD11 ' A' ' 121' ' ' LEU . . . 71.76 -132.46 19.91 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.886 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -115.7 34.78 4.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.987 0.422 . . . . 0.0 111.225 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 120' ' ' ALA . 96.5 mt -64.19 162.91 27.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.911 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.63 ' HA ' HH11 ' A' ' 97' ' ' ARG . 81.9 Cg_exo -43.57 80.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.772 2.315 . . . . 0.0 112.01 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.774 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 59.19 22.96 11.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.405 -178.606 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 6.8 mp 44.41 62.7 1.92 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.228 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.705 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 38.7 t70 -74.97 42.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.096 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.89 28.72 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.394 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 121' ' ' LEU . . . -77.58 122.17 24.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.706 0.288 . . . . 0.0 111.1 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -90.88 134.79 34.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.655 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 113' ' ' LEU . 30.1 m -145.78 140.59 21.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.669 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -121.25 120.43 35.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.415 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.445 ' O ' HD22 ' A' ' 136' ' ' LEU . 2.0 m-85 -84.38 47.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 110.992 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.558 ' HB3' ' HE1' ' A' ' 112' ' ' PHE . 21.2 tpp180 -64.33 126.77 28.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.509 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.544 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 65.3 m -98.47 158.95 15.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.324 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 133' ' ' ASP . 55.6 m-20 -52.69 148.28 13.43 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.831 -179.516 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.18 79.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.204 2.602 . . . . 0.0 112.717 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 131' ' ' ASP . 9.1 t0 -179.14 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.599 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.406 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 2.5 m-85 -108.78 130.85 55.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.199 179.41 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -102.75 130.64 49.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.904 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.766 HD11 ' HG2' ' A' ' 154' ' ' PRO . 22.8 tp -75.48 133.82 40.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.412 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.86 70.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.688 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.46 -132.65 1.96 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.819 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.507 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 70.8 m -76.12 55.13 0.92 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.708 0.29 . . . . 0.0 111.028 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.549 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 90.0 p -49.25 -43.11 42.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.671 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -100.46 133.93 44.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.229 178.844 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 126' ' ' VAL . 47.4 t -144.02 136.22 26.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.389 . . . . 0.0 110.953 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 57.5 t -122.46 117.05 50.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.343 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 149' ' ' TRP . 46.1 t -65.8 155.31 36.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.109 0.481 . . . . 0.0 111.502 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.705 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 46.5 t -166.44 122.01 1.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.838 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 57.68 44.13 21.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.081 0.467 . . . . 0.0 110.62 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.774 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 64.72 20.65 66.45 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.636 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -141.4 127.03 18.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.64 0.257 . . . . 0.0 110.749 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.696 ' HA ' ' HA ' ' A' ' 144' ' ' CYS . 58.0 m95 -71.94 139.36 48.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.934 0.397 . . . . 0.0 111.372 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.4 t -57.53 -62.46 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.378 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 71.1 p -95.38 137.08 22.12 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.755 -179.392 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 45.1 Cg_endo -67.69 140.38 51.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.882 2.388 . . . . 0.0 112.418 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.845 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 64.4 tttm -53.87 121.2 27.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.264 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.766 ' HG2' HD11 ' A' ' 136' ' ' LEU . 86.5 Cg_endo -81.32 -147.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.832 2.355 . . . . 0.0 112.932 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.423 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 19.5 p-80 -153.61 144.72 22.89 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' CYS . . . . . 0.473 ' SG ' HD13 ' A' ' 136' ' ' LEU . 64.8 m -98.47 142.64 29.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -133.7 139.24 46.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.829 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.59 138.41 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.507 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.889 179.935 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.841 0.353 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -170.72 131.3 0.86 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.8 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.56 ' HG3' ' H ' ' A' ' 95' ' ' PHE . 4.5 tp10 -173.42 -129.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.526 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.56 ' H ' ' HG3' ' A' ' 94' ' ' GLU . 19.3 t80 -177.76 132.52 0.16 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.66 0.267 . . . . 0.0 110.689 -179.606 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.5 141.14 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.532 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.826 ' HD2' ' HA ' ' A' ' 119' ' ' PRO . 39.0 ptt180 -163.64 49.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.543 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.8 HG21 ' HA ' ' A' ' 117' ' ' ASP . 4.9 pt -158.82 41.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.861 0.362 . . . . 0.0 110.839 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.599 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 74.6 m 62.31 134.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.971 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.3 m -40.32 119.97 1.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.716 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -74.83 -9.72 58.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.869 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.6 t -58.75 -19.93 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.837 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.472 ' HD2' ' HZ ' ' A' ' 128' ' ' PHE . 4.7 m-85 -64.62 -46.28 83.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.166 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.794 HD12 HG23 ' A' ' 105' ' ' THR . 1.7 pp -76.98 33.3 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.893 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.794 HG23 HD12 ' A' ' 104' ' ' LEU . 61.6 p -147.54 58.54 1.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.36 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.4 tp -94.49 135.75 35.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.5 -178.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -66.59 138.48 57.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.352 179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.6 m120 56.56 40.13 29.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.304 -179.619 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.28 168.46 41.53 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.214 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 28.9 mtpp -141.68 139.52 32.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.733 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.681 HG12 ' HB ' ' A' ' 126' ' ' VAL . 35.7 t -118.76 126.13 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -80.25 121.4 25.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.141 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.774 ' HA ' HG12 ' A' ' 126' ' ' VAL . 3.1 tm? -85.04 143.5 28.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.917 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.657 ' H ' HD22 ' A' ' 113' ' ' LEU . 43.4 m -152.96 65.96 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.574 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.409 ' HA3' HD21 ' A' ' 121' ' ' LEU . . . -158.1 -107.4 0.24 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.886 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.15 -124.29 1.3 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.848 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.8 ' HA ' HG21 ' A' ' 98' ' ' ILE . 37.6 t70 -148.68 47.84 1.02 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.237 0.541 . . . . 0.0 110.644 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.585 ' HB2' HD13 ' A' ' 121' ' ' LEU . 2.9 mm? -94.19 150.89 39.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.505 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.826 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 88.9 Cg_exo -43.47 105.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.37 2.047 . . . . 0.0 111.985 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 72.45 -37.95 0.4 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.357 -179.224 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.725 ' HB2' HG22 ' A' ' 98' ' ' ILE . 14.1 tp 58.06 56.24 4.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 0.0 111.16 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -70.14 69.29 0.34 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 179.59 -30.48 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.237 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.54 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . . . -49.05 153.04 0.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.972 0.415 . . . . 0.0 111.398 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.505 ' HD2' ' NH2' ' A' ' 141' ' ' ARG . 53.9 ttp180 -153.56 135.86 14.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.714 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.774 HG12 ' HA ' ' A' ' 113' ' ' LEU . 34.4 m -127.52 137.16 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.108 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -100.94 121.15 41.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.37 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.472 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.3 m-85 -86.03 150.77 24.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 15.8 ptm180 -163.96 134.86 4.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.759 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 68.0 m -89.2 155.11 19.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.496 -179.304 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -52.71 163.27 0.82 Allowed Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.383 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.73 52.07 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.205 2.603 . . . . 0.0 112.708 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -155.59 -39.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.5 m-85 -108.9 141.02 41.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.651 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -102.1 134.11 45.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.123 0.487 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.551 HD21 ' CG ' ' A' ' 154' ' ' PRO . 3.4 tm? -72.97 130.86 41.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.622 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.534 ' N ' HD13 ' A' ' 136' ' ' LEU . 26.6 t -134.57 66.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.573 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.03 -129.68 1.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 119.71 -1.233 . . . . 0.0 113.212 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.691 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 31.3 t -68.75 65.41 0.12 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.979 0.419 . . . . 0.0 111.384 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.476 ' HB3' HD12 ' A' ' 136' ' ' LEU . 94.5 p -63.12 -18.35 63.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.874 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.505 ' NH2' ' HD2' ' A' ' 125' ' ' ARG . 50.2 mtp85 -140.66 137.31 33.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.768 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 90.0 p -135.21 128.17 31.46 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.758 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.91 126.63 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.96 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 41.9 t -73.36 139.21 45.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.016 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -170.57 131.41 0.9 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.552 179.799 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 58.76 38.58 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.57 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 60.9 19.14 55.69 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.998 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -144.7 133.11 21.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.619 0.247 . . . . 0.0 111.239 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' TRP . . . . . 0.599 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 94.1 m95 -70.34 135.58 48.97 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.83 0.348 . . . . 0.0 110.995 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.0 t -57.42 -56.26 24.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.372 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.499 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 55.4 p -97.08 133.14 24.49 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 8.2 Cg_exo -71.97 149.11 52.55 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.22 2.613 . . . . 0.0 111.941 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -47.42 125.57 9.64 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-O 120.64 0.257 . . . . 0.0 111.216 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.691 ' HB3' ' H ' ' A' ' 139' ' ' SER . 58.0 Cg_endo -71.49 -146.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.63 2.22 . . . . 0.0 112.401 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' HIS . . . . . 0.426 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.7 145.41 23.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.451 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 70.8 m -96.66 133.64 40.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.82 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -124.76 136.29 53.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 p -64.67 137.15 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.035 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.958 179.937 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.784 0.326 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.629 ' HB1' ' CD1' ' A' ' 95' ' ' PHE . . . 63.66 127.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.396 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -83.45 40.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.399 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.629 ' CD1' ' HB1' ' A' ' 93' ' ' ALA . 3.0 m-85 -82.58 45.36 0.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.21 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t 65.19 139.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.473 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.881 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -172.44 121.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.896 -179.928 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 97' ' ' ARG . 1.5 pp -173.45 39.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.953 179.315 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.1 m 61.18 160.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.197 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.9 t -39.82 128.67 2.08 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.662 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.684 ' HA ' HD23 ' A' ' 104' ' ' LEU . 17.5 tppt? -76.6 -27.94 55.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.362 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.2 m -53.14 -38.33 62.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.317 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.472 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.8 m-85 -60.85 -39.23 88.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.278 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.684 HD23 ' HA ' ' A' ' 101' ' ' LYS . 2.1 mm? -53.37 -42.45 66.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.222 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.7 m -92.54 141.26 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.533 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 107' ' ' GLU . 5.3 tt -142.57 127.05 17.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.611 -179.239 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.528 ' N ' HD23 ' A' ' 106' ' ' LEU . 17.3 tp10 -67.14 128.08 35.01 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.1 m120 60.36 36.51 20.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.753 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -177.02 -177.96 46.37 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.06 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -142.8 144.84 32.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.624 0.25 . . . . 0.0 110.779 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 103' ' ' TYR . 65.3 t -105.21 124.98 60.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.862 0.363 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -75.53 127.52 33.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.056 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -90.97 143.3 26.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.682 ' N ' HD13 ' A' ' 113' ' ' LEU . 33.7 m -156.19 62.17 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.235 0.54 . . . . 0.0 110.573 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -159.62 -102.26 0.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.017 -179.683 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.768 ' H ' HD21 ' A' ' 121' ' ' LEU . . . 174.59 -128.4 1.44 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.008 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.422 ' HA ' ' CG2' ' A' ' 98' ' ' ILE . 52.7 p-10 -159.27 48.19 0.31 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.931 0.396 . . . . 0.0 111.004 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 118' ' ' LEU . 6.1 mp -98.99 163.57 18.49 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.221 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.881 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 81.2 Cg_exo -39.63 106.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.433 2.088 . . . . 0.0 112.193 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.471 ' H ' ' CG ' ' A' ' 97' ' ' ARG . . . 72.54 -32.29 0.24 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.716 -179.453 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.768 HD21 ' H ' ' A' ' 116' ' ' GLY . 27.5 tp 56.12 47.59 19.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.114 0.483 . . . . 0.0 110.228 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.81 136.18 46.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.968 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.456 ' HA2' HG22 ' A' ' 143' ' ' VAL . . . 76.74 31.96 51.94 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.168 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.815 ' H ' ' HB2' ' A' ' 144' ' ' CYS . . . -80.33 119.87 23.63 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.533 ' HB2' ' HB ' ' A' ' 114' ' ' THR . 67.0 mtt-85 -84.58 134.59 34.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.7 134.14 9.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.422 179.036 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -114.45 112.96 23.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.964 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.467 ' CE2' ' HG3' ' A' ' 153' ' ' LYS . 1.9 m-85 -80.29 136.5 36.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.635 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -165.04 131.79 2.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.343 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' CYS . . . . . 0.504 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 40.9 m -89.3 157.17 18.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.33 0.586 . . . . 0.0 112.497 -179.069 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.449 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 58.2 m-20 -52.67 159.24 1.79 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.997 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 21.1 Cg_endo -59.9 75.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.17 2.58 . . . . 0.0 112.43 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 131' ' ' ASP . 64.5 t0 -174.63 -40.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.048 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -116.08 132.33 56.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.182 178.61 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -102.74 127.45 49.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.138 0.494 . . . . 0.0 111.288 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 140' ' ' SER . 3.4 tm? -69.98 132.88 46.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.262 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.509 ' N ' HD13 ' A' ' 136' ' ' LEU . 36.6 t -134.82 76.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.816 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.44 -133.96 2.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.247 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.729 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 40.9 t -74.61 56.42 0.69 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.675 ' HB3' HD12 ' A' ' 136' ' ' LEU . 95.7 p -53.86 -30.33 45.14 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.825 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.578 ' HD2' ' OG ' ' A' ' 140' ' ' SER . 7.9 mpt_? -99.41 137.06 38.45 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.496 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.5 m -150.63 137.73 19.31 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.256 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 13.8 p -134.05 131.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 111.036 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.815 ' HB2' ' H ' ' A' ' 124' ' ' ALA . 4.1 m -58.14 154.93 12.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.332 0.587 . . . . 0.0 112.226 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.4 p -173.28 113.64 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.759 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 146' ' ' GLN . 62.6 tt0 60.92 48.46 6.68 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.096 0.474 . . . . 0.0 110.544 -179.411 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 58.22 18.08 33.76 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.355 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -141.63 138.22 32.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 110.639 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -68.1 135.29 51.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.219 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -57.48 -60.18 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.176 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.486 ' HB ' ' OG ' ' A' ' 139' ' ' SER . 33.3 p -99.79 132.69 22.55 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.799 0.333 . . . . 0.0 111.889 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.424 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 37.2 Cg_exo -60.6 150.75 80.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.977 2.452 . . . . 0.0 112.442 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 128' ' ' PHE . 57.5 tttp -55.91 129.81 72.41 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.729 ' HB3' ' N ' ' A' ' 139' ' ' SER . 59.4 Cg_endo -72.37 -152.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.729 2.286 . . . . 0.0 112.996 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -153.72 139.61 18.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 86.4 m -98.72 143.31 29.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.494 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -128.2 136.44 51.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.576 179.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.67 135.65 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.305 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.917 179.814 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.601 HD12 HD22 ' A' ' 121' ' ' LEU . 40.6 mm . . . . . 0 N--CA 1.449 -0.479 0 CA-C-O 121.209 0.528 . . . . 0.0 111.659 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.562 ' HB2' ' NE1' ' A' ' 149' ' ' TRP . 1.3 p -57.3 149.32 20.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.138 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.9 t -38.25 113.53 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.768 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.529 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -67.23 -14.26 62.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.767 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.1 t -53.5 -38.91 64.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.209 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.58 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.5 m-85 -53.34 -37.89 62.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.178 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.4 mt -50.92 -45.45 60.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.332 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.0 t -92.52 131.28 37.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 111.202 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.647 HD13 ' HE2' ' A' ' 153' ' ' LYS . 38.0 tp -145.34 132.28 20.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.457 ' HG3' ' ND2' ' A' ' 108' ' ' ASN . 5.6 tp10 -63.02 127.02 29.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.18 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.457 ' ND2' ' HG3' ' A' ' 107' ' ' GLU . 75.3 m-80 55.14 45.73 25.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.885 0.374 . . . . 0.0 110.415 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.0 157.44 26.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -130.62 139.7 50.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.746 0.308 . . . . 0.0 110.831 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 103' ' ' TYR . 96.1 t -106.51 132.95 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.576 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 3.7 m-85 -94.78 73.44 3.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 1.01 ' HA ' HG12 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -60.95 157.03 16.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 111.228 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 40.9 m -158.53 69.47 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.778 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.674 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -162.98 -44.92 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.642 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.44 -121.84 6.51 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.297 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.471 ' HA ' ' CD1' ' A' ' 98' ' ' ILE . 2.1 p30 -144.76 52.0 1.24 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.051 0.453 . . . . 0.0 111.474 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 118' ' ' LEU . 7.0 mp -88.08 158.13 50.21 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.909 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.46 ' C ' ' H ' ' A' ' 121' ' ' LEU . 85.1 Cg_exo -44.05 111.02 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.621 2.214 . . . . 0.0 112.601 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 70.77 -33.55 0.27 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.828 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.601 HD22 HD12 ' A' ' 98' ' ' ILE . 17.0 tp 64.28 43.9 4.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.05 0.452 . . . . 0.0 110.624 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.918 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 64.5 t0 -79.4 59.06 2.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.013 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.29 -29.48 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.375 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -49.68 147.53 3.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 111.923 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.561 ' NH2' ' HD3' ' A' ' 141' ' ' ARG . 51.6 mtp85 -138.72 126.78 22.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 1.01 HG12 ' HA ' ' A' ' 113' ' ' LEU . 33.7 m -116.72 130.3 71.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.029 0.442 . . . . 0.0 111.674 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.9 mt-10 -102.5 109.79 21.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.586 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' ' 140' ' ' SER . 21.2 m-85 -75.52 147.12 39.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.514 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 5.6 tpm_? -162.28 125.94 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.472 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.421 ' H ' ' HE ' ' A' ' 129' ' ' ARG . 56.6 m -89.29 149.14 23.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.074 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.57 163.31 0.79 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.634 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.63 57.3 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.43 2.753 . . . . 0.0 113.131 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -158.06 -43.3 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.3 m-85 -108.91 138.76 44.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.665 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.411 ' O ' HG23 ' A' ' 137' ' ' VAL . 18.7 p-80 -101.6 127.51 48.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.091 0.472 . . . . 0.0 110.993 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 137' ' ' VAL . 4.9 tt -65.04 131.23 46.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.184 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.629 ' N ' HD23 ' A' ' 136' ' ' LEU . 21.8 t -133.39 65.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.25 -135.63 2.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.396 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.51 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 80.6 p -73.37 62.08 0.69 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.532 ' HB3' HD22 ' A' ' 136' ' ' LEU . 98.5 p -57.61 -7.02 0.57 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.288 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.561 ' HD3' ' NH2' ' A' ' 125' ' ' ARG . 39.7 ttm180 -140.65 134.37 30.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.672 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 126' ' ' VAL . 47.6 t -146.39 119.5 8.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.569 HG13 ' OG ' ' A' ' 150' ' ' SER . 3.2 p -95.98 121.56 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 0.0 111.223 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.769 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 49.7 t -69.22 138.3 53.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.601 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.918 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 80.6 p -164.51 133.11 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.165 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 57.38 40.76 27.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.849 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 63.9 18.25 61.84 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.126 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -145.27 139.79 27.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 117.099 0.449 . . . . 0.0 111.45 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.562 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 32.7 m95 -72.12 139.0 48.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.195 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.569 ' OG ' HG13 ' A' ' 143' ' ' VAL . 75.4 m -57.49 -57.74 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.005 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 t -109.42 143.11 27.1 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-O 120.862 0.363 . . . . 0.0 111.87 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.0 148.14 93.79 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.125 2.55 . . . . 0.0 112.693 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.647 ' HE2' HD13 ' A' ' 106' ' ' LEU . 87.5 tttt -53.34 135.64 51.36 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.527 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.51 ' HB3' ' H ' ' A' ' 139' ' ' SER . 97.5 Cg_endo -85.4 -151.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.906 2.404 . . . . 0.0 112.872 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -153.7 151.09 29.25 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.4 m -97.28 129.85 44.54 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.766 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -108.78 135.4 50.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.027 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.84 140.2 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.982 -179.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.769 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 1.9 pp . . . . . 0 N--CA 1.451 -0.412 0 CA-C-O 121.182 0.515 . . . . 0.0 111.983 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 38.0 m -64.58 147.22 53.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.791 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 102' ' ' SER . 80.4 p -40.12 118.0 0.84 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 110.699 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.4 ' HA ' HD13 ' A' ' 104' ' ' LEU . 68.7 mttm -70.94 9.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.514 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 100' ' ' SER . 59.2 m -68.96 -39.2 79.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.189 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.916 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.8 m-85 -52.18 -37.84 55.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.984 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.552 ' H ' HD12 ' A' ' 104' ' ' LEU . 6.3 mp -50.22 142.48 9.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 0.0 111.03 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.9 p 61.84 132.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.673 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.1 tp -145.4 136.14 24.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.613 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.417 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 88.7 tt0 -57.12 132.3 52.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.389 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.497 ' HB3' ' OD1' ' A' ' 131' ' ' ASP . 76.4 m-20 57.52 42.81 23.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.617 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.76 172.82 45.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.517 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -141.66 146.37 36.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 0.0 110.476 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 60.6 t -118.12 127.44 75.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.424 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.7 m-85 -88.22 119.06 28.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.849 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.64 ' HA ' HG12 ' A' ' 126' ' ' VAL . 61.4 tp -83.53 146.73 28.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.266 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 33.2 m -162.16 66.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.65 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . -160.82 -42.35 0.02 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.848 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.02 -119.5 5.4 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.655 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -137.78 47.88 2.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.162 0.506 . . . . 0.0 111.042 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 71.7 mt -75.72 158.46 82.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.125 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -47.03 120.46 4.22 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.159 1.906 . . . . 0.0 111.625 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 51.98 31.32 8.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.2 0.524 . . . . 0.0 110.155 -178.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.769 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 13.9 tp 42.44 37.42 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.712 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -70.63 141.06 51.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.907 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.56 -24.62 9.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.78 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.715 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -57.25 152.89 13.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.761 0.315 . . . . 0.0 111.092 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.788 ' HD2' HH21 ' A' ' 141' ' ' ARG . 23.0 ptt-85 -165.45 133.19 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.679 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 113' ' ' LEU . 33.9 m -120.54 143.5 32.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.039 0.447 . . . . 0.0 111.798 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.462 ' HB2' ' NH1' ' A' ' 141' ' ' ARG . 40.7 tp10 -108.48 121.86 45.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.057 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.418 ' CD2' ' HD2' ' A' ' 154' ' ' PRO . 2.8 m-85 -83.7 154.48 23.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.624 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 5.1 tpm_? -157.57 127.28 6.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.23 143.84 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.905 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.497 ' OD1' ' HB3' ' A' ' 108' ' ' ASN . 12.8 p-10 -54.07 148.96 19.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.48 77.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.015 2.477 . . . . 0.0 112.862 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 131' ' ' ASP . 64.4 t0 179.02 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.72 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.497 ' CE2' HG22 ' A' ' 158' ' ' VAL . 3.6 m-85 -108.84 142.84 38.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.876 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -101.88 130.8 48.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.176 0.512 . . . . 0.0 110.961 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.623 HD21 ' HA ' ' A' ' 140' ' ' SER . 32.6 tp -70.25 126.82 30.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.964 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 41.7 t -137.89 71.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.937 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.49 -135.67 2.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.846 -1.169 . . . . 0.0 113.102 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.729 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.0 m -75.94 52.79 0.72 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.92 0.391 . . . . 0.0 110.601 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.623 ' HA ' HD21 ' A' ' 136' ' ' LEU . 47.2 t -46.25 -39.85 10.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.071 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.788 HH21 ' HD2' ' A' ' 125' ' ' ARG . 23.9 tpt180 -104.11 137.46 42.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.589 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.8 t -143.05 101.69 3.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.346 . . . . 0.0 110.597 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 150' ' ' SER . 7.7 p -96.8 129.89 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.065 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.715 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 1.8 m -74.62 146.99 42.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.395 0.617 . . . . 0.0 112.111 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.469 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 48.0 t -163.94 124.67 2.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.358 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 62.9 38.35 11.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.114 0.483 . . . . 0.0 110.419 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 63.12 25.73 68.46 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.562 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 145' ' ' SER . 23.6 pt20 -143.72 138.24 28.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.059 0.43 . . . . 0.0 111.262 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.526 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 59.4 m95 -65.04 138.02 58.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.466 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 47.5 t -57.43 -48.54 78.86 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.057 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.518 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 82.6 p -135.14 136.86 25.56 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.816 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 31.4 Cg_exo -61.97 156.35 49.87 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.04 2.494 . . . . 0.0 112.438 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.916 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 28.5 mtpp -52.42 129.17 42.81 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.428 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.729 ' HB3' ' N ' ' A' ' 139' ' ' SER . 60.7 Cg_endo -72.89 -143.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.728 2.285 . . . . 0.0 112.246 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.451 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 23.0 p-80 -153.71 145.25 23.23 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.986 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 81.7 m -96.23 125.87 41.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.509 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -109.06 142.99 38.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.385 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.497 HG22 ' CE2' ' A' ' 134' ' ' PHE . 61.9 t -61.83 139.96 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.044 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 22.1 p30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.026 179.808 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.637 HD12 HD22 ' A' ' 121' ' ' LEU . 46.7 mm . . . . . 0 CA--C 1.521 -0.137 0 CA-C-O 121.377 0.608 . . . . 0.0 112.342 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.51 ' HA ' ' C ' ' A' ' 147' ' ' GLY . 1.5 p -59.99 161.21 6.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.196 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -39.78 131.8 1.79 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.109 0.48 . . . . 0.0 111.453 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 21.8 pttp -96.48 78.56 3.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.674 0.749 . . . . 0.0 110.009 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.9 t -164.13 -34.9 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.076 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.7 m-85 -56.8 -26.33 57.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.192 0.52 . . . . 0.0 109.63 178.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.483 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 53.5 mt -50.23 -44.11 53.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.671 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.2 p -92.66 139.66 30.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.647 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.464 HD13 ' CE ' ' A' ' 153' ' ' LYS . 46.6 tp -143.07 133.72 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.389 . . . . 0.0 111.163 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.481 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 39.6 tt0 -67.8 129.98 41.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.333 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.481 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 76.1 m-80 56.6 37.09 28.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.964 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 130' ' ' CYS . . . -176.44 149.5 9.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.998 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -108.25 139.26 43.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.845 0.355 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.485 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 94.9 t -106.54 121.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.815 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -82.74 124.99 30.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.239 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.699 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -85.84 145.04 27.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.475 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.699 ' N ' HD13 ' A' ' 113' ' ' LEU . 28.7 m -155.75 63.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 110.854 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -161.04 -104.44 0.19 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.178 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 166.99 -129.64 1.96 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.739 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.453 ' HA ' HD11 ' A' ' 98' ' ' ILE . 58.7 m-20 -150.27 46.79 0.9 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 111.044 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 118' ' ' LEU . 7.1 mp -97.9 154.27 37.87 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.823 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.445 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 76.1 Cg_exo -46.78 122.13 5.68 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.466 2.111 . . . . 0.0 112.112 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 72.77 -40.74 0.48 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.528 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.637 HD22 HD12 ' A' ' 98' ' ' ILE . 14.8 tp 59.51 51.18 6.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.956 0.408 . . . . 0.0 110.943 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -73.26 66.25 0.89 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.247 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.31 -36.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.623 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.809 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -51.39 153.9 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.954 0.407 . . . . 0.0 111.483 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.501 ' O ' ' HB ' ' A' ' 114' ' ' THR . 50.8 ttp85 -158.94 126.07 4.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.176 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.485 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 24.6 m -108.17 136.67 42.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.022 0.439 . . . . 0.0 111.648 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -100.29 115.98 31.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.686 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -80.09 143.04 34.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.433 HH11 ' HG3' ' A' ' 129' ' ' ARG . 37.7 ttt85 -167.22 118.82 0.9 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.456 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 51.3 m -89.18 154.13 20.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.981 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -52.77 158.34 2.25 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.305 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.507 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 82.0 Cg_exo -47.49 162.81 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.829 2.353 . . . . 0.0 112.245 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.5 m-20 77.93 -35.07 0.19 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.791 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -106.32 127.14 53.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -108.34 131.1 55.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.034 0.445 . . . . 0.0 111.375 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.579 HD23 ' SG ' ' A' ' 156' ' ' CYS . 3.2 tm? -74.79 132.86 41.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.292 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.0 t -133.07 71.53 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.785 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.92 -132.5 1.82 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.057 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.604 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 61.2 p -72.83 61.56 0.55 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 110.648 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.559 ' HB3' HD12 ' A' ' 136' ' ' LEU . 97.0 p -55.6 -15.59 3.09 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.775 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -140.64 139.89 34.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.716 0.293 . . . . 0.0 111.266 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 96.6 p -139.54 117.01 11.35 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.255 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.413 ' HB ' ' OG ' ' A' ' 150' ' ' SER . 73.7 t -84.18 125.01 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 111.52 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.809 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 42.1 t -79.3 131.03 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.306 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.4 t -173.25 137.53 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 0.0 111.156 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 56.35 37.93 29.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.51 ' C ' ' HA ' ' A' ' 99' ' ' CYS . . . 56.78 24.66 49.62 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.644 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -143.07 134.55 26.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.657 0.265 . . . . 0.0 111.087 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -77.76 140.03 39.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 143' ' ' VAL . 63.1 m -57.4 -47.61 81.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.661 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 67.4 p -127.46 138.9 33.79 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 34.8 Cg_endo -64.86 -162.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.471 2.114 . . . . 0.0 112.566 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.464 ' CE ' HD13 ' A' ' 106' ' ' LEU . 14.4 mmmm -83.86 131.65 51.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.974 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.604 ' HB3' ' H ' ' A' ' 139' ' ' SER . 89.5 Cg_endo -81.75 -149.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.675 2.25 . . . . 0.0 112.483 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.455 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 27.5 p-80 -153.71 134.1 13.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.945 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.579 ' SG ' HD23 ' A' ' 136' ' ' LEU . 92.4 m -104.93 142.43 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.235 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -135.21 137.59 42.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.881 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.15 139.08 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.913 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.845 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 21.3 pt . . . . . 0 N--CA 1.467 0.381 0 CA-C-O 121.597 0.713 . . . . 0.0 112.72 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.519 ' HB2' HD23 ' A' ' 121' ' ' LEU . 92.2 m -57.36 167.41 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.767 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.6 p -40.17 143.77 0.26 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.751 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.626 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 4.6 ttmp? -99.68 78.45 2.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.227 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.2 t -166.24 -36.2 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.062 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -56.94 -32.4 65.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 110.389 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.419 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 64.5 mt -52.87 -46.18 67.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.568 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.2 p -92.63 137.69 32.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 0.0 111.194 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.738 HD13 ' HE3' ' A' ' 153' ' ' LYS . 29.2 tp -145.38 136.36 24.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.382 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.463 ' H ' HD12 ' A' ' 106' ' ' LEU . 42.2 tp10 -69.53 138.1 53.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.9 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.435 ' ND2' ' HG3' ' A' ' 107' ' ' GLU . 76.2 m-20 58.01 36.3 25.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.283 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 179.94 176.88 47.68 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.755 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -139.78 136.46 34.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 128' ' ' PHE . 94.9 t -106.11 123.86 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.8 m-85 -76.6 122.5 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.29 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.767 ' HA ' HG12 ' A' ' 126' ' ' VAL . 2.8 tt -95.35 140.6 30.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.711 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.759 ' N ' HD23 ' A' ' 113' ' ' LEU . 30.1 m -158.49 62.65 0.43 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.085 0.469 . . . . 0.0 110.739 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 118' ' ' LEU . . . -172.44 -16.28 0.02 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.716 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -49.77 147.59 6.75 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.372 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.713 ' C ' HD22 ' A' ' 118' ' ' LEU . 1.5 m-20 73.31 41.98 0.45 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 122.714 0.406 . . . . 0.0 111.753 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.713 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.7 mm? -141.82 149.4 53.02 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.59 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -50.28 116.94 2.77 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.481 2.121 . . . . 0.0 111.822 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.51 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 50.06 36.17 11.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.544 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.845 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 14.3 tp 52.22 42.24 30.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.491 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.89 142.27 57.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.589 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.76 33.93 84.78 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.425 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.873 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -93.44 144.09 25.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.892 0.377 . . . . 0.0 111.452 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -145.53 128.45 16.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.804 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 113' ' ' LEU . 34.4 m -136.11 142.15 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.751 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 41.4 tt0 -108.69 121.39 44.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.435 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.755 ' HA ' HG22 ' A' ' 111' ' ' VAL . 2.3 m-85 -86.86 44.11 1.14 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.841 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.631 ' HD3' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -67.16 133.5 49.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 110.667 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 69.5 m -105.16 155.85 18.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.638 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -53.7 156.84 4.34 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.116 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.519 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 86.6 Cg_exo -47.66 162.94 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.808 2.339 . . . . 0.0 112.466 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.557 ' HB3' ' ND2' ' A' ' 159' ' ' ASN . 57.3 m-20 78.31 -31.4 0.16 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.151 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -105.0 130.17 53.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.719 0.295 . . . . 0.0 110.393 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -111.39 130.58 55.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 111.516 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.594 HD22 ' O ' ' A' ' 128' ' ' PHE . 36.2 tp -78.05 136.4 37.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.419 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.0 66.06 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.14 -135.66 2.34 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.206 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.509 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 82.8 p -72.62 63.91 0.61 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.991 0.425 . . . . 0.0 110.78 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.552 ' HA ' HD21 ' A' ' 136' ' ' LEU . 88.0 p -56.08 -11.49 1.13 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.452 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 141' ' ' ARG . 69.3 mtt-85 -140.54 136.87 33.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 57.9 m -137.05 126.66 25.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.368 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 124' ' ' ALA . 5.9 p -116.71 130.15 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.922 0.391 . . . . 0.0 111.262 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.873 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 33.2 m -96.83 147.92 23.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.852 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.1 p -171.31 27.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.299 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.483 ' O ' ' HG3' ' A' ' 146' ' ' GLN . 70.7 tp60 -176.26 37.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.06 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.51 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 60.0 10.49 14.58 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.769 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -141.52 134.25 28.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.688 0.28 . . . . 0.0 110.92 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.519 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 38.7 m95 -64.86 134.97 55.18 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.564 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.2 m -57.42 -57.07 14.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.224 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 68.6 p -103.69 131.75 21.72 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.26 140.57 89.38 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.81 2.34 . . . . 0.0 111.895 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.738 ' HE3' HD13 ' A' ' 106' ' ' LEU . 61.2 tttp -47.09 132.93 9.1 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.276 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.509 ' HB3' ' H ' ' A' ' 139' ' ' SER . 65.1 Cg_endo -89.26 -151.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.024 2.483 . . . . 0.0 113.004 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -153.76 138.09 16.65 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.06 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.496 ' SG ' HD13 ' A' ' 136' ' ' LEU . 85.7 m -98.69 133.27 43.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.855 0.36 . . . . 0.0 110.83 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -103.02 136.93 41.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.727 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.68 142.42 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.901 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' A' ' 133' ' ' ASP . 23.4 p30 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.992 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.717 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.6 pp . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 121.143 0.497 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.724 ' HB2' HD22 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -63.8 151.55 41.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.964 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.0 t -39.89 111.18 0.18 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.015 0.436 . . . . 0.0 111.125 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.523 ' HG3' HD13 ' A' ' 98' ' ' ILE . 55.1 mtmt -63.6 -22.37 66.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.984 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 t -53.5 -32.17 49.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.653 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 3.4 m-85 -76.23 45.28 0.36 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.608 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.576 HD21 HD23 ' A' ' 113' ' ' LEU . 93.9 mt -132.82 -37.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 0.0 110.677 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 t -92.54 132.77 36.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.964 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.6 tp -145.44 125.06 13.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.54 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -82.83 45.15 0.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.066 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 p30 179.55 36.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.363 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.63 -155.39 26.37 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.959 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -142.06 150.55 41.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.818 0.342 . . . . 0.0 110.7 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.1 t -106.56 125.19 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.496 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.0 m-85 -85.38 76.83 10.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.58 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.945 ' HA ' HG12 ' A' ' 126' ' ' VAL . 3.4 tm? -54.96 141.52 33.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.339 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.722 ' N ' HD13 ' A' ' 113' ' ' LEU . 23.6 m -157.46 61.33 0.49 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.657 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.563 ' C ' HD13 ' A' ' 118' ' ' LEU . . . 173.38 41.94 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.732 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.82 123.42 6.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.186 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.408 ' C ' HD12 ' A' ' 118' ' ' LEU . 1.5 m-20 66.25 52.27 1.15 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.563 HD13 ' C ' ' A' ' 115' ' ' GLY . 10.7 mp -119.29 148.42 45.26 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.532 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -54.73 82.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.031 2.487 . . . . 0.0 111.748 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.613 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 62.12 13.45 5.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.576 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.724 HD22 ' HB2' ' A' ' 99' ' ' CYS . 7.3 mp 47.92 59.54 4.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.782 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.0 46.02 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.049 0.452 . . . . 0.0 110.567 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 171.64 -26.16 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.281 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -50.52 155.21 1.12 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 111.298 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.513 ' O ' ' HB ' ' A' ' 114' ' ' THR . 39.0 ptt180 -160.65 130.48 5.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.281 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.945 HG12 ' HA ' ' A' ' 113' ' ' LEU . 34.8 m -107.62 134.12 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.163 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 96.3 mt-10 -95.03 122.05 37.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.704 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.481 ' HE2' ' HE3' ' A' ' 153' ' ' LYS . 30.3 m-85 -88.28 149.08 24.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.654 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.412 HH11 ' HG3' ' A' ' 129' ' ' ARG . 40.1 ttt85 -153.62 126.97 8.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.739 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 16.6 t -89.24 151.28 22.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.016 0.436 . . . . 0.0 111.505 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -52.75 151.63 7.94 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.486 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.8 73.63 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.186 2.591 . . . . 0.0 112.747 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -176.31 -42.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.699 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.631 ' HB2' ' SG ' ' A' ' 130' ' ' CYS . 4.5 m-85 -109.51 143.53 39.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.545 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -99.44 135.05 41.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.304 0.574 . . . . 0.0 111.514 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.915 HD21 ' HA ' ' A' ' 140' ' ' SER . 35.5 tp -70.9 124.06 23.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.928 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.15 63.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.379 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -171.21 -128.63 1.05 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.921 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.661 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 60.1 m -73.54 57.14 0.54 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.878 0.371 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.915 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.9 t -51.66 -25.47 7.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.269 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 12.9 mtp-105 -137.82 129.71 28.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.572 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.9 m -127.21 120.2 28.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.426 HG13 ' OG ' ' A' ' 150' ' ' SER . 3.8 p -104.99 124.6 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.413 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 38.9 t -72.79 151.74 41.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.169 0.509 . . . . 0.0 111.587 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.5 m -161.44 121.71 2.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.563 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 57.92 43.17 21.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.315 0.578 . . . . 0.0 109.848 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.613 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 61.0 28.2 68.4 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.444 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -142.92 130.29 21.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.691 0.282 . . . . 0.0 110.61 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.465 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 35.9 m95 -72.11 132.07 43.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.59 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.426 ' OG ' HG13 ' A' ' 143' ' ' VAL . 70.9 m -57.51 -60.64 3.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 70.9 p -99.78 133.32 21.82 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.245 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.447 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 23.1 Cg_exo -64.9 -158.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.684 2.256 . . . . 0.0 112.326 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.481 ' HE3' ' HE2' ' A' ' 128' ' ' PHE . 14.2 mmmm -87.51 129.49 50.91 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.767 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.661 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.4 Cg_endo -75.26 -156.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.401 2.067 . . . . 0.0 112.803 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.72 148.77 26.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.938 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 134' ' ' PHE . 97.1 m -97.07 130.54 44.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -108.72 135.11 50.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.692 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.12 128.81 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.935 -179.876 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.5 pp . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.575 0.226 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 6.1 t 59.38 150.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.576 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.706 ' HB2' ' HD1' ' A' ' 149' ' ' TRP . 57.4 m -39.86 125.55 1.9 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.976 0.417 . . . . 0.0 111.301 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.484 ' HD3' HD21 ' A' ' 104' ' ' LEU . 16.8 tppt? -86.31 -36.43 19.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.537 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.9 p -69.0 40.3 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.475 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 5.5 m-85 -128.41 -47.97 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.774 HD12 ' H ' ' A' ' 105' ' ' THR . 0.4 OUTLIER -54.8 -30.0 55.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.995 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.774 ' H ' HD12 ' A' ' 104' ' ' LEU . 6.8 t -92.48 132.43 36.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.775 0.321 . . . . 0.0 111.138 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.89 HD13 ' HE3' ' A' ' 153' ' ' LYS . 34.5 tp -145.39 128.59 16.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.467 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -74.1 130.28 39.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.961 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.505 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.0 m120 60.23 38.88 19.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.621 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.75 151.86 13.1 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.845 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -110.68 137.0 48.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.49 126.74 62.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.541 ' C ' HG23 ' A' ' 126' ' ' VAL . 3.0 m-85 -79.35 60.39 3.13 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.006 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.564 HD22 ' HB3' ' A' ' 104' ' ' LEU . 60.2 tp -58.5 140.96 53.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.559 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 31.3 m -155.62 55.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.492 0.663 . . . . 0.0 109.85 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 168.46 99.98 0.13 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.843 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 117' ' ' ASP . . . -165.32 151.34 20.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.774 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.735 ' C ' HD22 ' A' ' 118' ' ' LEU . 38.8 t70 77.23 41.21 0.15 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.037 0.446 . . . . 0.0 110.975 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.735 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.2 mm? -144.14 150.9 50.49 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 12.0 Cg_endo -55.47 81.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.841 2.361 . . . . 0.0 112.187 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 73.69 -38.07 0.39 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.271 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.657 HD23 ' HB2' ' A' ' 124' ' ' ALA . 17.6 tp 55.2 80.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.89 0.376 . . . . 0.0 110.746 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.02 48.69 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.139 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -178.26 26.12 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.36 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.657 ' HB2' HD23 ' A' ' 121' ' ' LEU . . . -80.52 142.3 34.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.616 0.246 . . . . 0.0 110.669 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.559 ' O ' ' HB ' ' A' ' 114' ' ' THR . 45.7 mtp85 -131.73 150.48 52.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 111.278 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.541 HG23 ' C ' ' A' ' 112' ' ' PHE . 7.6 p -154.49 158.27 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.279 0.562 . . . . 0.0 111.252 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.536 ' N ' HG22 ' A' ' 126' ' ' VAL . 43.6 tt0 -136.94 89.71 2.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.106 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.481 ' H ' ' HD1' ' A' ' 128' ' ' PHE . 4.2 m-85 -59.11 148.57 30.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.714 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.8 tpt85 -159.52 128.36 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 35.4 t -89.22 150.23 22.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.301 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -53.67 156.61 4.52 Favored Pre-proline 0 N--CA 1.462 0.149 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.34 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 80.0 Cg_exo -45.64 162.02 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.978 2.452 . . . . 0.0 112.718 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 28.1 m-20 77.83 -36.57 0.22 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.61 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.403 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.9 m-85 -107.49 128.65 54.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.919 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.47 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -102.86 137.16 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.077 0.465 . . . . 0.0 111.409 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 154' ' ' PRO . 6.9 tt -78.89 127.24 31.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.339 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.469 ' N ' HD23 ' A' ' 136' ' ' LEU . 26.3 t -130.07 65.66 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.476 ' H ' HD23 ' A' ' 136' ' ' LEU . . . -170.54 -125.38 0.8 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.636 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.792 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 29.2 t -73.37 59.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 111.295 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.409 ' HB2' HD22 ' A' ' 136' ' ' LEU . 35.3 t -58.29 -24.77 60.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.604 ' HD2' ' N ' ' A' ' 142' ' ' SER . 4.0 tmm_? -140.55 131.29 25.76 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.421 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.643 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 50.7 m -132.23 153.32 50.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 124' ' ' ALA . 77.3 t -142.78 125.3 13.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.278 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 61.3 m -68.18 153.86 42.89 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -157.45 -23.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.285 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 146' ' ' GLN . 4.2 tp-100 -159.2 58.16 0.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.031 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 73.57 -8.08 11.28 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.914 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.74 136.17 33.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 111.023 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.706 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 60.2 m95 -60.57 150.32 32.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.752 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.9 p -54.21 -58.77 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.536 HG23 ' OG ' ' A' ' 139' ' ' SER . 2.7 t -104.25 144.88 29.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.378 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 17.7 Cg_endo -59.25 -147.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.993 2.462 . . . . 0.0 113.034 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.89 ' HE3' HD13 ' A' ' 106' ' ' LEU . 55.0 tttp -108.92 135.32 20.15 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.604 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 73.4 Cg_endo -76.68 -155.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.492 2.128 . . . . 0.0 113.037 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -153.77 161.24 42.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 88.1 m -96.11 131.62 42.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.787 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.47 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 4.2 tp-100 -118.84 138.14 52.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.917 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.65 136.56 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.237 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 24.1 p30 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.04 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 98' ' ' ILE . 1.7 pp . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.185 0.517 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.622 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 72.8 m -59.89 140.37 56.7 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.8 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.4 p -37.93 113.36 0.27 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.087 0.47 . . . . 0.0 111.62 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.418 ' HB3' HD12 ' A' ' 104' ' ' LEU . 98.3 mttt -69.43 1.95 3.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.316 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.2 p -59.63 -37.52 78.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.879 0.371 . . . . 0.0 110.569 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.526 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 1.4 m-85 -54.38 -35.43 62.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.851 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 101' ' ' LYS . 79.3 mt -53.53 139.45 31.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.33 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.9 p 60.52 130.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.497 0.498 . . . . 0.0 111.106 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.823 HD13 ' HE2' ' A' ' 153' ' ' LYS . 30.9 tp -145.37 134.88 23.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.305 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pm0 -63.62 133.03 52.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.323 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.404 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.9 m120 58.42 42.99 20.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.41 -177.58 43.66 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.563 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -142.03 151.89 42.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.607 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 86.5 t -129.14 123.98 59.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.349 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.594 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.5 m-85 -89.79 119.42 30.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.748 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HA ' HG12 ' A' ' 126' ' ' VAL . 54.9 tp -80.92 145.3 31.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.858 0.361 . . . . 0.0 110.932 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 23.7 m -158.88 56.16 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.733 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -159.0 -108.88 0.25 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.818 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 158.68 -124.67 1.4 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.863 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -151.4 53.03 0.84 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.189 0.519 . . . . 0.0 110.228 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 97.3 mt -99.35 156.89 34.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.879 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.447 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 80.6 Cg_exo -44.32 111.24 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.45 2.1 . . . . 0.0 112.182 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 72.66 -38.99 0.44 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.593 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 119' ' ' PRO . 16.5 tp 58.23 51.94 7.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.968 0.413 . . . . 0.0 111.122 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.3 60.4 1.52 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.008 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.29 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.396 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -49.92 152.27 1.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.486 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.502 ' O ' ' HB ' ' A' ' 114' ' ' THR . 79.1 ttt180 -155.63 122.05 5.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.409 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.593 HG23 ' CE1' ' A' ' 128' ' ' PHE . 26.8 m -111.82 134.71 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.159 0.504 . . . . 0.0 111.772 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -87.34 141.84 28.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.226 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.593 ' CE1' HG23 ' A' ' 126' ' ' VAL . 14.4 m-85 -117.09 140.23 49.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.491 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -162.36 131.02 4.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.661 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 7.1 t -89.22 155.11 19.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.909 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 133' ' ' ASP . 45.9 m-20 -52.75 151.62 7.95 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.496 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.03 76.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.284 2.656 . . . . 0.0 113.133 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 131' ' ' ASP . 33.4 t70 -178.68 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.702 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.549 ' HB2' ' SG ' ' A' ' 130' ' ' CYS . 5.0 m-85 -108.93 145.83 34.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.55 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -101.08 140.03 35.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.32 0.581 . . . . 0.0 111.287 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.558 HD13 ' N ' ' A' ' 137' ' ' VAL . 2.4 tm? -79.61 127.09 31.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.971 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.558 ' N ' HD13 ' A' ' 136' ' ' LEU . 44.6 t -132.38 71.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.549 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.98 -130.25 1.56 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.879 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.743 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 31.4 t -73.53 58.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 111.268 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.477 ' HB3' HD12 ' A' ' 136' ' ' LEU . 96.5 p -51.71 -26.29 9.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.122 0.487 . . . . 0.0 109.885 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.407 ' HD2' ' NH2' ' A' ' 125' ' ' ARG . 34.2 ptt85 -140.62 128.95 22.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.272 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 99.8 p -125.74 128.27 47.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 111.038 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 89.1 t -103.13 117.56 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 42.6 t -64.54 136.69 57.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.455 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.1 t -164.47 130.29 2.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 111.201 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 39.5 tt0 56.75 43.16 25.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.28 0.562 . . . . 0.0 110.538 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 60.53 17.4 47.95 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.94 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -143.52 135.03 26.2 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.886 0.343 . . . . 0.0 111.128 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.622 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 95.5 m95 -68.97 135.19 50.57 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.838 0.352 . . . . 0.0 111.126 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -57.46 -55.16 38.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.3 p -103.97 132.11 21.33 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.63 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.526 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 54.3 Cg_endo -69.37 136.49 34.15 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.797 2.331 . . . . 0.0 112.473 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.823 ' HE2' HD13 ' A' ' 106' ' ' LEU . 85.9 tttt -40.01 129.03 1.6 Allowed Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.459 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 95.2 Cg_endo -79.2 -154.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.906 2.404 . . . . 0.0 113.221 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -153.74 169.42 23.38 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 92.3 m -98.72 136.79 38.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.418 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -131.25 131.14 43.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 110.857 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.43 132.08 29.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.322 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.904 179.862 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 tt . . . . . 0 N--CA 1.441 -0.91 0 CA-C-O 120.919 0.39 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 14.4 m -48.85 138.41 11.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.376 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.7 m -39.86 128.45 2.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.416 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.406 ' HA ' HD13 ' A' ' 104' ' ' LEU . 33.1 mmtp -82.0 -15.95 51.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.923 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.7 m -53.11 -42.41 65.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.085 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -57.5 -41.48 80.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.014 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.605 ' N ' HD12 ' A' ' 104' ' ' LEU . 3.6 mp -77.88 40.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.8 m -147.39 62.68 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.481 HD21 ' SG ' ' A' ' 130' ' ' CYS . 49.9 tp -94.55 124.97 38.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.849 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.421 ' OE1' ' ND2' ' A' ' 108' ' ' ASN . 0.0 OUTLIER -90.58 41.0 1.04 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.017 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.421 ' ND2' ' OE1' ' A' ' 107' ' ' GLU . 78.4 m-20 -160.12 27.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.697 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 161.07 -146.48 12.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.997 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 7.9 mtpm? -141.94 143.37 33.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.296 -0.452 . . . . 0.0 110.663 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.71 119.84 54.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.831 0.348 . . . . 0.0 110.519 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.432 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 1.7 m-85 -71.71 123.02 21.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.907 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.591 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -89.17 141.34 28.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.625 HG21 ' NH2' ' A' ' 125' ' ' ARG . 25.2 m -157.95 54.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.868 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.96 -105.57 0.43 Allowed Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.934 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.628 ' H ' HD21 ' A' ' 121' ' ' LEU . . . 165.82 -126.46 1.48 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.42 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -167.32 67.17 0.09 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.157 0.504 . . . . 0.0 109.984 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.698 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 71.5 mt -127.97 168.76 14.32 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.116 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.698 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 76.3 Cg_exo -38.18 97.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.635 2.224 . . . . 0.0 112.125 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 70.68 -20.05 0.21 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.847 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.673 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 19.8 tp 62.31 54.01 2.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.93 0.395 . . . . 0.0 110.76 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.699 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 33.1 t70 -56.83 129.51 41.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.182 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.74 26.31 38.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.988 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 1.086 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -79.64 156.91 27.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.625 ' NH2' HG21 ' A' ' 114' ' ' THR . 56.4 ttp85 -154.34 145.27 22.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.407 . . . . 0.0 111.405 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.7 m -148.35 138.23 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.582 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.449 ' HG3' ' NH1' ' A' ' 141' ' ' ARG . 43.3 tt0 -110.79 115.83 30.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.582 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.558 ' HE2' ' HG3' ' A' ' 153' ' ' LYS . 2.0 m-85 -73.95 143.0 45.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -156.3 117.84 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.704 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.558 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 95.2 m -92.32 156.25 17.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.571 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -52.7 153.11 6.01 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.476 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.37 78.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.128 2.552 . . . . 0.0 112.668 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -177.46 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.646 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.675 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 0.6 OUTLIER -108.61 134.52 51.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.924 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.474 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 20.3 p-80 -102.66 127.33 49.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.122 0.486 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.75 HD21 ' HA ' ' A' ' 140' ' ' SER . 26.6 tp -70.21 126.61 30.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.131 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.7 67.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.638 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -174.74 -135.31 2.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.072 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.73 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 65.0 m -74.74 55.04 0.66 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.75 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.8 t -48.42 -43.53 34.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.09 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.574 ' HD2' ' N ' ' A' ' 141' ' ' ARG . 0.4 OUTLIER -102.02 133.63 46.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.9 m -133.91 130.0 37.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.713 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.61 123.97 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.299 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 1.086 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 41.1 t -100.7 145.21 28.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.687 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.699 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 81.1 p -168.14 35.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 175.8 39.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.276 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 61.71 10.98 27.52 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.112 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.15 134.81 28.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.562 0.22 . . . . 0.0 110.592 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -73.42 137.11 44.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.366 . . . . 0.0 111.13 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.2 t -57.49 -59.66 4.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.35 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 82.7 p -96.44 134.52 23.32 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 15.9 Cg_exo -67.53 146.28 73.5 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.935 2.423 . . . . 0.0 111.949 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.558 ' HG3' ' HE2' ' A' ' 128' ' ' PHE . 88.2 tttt -51.17 122.93 19.24 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.858 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.73 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.2 Cg_endo -75.25 -150.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.734 2.289 . . . . 0.0 112.953 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -153.74 139.88 18.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 67.5 m -98.79 139.28 34.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.003 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.474 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 39.3 tt0 -102.93 132.53 49.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.11 126.91 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.338 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.395 179.667 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.625 HG22 HD11 ' A' ' 121' ' ' LEU . 1.4 pt . . . . . 0 N--CA 1.464 0.252 0 CA-C-O 120.745 0.307 . . . . 0.0 110.94 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.528 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 99.7 m -64.16 136.18 57.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.4 m -41.42 131.12 2.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.275 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.575 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -76.63 15.56 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.177 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.4 m -68.93 -39.81 79.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 111.433 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.496 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 1.8 m-85 -64.59 -70.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.599 HD23 HD13 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -46.98 156.97 0.18 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.97 0.414 . . . . 0.0 111.484 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.6 m 64.67 73.13 0.43 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.34 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.689 ' HB2' ' HZ3' ' A' ' 153' ' ' LYS . 49.3 tp -93.14 136.52 33.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.333 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.83 135.06 57.58 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 58.97 40.93 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.075 0.464 . . . . 0.0 110.186 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.37 169.58 41.81 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.934 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -136.93 129.66 30.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.958 0.409 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.489 HG12 ' HB ' ' A' ' 126' ' ' VAL . 58.4 t -111.15 126.53 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.227 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.5 m-85 -70.87 111.33 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.19 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.599 HD13 HD23 ' A' ' 104' ' ' LEU . 58.5 tp -80.84 145.26 31.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.931 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.4 m -161.88 54.42 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.849 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.506 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . -174.76 61.26 0.11 Allowed Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.697 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.46 -53.37 45.52 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 114.634 0.613 . . . . 0.0 114.634 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -164.08 54.7 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.425 0.613 . . . . 0.0 111.821 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 120' ' ' ALA . 7.1 mp -87.74 159.19 49.75 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.355 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -47.52 83.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.541 2.16 . . . . 0.0 111.638 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 59.83 23.12 12.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.902 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 7.8 mp 52.22 53.26 12.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.62 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 38.6 t70 -76.79 44.93 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.211 0.529 . . . . 0.0 110.329 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 125' ' ' ARG . . . 172.5 -27.65 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.536 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -51.8 144.55 11.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.783 0.325 . . . . 0.0 111.251 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.567 ' HG2' HG22 ' A' ' 143' ' ' VAL . 84.2 mtm180 -147.84 136.98 22.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.003 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' A' ' 113' ' ' LEU . 31.6 m -121.91 131.98 71.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.004 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.16 124.2 39.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.606 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.483 ' CE1' HG23 ' A' ' 126' ' ' VAL . 0.8 OUTLIER -87.09 138.17 31.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.98 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -145.92 127.47 15.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.491 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 96.5 m -89.29 145.32 25.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.692 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 134' ' ' PHE . 3.2 t70 -55.63 146.79 43.58 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.616 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 131' ' ' ASP . 88.4 Cg_exo -36.82 137.0 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.863 2.376 . . . . 0.0 112.593 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 51.5 m-20 75.0 22.21 1.85 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.512 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 16.9 m-85 -134.97 131.54 37.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.562 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -106.03 135.23 47.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.926 0.393 . . . . 0.0 110.836 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.823 HD11 ' HG2' ' A' ' 154' ' ' PRO . 17.5 tp -78.15 143.07 37.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.406 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 137' ' ' VAL . 14.5 p -134.92 59.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.87 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 169.28 -126.15 1.34 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 119.013 -1.565 . . . . 0.0 113.764 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.941 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 29.9 t -65.66 65.8 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.796 0.332 . . . . 0.0 111.258 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.649 ' HA ' HD21 ' A' ' 136' ' ' LEU . 95.6 p -61.88 -26.55 68.22 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.331 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -140.68 125.23 17.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.502 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m -116.35 137.33 52.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.793 0.33 . . . . 0.0 110.736 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.567 HG22 ' HG2' ' A' ' 125' ' ' ARG . 92.3 t -131.32 115.45 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.038 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 69.7 m -80.31 153.19 28.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.832 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 40.8 t -152.43 -23.01 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.661 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -146.58 46.18 1.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.15 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 64.74 24.18 69.58 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.882 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -141.7 132.74 26.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.293 0.237 . . . . 0.0 110.483 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.528 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 72.4 m95 -66.41 145.22 55.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 110.864 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.414 ' CB ' ' H ' ' A' ' 143' ' ' VAL . 47.3 t -56.27 -48.61 76.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.294 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.75 HG23 ' OG ' ' A' ' 139' ' ' SER . 1.0 OUTLIER -135.52 139.24 30.59 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-O 120.847 0.356 . . . . 0.0 111.765 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 17.8 Cg_endo -59.76 137.7 78.44 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.444 2.763 . . . . 0.0 113.842 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.838 ' HD3' ' HD2' ' A' ' 154' ' ' PRO . 2.7 tppp? -50.42 126.75 22.72 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.77 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 96.1 Cg_endo -85.03 -140.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.096 2.531 . . . . 0.0 112.278 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.505 ' O ' HG12 ' A' ' 137' ' ' VAL . 18.4 p-80 -153.69 149.31 27.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.876 0.369 . . . . 0.0 111.077 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.3 m -95.32 132.74 40.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.363 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -123.58 139.4 54.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.359 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.23 133.73 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.779 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.934 179.942 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.457 -0.122 0 CA-C-O 121.053 0.454 . . . . 0.0 111.771 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.7 m -63.43 153.1 36.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.635 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 102' ' ' SER . 47.7 t -39.44 104.02 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.167 0.508 . . . . 0.0 110.879 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.639 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -66.46 3.95 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.328 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 100' ' ' SER . 47.7 t -68.11 -38.62 82.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.49 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.637 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.3 m-85 -51.5 -38.4 53.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.13 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.543 HD21 HD23 ' A' ' 113' ' ' LEU . 83.1 mt -53.77 -43.51 69.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.725 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.2 t -92.61 136.59 33.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.592 HD13 ' CE ' ' A' ' 153' ' ' LYS . 34.8 tp -145.42 128.94 17.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.909 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.92 42.24 0.62 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.284 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -154.08 -31.31 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.801 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.552 ' HA2' ' OD1' ' A' ' 131' ' ' ASP . . . -153.9 -148.37 4.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.174 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -131.15 137.42 49.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.779 0.323 . . . . 0.0 110.827 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.637 HG21 ' O ' ' A' ' 103' ' ' TYR . 60.1 t -108.72 121.82 62.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.864 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -69.17 124.32 23.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.513 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.705 HD22 ' H ' ' A' ' 114' ' ' THR . 3.1 tm? -99.7 142.16 31.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.395 0.617 . . . . 0.0 111.804 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.705 ' H ' HD22 ' A' ' 113' ' ' LEU . 22.6 m -157.47 42.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.861 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.553 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . 162.0 95.81 0.11 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.629 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.32 43.28 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.354 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.531 ' O ' HD23 ' A' ' 118' ' ' LEU . 53.1 p-10 -173.13 33.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 0.0 110.647 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.617 ' HB2' HD23 ' A' ' 121' ' ' LEU . 86.1 mt -141.13 140.76 21.71 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.526 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.407 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 51.0 Cg_exo -52.54 117.36 3.58 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.579 2.186 . . . . 0.0 112.813 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 71.18 -38.03 0.41 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.686 HD22 ' HB2' ' A' ' 124' ' ' ALA . 46.5 mt 63.04 55.23 1.99 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.799 0.333 . . . . 0.0 110.789 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -76.54 48.97 0.58 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.617 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.16 -20.11 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.789 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.848 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.97 143.02 4.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 111.672 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.621 ' HD2' HH22 ' A' ' 141' ' ' ARG . 84.9 mtm180 -136.57 141.6 43.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.13 136.2 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -114.27 113.4 24.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.484 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 3.0 m-85 -77.99 147.03 35.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.148 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 129' ' ' ARG . 38.1 ttt85 -158.07 129.34 6.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.078 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 31.1 m -89.07 139.52 30.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.02 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' ' HA2' ' A' ' 109' ' ' GLY . 82.3 m-20 -52.63 151.44 7.92 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.232 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.69 77.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.023 2.482 . . . . 0.0 112.422 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 131' ' ' ASP . 65.1 t0 -179.44 -41.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.432 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 2.9 m-85 -110.09 140.93 43.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.229 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -102.72 127.8 49.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.863 0.364 . . . . 0.0 110.573 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' A' ' 140' ' ' SER . 2.7 tm? -77.35 129.34 35.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.07 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.553 ' N ' HD13 ' A' ' 136' ' ' LEU . 39.4 t -136.82 72.46 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.24 -135.89 2.41 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.632 -1.271 . . . . 0.0 113.318 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.477 ' HB3' ' OG1' ' A' ' 151' ' ' THR . 68.6 m -76.37 54.54 0.92 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.708 0.29 . . . . 0.0 110.94 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.572 ' HB3' HD12 ' A' ' 136' ' ' LEU . 88.8 p -47.07 -37.46 9.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.541 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.621 HH22 ' HD2' ' A' ' 125' ' ' ARG . 40.6 ttt85 -99.4 138.27 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.505 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.1 t -150.37 132.0 14.88 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.726 0.298 . . . . 0.0 110.655 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 125' ' ' ARG . 83.5 t -117.66 127.41 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.298 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.848 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 49.9 t -71.43 140.17 49.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -169.19 129.35 1.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.592 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 56.76 40.28 29.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 59.12 22.54 55.75 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.407 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.18 132.51 24.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.648 0.261 . . . . 0.0 110.687 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -69.5 141.29 53.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.839 0.352 . . . . 0.0 111.034 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.0 m -57.4 -54.41 47.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.05 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.477 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 65.0 p -115.71 137.34 23.17 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.399 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 139' ' ' SER . 31.7 Cg_exo -58.76 142.2 98.54 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.817 2.345 . . . . 0.0 112.227 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.592 ' CE ' HD13 ' A' ' 106' ' ' LEU . 62.6 tttp -50.42 130.93 25.89 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.247 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.475 ' HG2' HD21 ' A' ' 136' ' ' LEU . 59.4 Cg_endo -72.39 -152.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.649 2.232 . . . . 0.0 112.555 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -153.63 143.7 22.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.133 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 81.1 m -98.15 129.68 44.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.37 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -119.28 140.82 49.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.937 0.398 . . . . 0.0 111.516 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.07 135.92 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.786 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.888 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 1.058 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 94.5 mt . . . . . 0 N--CA 1.457 -0.094 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.8 m -62.48 150.52 39.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.717 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 102' ' ' SER . 57.5 m -40.68 105.07 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.603 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -69.13 15.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.719 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 100' ' ' SER . 46.9 t -68.92 -35.38 76.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.061 0.458 . . . . 0.0 110.029 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -51.65 -35.19 41.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.241 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.731 HD21 HD13 ' A' ' 113' ' ' LEU . 91.4 mt -53.47 -43.93 68.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.211 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.4 m -92.56 128.61 38.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.541 HD13 ' CE ' ' A' ' 153' ' ' LYS . 34.9 tp -145.45 132.91 20.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.366 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.41 132.91 47.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.492 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 56.24 43.98 25.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.545 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.81 163.82 32.99 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.519 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.58 ' NZ ' ' HB2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -138.89 134.39 33.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.775 0.322 . . . . 0.0 110.684 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' A' ' 126' ' ' VAL . 57.7 t -114.13 126.96 71.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.647 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -73.34 124.82 26.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.211 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.731 HD13 HD21 ' A' ' 104' ' ' LEU . 52.9 tp -89.54 143.35 26.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.225 0.535 . . . . 0.0 112.088 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.577 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.2 m -162.37 52.4 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.395 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.641 ' O ' HD11 ' A' ' 121' ' ' LEU . . . 161.95 103.39 0.18 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.709 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.86 47.84 0.22 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.113 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.643 ' O ' HD13 ' A' ' 118' ' ' LEU . 2.7 p30 -174.5 36.43 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.35 . . . . 0.0 111.156 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 117' ' ' ASP . 2.2 mm? -134.98 151.85 76.22 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.582 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.4 124.26 11.64 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.345 2.03 . . . . 0.0 111.424 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 53.16 32.0 12.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.069 0.461 . . . . 0.0 110.279 -179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 1.058 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 14.7 tp 50.58 46.73 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.927 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -66.68 141.08 57.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.122 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.8 31.36 80.65 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.469 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.919 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . . . -85.65 145.17 27.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.737 0.303 . . . . 0.0 110.976 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.577 ' O ' ' HB ' ' A' ' 114' ' ' THR . 53.4 ttt-85 -160.4 127.07 4.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.692 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 113' ' ' LEU . 28.3 m -137.54 136.96 46.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.68 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -102.38 122.71 44.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.123 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.569 ' HE2' ' HG3' ' A' ' 153' ' ' LYS . 5.7 m-85 -83.61 150.21 26.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.134 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -157.04 126.13 5.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.588 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 73.4 m -89.91 136.91 32.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.218 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -57.78 159.33 10.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.965 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 88.3 Cg_exo -40.89 152.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.96 2.44 . . . . 0.0 112.721 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 57.8 m-20 78.03 -34.38 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.039 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -106.02 128.21 53.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.3 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . 0.447 ' H ' ' CD2' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -106.27 140.08 39.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.14 0.495 . . . . 0.0 111.878 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.817 HD21 ' HA ' ' A' ' 140' ' ' SER . 36.5 tp -78.11 128.44 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.704 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.42 64.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.577 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.73 -135.83 2.05 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.219 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.678 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 63.8 m -72.04 63.92 0.51 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.114 0.483 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.817 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.1 t -55.31 -16.96 3.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.467 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -140.64 136.03 32.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.89 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 79.2 p -135.57 141.87 45.23 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.49 ' H ' ' HB3' ' A' ' 150' ' ' SER . 95.5 t -135.82 126.18 42.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.066 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.867 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 57.2 m -92.95 148.46 21.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.039 0.447 . . . . 0.0 111.735 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.6 t -163.15 26.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.148 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 175.86 39.51 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.275 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 62.66 19.37 60.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.495 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -142.38 132.77 24.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.664 0.268 . . . . 0.0 110.641 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -64.56 143.01 58.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.967 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 48.5 t -57.14 -47.43 81.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.714 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 59.8 p -127.68 133.57 25.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.342 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.25 142.99 77.61 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.879 2.386 . . . . 0.0 112.619 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.569 ' HG3' ' HE2' ' A' ' 128' ' ' PHE . 87.4 tttt -48.86 128.24 14.39 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.28 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.678 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.0 Cg_endo -75.91 -150.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.704 2.269 . . . . 0.0 112.672 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.405 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.6 p-80 -153.69 151.51 29.74 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.08 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 90.2 m -98.61 137.09 37.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.727 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -120.4 135.83 54.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.362 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.65 143.63 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.973 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 133' ' ' ASP . 23.5 p30 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.09 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.629 HD13 ' HA ' ' A' ' 117' ' ' ASP . 12.8 mt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.923 0.392 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.539 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 72.9 m 58.77 149.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.876 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -40.41 100.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.549 ' HG3' HD12 ' A' ' 104' ' ' LEU . 27.7 ttpp -59.9 -20.61 58.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.861 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.8 p -53.24 -33.51 53.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.292 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -56.95 -44.87 82.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.662 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.549 HD12 ' HG3' ' A' ' 101' ' ' LYS . 92.7 mt -49.61 -39.98 37.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.7 p -92.55 131.87 37.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.652 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.859 HD13 ' HE3' ' A' ' 153' ' ' LYS . 55.4 tp -145.36 130.68 18.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.18 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.57 132.3 47.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.433 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.77 43.89 24.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.566 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.19 164.4 34.92 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.472 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -136.7 134.35 37.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.736 0.303 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 86.9 t -106.48 126.07 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.391 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.585 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.5 m-85 -74.71 127.43 33.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -81.6 140.97 34.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.076 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.649 ' N ' HD13 ' A' ' 113' ' ' LEU . 28.2 m -158.1 56.11 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.083 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.99 -101.87 0.2 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.012 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.651 ' H ' HD21 ' A' ' 121' ' ' LEU . . . -179.97 -131.55 1.66 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.225 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.699 ' C ' HD12 ' A' ' 118' ' ' LEU . 39.0 t70 -165.8 58.38 0.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.974 0.416 . . . . 0.0 110.34 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.699 HD12 ' C ' ' A' ' 117' ' ' ASP . 8.0 mp -131.38 156.98 79.39 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.515 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.439 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 95.6 Cg_exo -42.89 119.89 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.445 2.097 . . . . 0.0 112.468 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 72.99 -40.24 0.47 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.672 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.651 HD21 ' H ' ' A' ' 116' ' ' GLY . 21.2 tp 55.23 57.21 5.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.949 0.404 . . . . 0.0 110.857 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -51.19 137.1 23.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.15 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.22 33.52 64.78 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.895 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.586 ' HB3' ' SG ' ' A' ' 144' ' ' CYS . . . -84.35 148.53 26.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.523 0.201 . . . . 0.0 110.595 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.422 ' O ' ' HB ' ' A' ' 114' ' ' THR . 66.1 mtm-85 -144.87 141.96 29.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.985 0.421 . . . . 0.0 111.338 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.58 HG23 ' CE1' ' A' ' 128' ' ' PHE . 23.9 m -147.8 132.08 9.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.715 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.7 mt-10 -93.05 131.43 38.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.292 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.58 ' CE1' HG23 ' A' ' 126' ' ' VAL . 4.3 m-85 -103.47 145.84 29.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.029 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.508 ' HG2' HH11 ' A' ' 129' ' ' ARG . 2.9 ptp85 -168.89 129.98 1.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.651 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 26.2 t -89.22 150.5 22.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.235 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -52.68 155.8 3.68 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.32 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 84.9 Cg_exo -46.28 159.21 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.68 2.254 . . . . 0.0 112.149 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 25.3 m-20 78.27 -37.53 0.22 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.61 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -108.05 128.96 55.13 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -108.66 133.52 52.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 111.596 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 137' ' ' VAL . 7.9 tt -71.42 137.53 48.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.02 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.551 ' N ' HD23 ' A' ' 136' ' ' LEU . 42.8 t -131.37 73.08 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.769 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.46 -133.43 2.22 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.081 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.58 ' OG ' ' HD3' ' A' ' 154' ' ' PRO . 43.6 p -73.72 62.6 0.81 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.528 ' HB3' HD22 ' A' ' 136' ' ' LEU . 99.8 p -56.27 -14.93 3.19 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.801 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.647 ' HD2' ' O ' ' A' ' 141' ' ' ARG . 7.6 ppt_? -140.62 140.52 35.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.599 0.237 . . . . 0.0 110.964 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 56.1 m -136.55 148.93 47.84 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.855 0.359 . . . . 0.0 111.278 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.21 129.87 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.374 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.586 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 98.3 m -75.06 174.93 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.509 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.7 t -172.21 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.452 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -150.8 49.5 0.86 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.59 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 65.68 19.35 67.08 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.259 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -142.82 132.19 23.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.548 0.213 . . . . 0.0 110.731 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.539 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 97.7 m95 -65.15 135.83 55.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.647 0.261 . . . . 0.0 110.941 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.8 t -57.48 -52.76 64.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.483 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.7 p -104.3 146.15 32.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.971 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.83 -152.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.622 2.215 . . . . 0.0 112.739 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.859 ' HE3' HD13 ' A' ' 106' ' ' LEU . 59.0 tptt -121.77 123.62 27.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.262 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.782 ' HD2' ' HD2' ' A' ' 153' ' ' LYS . 98.3 Cg_endo -85.45 -146.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.66 2.24 . . . . 0.0 113.214 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.445 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.7 p-80 -153.72 -149.28 0.28 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 85.6 m -133.07 134.83 44.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.533 ' NE2' HG21 ' A' ' 137' ' ' VAL . 8.3 tt0 -116.85 130.03 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.456 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.0 p -62.14 137.99 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.125 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.6 p30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.954 -179.846 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.777 ' HA ' HD13 ' A' ' 121' ' ' LEU . 11.4 pt . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.527 0.679 . . . . 0.0 112.409 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.609 ' SG ' HD22 ' A' ' 121' ' ' LEU . 3.2 p -60.7 136.04 57.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.726 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 102' ' ' SER . 80.4 p -39.89 130.31 2.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.592 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.581 ' NZ ' HD12 ' A' ' 98' ' ' ILE . 60.5 mttp -75.11 16.12 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.345 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 100' ' ' SER . 79.6 p -68.96 -44.8 72.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.866 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -59.07 -36.83 75.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.412 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.412 HD21 HD23 ' A' ' 113' ' ' LEU . 94.9 mt -50.55 149.39 3.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.747 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.3 p 62.66 137.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.115 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.796 HD13 ' HE2' ' A' ' 153' ' ' LYS . 36.1 tp -145.41 139.66 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.26 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -68.04 130.0 41.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.235 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 57.37 41.74 25.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.713 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.49 152.82 10.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.636 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.48 132.01 56.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.724 0.297 . . . . 0.0 110.685 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.757 HG22 ' HA ' ' A' ' 128' ' ' PHE . 98.5 t -108.32 121.96 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.288 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.7 m-85 -74.82 126.08 30.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.152 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.681 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -108.58 142.06 39.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.411 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.681 ' N ' HD13 ' A' ' 113' ' ' LEU . 94.7 m -163.58 97.66 0.88 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.608 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.493 ' O ' ' HG ' ' A' ' 121' ' ' LEU . . . 163.08 -30.26 0.27 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.883 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -41.58 150.14 0.26 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.528 -0.368 . . . . 0.0 113.901 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.672 ' C ' HD22 ' A' ' 118' ' ' LEU . 32.5 m-20 72.23 37.11 0.99 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.826 0.45 . . . . 0.0 111.704 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.672 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.3 mm? -142.44 148.67 48.2 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.953 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.86 97.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.797 2.332 . . . . 0.0 112.616 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.402 ' HB1' ' H ' ' A' ' 147' ' ' GLY . . . 55.64 17.06 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.574 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.777 HD13 ' HA ' ' A' ' 98' ' ' ILE . 10.4 mp 46.11 62.44 2.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.25 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.53 46.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.169 0.509 . . . . 0.0 110.376 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.86 27.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.029 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.784 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -81.46 142.08 33.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.754 0.311 . . . . 0.0 111.397 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.56 130.29 34.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.621 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 113' ' ' LEU . 19.0 m -136.1 144.13 34.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.468 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 87.2 tt0 -119.09 122.05 41.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.229 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.757 ' HA ' HG22 ' A' ' 111' ' ' VAL . 9.4 m-85 -85.65 53.51 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.965 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.499 ' HB3' ' NH1' ' A' ' 129' ' ' ARG . 12.8 mtp-105 -58.88 128.62 38.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 0.0 111.001 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 61.3 m -89.55 147.21 24.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.891 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 133' ' ' ASP . 52.6 p-10 -52.81 153.0 6.27 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.031 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.36 75.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.001 2.468 . . . . 0.0 112.755 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.5 t70 179.93 -40.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.435 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 3.5 m-85 -108.63 139.65 43.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.259 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -102.86 131.45 49.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.053 0.454 . . . . 0.0 110.757 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.852 HD21 ' HA ' ' A' ' 140' ' ' SER . 23.2 tp -69.91 131.9 45.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.982 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.1 t -136.25 67.8 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.94 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.59 -136.5 2.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.47 -1.348 . . . . 0.0 113.376 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.495 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 62.2 m -74.62 58.12 0.77 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.997 0.427 . . . . 0.0 110.565 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.852 ' HA ' HD21 ' A' ' 136' ' ' LEU . 39.3 t -47.63 -44.03 26.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.416 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -102.62 133.03 48.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.968 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.7 t -138.32 125.23 21.18 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.64 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 96.8 t -111.89 125.62 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.086 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.784 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 73.9 m -72.83 143.35 47.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.017 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.5 p -163.51 128.69 3.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.097 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 1.5 mp0 55.79 38.21 29.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.451 . . . . 0.0 109.917 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.402 ' H ' ' HB1' ' A' ' 120' ' ' ALA . . . 62.29 28.21 70.53 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.351 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -143.23 131.53 22.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.576 0.227 . . . . 0.0 110.593 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -69.85 137.43 51.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.2 t -57.49 -56.46 21.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.644 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 82.0 p -111.75 137.64 21.32 Favored Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 32.2 Cg_exo -58.41 147.17 86.96 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.879 2.386 . . . . 0.0 112.268 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.796 ' HE2' HD13 ' A' ' 106' ' ' LEU . 85.9 tttt -52.79 125.65 39.16 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.495 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.8 Cg_endo -76.78 -154.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.76 2.306 . . . . 0.0 112.655 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -153.67 150.67 28.82 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.229 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 76.5 m -97.33 134.91 39.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.228 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -124.47 131.42 53.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.715 0.293 . . . . 0.0 110.721 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 7.3 p -74.09 129.27 36.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 111.641 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.184 -0.913 . . . . 0.0 111.091 179.758 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.679 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.52 0 CA-C-O 120.872 0.367 . . . . 0.0 111.104 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 39.1 m -57.1 143.77 37.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.866 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.6 t -39.88 128.56 2.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.075 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.69 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -72.73 -14.27 61.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.364 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.5 p -53.1 -47.06 68.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.53 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -59.44 -41.27 89.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.252 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 86.8 mt -51.86 -36.89 49.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.23 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.5 p -92.49 141.42 28.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.608 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.498 HD22 ' H ' ' A' ' 108' ' ' ASN . 1.9 tt -140.84 120.93 13.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.532 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 108' ' ' ASN . 3.8 mm-40 -82.64 30.05 0.43 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.498 ' H ' HD22 ' A' ' 106' ' ' LEU . 72.3 m-80 -166.14 25.68 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.54 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.15 -156.67 23.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.656 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -141.96 134.01 27.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.632 0.253 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 94.0 t -106.59 121.18 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.023 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.2 m-85 -74.78 116.35 15.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.437 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.2 tp -83.28 142.77 30.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.393 . . . . 0.0 111.422 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 114' ' ' THR . 32.3 m -163.28 61.17 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.393 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.486 ' O ' HD13 ' A' ' 118' ' ' LEU . . . -152.39 -39.35 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.839 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.06 -125.74 7.35 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.885 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.457 ' HA ' HD11 ' A' ' 121' ' ' LEU . 52.0 p-10 -147.47 48.3 1.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.999 0.428 . . . . 0.0 111.163 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 121' ' ' LEU . 6.7 mp -80.77 161.38 63.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.402 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 83.6 Cg_exo -43.82 94.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.459 2.106 . . . . 0.0 112.343 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 69.25 -9.03 0.65 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.961 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 118' ' ' LEU . 7.6 mp 61.46 57.68 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.593 0.235 . . . . 0.0 110.883 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -75.12 49.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 110.587 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 178.99 -13.68 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.905 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.993 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -50.75 147.54 4.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.928 0.394 . . . . 0.0 111.335 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.684 ' CD ' HG22 ' A' ' 143' ' ' VAL . 43.8 mmm-85 -146.25 133.57 20.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.657 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.415 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 35.7 m -127.03 132.13 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 111.584 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 52.4 mm-40 -103.32 138.63 39.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.839 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -105.58 145.06 31.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.043 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -148.52 122.53 9.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.355 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 59.3 m -89.22 143.89 26.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.052 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 133' ' ' ASP . 1.4 m-20 -52.8 151.94 7.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.883 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.28 75.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.13 2.553 . . . . 0.0 112.722 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' ASP . 38.9 t70 178.89 -36.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.646 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 1.6 m-85 -108.8 136.67 47.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.068 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -102.84 130.13 49.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 0.0 110.532 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 140' ' ' SER . 35.8 tp -71.46 130.32 41.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.056 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.33 68.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.785 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 174.61 -129.21 1.55 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 119.512 -1.327 . . . . 0.0 113.347 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.736 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 30.1 t -68.86 63.63 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.89 0.376 . . . . 0.0 111.259 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.812 ' HA ' HD21 ' A' ' 136' ' ' LEU . 93.4 p -57.77 -23.99 54.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.526 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -140.61 136.17 32.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.79 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.548 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 46.7 t -127.92 125.48 39.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.559 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.684 HG22 ' CD ' ' A' ' 125' ' ' ARG . 46.3 t -97.72 120.24 46.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.244 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.993 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 52.7 t -77.94 122.94 26.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.4 p -104.65 -123.72 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.703 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -75.88 55.89 0.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.68 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.03 21.13 66.13 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.776 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -143.09 137.07 28.91 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.65 0.262 . . . . 0.0 111.239 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 83.3 m95 -67.24 139.79 57.37 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.875 0.369 . . . . 0.0 111.51 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.508 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 46.7 t -57.49 -53.86 53.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.978 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.587 HG23 ' OG ' ' A' ' 139' ' ' SER . 2.4 t -127.06 141.41 40.59 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.698 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.3 145.32 98.19 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.174 2.583 . . . . 0.0 112.979 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -49.91 134.76 21.24 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.381 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.736 ' HB3' ' H ' ' A' ' 139' ' ' SER . 97.0 Cg_endo -79.48 -149.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.749 2.299 . . . . 0.0 112.759 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.404 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.2 p-80 -153.72 145.71 23.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 75.2 m -96.81 127.52 42.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.544 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -111.09 129.48 55.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.064 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.22 136.29 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.826 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.886 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.633 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.675 0.274 . . . . 0.0 110.693 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 61.2 m -55.88 135.7 51.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.509 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.4 p -42.15 127.27 3.49 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -77.86 16.23 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.5 m -68.26 -42.25 79.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 110.359 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.503 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.2 m-85 -62.03 -46.28 89.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.728 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.423 ' HA ' HG11 ' A' ' 111' ' ' VAL . 92.4 mt -64.64 -30.63 71.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.979 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.2 p -92.46 72.63 5.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.633 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.796 HD22 ' H ' ' A' ' 109' ' ' GLY . 1.3 tt -94.54 124.27 38.46 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 38.5 tt0 -81.84 34.99 0.41 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.082 0.468 . . . . 0.0 111.38 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.417 ' N ' HD22 ' A' ' 106' ' ' LEU . 7.3 m120 -160.75 -49.17 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.4 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.796 ' H ' HD22 ' A' ' 106' ' ' LEU . . . -86.68 -151.96 20.51 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.964 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 111' ' ' VAL . 86.0 tttt -142.04 -42.33 0.34 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.811 0.339 . . . . 0.0 110.602 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 10.5 p 48.55 115.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.947 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -75.17 127.48 33.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.111 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.3 tp -90.84 146.23 24.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.065 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 24.8 m -157.11 53.97 0.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.398 0.618 . . . . 0.0 109.912 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.664 ' C ' HD11 ' A' ' 121' ' ' LEU . . . 164.96 107.68 0.2 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.702 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.53 140.67 7.72 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.862 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.726 ' C ' HD12 ' A' ' 118' ' ' LEU . 9.4 t70 73.87 53.38 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.137 0.494 . . . . 0.0 111.073 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.726 HD12 ' C ' ' A' ' 117' ' ' ASP . 9.3 mp -140.27 152.4 66.89 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.657 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -57.24 113.75 1.63 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.228 1.952 . . . . 0.0 110.999 179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.573 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 56.55 18.27 3.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.143 0.497 . . . . 0.0 109.887 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.778 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 14.9 tp 45.54 42.94 8.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.069 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -62.78 137.39 58.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.63 37.53 61.8 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.979 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.822 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -98.73 142.76 29.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.685 0.279 . . . . 0.0 110.867 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.512 ' O ' ' HB ' ' A' ' 114' ' ' THR . 66.2 mtm-85 -131.49 138.54 49.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.94 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.6 m -144.53 134.75 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.273 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -113.68 105.93 13.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.39 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 66.3 m-85 -68.78 146.49 52.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.102 0.477 . . . . 0.0 111.625 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' ' 129' ' ' ARG . 41.3 ttt85 -153.16 125.42 8.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.657 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.637 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 56.5 m -89.26 139.97 29.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.558 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.501 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 47.4 p-10 -54.26 161.09 2.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.703 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.559 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 1.8 Cg_endo -45.04 152.44 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.835 2.357 . . . . 0.0 111.899 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.559 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 35.0 t70 79.62 -29.57 0.14 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.485 ' CE2' HG22 ' A' ' 158' ' ' VAL . 35.6 m-85 -106.45 132.43 52.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.711 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -112.28 136.02 52.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.992 0.425 . . . . 0.0 111.191 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.896 HD21 ' HA ' ' A' ' 140' ' ' SER . 29.6 tp -77.3 129.77 36.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.3 t -136.2 68.91 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.861 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 176.82 -129.99 1.57 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.267 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.741 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 31.3 t -70.06 62.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.035 0.445 . . . . 0.0 111.206 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.896 ' HA ' HD21 ' A' ' 136' ' ' LEU . 36.2 t -58.13 -23.13 53.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.81 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -127.28 139.71 52.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.654 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.6 t -144.48 134.82 24.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.687 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -122.54 125.56 72.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.822 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 7.5 m -64.46 148.46 50.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.331 0.586 . . . . 0.0 112.091 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.6 p -166.82 124.26 1.29 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.32 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 59.3 39.02 22.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.082 0.468 . . . . 0.0 110.079 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.573 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 62.11 24.1 64.74 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.659 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -142.42 135.93 29.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.505 0.193 . . . . 0.0 110.81 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.457 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 59.5 m95 -64.33 133.03 51.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.741 0.305 . . . . 0.0 110.546 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -57.44 -59.43 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.009 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.9 p -94.11 135.48 24.54 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.778 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.16 142.91 82.37 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.726 2.284 . . . . 0.0 111.915 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -50.72 129.29 27.41 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.302 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.741 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.8 Cg_endo -75.69 -148.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.692 2.261 . . . . 0.0 112.47 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.422 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 15.5 p-80 -153.69 143.32 21.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.172 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 88.3 m -97.63 130.85 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.031 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -124.02 143.36 50.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.184 0.516 . . . . 0.0 111.794 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.485 HG22 ' CE2' ' A' ' 134' ' ' PHE . 4.5 t -66.0 137.27 25.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.982 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.2 p30 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.173 -0.917 . . . . 0.0 111.002 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.96 HG22 ' HB2' ' A' ' 121' ' ' LEU . 4.4 pt . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 121.029 0.443 . . . . 0.0 111.82 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.673 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 2.4 p -53.5 136.55 38.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.698 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 102' ' ' SER . 46.8 t -40.4 128.83 2.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.973 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -74.46 23.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.528 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.571 ' O ' HG22 ' A' ' 105' ' ' THR . 77.7 p -68.87 -41.16 78.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.029 0.442 . . . . 0.0 110.506 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.476 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.7 m-85 -67.92 -25.29 65.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.449 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.409 HD21 HD23 ' A' ' 113' ' ' LEU . 79.0 mt -68.86 23.9 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 102' ' ' SER . 9.2 t -148.36 129.55 14.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.56 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 43.5 tp -145.44 127.37 15.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 107' ' ' GLU . 41.9 tp10 -82.36 46.15 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.095 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -158.89 -30.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.215 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.643 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -158.33 -150.77 5.86 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.386 -0.912 . . . . 0.0 113.349 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -130.23 152.07 50.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.816 0.341 . . . . 0.0 111.005 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 103' ' ' TYR . 61.0 t -105.79 126.4 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -80.17 69.18 6.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.977 ' HA ' HG12 ' A' ' 126' ' ' VAL . 3.3 tm? -63.73 145.12 56.35 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.705 ' N ' HD13 ' A' ' 113' ' ' LEU . 56.4 m -149.06 81.74 1.43 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.022 0.439 . . . . 0.0 111.391 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.613 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . 177.03 -103.01 0.17 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.216 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . 59.58 144.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.073 0.389 . . . . 0.0 114.073 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.705 ' C ' HD22 ' A' ' 118' ' ' LEU . 57.6 m-20 71.86 49.84 0.25 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.705 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.4 mm? -142.23 138.68 16.88 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.883 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 120' ' ' ALA . 70.1 Cg_endo -74.55 33.94 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.376 2.051 . . . . 0.0 112.192 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 119' ' ' PRO . . . 172.19 -44.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.732 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.96 ' HB2' HG22 ' A' ' 98' ' ' ILE . 15.2 tp 59.7 43.9 14.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 64.4 t0 -79.97 58.49 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.822 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.37 -27.09 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.738 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -48.83 153.53 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.063 0.458 . . . . 0.0 111.707 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -139.5 136.67 34.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.369 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.977 HG12 ' HA ' ' A' ' 113' ' ' LEU . 29.1 m -125.66 139.26 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.07 0.462 . . . . 0.0 111.942 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -120.71 98.24 5.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.397 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.476 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 4.6 m-85 -64.65 147.45 52.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.347 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -159.95 115.52 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.409 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.643 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 91.7 m -89.17 149.16 23.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.456 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.469 ' OD1' ' HA2' ' A' ' 109' ' ' GLY . 1.3 m-20 -52.7 158.35 2.2 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.083 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.509 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 99.3 Cg_exo -43.04 159.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.906 2.404 . . . . 0.0 112.564 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 49.8 m-20 80.76 -31.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.79 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.86 143.97 33.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.414 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -133.99 131.31 38.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.973 0.416 . . . . 0.0 111.015 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.768 HD11 ' HG2' ' A' ' 154' ' ' PRO . 24.4 tp -78.32 133.77 37.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.668 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.99 71.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.66 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.67 -133.61 2.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.955 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.597 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 58.7 m -76.05 54.82 0.88 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.739 0.304 . . . . 0.0 110.958 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.424 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 95.7 p -50.0 -41.31 46.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -99.38 130.23 45.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.482 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 126' ' ' VAL . 44.0 t -134.9 127.27 30.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.902 0.382 . . . . 0.0 110.74 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.5 t -93.81 128.67 45.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.357 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.735 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 48.9 t -83.03 134.43 35.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.887 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 79.3 p -175.04 132.95 0.32 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.972 0.415 . . . . 0.0 111.853 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 53.53 46.29 26.42 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.881 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.673 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . 52.76 23.35 14.52 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.961 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -142.49 130.22 21.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.66 0.267 . . . . 0.0 110.824 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.466 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 65.3 m95 -75.98 135.18 40.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 111.03 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 m -57.52 -53.98 51.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.036 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 80.8 p -107.5 129.53 24.11 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.477 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 139' ' ' SER . 38.8 Cg_exo -60.74 142.87 98.97 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.745 2.296 . . . . 0.0 111.866 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.56 ' NZ ' HD13 ' A' ' 106' ' ' LEU . 57.1 tttm -51.76 125.87 30.74 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.305 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.768 ' HG2' HD11 ' A' ' 136' ' ' LEU . 80.8 Cg_endo -79.26 -149.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.666 2.244 . . . . 0.0 112.433 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -153.95 141.47 19.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.741 0.305 . . . . 0.0 111.446 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 95.1 m -98.58 132.76 43.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.602 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -103.03 133.92 47.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.426 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.86 138.67 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.738 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' A' ' 133' ' ' ASP . 24.6 p30 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.029 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.494 HD11 ' C ' ' A' ' 117' ' ' ASP . 1.6 mp . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.966 0.412 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.47 ' O ' HG22 ' A' ' 98' ' ' ILE . 69.4 m -57.44 146.54 29.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.518 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 99' ' ' CYS . 52.8 m -35.85 120.98 0.63 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.017 0.437 . . . . 0.0 111.491 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.566 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -72.82 3.22 5.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.883 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.6 p -66.48 -41.95 88.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.353 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.554 ' HD2' ' HZ ' ' A' ' 128' ' ' PHE . 2.1 m-85 -54.23 -42.28 69.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.307 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 84.8 mt -59.25 -35.89 74.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -92.55 69.39 4.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.648 HD13 ' HE2' ' A' ' 153' ' ' LYS . 28.7 tp -94.61 130.99 40.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.187 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -67.57 136.06 53.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.289 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.522 ' HB3' ' OD1' ' A' ' 131' ' ' ASP . 75.4 m-20 55.83 44.11 26.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.353 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.59 164.65 34.44 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.493 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -136.99 130.91 32.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 0.0 110.489 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 48.5 t -106.5 123.09 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.3 m-85 -78.4 125.84 29.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.019 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.473 HD12 ' H ' ' A' ' 114' ' ' THR . 60.8 tp -85.18 150.91 24.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.252 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.473 ' H ' HD12 ' A' ' 113' ' ' LEU . 27.8 m -156.59 56.8 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.531 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -157.0 -105.15 0.22 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.21 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.57 -127.43 1.34 Allowed Glycine 0 CA--C 1.516 0.146 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.752 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.494 ' C ' HD11 ' A' ' 98' ' ' ILE . 38.8 t70 -152.15 41.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.298 0.57 . . . . 0.0 110.466 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.5 mt -95.02 152.01 39.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.36 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 86.6 Cg_exo -42.96 123.11 3.01 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.369 2.046 . . . . 0.0 111.998 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 73.63 -37.44 0.37 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.401 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.808 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 22.9 tp 55.88 45.15 24.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 111.18 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 8.1 t70 -65.51 133.42 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.69 -28.54 13.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.477 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 1.044 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.15 143.3 3.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.742 0.306 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.595 ' CD ' HG22 ' A' ' 143' ' ' VAL . 40.6 mmm-85 -129.6 144.9 51.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.21 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 32.8 m -142.38 134.93 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.553 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -107.97 116.84 32.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.704 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.554 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.5 m-85 -80.16 147.68 31.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.993 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -156.19 124.91 5.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.974 0.416 . . . . 0.0 110.815 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 136' ' ' LEU . 68.7 m -89.52 146.42 24.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.119 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' HB3' ' A' ' 108' ' ' ASN . 12.1 p-10 -55.28 154.97 10.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.735 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 2.3 Cg_endo -45.08 155.38 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.935 2.423 . . . . 0.0 111.906 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.4 m-20 78.57 -34.72 0.17 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.776 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 10.7 m-85 -106.53 126.51 52.36 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -106.89 137.19 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 111.296 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' A' ' 140' ' ' SER . 33.6 tp -71.24 136.84 48.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.724 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.31 67.78 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.577 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.75 -136.06 2.32 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.295 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.57 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 92.9 p -74.13 59.74 0.76 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.873 0.368 . . . . 0.0 110.75 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.631 ' HA ' HD21 ' A' ' 136' ' ' LEU . 97.0 p -47.94 -34.72 9.53 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.179 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 141' ' ' ARG . 21.2 mmt85 -109.55 138.79 45.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.706 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 45.3 t -143.57 127.03 16.84 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.595 HG22 ' CD ' ' A' ' 125' ' ' ARG . 24.0 t -103.91 117.8 50.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.775 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 1.044 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 50.7 t -71.82 140.43 49.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.936 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 43.8 t -169.43 131.97 1.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.819 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 56.35 41.8 28.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.583 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.67 25.06 50.25 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -141.68 132.51 25.83 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.489 0.185 . . . . 0.0 110.662 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.411 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 72.6 m95 -71.26 138.95 49.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.074 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.9 t -57.44 -58.46 8.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.279 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 82.8 p -101.78 136.55 19.52 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.6 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 33.3 Cg_exo -60.44 138.83 83.1 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.736 2.291 . . . . 0.0 111.954 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.648 ' HE2' HD13 ' A' ' 106' ' ' LEU . 84.5 tttt -47.99 131.48 12.01 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.341 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.57 ' HB3' ' H ' ' A' ' 139' ' ' SER . 88.4 Cg_endo -84.37 -148.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.873 2.382 . . . . 0.0 113.029 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.439 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.6 p-80 -153.66 149.69 27.81 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.965 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 91.4 m -97.91 136.16 38.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.01 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -136.93 133.98 36.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 134' ' ' PHE . 8.7 p -65.6 142.55 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.277 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.884 -179.946 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.756 HG22 ' H ' ' A' ' 118' ' ' LEU . 14.7 pt . . . . . 0 N--CA 1.464 0.264 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.503 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 36.1 m 55.97 142.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.3 p -44.08 130.67 6.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.944 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.544 ' HB2' HD12 ' A' ' 104' ' ' LEU . 18.0 ptpt -77.45 10.75 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.513 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.2 m -68.93 -44.76 72.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 110.693 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 103' ' ' TYR . 1.2 m-85 -62.63 -33.1 74.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.253 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.759 HD22 HD22 ' A' ' 113' ' ' LEU . 65.8 mt -49.8 -45.45 49.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.1 t -92.51 138.65 31.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.109 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.803 HD13 ' HE3' ' A' ' 153' ' ' LYS . 28.6 tp -143.75 126.41 16.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.023 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.496 ' HG3' ' ND2' ' A' ' 108' ' ' ASN . 17.0 tp10 -73.45 124.59 26.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.018 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.496 ' ND2' ' HG3' ' A' ' 107' ' ' GLU . 74.4 m-20 56.3 49.15 15.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.524 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.74 148.42 11.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.891 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.722 ' HB2' ' HD2' ' A' ' 129' ' ' ARG . 55.1 mtpt -102.53 138.84 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.74 119.22 59.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.541 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.615 ' C ' HG23 ' A' ' 126' ' ' VAL . 2.6 m-85 -83.14 60.43 5.51 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.268 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.759 HD22 HD22 ' A' ' 104' ' ' LEU . 63.2 tp -59.52 145.99 42.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.15 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 27.1 m -158.86 53.31 0.41 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.587 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.467 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . 177.14 105.08 0.19 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.147 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.503 ' N ' HD21 ' A' ' 121' ' ' LEU . . . -163.12 138.16 5.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.784 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.687 ' C ' HD12 ' A' ' 118' ' ' LEU . 8.2 t70 73.2 42.21 0.45 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.98 0.419 . . . . 0.0 111.055 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.756 ' H ' HG22 ' A' ' 98' ' ' ILE . 9.5 mp -137.38 150.1 67.63 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -44.87 89.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.987 2.458 . . . . 0.0 112.818 -179.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . 56.0 13.58 1.18 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.734 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 118' ' ' LEU . 58.7 mt 50.09 60.32 3.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.538 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.817 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 9.1 t70 -76.11 45.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.229 0.538 . . . . 0.0 110.412 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.59 25.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.127 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.946 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -84.13 153.19 23.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.719 0.295 . . . . 0.0 111.002 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.649 ' O ' ' HB ' ' A' ' 114' ' ' THR . 4.4 tmm_? -151.48 140.67 21.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.441 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.615 HG23 ' C ' ' A' ' 112' ' ' PHE . 1.6 p -151.35 148.28 14.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.493 0.663 . . . . 0.0 112.107 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -113.3 118.11 33.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.689 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.527 ' HB2' ' HA ' ' A' ' 140' ' ' SER . 6.3 m-85 -89.0 145.58 25.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.097 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.722 ' HD2' ' HB2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -159.57 138.94 11.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.437 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 66.0 m -89.24 144.21 26.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.681 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.537 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 9.0 p-10 -54.02 160.68 2.15 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.556 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 2.8 Cg_endo -44.98 149.72 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.86 2.374 . . . . 0.0 111.692 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.556 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 36.1 t70 80.64 -31.37 0.12 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.578 -178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -108.86 132.44 54.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.191 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -108.94 148.09 31.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.169 0.509 . . . . 0.0 111.925 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 140' ' ' SER . 1.1 tm? -79.2 128.73 33.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.701 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.668 ' N ' HD13 ' A' ' 136' ' ' LEU . 21.7 t -132.63 60.31 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.66 0.266 . . . . 0.0 111.602 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . 0.402 ' H ' ' CD1' ' A' ' 136' ' ' LEU . . . -176.65 -133.85 1.87 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.206 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.585 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 63.9 m -73.4 59.64 0.6 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.392 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.686 ' HB2' HD12 ' A' ' 136' ' ' LEU . 38.9 t -62.49 -2.48 1.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 139' ' ' SER . 79.2 ttt180 -140.65 133.96 29.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.517 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 61.2 m -147.41 134.02 19.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.52 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 124' ' ' ALA . 94.3 t -128.73 122.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 111.316 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.946 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 55.4 m -85.16 140.87 30.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.497 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.817 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 79.7 p -169.65 31.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.063 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 177.47 34.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.061 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 59.6 14.97 31.02 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.465 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -142.63 133.73 25.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.536 0.208 . . . . 0.0 110.686 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.503 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 74.2 m95 -66.89 137.61 56.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.699 0.285 . . . . 0.0 110.761 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.0 m -57.39 -56.22 24.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.556 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 66.9 p -106.23 136.69 19.31 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.764 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 53.2 Cg_exo -55.89 151.58 40.31 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.865 2.377 . . . . 0.0 112.187 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.803 ' HE3' HD13 ' A' ' 106' ' ' LEU . 4.8 tmtm? -51.21 121.74 16.96 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.575 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.585 ' HB3' ' N ' ' A' ' 139' ' ' SER . 47.7 Cg_endo -69.71 -160.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.676 2.25 . . . . 0.0 112.975 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.74 148.98 27.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.72 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 97.1 m -97.88 139.6 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 0.0 111.408 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -130.98 129.77 42.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.1 p -63.7 143.31 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.189 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . 0.432 HD22 ' N ' ' A' ' 159' ' ' ASN . 2.6 m120 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.973 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.616 ' HB ' ' HA ' ' A' ' 117' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.187 0 CA-C-O 120.731 0.3 . . . . 0.0 110.497 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.464 ' HB3' ' CZ2' ' A' ' 149' ' ' TRP . 80.4 m 64.27 133.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.243 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.536 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 37.3 t -41.56 127.69 3.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.905 0.383 . . . . 0.0 111.245 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -75.5 -37.42 60.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.503 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.9 t -53.21 -43.38 67.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.664 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.797 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.4 m-85 -59.38 -34.89 72.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.514 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.22 -43.87 74.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.988 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.9 t -92.55 145.98 24.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.975 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.618 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 22.0 tp -144.36 130.1 19.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.342 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.15 132.95 42.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.392 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.416 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.6 m120 57.49 41.01 26.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.614 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.97 152.0 10.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.057 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -104.78 154.02 20.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.58 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.476 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 99.1 t -131.17 118.52 41.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.298 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.2 m-85 -73.08 80.08 1.23 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.513 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.877 ' HA ' HG12 ' A' ' 126' ' ' VAL . 7.7 tt -51.88 140.25 20.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.155 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.622 ' N ' HD23 ' A' ' 113' ' ' LEU . 20.6 m -153.33 53.73 0.74 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.267 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . 128.0 110.24 1.55 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.869 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -171.31 50.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.024 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.768 ' C ' HD22 ' A' ' 118' ' ' LEU . 12.3 p-10 -171.29 39.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 110.821 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.768 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.2 mm? -145.36 153.68 52.39 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.248 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.484 ' O ' ' HB3' ' A' ' 120' ' ' ALA . 5.0 Cg_endo -48.41 81.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.959 2.439 . . . . 0.0 111.873 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.543 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 75.2 -40.81 0.44 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.035 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 118' ' ' LEU . 19.2 tp 53.07 58.98 4.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.06 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.35 84.5 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.588 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 121' ' ' LEU . . . 163.9 -35.8 0.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.912 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.545 ' HB2' HD23 ' A' ' 121' ' ' LEU . . . -49.81 150.67 2.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.725 0.298 . . . . 0.0 111.171 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.55 ' O ' ' HB ' ' A' ' 114' ' ' THR . 58.6 ttp180 -157.67 118.02 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.232 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.877 HG12 ' HA ' ' A' ' 113' ' ' LEU . 30.4 m -97.89 133.65 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.2 mt-10 -92.56 115.99 28.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -76.33 150.88 36.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.996 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 129' ' ' ARG . 11.3 tpt180 -158.65 131.78 7.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 83.6 m -90.28 155.71 18.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.155 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -52.6 158.03 2.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.223 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.55 62.97 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.178 2.585 . . . . 0.0 112.737 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -177.12 -29.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.781 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 4.1 m-85 -108.66 139.91 42.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.335 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -102.85 133.37 48.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.179 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' A' ' 140' ' ' SER . 37.1 tp -76.17 131.16 39.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.871 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.3 t -135.92 68.04 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.789 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.54 -131.94 1.76 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.151 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.5 p -71.39 63.29 0.38 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 110.661 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.768 ' HA ' HD21 ' A' ' 136' ' ' LEU . 93.0 p -55.67 -20.28 13.61 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.911 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -140.59 136.58 32.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 111.141 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.596 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 60.5 m -129.58 136.22 49.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.708 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 82.2 t -117.85 132.82 66.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.274 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 75.4 m -60.19 142.74 53.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.299 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.7 t -173.02 120.01 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 58.15 42.68 21.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.902 0.382 . . . . 0.0 110.782 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 64.48 11.57 48.38 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.667 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -142.84 135.66 27.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.271 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 54.4 m95 -67.22 142.23 57.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.669 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.4 m -55.08 -57.48 11.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.8 p -98.91 133.78 22.02 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.807 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.455 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 40.1 Cg_endo -67.08 -160.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.315 2.01 . . . . 0.0 112.255 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.797 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 4.5 mmmp? -84.95 130.23 53.25 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.831 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.551 ' HD2' ' HZ2' ' A' ' 153' ' ' LYS . 90.1 Cg_endo -81.1 -151.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.636 2.224 . . . . 0.0 112.545 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.432 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.4 p-80 -153.73 139.94 18.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 78.6 m -98.71 127.72 44.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.541 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -105.17 141.03 37.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.337 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.31 140.22 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.078 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.3 p30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.971 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.525 ' O ' HD12 ' A' ' 98' ' ' ILE . 1.5 pp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 121.499 0.666 . . . . 0.0 112.003 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.652 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 3.6 m -83.36 146.09 28.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.144 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.4 m -40.21 121.21 1.32 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 111.029 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -70.73 -24.06 62.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.154 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.5 t -53.05 -42.15 65.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.722 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.521 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.0 m-85 -62.93 -42.96 99.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.545 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.07 -38.24 73.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.414 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 t -92.5 135.69 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 111.312 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.589 ' HB3' ' O ' ' A' ' 109' ' ' GLY . 21.3 tp -145.41 129.76 17.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.715 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -81.4 38.52 0.49 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.49 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.9 p30 177.21 26.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.388 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 106' ' ' LEU . . . 168.84 155.89 10.08 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.535 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.589 ' NZ ' ' HB2' ' A' ' 110' ' ' LYS . 9.8 mtmp? -101.32 146.01 28.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.116 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 103' ' ' TYR . 64.5 t -105.4 120.77 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 111.38 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.432 ' CE1' ' HD2' ' A' ' 129' ' ' ARG . 1.6 m-85 -84.59 68.26 10.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.841 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.965 ' HA ' HG12 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -62.56 147.52 48.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.02 0.438 . . . . 0.0 111.295 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.9 m -133.2 70.84 1.46 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.1 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -165.18 -98.25 0.12 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.94 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.601 ' H ' HD21 ' A' ' 121' ' ' LEU . . . 61.06 127.6 0.01 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.391 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.561 ' O ' HD23 ' A' ' 118' ' ' LEU . 62.1 t0 60.31 49.48 7.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.973 0.416 . . . . 0.0 111.369 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.657 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 68.8 mt -131.83 143.3 48.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.732 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.5 85.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.667 2.245 . . . . 0.0 111.581 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.533 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 61.79 17.11 8.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.202 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.657 ' HG ' ' HB2' ' A' ' 118' ' ' LEU . 7.4 mp 40.72 53.84 3.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.844 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.43 45.59 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.228 0.537 . . . . 0.0 110.234 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.2 -25.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.779 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -57.51 147.4 26.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.875 0.369 . . . . 0.0 111.211 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' ' 125' ' ' ARG . 50.5 ttp85 -133.36 137.81 46.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.629 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.965 HG12 ' HA ' ' A' ' 113' ' ' LEU . 32.8 m -120.12 135.76 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.017 0.437 . . . . 0.0 111.643 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -112.89 113.58 25.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.095 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -76.01 141.86 42.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 111.654 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.432 ' HD2' ' CE1' ' A' ' 112' ' ' PHE . 71.1 mtt-85 -148.91 108.88 4.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.117 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 95.6 m -89.54 160.75 16.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.957 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -52.69 156.6 3.12 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.448 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.5 56.07 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.06 2.507 . . . . 0.0 112.588 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -153.07 -37.45 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.648 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -108.8 134.18 51.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.636 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -101.22 132.92 46.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.171 0.51 . . . . 0.0 111.176 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.696 HD21 ' HA ' ' A' ' 140' ' ' SER . 23.0 tp -76.39 129.99 37.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.693 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.5 t -136.3 61.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.697 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.14 -138.01 2.41 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.503 -1.332 . . . . 0.0 113.406 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.66 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.4 m -74.6 57.8 0.75 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 110.975 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.696 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.0 t -49.94 -38.36 36.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.001 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.04 136.18 44.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.434 ' O ' HG22 ' A' ' 126' ' ' VAL . 53.4 m -146.42 125.99 13.31 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.811 0.339 . . . . 0.0 111.304 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 76.5 t -104.95 125.39 59.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.669 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 48.1 t -71.42 151.86 43.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.099 0.476 . . . . 0.0 111.587 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -168.72 122.97 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.892 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.6 tt0 54.48 43.23 30.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.263 0.554 . . . . 0.0 109.634 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.533 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 58.01 29.2 61.95 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.858 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -139.69 131.34 27.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.641 0.258 . . . . 0.0 110.408 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -75.45 139.34 42.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 111.625 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.1 t -57.42 -58.48 8.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.199 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 77.3 p -106.93 134.64 19.77 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.514 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 139' ' ' SER . 35.5 Cg_exo -57.8 142.41 96.16 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.668 2.246 . . . . 0.0 112.041 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.517 ' CE ' HD13 ' A' ' 106' ' ' LEU . 87.2 tttt -51.62 125.86 29.43 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.131 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.66 ' HB3' ' N ' ' A' ' 139' ' ' SER . 61.1 Cg_endo -73.21 -152.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.595 2.197 . . . . 0.0 112.427 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -153.68 133.67 13.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.905 0.383 . . . . 0.0 111.295 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 16.6 m -98.83 132.46 44.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.912 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.4 ' HA ' ' NE2' ' A' ' 157' ' ' GLN . 2.9 tp-100 -124.38 139.66 53.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.051 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.97 134.52 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.3 p30 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.984 -179.858 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.496 HD12 ' HE2' ' A' ' 101' ' ' LYS . 15.3 pt . . . . . 0 N--CA 1.467 0.421 0 CA-C-O 121.675 0.75 . . . . 0.0 112.856 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.557 ' HB2' ' NE1' ' A' ' 149' ' ' TRP . 2.4 p -62.01 136.84 58.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.563 178.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -40.02 127.54 2.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.253 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.496 ' HE2' HD12 ' A' ' 98' ' ' ILE . 68.5 mttm -77.43 14.94 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.434 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -68.9 -39.01 79.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.027 0.442 . . . . 0.0 110.432 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.769 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.6 m-85 -56.3 -34.08 66.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.523 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.559 HD11 HD13 ' A' ' 113' ' ' LEU . 86.3 mt -74.71 38.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.685 -179.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 74.2 m -147.46 114.48 6.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 111.0 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.5 mt -145.5 128.21 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -82.58 43.13 0.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -177.02 -43.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.017 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 130' ' ' CYS . . . -79.11 -162.37 23.19 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.732 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 111' ' ' VAL . 22.7 tptm -142.12 -43.81 0.34 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.723 0.297 . . . . 0.0 110.805 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 11.9 p 49.1 120.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.015 179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.3 m-85 -84.38 117.92 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.579 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.559 HD13 HD11 ' A' ' 104' ' ' LEU . 55.1 tp -83.52 145.51 28.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 111.447 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.0 m -158.51 53.06 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.803 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . 165.33 105.48 0.19 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.825 -179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.64 140.02 6.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.634 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.494 ' O ' HD23 ' A' ' 118' ' ' LEU . 57.2 m-20 62.52 43.98 7.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.86 0.362 . . . . 0.0 111.216 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 84.5 mt -134.82 144.68 51.54 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.18 96.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.965 2.443 . . . . 0.0 113.796 -179.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 121' ' ' LEU . . . 68.62 -29.83 0.17 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.715 HD22 ' HB2' ' A' ' 124' ' ' ALA . 32.0 mt 65.11 51.27 1.7 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.829 0.347 . . . . 0.0 111.019 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -77.17 51.42 0.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.548 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.64 -21.03 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.205 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.962 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.94 148.45 1.67 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.735 0.302 . . . . 0.0 111.418 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.533 ' O ' ' HB ' ' A' ' 114' ' ' THR . 70.1 mtt-85 -141.73 141.07 33.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 34.5 m -133.59 137.02 53.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 111.14 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -116.17 99.25 7.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 46.3 m-85 -68.06 139.39 56.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.42 . . . . 0.0 111.106 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -142.71 133.17 24.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.243 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.529 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 60.7 m -89.19 148.7 23.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 133' ' ' ASP . 45.7 p-10 -52.67 153.93 5.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.31 72.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.235 2.623 . . . . 0.0 113.204 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 131' ' ' ASP . 38.9 t70 178.66 -39.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.048 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 5.6 m-85 -107.0 139.18 41.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.904 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -102.83 134.26 46.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 111.151 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 140' ' ' SER . 19.8 tp -76.54 131.92 39.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.923 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.58 66.23 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.861 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -171.98 -136.91 2.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.149 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.632 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 45.4 p -76.55 53.98 0.91 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.989 0.423 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.634 ' HA ' HD21 ' A' ' 136' ' ' LEU . 47.6 t -49.07 -43.91 41.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.246 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -99.48 133.24 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.657 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.5 t -141.23 125.08 17.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.684 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 90.5 t -100.19 123.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.385 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.962 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 47.2 t -76.7 136.12 39.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.621 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.2 t -172.68 134.01 0.61 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.774 0.321 . . . . 0.0 111.183 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.427 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 0.5 OUTLIER 57.4 41.44 26.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.85 18.55 25.89 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.998 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -141.09 131.09 24.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 110.619 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.557 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 33.6 m95 -73.03 138.29 45.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.173 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 54.0 m -57.45 -52.99 63.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.004 179.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 78.8 p -114.4 136.95 22.38 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.481 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 30.0 Cg_exo -62.03 -159.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.512 2.141 . . . . 0.0 112.428 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.769 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 60.8 mtpt -96.66 125.77 45.68 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.965 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.632 ' HB2' HD11 ' A' ' 136' ' ' LEU . 68.1 Cg_endo -74.36 -148.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.282 1.988 . . . . 0.0 111.939 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -153.74 143.11 21.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.902 0.382 . . . . 0.0 111.283 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 79.3 m -96.72 132.99 41.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.168 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -131.31 140.26 49.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.398 . . . . 0.0 111.481 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.7 p -64.34 137.72 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.01 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.881 179.975 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.599 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 121.236 0.541 . . . . 0.0 111.463 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.671 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 3.2 m -63.58 173.4 1.68 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.55 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.404 ' HB2' ' CD1' ' A' ' 149' ' ' TRP . 52.0 m -42.4 129.22 3.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 111.195 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.759 ' HD2' HD12 ' A' ' 104' ' ' LEU . 24.0 tptm -76.89 -31.43 56.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.432 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.8 p -53.08 -43.86 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.945 -179.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.845 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.3 m-85 -56.9 -41.45 78.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.694 0.283 . . . . 0.0 111.065 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.759 HD12 ' HD2' ' A' ' 101' ' ' LYS . 90.9 mt -58.65 139.95 55.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.3 m 65.35 137.72 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.168 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.542 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 46.2 tp -145.43 133.68 21.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.417 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.76 140.51 56.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.22 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 65.19 30.82 11.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.394 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 175.7 -168.26 40.52 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.042 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.694 ' HD3' ' N ' ' A' ' 111' ' ' VAL . 1.5 tmtp? -141.95 143.29 33.17 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.694 ' N ' ' HD3' ' A' ' 110' ' ' LYS . 71.2 t -106.39 120.73 57.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.929 0.395 . . . . 0.0 111.458 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.558 ' HE1' ' HB3' ' A' ' 129' ' ' ARG . 3.3 m-85 -70.22 125.99 28.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.045 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.648 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -105.78 141.64 36.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.939 0.4 . . . . 0.0 110.94 -179.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.648 ' N ' HD13 ' A' ' 113' ' ' LEU . 35.6 m -158.89 65.61 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.619 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.527 ' O ' ' HG ' ' A' ' 118' ' ' LEU . . . -156.83 -43.53 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.649 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.464 ' O ' HD11 ' A' ' 121' ' ' LEU . . . 71.76 -132.46 19.91 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.886 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -115.7 34.78 4.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.987 0.422 . . . . 0.0 111.225 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 120' ' ' ALA . 96.5 mt -64.19 162.91 27.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.911 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 81.9 Cg_exo -43.57 80.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.772 2.315 . . . . 0.0 112.01 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.774 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 59.19 22.96 11.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.405 -178.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 6.8 mp 44.41 62.7 1.92 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.228 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.705 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 38.7 t70 -74.97 42.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.096 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.89 28.72 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.394 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 121' ' ' LEU . . . -77.58 122.17 24.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.706 0.288 . . . . 0.0 111.1 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -90.88 134.79 34.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.655 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 113' ' ' LEU . 30.1 m -145.78 140.59 21.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.669 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -121.25 120.43 35.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.415 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.445 ' O ' HD22 ' A' ' 136' ' ' LEU . 2.0 m-85 -84.38 47.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 110.992 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.558 ' HB3' ' HE1' ' A' ' 112' ' ' PHE . 21.2 tpp180 -64.33 126.77 28.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.509 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.544 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 65.3 m -98.47 158.95 15.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.324 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 133' ' ' ASP . 55.6 m-20 -52.69 148.28 13.43 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.831 -179.516 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.18 79.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.204 2.602 . . . . 0.0 112.717 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 131' ' ' ASP . 9.1 t0 -179.14 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.599 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.406 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 2.5 m-85 -108.78 130.85 55.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.199 179.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -102.75 130.64 49.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.904 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.766 HD11 ' HG2' ' A' ' 154' ' ' PRO . 22.8 tp -75.48 133.82 40.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.412 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.86 70.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.688 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.46 -132.65 1.96 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.819 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.507 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 70.8 m -76.12 55.13 0.92 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.708 0.29 . . . . 0.0 111.028 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.549 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 90.0 p -49.25 -43.11 42.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.671 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -100.46 133.93 44.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.229 178.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 126' ' ' VAL . 47.4 t -144.02 136.22 26.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.389 . . . . 0.0 110.953 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 57.5 t -122.46 117.05 50.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.343 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 149' ' ' TRP . 46.1 t -65.8 155.31 36.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.109 0.481 . . . . 0.0 111.502 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.705 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 46.5 t -166.44 122.01 1.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.838 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 57.68 44.13 21.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.081 0.467 . . . . 0.0 110.62 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.774 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 64.72 20.65 66.45 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.636 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -141.4 127.03 18.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.64 0.257 . . . . 0.0 110.749 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.696 ' HA ' ' HA ' ' A' ' 144' ' ' CYS . 58.0 m95 -71.94 139.36 48.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.934 0.397 . . . . 0.0 111.372 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.4 t -57.53 -62.46 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.378 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 71.1 p -95.38 137.08 22.12 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.755 -179.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 45.1 Cg_endo -67.69 140.38 51.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.882 2.388 . . . . 0.0 112.418 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.845 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 64.4 tttm -53.87 121.2 27.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.264 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.766 ' HG2' HD11 ' A' ' 136' ' ' LEU . 86.5 Cg_endo -81.32 -147.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.832 2.355 . . . . 0.0 112.932 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.423 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 19.5 p-80 -153.61 144.72 22.89 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . 0.473 ' SG ' HD13 ' A' ' 136' ' ' LEU . 64.8 m -98.47 142.64 29.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -133.7 139.24 46.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.829 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.59 138.41 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.507 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.889 179.935 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.8 HG21 ' HA ' ' A' ' 117' ' ' ASP . 4.9 pt . . . . . 0 CA--C 1.519 -0.239 0 CA-C-O 120.861 0.362 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.599 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 74.6 m 62.31 134.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.971 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.3 m -40.32 119.97 1.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.716 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -74.83 -9.72 58.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.869 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.6 t -58.75 -19.93 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.837 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.472 ' HD2' ' HZ ' ' A' ' 128' ' ' PHE . 4.7 m-85 -64.62 -46.28 83.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.166 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.794 HD12 HG23 ' A' ' 105' ' ' THR . 1.7 pp -76.98 33.3 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.893 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.794 HG23 HD12 ' A' ' 104' ' ' LEU . 61.6 p -147.54 58.54 1.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.36 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.4 tp -94.49 135.75 35.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.5 -178.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.53 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 87.9 tt0 -66.59 138.48 57.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.352 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.53 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 75.1 m-20 56.56 40.13 29.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.304 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.28 168.46 41.53 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.214 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 28.9 mtpp -141.68 139.52 32.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.733 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.681 HG12 ' HB ' ' A' ' 126' ' ' VAL . 35.7 t -118.76 126.13 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -80.25 121.4 25.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.141 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.774 ' HA ' HG12 ' A' ' 126' ' ' VAL . 3.1 tm? -85.04 143.5 28.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.917 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.657 ' H ' HD22 ' A' ' 113' ' ' LEU . 43.4 m -152.96 65.96 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.574 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.409 ' HA3' HD21 ' A' ' 121' ' ' LEU . . . -158.1 -107.4 0.24 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.886 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.15 -124.29 1.3 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.848 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.8 ' HA ' HG21 ' A' ' 98' ' ' ILE . 37.6 t70 -148.68 47.84 1.02 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.237 0.541 . . . . 0.0 110.644 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.585 ' HB2' HD13 ' A' ' 121' ' ' LEU . 2.9 mm? -94.19 150.89 39.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.505 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 121' ' ' LEU . 88.9 Cg_exo -43.47 105.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.37 2.047 . . . . 0.0 111.985 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 72.45 -37.95 0.4 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.357 -179.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.725 ' HB2' HG22 ' A' ' 98' ' ' ILE . 14.1 tp 58.06 56.24 4.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 0.0 111.16 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -70.14 69.29 0.34 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 179.59 -30.48 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.237 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.54 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . . . -49.05 153.04 0.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.972 0.415 . . . . 0.0 111.398 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.505 ' HD2' ' NH2' ' A' ' 141' ' ' ARG . 53.9 ttp180 -153.56 135.86 14.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.714 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.774 HG12 ' HA ' ' A' ' 113' ' ' LEU . 34.4 m -127.52 137.16 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.108 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -100.94 121.15 41.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.37 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.472 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.3 m-85 -86.03 150.77 24.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 15.8 ptm180 -163.96 134.86 4.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.759 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 68.0 m -89.2 155.11 19.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.496 -179.304 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -52.71 163.27 0.82 Allowed Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.383 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.73 52.07 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.205 2.603 . . . . 0.0 112.708 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -155.59 -39.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.5 m-85 -108.9 141.02 41.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.651 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -102.1 134.11 45.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.123 0.487 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.551 HD21 ' CG ' ' A' ' 154' ' ' PRO . 3.4 tm? -72.97 130.86 41.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.622 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.534 ' N ' HD13 ' A' ' 136' ' ' LEU . 26.6 t -134.57 66.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.573 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.03 -129.68 1.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 119.71 -1.233 . . . . 0.0 113.212 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.691 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 31.3 t -68.75 65.41 0.12 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.979 0.419 . . . . 0.0 111.384 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.476 ' HB3' HD12 ' A' ' 136' ' ' LEU . 94.5 p -63.12 -18.35 63.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.874 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.505 ' NH2' ' HD2' ' A' ' 125' ' ' ARG . 50.2 mtp85 -140.66 137.31 33.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.768 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 90.0 p -135.21 128.17 31.46 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.758 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.91 126.63 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.96 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 41.9 t -73.36 139.21 45.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.016 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -170.57 131.41 0.9 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.552 179.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 58.76 38.58 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.57 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 60.9 19.14 55.69 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.998 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -144.7 133.11 21.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.619 0.247 . . . . 0.0 111.239 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . 0.599 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 94.1 m95 -70.34 135.58 48.97 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.83 0.348 . . . . 0.0 110.995 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.0 t -57.42 -56.26 24.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.372 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.499 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 55.4 p -97.08 133.14 24.49 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 8.2 Cg_exo -71.97 149.11 52.55 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.22 2.613 . . . . 0.0 111.941 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -47.42 125.57 9.64 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-O 120.64 0.257 . . . . 0.0 111.216 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.691 ' HB3' ' H ' ' A' ' 139' ' ' SER . 58.0 Cg_endo -71.49 -146.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.63 2.22 . . . . 0.0 112.401 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . 0.426 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.7 145.41 23.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.451 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 70.8 m -96.66 133.64 40.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.82 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -124.76 136.29 53.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 p -64.67 137.15 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.035 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.958 179.937 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.422 ' CG2' ' HA ' ' A' ' 117' ' ' ASP . 1.5 pp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.803 0.335 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.1 m 61.18 160.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.197 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.9 t -39.82 128.67 2.08 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.662 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.684 ' HA ' HD23 ' A' ' 104' ' ' LEU . 17.5 tppt? -76.6 -27.94 55.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.362 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.2 m -53.14 -38.33 62.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.317 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.472 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.8 m-85 -60.85 -39.23 88.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.278 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.684 HD23 ' HA ' ' A' ' 101' ' ' LYS . 2.1 mm? -53.37 -42.45 66.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.222 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.7 m -92.54 141.26 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.533 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 107' ' ' GLU . 5.3 tt -142.57 127.05 17.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.611 -179.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.528 ' N ' HD23 ' A' ' 106' ' ' LEU . 17.3 tp10 -67.14 128.08 35.01 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 60.36 36.51 20.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.753 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -177.02 -177.96 46.37 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.06 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -142.8 144.84 32.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.624 0.25 . . . . 0.0 110.779 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 103' ' ' TYR . 65.3 t -105.21 124.98 60.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.862 0.363 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -75.53 127.52 33.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.056 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -90.97 143.3 26.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.682 ' N ' HD13 ' A' ' 113' ' ' LEU . 33.7 m -156.19 62.17 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.235 0.54 . . . . 0.0 110.573 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -159.62 -102.26 0.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.017 -179.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.768 ' H ' HD21 ' A' ' 121' ' ' LEU . . . 174.59 -128.4 1.44 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.008 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.422 ' HA ' ' CG2' ' A' ' 98' ' ' ILE . 52.7 p-10 -159.27 48.19 0.31 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.931 0.396 . . . . 0.0 111.004 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 118' ' ' LEU . 6.1 mp -98.99 163.57 18.49 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.221 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 81.2 Cg_exo -39.63 106.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.433 2.088 . . . . 0.0 112.193 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 72.54 -32.29 0.24 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.716 -179.453 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.768 HD21 ' H ' ' A' ' 116' ' ' GLY . 27.5 tp 56.12 47.59 19.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.114 0.483 . . . . 0.0 110.228 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.81 136.18 46.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.968 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.456 ' HA2' HG22 ' A' ' 143' ' ' VAL . . . 76.74 31.96 51.94 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.168 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.815 ' H ' ' HB2' ' A' ' 144' ' ' CYS . . . -80.33 119.87 23.63 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.533 ' HB2' ' HB ' ' A' ' 114' ' ' THR . 67.0 mtt-85 -84.58 134.59 34.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.7 134.14 9.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.422 179.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -114.45 112.96 23.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.964 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.467 ' CE2' ' HG3' ' A' ' 153' ' ' LYS . 1.9 m-85 -80.29 136.5 36.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.635 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -165.04 131.79 2.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.343 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' CYS . . . . . 0.504 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 40.9 m -89.3 157.17 18.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.33 0.586 . . . . 0.0 112.497 -179.069 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 58.2 m-20 -52.67 159.24 1.79 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.997 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 21.1 Cg_endo -59.9 75.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.17 2.58 . . . . 0.0 112.43 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 131' ' ' ASP . 64.5 t0 -174.63 -40.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.048 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -116.08 132.33 56.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.182 178.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -102.74 127.45 49.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.138 0.494 . . . . 0.0 111.288 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 140' ' ' SER . 3.4 tm? -69.98 132.88 46.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.262 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.509 ' N ' HD13 ' A' ' 136' ' ' LEU . 36.6 t -134.82 76.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.816 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.44 -133.96 2.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.247 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.729 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 40.9 t -74.61 56.42 0.69 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . 0.675 ' HB3' HD12 ' A' ' 136' ' ' LEU . 95.7 p -53.86 -30.33 45.14 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.825 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.578 ' HD2' ' OG ' ' A' ' 140' ' ' SER . 7.9 mpt_? -99.41 137.06 38.45 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.496 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.5 m -150.63 137.73 19.31 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.256 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 13.8 p -134.05 131.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 111.036 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.815 ' HB2' ' H ' ' A' ' 124' ' ' ALA . 4.1 m -58.14 154.93 12.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.332 0.587 . . . . 0.0 112.226 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.4 p -173.28 113.64 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.759 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 146' ' ' GLN . 8.0 tt0 60.92 48.46 6.68 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.096 0.474 . . . . 0.0 110.544 -179.411 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 58.22 18.08 33.76 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.355 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -141.63 138.22 32.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 110.639 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -68.1 135.29 51.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.219 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -57.48 -60.18 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.176 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.486 ' HB ' ' OG ' ' A' ' 139' ' ' SER . 33.3 p -99.79 132.69 22.55 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.799 0.333 . . . . 0.0 111.889 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.424 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 37.2 Cg_exo -60.6 150.75 80.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.977 2.452 . . . . 0.0 112.442 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 128' ' ' PHE . 57.5 tttp -55.91 129.81 72.41 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.729 ' HB3' ' N ' ' A' ' 139' ' ' SER . 59.4 Cg_endo -72.37 -152.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.729 2.286 . . . . 0.0 112.996 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -153.72 139.61 18.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 86.4 m -98.72 143.31 29.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.494 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -128.2 136.44 51.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.576 179.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.67 135.65 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.305 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.917 179.814 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.486 ' OE1' ' N ' ' A' ' 92' ' ' GLU . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.555 0.217 . . . . 0.0 111.078 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.437 ' N ' ' HG2' ' A' ' 92' ' ' GLU . . . 55.75 -139.78 0.94 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.131 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -173.8 133.72 0.46 Allowed 'General case' 0 C--O 1.231 0.128 0 CA-C-O 120.775 0.321 . . . . 0.0 110.75 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.0 t80 57.72 -129.03 1.59 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.369 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 62.4 t -71.13 128.87 34.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.83 0.348 . . . . 0.0 111.13 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.944 ' HD3' ' HA ' ' A' ' 119' ' ' PRO . 2.1 ptp85 -80.7 47.6 0.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.306 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.601 HD12 HD22 ' A' ' 121' ' ' LEU . 40.6 mm -145.34 141.18 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-O 121.209 0.528 . . . . 0.0 111.659 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.562 ' HB2' ' NE1' ' A' ' 149' ' ' TRP . 1.3 p -57.3 149.32 20.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.36 -0.837 . . . . 0.0 110.138 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 41.9 t -38.25 113.53 0.29 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.156 0.503 . . . . 0.0 111.768 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.529 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 0.1 OUTLIER -67.23 -14.26 62.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.767 179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 45.1 t -53.5 -38.91 64.15 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.209 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.58 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.5 m-85 -53.34 -37.89 62.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.178 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.4 mt -50.92 -45.45 60.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.332 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.0 t -92.52 131.28 37.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 111.202 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.647 HD13 ' HE2' ' A' ' 153' ' ' LYS . 38.0 tp -145.34 132.28 20.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.062 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.457 ' HG3' ' ND2' ' A' ' 108' ' ' ASN . 5.6 tp10 -63.02 127.02 29.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.18 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.457 ' ND2' ' HG3' ' A' ' 107' ' ' GLU . 75.3 m-80 55.14 45.73 25.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.885 0.374 . . . . 0.0 110.415 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.0 157.44 26.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.576 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -130.62 139.7 50.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.746 0.308 . . . . 0.0 110.831 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 103' ' ' TYR . 96.1 t -106.51 132.95 52.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.031 0.443 . . . . 0.0 111.576 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.447 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 3.7 m-85 -94.78 73.44 3.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.151 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.01 ' HA ' HG12 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -60.95 157.03 16.21 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.974 0.416 . . . . 0.0 111.228 -179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 124' ' ' ALA . 40.9 m -158.53 69.47 0.5 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.778 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.674 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -162.98 -44.92 0.02 OUTLIER Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.642 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.44 -121.84 6.51 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.297 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.471 ' HA ' ' CD1' ' A' ' 98' ' ' ILE . 2.1 p30 -144.76 52.0 1.24 Allowed 'General case' 0 CA--C 1.529 0.144 0 CA-C-O 121.051 0.453 . . . . 0.0 111.474 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.474 ' N ' HD12 ' A' ' 118' ' ' LEU . 7.0 mp -88.08 158.13 50.21 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.909 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.944 ' HA ' ' HD3' ' A' ' 97' ' ' ARG . 85.1 Cg_exo -44.05 111.02 0.23 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.621 2.214 . . . . 0.0 112.601 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.761 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 70.77 -33.55 0.27 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.828 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.601 HD22 HD12 ' A' ' 98' ' ' ILE . 17.0 tp 64.28 43.9 4.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.05 0.452 . . . . 0.0 110.624 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.918 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 64.5 t0 -79.4 59.06 2.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.013 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -172.29 -29.48 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.375 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.769 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -49.68 147.53 3.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.051 0.453 . . . . 0.0 111.923 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.561 ' NH2' ' HD3' ' A' ' 141' ' ' ARG . 51.6 mtp85 -138.72 126.78 22.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.819 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 1.01 HG12 ' HA ' ' A' ' 113' ' ' LEU . 33.7 m -116.72 130.3 71.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.029 0.442 . . . . 0.0 111.674 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.9 mt-10 -102.5 109.79 21.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.586 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.487 ' HB2' ' HA ' ' A' ' 140' ' ' SER . 21.2 m-85 -75.52 147.12 39.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.514 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 5.6 tpm_? -162.28 125.94 3.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.472 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.421 ' H ' ' HE ' ' A' ' 129' ' ' ARG . 56.6 m -89.29 149.14 23.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.074 -179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -52.57 163.31 0.79 Allowed Pre-proline 0 N--CA 1.464 0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.634 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.63 57.3 0.72 Allowed 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 123.43 2.753 . . . . 0.0 113.131 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -158.06 -43.3 0.06 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.3 m-85 -108.91 138.76 44.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.665 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.411 ' O ' HG23 ' A' ' 137' ' ' VAL . 18.7 p-80 -101.6 127.51 48.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.091 0.472 . . . . 0.0 110.993 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 137' ' ' VAL . 4.9 tt -65.04 131.23 46.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.184 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.629 ' N ' HD23 ' A' ' 136' ' ' LEU . 21.8 t -133.39 65.37 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.25 -135.63 2.44 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.612 -1.28 . . . . 0.0 113.396 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.51 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 80.6 p -73.37 62.08 0.69 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.92 0.39 . . . . 0.0 110.837 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.532 ' HB3' HD22 ' A' ' 136' ' ' LEU . 98.5 p -57.61 -7.02 0.57 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.288 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.561 ' HD3' ' NH2' ' A' ' 125' ' ' ARG . 39.7 ttm180 -140.65 134.37 30.33 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.672 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.518 ' O ' HG22 ' A' ' 126' ' ' VAL . 47.6 t -146.39 119.5 8.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.052 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.569 HG13 ' OG ' ' A' ' 150' ' ' SER . 3.2 p -95.98 121.56 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.121 0.486 . . . . 0.0 111.223 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.769 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 49.7 t -69.22 138.3 53.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.601 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.918 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 80.6 p -164.51 133.11 3.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.165 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 57.38 40.76 27.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.849 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 63.9 18.25 61.84 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.654 -0.703 . . . . 0.0 113.126 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -145.27 139.79 27.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 117.099 0.449 . . . . 0.0 111.45 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.562 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 32.7 m95 -72.12 139.0 48.12 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.195 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.569 ' OG ' HG13 ' A' ' 143' ' ' VAL . 75.4 m -57.49 -57.74 11.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.005 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.5 t -109.42 143.11 27.1 Favored Pre-proline 0 CA--C 1.529 0.159 0 CA-C-O 120.862 0.363 . . . . 0.0 111.87 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -63.0 148.14 93.79 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.125 2.55 . . . . 0.0 112.693 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.647 ' HE2' HD13 ' A' ' 106' ' ' LEU . 87.5 tttt -53.34 135.64 51.36 Favored Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.527 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.51 ' HB3' ' H ' ' A' ' 139' ' ' SER . 97.5 Cg_endo -85.4 -151.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.906 2.404 . . . . 0.0 112.872 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -153.7 151.09 29.25 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.988 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.4 m -97.28 129.85 44.54 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.766 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 42.3 tt0 -108.78 135.4 50.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.027 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.5 p -66.84 140.2 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.4 p30 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.149 -0.929 . . . . 0.0 110.982 -179.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 53.9 mm-40 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.855 0.359 . . . . 0.0 111.009 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.09 -141.56 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.517 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 58.56 47.64 13.04 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.04 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.434 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 4.1 m-85 -59.91 136.07 57.89 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.796 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.4 p -174.89 139.12 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.261 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.771 ' HB2' ' H ' ' A' ' 120' ' ' ALA . 0.0 OUTLIER -169.28 61.05 0.05 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.882 179.895 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.769 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 1.9 pp -142.19 153.44 18.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.983 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 38.0 m -64.58 147.22 53.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.791 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 102' ' ' SER . 80.4 p -40.12 118.0 0.84 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.858 0.361 . . . . 0.0 110.699 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.4 ' HA ' HD13 ' A' ' 104' ' ' LEU . 68.7 mttm -70.94 9.01 0.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.514 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 100' ' ' SER . 59.2 m -68.96 -39.2 79.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.189 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.916 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.8 m-85 -52.18 -37.84 55.97 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.984 -179.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.552 ' H ' HD12 ' A' ' 104' ' ' LEU . 6.3 mp -50.22 142.48 9.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.69 0.281 . . . . 0.0 111.03 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.9 p 61.84 132.17 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.673 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 57.1 tp -145.4 136.14 24.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.613 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.417 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 88.7 tt0 -57.12 132.3 52.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.389 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.497 ' HB3' ' OD1' ' A' ' 131' ' ' ASP . 76.4 m-20 57.52 42.81 23.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.617 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.76 172.82 45.14 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.517 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -141.66 146.37 36.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.779 0.323 . . . . 0.0 110.476 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 60.6 t -118.12 127.44 75.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.424 -179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.7 m-85 -88.22 119.06 28.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.849 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.64 ' HA ' HG12 ' A' ' 126' ' ' VAL . 61.4 tp -83.53 146.73 28.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.266 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.498 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 33.2 m -162.16 66.43 0.24 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.65 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.417 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . -160.82 -42.35 0.02 OUTLIER Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.848 -179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.02 -119.5 5.4 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.655 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -137.78 47.88 2.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.162 0.506 . . . . 0.0 111.042 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 71.7 mt -75.72 158.46 82.88 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.125 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.486 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 74.5 Cg_exo -47.03 120.46 4.22 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.159 1.906 . . . . 0.0 111.625 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.771 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 51.98 31.32 8.45 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.2 0.524 . . . . 0.0 110.155 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.769 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 13.9 tp 42.44 37.42 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.712 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -70.63 141.06 51.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.907 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.56 -24.62 9.72 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.78 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.715 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -57.25 152.89 13.04 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.761 0.315 . . . . 0.0 111.092 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.788 ' HD2' HH21 ' A' ' 141' ' ' ARG . 23.0 ptt-85 -165.45 133.19 3.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.679 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 113' ' ' LEU . 33.9 m -120.54 143.5 32.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.039 0.447 . . . . 0.0 111.798 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.462 ' HB2' ' NH1' ' A' ' 141' ' ' ARG . 40.7 tp10 -108.48 121.86 45.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.057 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.418 ' CD2' ' HD2' ' A' ' 154' ' ' PRO . 2.8 m-85 -83.7 154.48 23.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.868 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.624 ' HA ' ' HE ' ' A' ' 129' ' ' ARG . 5.1 tpm_? -157.57 127.28 6.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.863 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.23 143.84 26.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.905 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.497 ' OD1' ' HB3' ' A' ' 108' ' ' ASN . 12.8 p-10 -54.07 148.96 19.89 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.48 77.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.015 2.477 . . . . 0.0 112.862 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.458 ' N ' ' O ' ' A' ' 131' ' ' ASP . 64.4 t0 179.02 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.72 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.497 ' CE2' HG22 ' A' ' 158' ' ' VAL . 3.6 m-85 -108.84 142.84 38.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.876 179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.1 p-80 -101.88 130.8 48.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.176 0.512 . . . . 0.0 110.961 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.623 HD21 ' HA ' ' A' ' 140' ' ' SER . 32.6 tp -70.25 126.82 30.76 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.964 -179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 41.7 t -137.89 71.84 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.937 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.49 -135.67 2.21 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 119.846 -1.169 . . . . 0.0 113.102 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.729 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.0 m -75.94 52.79 0.72 Allowed 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 120.92 0.391 . . . . 0.0 110.601 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.623 ' HA ' HD21 ' A' ' 136' ' ' LEU . 47.2 t -46.25 -39.85 10.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.071 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.788 HH21 ' HD2' ' A' ' 125' ' ' ARG . 23.9 tpt180 -104.11 137.46 42.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.589 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.8 t -143.05 101.69 3.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.826 0.346 . . . . 0.0 110.597 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 150' ' ' SER . 7.7 p -96.8 129.89 46.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.065 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.715 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 1.8 m -74.62 146.99 42.01 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.395 0.617 . . . . 0.0 112.111 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.469 ' O ' ' HG2' ' A' ' 148' ' ' GLN . 48.0 t -163.94 124.67 2.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.358 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 62.9 38.35 11.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.114 0.483 . . . . 0.0 110.419 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 63.12 25.73 68.46 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.56 -0.745 . . . . 0.0 113.562 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 145' ' ' SER . 23.6 pt20 -143.72 138.24 28.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.059 0.43 . . . . 0.0 111.262 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.526 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 59.4 m95 -65.04 138.02 58.07 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.466 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 143' ' ' VAL . 47.5 t -57.43 -48.54 78.86 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.057 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.518 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 82.6 p -135.14 136.86 25.56 Favored Pre-proline 0 CA--C 1.529 0.152 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.816 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 31.4 Cg_exo -61.97 156.35 49.87 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.04 2.494 . . . . 0.0 112.438 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.916 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 28.5 mtpp -52.42 129.17 42.81 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.428 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.729 ' HB3' ' N ' ' A' ' 139' ' ' SER . 60.7 Cg_endo -72.89 -143.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.728 2.285 . . . . 0.0 112.246 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.451 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 23.0 p-80 -153.71 145.25 23.23 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.986 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 81.7 m -96.23 125.87 41.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.509 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -109.06 142.99 38.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.385 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.497 HG22 ' CE2' ' A' ' 134' ' ' PHE . 61.9 t -61.83 139.96 19.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.044 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 22.1 p30 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.234 -0.889 . . . . 0.0 111.026 179.808 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.846 0.355 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.51 -42.62 88.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.995 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -173.22 -139.91 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.58 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -170.93 -134.09 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 67.0 t -72.64 126.1 32.62 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.956 0.408 . . . . 0.0 111.272 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.957 ' HG2' HG12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -88.82 -158.47 0.49 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.893 179.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.957 HG12 ' HG2' ' A' ' 97' ' ' ARG . 46.7 mm 64.74 143.79 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.342 178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.51 ' HA ' ' C ' ' A' ' 147' ' ' GLY . 1.5 p -59.99 161.21 6.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.196 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 53.2 m -39.78 131.8 1.79 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.109 0.48 . . . . 0.0 111.453 -179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.408 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 21.8 pttp -96.48 78.56 3.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.674 0.749 . . . . 0.0 110.009 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.9 t -164.13 -34.9 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.076 -179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.7 m-85 -56.8 -26.33 57.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.192 0.52 . . . . 0.0 109.63 178.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.483 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 53.5 mt -50.23 -44.11 53.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.671 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 69.2 p -92.66 139.66 30.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.647 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.464 HD13 ' CE ' ' A' ' 153' ' ' LYS . 46.6 tp -143.07 133.72 25.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.389 . . . . 0.0 111.163 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.481 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 39.6 tt0 -67.8 129.98 41.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.333 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.481 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 76.1 m-80 56.6 37.09 28.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.964 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 130' ' ' CYS . . . -176.44 149.5 9.81 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.998 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -108.25 139.26 43.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.845 0.355 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.485 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 94.9 t -106.54 121.75 59.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.815 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -82.74 124.99 30.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.239 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.699 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -85.84 145.04 27.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.475 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.699 ' N ' HD13 ' A' ' 113' ' ' LEU . 28.7 m -155.75 63.44 0.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 110.854 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 124' ' ' ALA . . . -161.04 -104.44 0.19 Allowed Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.178 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 166.99 -129.64 1.96 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.739 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.453 ' HA ' HD11 ' A' ' 98' ' ' ILE . 58.7 m-20 -150.27 46.79 0.9 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.952 0.406 . . . . 0.0 111.044 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 118' ' ' LEU . 7.1 mp -97.9 154.27 37.87 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.823 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.568 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 76.1 Cg_exo -46.78 122.13 5.68 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.466 2.111 . . . . 0.0 112.112 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.784 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 72.77 -40.74 0.48 Allowed 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.528 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.637 HD22 HD12 ' A' ' 98' ' ' ILE . 14.8 tp 59.51 51.18 6.71 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.956 0.408 . . . . 0.0 110.943 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -73.26 66.25 0.89 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.247 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -177.31 -36.8 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.623 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.809 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -51.39 153.9 1.98 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.954 0.407 . . . . 0.0 111.483 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.501 ' O ' ' HB ' ' A' ' 114' ' ' THR . 50.8 ttp85 -158.94 126.07 4.81 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.176 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.485 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 24.6 m -108.17 136.67 42.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 121.022 0.439 . . . . 0.0 111.648 -179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -100.29 115.98 31.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.686 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -80.09 143.04 34.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.945 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.433 HH11 ' HG3' ' A' ' 129' ' ' ARG . 37.7 ttt85 -167.22 118.82 0.9 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.834 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.456 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 51.3 m -89.18 154.13 20.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.981 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -52.77 158.34 2.25 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.305 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.507 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 82.0 Cg_exo -47.49 162.81 0.2 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.829 2.353 . . . . 0.0 112.245 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.5 m-20 77.93 -35.07 0.19 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.791 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -106.32 127.14 53.03 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.8 p-80 -108.34 131.1 55.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.034 0.445 . . . . 0.0 111.375 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.579 HD23 ' SG ' ' A' ' 156' ' ' CYS . 3.2 tm? -74.79 132.86 41.91 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.292 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.0 t -133.07 71.53 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.785 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.92 -132.5 1.82 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.057 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.604 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 61.2 p -72.83 61.56 0.55 Allowed 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 110.648 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.559 ' HB3' HD12 ' A' ' 136' ' ' LEU . 97.0 p -55.6 -15.59 3.09 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.775 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 23.3 ptt-85 -140.64 139.89 34.93 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.716 0.293 . . . . 0.0 111.266 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 96.6 p -139.54 117.01 11.35 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.255 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.413 ' HB ' ' OG ' ' A' ' 150' ' ' SER . 73.7 t -84.18 125.01 40.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.039 0.447 . . . . 0.0 111.52 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.809 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 42.1 t -79.3 131.03 36.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.306 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.4 t -173.25 137.53 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.748 0.309 . . . . 0.0 111.156 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 56.35 37.93 29.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.743 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.51 ' C ' ' HA ' ' A' ' 99' ' ' CYS . . . 56.78 24.66 49.62 Favored Glycine 0 CA--C 1.52 0.352 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.644 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -143.07 134.55 26.27 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.657 0.265 . . . . 0.0 111.087 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -77.76 140.03 39.43 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.413 ' OG ' ' HB ' ' A' ' 143' ' ' VAL . 63.1 m -57.4 -47.61 81.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.661 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 67.4 p -127.46 138.9 33.79 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.433 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 34.8 Cg_endo -64.86 -162.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.471 2.114 . . . . 0.0 112.566 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.464 ' CE ' HD13 ' A' ' 106' ' ' LEU . 14.4 mmmm -83.86 131.65 51.06 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.974 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.604 ' HB3' ' H ' ' A' ' 139' ' ' SER . 89.5 Cg_endo -81.75 -149.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.675 2.25 . . . . 0.0 112.483 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.455 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 27.5 p-80 -153.71 134.1 13.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.945 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.579 ' SG ' HD23 ' A' ' 136' ' ' LEU . 92.4 m -104.93 142.43 34.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.235 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -135.21 137.59 42.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.881 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.15 139.08 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.146 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.5 m-80 . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.913 179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.613 0.244 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -172.0 -47.15 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.82 0.343 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.48 135.19 55.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.647 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -78.33 44.81 0.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.983 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.6 p -59.71 125.83 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.912 0.387 . . . . 0.0 111.106 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.862 ' HG2' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -85.51 -148.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.182 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.862 HG23 ' HG2' ' A' ' 97' ' ' ARG . 21.3 pt 52.75 137.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 123.969 0.908 . . . . 0.0 112.72 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.519 ' HB2' HD23 ' A' ' 121' ' ' LEU . 92.2 m -57.36 167.41 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.767 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 83.6 p -40.17 143.77 0.26 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.751 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.626 ' HB2' ' NZ ' ' A' ' 101' ' ' LYS . 4.6 ttmp? -99.68 78.45 2.15 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.227 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.2 t -166.24 -36.2 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.062 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -56.94 -32.4 65.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.925 0.393 . . . . 0.0 110.389 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.419 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 64.5 mt -52.87 -46.18 67.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.568 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.2 p -92.63 137.69 32.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.791 0.329 . . . . 0.0 111.194 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.738 HD13 ' HE3' ' A' ' 153' ' ' LYS . 29.2 tp -145.38 136.36 24.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.382 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.463 ' H ' HD12 ' A' ' 106' ' ' LEU . 42.2 tp10 -69.53 138.1 53.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.9 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.435 ' ND2' ' HG3' ' A' ' 107' ' ' GLU . 76.2 m-20 58.01 36.3 25.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.283 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 179.94 176.88 47.68 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.755 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -139.78 136.46 34.11 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 128' ' ' PHE . 94.9 t -106.11 123.86 61.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.907 0.384 . . . . 0.0 111.617 -179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.551 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.8 m-85 -76.6 122.5 24.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.29 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.767 ' HA ' HG12 ' A' ' 126' ' ' VAL . 2.8 tt -95.35 140.6 30.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.711 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.759 ' N ' HD23 ' A' ' 113' ' ' LEU . 30.1 m -158.49 62.65 0.43 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.085 0.469 . . . . 0.0 110.739 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.591 ' O ' HD23 ' A' ' 118' ' ' LEU . . . -172.44 -16.28 0.02 OUTLIER Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.716 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -49.77 147.59 6.75 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.15 -0.548 . . . . 0.0 113.372 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.713 ' C ' HD22 ' A' ' 118' ' ' LEU . 1.5 m-20 73.31 41.98 0.45 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 122.714 0.406 . . . . 0.0 111.753 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.713 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.7 mm? -141.82 149.4 53.02 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.59 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_exo -50.28 116.94 2.77 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.481 2.121 . . . . 0.0 111.822 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.807 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 50.06 36.17 11.46 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.544 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.845 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 14.3 tp 52.22 42.24 30.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.491 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.89 142.27 57.96 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.589 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 60.76 33.93 84.78 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.425 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.873 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -93.44 144.09 25.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.892 0.377 . . . . 0.0 111.452 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -145.53 128.45 16.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.804 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' A' ' 113' ' ' LEU . 34.4 m -136.11 142.15 39.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.751 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.555 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 41.4 tt0 -108.69 121.39 44.94 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.435 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.755 ' HA ' HG22 ' A' ' 111' ' ' VAL . 2.3 m-85 -86.86 44.11 1.14 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.841 -179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.631 ' HD3' ' O ' ' A' ' 129' ' ' ARG . 0.0 OUTLIER -67.16 133.5 49.92 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.932 0.396 . . . . 0.0 110.667 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 69.5 m -105.16 155.85 18.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.638 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -53.7 156.84 4.34 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.116 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.519 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 86.6 Cg_exo -47.66 162.94 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.808 2.339 . . . . 0.0 112.466 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.557 ' HB3' ' ND2' ' A' ' 159' ' ' ASN . 57.3 m-20 78.31 -31.4 0.16 Allowed 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.151 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -105.0 130.17 53.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.719 0.295 . . . . 0.0 110.393 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -111.39 130.58 55.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.965 0.412 . . . . 0.0 111.516 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.594 HD22 ' O ' ' A' ' 128' ' ' PHE . 36.2 tp -78.05 136.4 37.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.419 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.7 t -132.0 66.06 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.14 -135.66 2.34 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.206 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.509 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 82.8 p -72.62 63.91 0.61 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.991 0.425 . . . . 0.0 110.78 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.552 ' HA ' HD21 ' A' ' 136' ' ' LEU . 88.0 p -56.08 -11.49 1.13 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.452 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.438 ' HG2' HH11 ' A' ' 141' ' ' ARG . 69.3 mtt-85 -140.54 136.87 33.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.878 0.37 . . . . 0.0 110.989 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 57.9 m -137.05 126.66 25.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.368 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 124' ' ' ALA . 5.9 p -116.71 130.15 72.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.922 0.391 . . . . 0.0 111.262 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.873 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 33.2 m -96.83 147.92 23.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.852 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.1 p -171.31 27.21 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.299 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.483 ' O ' ' HG3' ' A' ' 146' ' ' GLN . 70.7 tp60 -176.26 37.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.06 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.51 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 60.0 10.49 14.58 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.769 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -141.52 134.25 28.64 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.688 0.28 . . . . 0.0 110.92 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.519 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 38.7 m95 -64.86 134.97 55.18 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.564 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 75.2 m -57.42 -57.07 14.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.224 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.495 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 68.6 p -103.69 131.75 21.72 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.26 140.57 89.38 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.81 2.34 . . . . 0.0 111.895 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.738 ' HE3' HD13 ' A' ' 106' ' ' LEU . 61.2 tttp -47.09 132.93 9.1 Favored Pre-proline 0 CA--C 1.531 0.218 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.276 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.509 ' HB3' ' H ' ' A' ' 139' ' ' SER . 65.1 Cg_endo -89.26 -151.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.024 2.483 . . . . 0.0 113.004 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.8 p-80 -153.76 138.09 16.65 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.06 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.496 ' SG ' HD13 ' A' ' 136' ' ' LEU . 85.7 m -98.69 133.27 43.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.855 0.36 . . . . 0.0 110.83 179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -103.02 136.93 41.91 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.727 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.68 142.42 15.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.901 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.557 ' ND2' ' HB3' ' A' ' 133' ' ' ASP . 23.4 p30 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.992 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.867 0.365 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.62 -46.49 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.011 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.73 137.13 57.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.945 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.473 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 2.0 m-85 -59.98 134.48 57.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.089 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 16.8 m -154.36 139.93 10.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.038 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.494 ' CD ' ' HA ' ' A' ' 119' ' ' PRO . 3.2 ptp85 -161.04 126.8 3.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.96 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.717 ' O ' HD12 ' A' ' 98' ' ' ILE . 2.6 pp -156.23 148.36 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.239 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.724 ' HB2' HD22 ' A' ' 121' ' ' LEU . 0.1 OUTLIER -63.8 151.55 41.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.964 179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.0 t -39.89 111.18 0.18 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.015 0.436 . . . . 0.0 111.125 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.523 ' HG3' HD13 ' A' ' 98' ' ' ILE . 55.1 mtmt -63.6 -22.37 66.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.984 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 44.5 t -53.5 -32.17 49.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.653 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 152' ' ' PRO . 3.4 m-85 -76.23 45.28 0.36 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.608 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.576 HD21 HD23 ' A' ' 113' ' ' LEU . 93.9 mt -132.82 -37.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.889 0.376 . . . . 0.0 110.677 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 t -92.54 132.77 36.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.964 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.6 tp -145.44 125.06 13.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.54 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -82.83 45.15 0.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.066 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.9 p30 179.55 36.03 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.363 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 157.63 -155.39 26.37 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.959 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -142.06 150.55 41.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.818 0.342 . . . . 0.0 110.7 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 98.1 t -106.56 125.19 62.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.496 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.0 m-85 -85.38 76.83 10.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.58 179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.945 ' HA ' HG12 ' A' ' 126' ' ' VAL . 3.4 tm? -54.96 141.52 33.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.339 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.722 ' N ' HD13 ' A' ' 113' ' ' LEU . 23.6 m -157.46 61.33 0.49 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.657 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.563 ' C ' HD13 ' A' ' 118' ' ' LEU . . . 173.38 41.94 0.04 OUTLIER Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.732 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -76.82 123.42 6.62 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.186 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.408 ' C ' HD12 ' A' ' 118' ' ' LEU . 1.5 m-20 66.25 52.27 1.15 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.563 HD13 ' C ' ' A' ' 115' ' ' GLY . 10.7 mp -119.29 148.42 45.26 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.532 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.494 ' HA ' ' CD ' ' A' ' 97' ' ' ARG . 41.7 Cg_exo -54.73 82.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.031 2.487 . . . . 0.0 111.748 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.613 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 62.12 13.45 5.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.576 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.724 HD22 ' HB2' ' A' ' 99' ' ' CYS . 7.3 mp 47.92 59.54 4.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.782 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.0 46.02 0.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.049 0.452 . . . . 0.0 110.567 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 171.64 -26.16 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.121 -0.562 . . . . 0.0 112.281 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -50.52 155.21 1.12 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.811 0.339 . . . . 0.0 111.298 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.513 ' O ' ' HB ' ' A' ' 114' ' ' THR . 39.0 ptt180 -160.65 130.48 5.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.281 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.945 HG12 ' HA ' ' A' ' 113' ' ' LEU . 34.8 m -107.62 134.12 50.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.163 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 96.3 mt-10 -95.03 122.05 37.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.704 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.481 ' HE2' ' HE3' ' A' ' 153' ' ' LYS . 30.3 m-85 -88.28 149.08 24.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.654 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.412 HH11 ' HG3' ' A' ' 129' ' ' ARG . 40.1 ttt85 -153.62 126.97 8.56 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.739 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 16.6 t -89.24 151.28 22.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.016 0.436 . . . . 0.0 111.505 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -52.75 151.63 7.94 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.486 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -62.8 73.63 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 123.186 2.591 . . . . 0.0 112.747 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -176.31 -42.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.699 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.631 ' HB2' ' SG ' ' A' ' 130' ' ' CYS . 4.5 m-85 -109.51 143.53 39.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.545 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -99.44 135.05 41.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.304 0.574 . . . . 0.0 111.514 -179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.915 HD21 ' HA ' ' A' ' 140' ' ' SER . 35.5 tp -70.9 124.06 23.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.928 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.15 63.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.379 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -171.21 -128.63 1.05 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.127 -1.035 . . . . 0.0 112.921 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.661 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 60.1 m -73.54 57.14 0.54 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.878 0.371 . . . . 0.0 110.884 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.915 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.9 t -51.66 -25.47 7.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.269 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 12.9 mtp-105 -137.82 129.71 28.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.572 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.9 m -127.21 120.2 28.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.426 HG13 ' OG ' ' A' ' 150' ' ' SER . 3.8 p -104.99 124.6 59.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.413 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 38.9 t -72.79 151.74 41.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.169 0.509 . . . . 0.0 111.587 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.5 m -161.44 121.71 2.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.563 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 57.92 43.17 21.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.315 0.578 . . . . 0.0 109.848 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.613 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 61.0 28.2 68.4 Favored Glycine 0 CA--C 1.52 0.367 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.444 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -142.92 130.29 21.06 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.691 0.282 . . . . 0.0 110.61 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.465 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 35.9 m95 -72.11 132.07 43.69 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.59 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.426 ' OG ' HG13 ' A' ' 143' ' ' VAL . 70.9 m -57.51 -60.64 3.35 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.949 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 70.9 p -99.78 133.32 21.82 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.245 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.447 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 23.1 Cg_exo -64.9 -158.43 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.684 2.256 . . . . 0.0 112.326 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.481 ' HE3' ' HE2' ' A' ' 128' ' ' PHE . 14.2 mmmm -87.51 129.49 50.91 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.767 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.661 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.4 Cg_endo -75.26 -156.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.401 2.067 . . . . 0.0 112.803 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.72 148.77 26.77 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.938 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.437 ' HB3' ' CB ' ' A' ' 134' ' ' PHE . 97.1 m -97.07 130.54 44.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -108.72 135.11 50.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.692 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.12 128.81 35.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.935 -179.876 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 9.1 tm-20 . . . . . 0 N--CA 1.486 1.368 0 CA-C-O 120.788 0.328 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 54.75 41.96 31.54 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.156 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -175.88 54.76 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.388 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -162.98 137.93 6.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.91 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.541 ' O ' HG13 ' A' ' 98' ' ' ILE . 90.7 t -145.68 135.51 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.846 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.753 ' O ' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -62.83 126.74 28.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.753 HG23 ' O ' ' A' ' 97' ' ' ARG . 1.5 pp -171.75 32.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.137 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.482 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 147' ' ' GLY . 6.1 t 59.38 150.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.576 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.706 ' HB2' ' HD1' ' A' ' 149' ' ' TRP . 57.4 m -39.86 125.55 1.9 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 120.976 0.417 . . . . 0.0 111.301 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.484 ' HD3' HD21 ' A' ' 104' ' ' LEU . 16.8 tppt? -86.31 -36.43 19.3 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.537 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 79.9 p -69.0 40.3 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.475 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 5.5 m-85 -128.41 -47.97 1.3 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.862 0.363 . . . . 0.0 111.296 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.774 HD12 ' H ' ' A' ' 105' ' ' THR . 0.4 OUTLIER -54.8 -30.0 55.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.995 -179.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.774 ' H ' HD12 ' A' ' 104' ' ' LEU . 6.8 t -92.48 132.43 36.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.775 0.321 . . . . 0.0 111.138 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.89 HD13 ' HE3' ' A' ' 153' ' ' LYS . 34.5 tp -145.39 128.59 16.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.467 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -74.1 130.28 39.49 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.09 -0.504 . . . . 0.0 109.961 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.505 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.0 m120 60.23 38.88 19.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.621 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.75 151.86 13.1 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.845 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 pttt -110.68 137.0 48.91 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.783 0.325 . . . . 0.0 110.814 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.49 126.74 62.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.367 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.541 ' C ' HG23 ' A' ' 126' ' ' VAL . 3.0 m-85 -79.35 60.39 3.13 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.006 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.564 HD22 ' HB3' ' A' ' 104' ' ' LEU . 60.2 tp -58.5 140.96 53.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.559 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 31.3 m -155.62 55.18 0.61 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.492 0.663 . . . . 0.0 109.85 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 168.46 99.98 0.13 Allowed Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.843 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 117' ' ' ASP . . . -165.32 151.34 20.06 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.774 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.735 ' C ' HD22 ' A' ' 118' ' ' LEU . 38.8 t70 77.23 41.21 0.15 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.037 0.446 . . . . 0.0 110.975 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.735 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.2 mm? -144.14 150.9 50.49 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.512 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.632 ' HA ' ' HG2' ' A' ' 97' ' ' ARG . 12.0 Cg_endo -55.47 81.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.841 2.361 . . . . 0.0 112.187 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 73.69 -38.07 0.39 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.271 -179.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.657 HD23 ' HB2' ' A' ' 124' ' ' ALA . 17.6 tp 55.2 80.85 0.12 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.89 0.376 . . . . 0.0 110.746 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -75.02 48.69 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.139 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -178.26 26.12 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.36 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.657 ' HB2' HD23 ' A' ' 121' ' ' LEU . . . -80.52 142.3 34.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.616 0.246 . . . . 0.0 110.669 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.559 ' O ' ' HB ' ' A' ' 114' ' ' THR . 45.7 mtp85 -131.73 150.48 52.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.902 0.382 . . . . 0.0 111.278 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.541 HG23 ' C ' ' A' ' 112' ' ' PHE . 7.6 p -154.49 158.27 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.279 0.562 . . . . 0.0 111.252 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.536 ' N ' HG22 ' A' ' 126' ' ' VAL . 43.6 tt0 -136.94 89.71 2.47 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.106 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.481 ' H ' ' HD1' ' A' ' 128' ' ' PHE . 4.2 m-85 -59.11 148.57 30.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.714 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.8 tpt85 -159.52 128.36 5.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.54 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 35.4 t -89.22 150.23 22.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.301 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -53.67 156.61 4.52 Favored Pre-proline 0 N--CA 1.462 0.149 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.34 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 80.0 Cg_exo -45.64 162.02 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.978 2.452 . . . . 0.0 112.718 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.502 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 28.1 m-20 77.83 -36.57 0.22 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.61 -179.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.403 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.9 m-85 -107.49 128.65 54.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.919 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.47 ' CD2' ' HB3' ' A' ' 157' ' ' GLN . 0.4 OUTLIER -102.86 137.16 41.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.077 0.465 . . . . 0.0 111.409 -179.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.491 HD11 ' HG3' ' A' ' 154' ' ' PRO . 6.9 tt -78.89 127.24 31.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.339 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.469 ' N ' HD23 ' A' ' 136' ' ' LEU . 26.3 t -130.07 65.66 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.799 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.476 ' H ' HD23 ' A' ' 136' ' ' LEU . . . -170.54 -125.38 0.8 Allowed Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.636 -179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.792 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 29.2 t -73.37 59.0 0.57 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 111.295 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.409 ' HB2' HD22 ' A' ' 136' ' ' LEU . 35.3 t -58.29 -24.77 60.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.012 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.604 ' HD2' ' N ' ' A' ' 142' ' ' SER . 4.0 tmm_? -140.55 131.29 25.76 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.421 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.643 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 50.7 m -132.23 153.32 50.74 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.629 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 124' ' ' ALA . 77.3 t -142.78 125.3 13.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.278 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 61.3 m -68.18 153.86 42.89 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.491 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -157.45 -23.89 0.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.285 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 146' ' ' GLN . 4.2 tp-100 -159.2 58.16 0.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.031 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 73.57 -8.08 11.28 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.914 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -139.74 136.17 33.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 111.023 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.706 ' HD1' ' HB2' ' A' ' 100' ' ' SER . 60.2 m95 -60.57 150.32 32.0 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.752 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.9 p -54.21 -58.77 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.189 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.536 HG23 ' OG ' ' A' ' 139' ' ' SER . 2.7 t -104.25 144.88 29.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.378 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 17.7 Cg_endo -59.25 -147.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.993 2.462 . . . . 0.0 113.034 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.89 ' HE3' HD13 ' A' ' 106' ' ' LEU . 55.0 tttp -108.92 135.32 20.15 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.604 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.792 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 73.4 Cg_endo -76.68 -155.68 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.492 2.128 . . . . 0.0 113.037 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -153.77 161.24 42.26 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.893 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 88.1 m -96.11 131.62 42.35 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.787 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.47 ' HB3' ' CD2' ' A' ' 135' ' ' HIS . 4.2 tp-100 -118.84 138.14 52.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.917 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.65 136.56 26.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.237 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 133' ' ' ASP . 24.1 p30 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.04 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.818 0.342 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -176.92 45.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.892 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.25 147.72 20.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.094 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -161.63 141.81 10.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.043 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 30.3 m -150.68 138.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.618 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.794 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -167.2 58.42 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.054 0.454 . . . . 0.0 111.585 -179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.666 ' O ' HD12 ' A' ' 98' ' ' ILE . 1.7 pp -150.27 149.56 14.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.243 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.622 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 72.8 m -59.89 140.37 56.7 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.8 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 78.4 p -37.93 113.36 0.27 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 121.087 0.47 . . . . 0.0 111.62 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.418 ' HB3' HD12 ' A' ' 104' ' ' LEU . 98.3 mttt -69.43 1.95 3.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.316 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.2 p -59.63 -37.52 78.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.879 0.371 . . . . 0.0 110.569 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.526 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 1.4 m-85 -54.38 -35.43 62.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.851 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.418 HD12 ' HB3' ' A' ' 101' ' ' LYS . 79.3 mt -53.53 139.45 31.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.33 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.9 p 60.52 130.84 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 O-C-N 123.497 0.498 . . . . 0.0 111.106 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.823 HD13 ' HE2' ' A' ' 153' ' ' LYS . 30.9 tp -145.37 134.88 23.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.305 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 10.8 pm0 -63.62 133.03 52.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.323 179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.404 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.9 m120 58.42 42.99 20.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.836 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.41 -177.58 43.66 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.563 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -142.03 151.89 42.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.793 0.33 . . . . 0.0 110.607 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.481 ' HA ' ' O ' ' A' ' 127' ' ' GLU . 86.5 t -129.14 123.98 59.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.349 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.594 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 1.5 m-85 -89.79 119.42 30.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.748 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HA ' HG12 ' A' ' 126' ' ' VAL . 54.9 tp -80.92 145.3 31.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.858 0.361 . . . . 0.0 110.932 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 23.7 m -158.88 56.16 0.43 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.733 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -159.0 -108.88 0.25 Allowed Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.818 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 158.68 -124.67 1.4 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.863 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -151.4 53.03 0.84 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.189 0.519 . . . . 0.0 110.228 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 97.3 mt -99.35 156.89 34.92 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.879 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.794 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 80.6 Cg_exo -44.32 111.24 0.26 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.45 2.1 . . . . 0.0 112.182 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.629 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 72.66 -38.99 0.44 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.593 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 119' ' ' PRO . 16.5 tp 58.23 51.94 7.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.968 0.413 . . . . 0.0 111.122 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -76.3 60.4 1.52 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.008 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -168.29 -32.87 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.396 -179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -49.92 152.27 1.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.915 0.388 . . . . 0.0 111.486 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.502 ' O ' ' HB ' ' A' ' 114' ' ' THR . 79.1 ttt180 -155.63 122.05 5.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.409 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.593 HG23 ' CE1' ' A' ' 128' ' ' PHE . 26.8 m -111.82 134.71 53.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.159 0.504 . . . . 0.0 111.772 -179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.594 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -87.34 141.84 28.33 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.474 -0.784 . . . . 0.0 111.226 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.593 ' CE1' HG23 ' A' ' 126' ' ' VAL . 14.4 m-85 -117.09 140.23 49.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.491 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -162.36 131.02 4.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.661 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.549 ' SG ' ' HB2' ' A' ' 134' ' ' PHE . 7.1 t -89.22 155.11 19.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.909 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' A' ' 133' ' ' ASP . 45.9 m-20 -52.75 151.62 7.95 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.496 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.03 76.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.284 2.656 . . . . 0.0 113.133 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 131' ' ' ASP . 33.4 t70 -178.68 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.702 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.549 ' HB2' ' SG ' ' A' ' 130' ' ' CYS . 5.0 m-85 -108.93 145.83 34.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.55 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -101.08 140.03 35.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.32 0.581 . . . . 0.0 111.287 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.558 HD13 ' N ' ' A' ' 137' ' ' VAL . 2.4 tm? -79.61 127.09 31.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.971 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.558 ' N ' HD13 ' A' ' 136' ' ' LEU . 44.6 t -132.38 71.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.549 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.98 -130.25 1.56 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 119.996 -1.097 . . . . 0.0 112.879 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.743 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 31.4 t -73.53 58.02 0.57 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.768 0.318 . . . . 0.0 111.268 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.477 ' HB3' HD12 ' A' ' 136' ' ' LEU . 96.5 p -51.71 -26.29 9.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.122 0.487 . . . . 0.0 109.885 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.407 ' HD2' ' NH2' ' A' ' 125' ' ' ARG . 34.2 ptt85 -140.62 128.95 22.47 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.272 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 99.8 p -125.74 128.27 47.48 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 111.038 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 89.1 t -103.13 117.56 48.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.901 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 42.6 t -64.54 136.69 57.29 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.455 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.1 t -164.47 130.29 2.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.906 0.384 . . . . 0.0 111.201 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.409 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 39.5 tt0 56.75 43.16 25.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.28 0.562 . . . . 0.0 110.538 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 60.53 17.4 47.95 Favored Glycine 0 CA--C 1.523 0.588 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.94 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -143.52 135.03 26.2 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.886 0.343 . . . . 0.0 111.128 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.622 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 95.5 m95 -68.97 135.19 50.57 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.838 0.352 . . . . 0.0 111.126 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -57.46 -55.16 38.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.3 p -103.97 132.11 21.33 Favored Pre-proline 0 CA--C 1.531 0.237 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.63 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.526 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 54.3 Cg_endo -69.37 136.49 34.15 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.797 2.331 . . . . 0.0 112.473 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.823 ' HE2' HD13 ' A' ' 106' ' ' LEU . 85.9 tttt -40.01 129.03 1.6 Allowed Pre-proline 0 CA--C 1.532 0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.459 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.743 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 95.2 Cg_endo -79.2 -154.79 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.906 2.404 . . . . 0.0 113.221 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -153.74 169.42 23.38 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.902 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 92.3 m -98.72 136.79 38.26 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.418 179.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -131.25 131.14 43.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 110.857 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.43 132.08 29.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.322 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.7 p30 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.272 -0.871 . . . . 0.0 110.904 179.862 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.849 0.357 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.86 -44.34 73.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 57.5 45.92 18.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.322 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -173.87 135.53 0.5 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.333 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.8 p -66.54 146.54 13.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.042 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.621 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -145.61 136.1 24.15 Favored 'General case' 0 CA--C 1.506 -0.717 0 CA-C-O 121.422 0.629 . . . . 0.0 111.18 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 6.7 tt 175.21 144.35 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.042 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 14.4 m -48.85 138.41 11.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.376 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 48.7 m -39.86 128.45 2.1 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.416 -178.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.406 ' HA ' HD13 ' A' ' 104' ' ' LEU . 33.1 mmtp -82.0 -15.95 51.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.923 179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 49.7 m -53.11 -42.41 65.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.085 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -57.5 -41.48 80.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.014 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.605 ' N ' HD12 ' A' ' 104' ' ' LEU . 3.6 mp -77.88 40.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.175 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 27.8 m -147.39 62.68 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.872 0.368 . . . . 0.0 111.002 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.481 HD21 ' SG ' ' A' ' 130' ' ' CYS . 49.9 tp -94.55 124.97 38.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.849 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.421 ' OE1' ' ND2' ' A' ' 108' ' ' ASN . 0.0 OUTLIER -90.58 41.0 1.04 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.094 -0.503 . . . . 0.0 112.017 -179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.421 ' ND2' ' OE1' ' A' ' 107' ' ' GLU . 78.4 m-20 -160.12 27.84 0.17 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.697 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 161.07 -146.48 12.38 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.997 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HB3' ' NZ ' ' A' ' 110' ' ' LYS . 7.9 mtpm? -141.94 143.37 33.22 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.296 -0.452 . . . . 0.0 110.663 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 88.6 t -104.71 119.84 54.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.831 0.348 . . . . 0.0 110.519 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.432 ' N ' ' HD1' ' A' ' 112' ' ' PHE . 1.7 m-85 -71.71 123.02 21.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.907 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.591 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -89.17 141.34 28.6 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.625 HG21 ' NH2' ' A' ' 125' ' ' ARG . 25.2 m -157.95 54.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.868 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.96 -105.57 0.43 Allowed Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.934 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.628 ' H ' HD21 ' A' ' 121' ' ' LEU . . . 165.82 -126.46 1.48 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.322 -0.942 . . . . 0.0 113.42 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -167.32 67.17 0.09 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.157 0.504 . . . . 0.0 109.984 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.698 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 71.5 mt -127.97 168.76 14.32 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.116 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.698 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 76.3 Cg_exo -38.18 97.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.635 2.224 . . . . 0.0 112.125 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 70.68 -20.05 0.21 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.847 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.673 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 19.8 tp 62.31 54.01 2.68 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.93 0.395 . . . . 0.0 110.76 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.699 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 33.1 t70 -56.83 129.51 41.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.182 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 84.74 26.31 38.75 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.988 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 1.086 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -79.64 156.91 27.41 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.625 ' NH2' HG21 ' A' ' 114' ' ' THR . 56.4 ttp85 -154.34 145.27 22.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.956 0.407 . . . . 0.0 111.405 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.7 m -148.35 138.23 16.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.582 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.449 ' HG3' ' NH1' ' A' ' 141' ' ' ARG . 43.3 tt0 -110.79 115.83 30.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.582 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.558 ' HE2' ' HG3' ' A' ' 153' ' ' LYS . 2.0 m-85 -73.95 143.0 45.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -156.3 117.84 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.704 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.558 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 95.2 m -92.32 156.25 17.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.571 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -52.7 153.11 6.01 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.476 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.37 78.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.128 2.552 . . . . 0.0 112.668 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -177.46 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.646 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.675 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 0.6 OUTLIER -108.61 134.52 51.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.924 179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.474 ' CE1' ' HB3' ' A' ' 157' ' ' GLN . 20.3 p-80 -102.66 127.33 49.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.122 0.486 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.75 HD21 ' HA ' ' A' ' 140' ' ' SER . 26.6 tp -70.21 126.61 30.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.131 -179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.3 t -135.7 67.67 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.638 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -174.74 -135.31 2.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.072 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.73 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 65.0 m -74.74 55.04 0.66 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 120.83 0.348 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.75 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.8 t -48.42 -43.53 34.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.09 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.574 ' HD2' ' N ' ' A' ' 141' ' ' ARG . 0.4 OUTLIER -102.02 133.63 46.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.654 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.9 m -133.91 130.0 37.14 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.713 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 98.8 t -116.61 123.97 72.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.299 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 1.086 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 41.1 t -100.7 145.21 28.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.687 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.699 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 81.1 p -168.14 35.78 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 175.8 39.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.276 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 61.71 10.98 27.52 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.112 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.15 134.81 28.3 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.562 0.22 . . . . 0.0 110.592 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -73.42 137.11 44.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.366 . . . . 0.0 111.13 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.2 t -57.49 -59.66 4.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.35 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 82.7 p -96.44 134.52 23.32 Favored Pre-proline 0 C--N 1.332 -0.176 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 15.9 Cg_exo -67.53 146.28 73.5 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.935 2.423 . . . . 0.0 111.949 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.558 ' HG3' ' HE2' ' A' ' 128' ' ' PHE . 88.2 tttt -51.17 122.93 19.24 Favored Pre-proline 0 CA--C 1.531 0.24 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.858 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.73 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.2 Cg_endo -75.25 -150.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.734 2.289 . . . . 0.0 112.953 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -153.74 139.88 18.41 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.0 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 67.5 m -98.79 139.28 34.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.003 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.474 ' HB3' ' CE1' ' A' ' 135' ' ' HIS . 39.3 tt0 -102.93 132.53 49.1 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.11 126.91 31.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.338 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m120 . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.395 179.667 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.835 0.35 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -176.82 -43.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.076 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -59.05 135.14 57.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.989 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.507 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 1.1 m-85 -64.66 129.23 39.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.796 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 p 177.77 141.32 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.173 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.82 ' O ' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -168.66 109.51 0.51 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.465 179.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.82 HG23 ' O ' ' A' ' 97' ' ' ARG . 1.4 pt -175.87 135.72 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.94 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.528 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 99.7 m -64.16 136.18 57.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.622 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 54.4 m -41.42 131.12 2.94 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.275 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.575 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -76.63 15.56 0.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.177 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 50.4 m -68.93 -39.81 79.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.916 0.389 . . . . 0.0 111.433 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.496 ' OH ' ' HA ' ' A' ' 152' ' ' PRO . 1.8 m-85 -64.59 -70.57 0.22 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.599 HD23 HD13 ' A' ' 113' ' ' LEU . 0.5 OUTLIER -46.98 156.97 0.18 Allowed 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 120.97 0.414 . . . . 0.0 111.484 -178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 24.6 m 64.67 73.13 0.43 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.34 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.689 ' HB2' ' HZ3' ' A' ' 153' ' ' LYS . 49.3 tp -93.14 136.52 33.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.333 -179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.83 135.06 57.58 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 179.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 58.97 40.93 21.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.075 0.464 . . . . 0.0 110.186 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.37 169.58 41.81 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.934 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -136.93 129.66 30.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.958 0.409 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.489 HG12 ' HB ' ' A' ' 126' ' ' VAL . 58.4 t -111.15 126.53 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.227 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.5 m-85 -70.87 111.33 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.19 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.599 HD13 HD23 ' A' ' 104' ' ' LEU . 58.5 tp -80.84 145.26 31.49 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.931 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.4 m -161.88 54.42 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.849 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.506 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . -174.76 61.26 0.11 Allowed Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.697 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -57.46 -53.37 45.52 Favored Glycine 0 CA--C 1.52 0.372 0 N-CA-C 114.634 0.613 . . . . 0.0 114.634 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -164.08 54.7 0.15 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 117.425 0.613 . . . . 0.0 111.821 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.529 ' O ' ' N ' ' A' ' 120' ' ' ALA . 7.1 mp -87.74 159.19 49.75 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.355 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.521 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 75.4 Cg_exo -47.52 83.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.541 2.16 . . . . 0.0 111.638 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.529 ' N ' ' O ' ' A' ' 118' ' ' LEU . . . 59.83 23.12 12.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.902 -178.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.713 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 7.8 mp 52.22 53.26 12.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.62 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 38.6 t70 -76.79 44.93 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.211 0.529 . . . . 0.0 110.329 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 125' ' ' ARG . . . 172.5 -27.65 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.536 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -51.8 144.55 11.08 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.783 0.325 . . . . 0.0 111.251 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.567 ' HG2' HG22 ' A' ' 143' ' ' VAL . 84.2 mtm180 -147.84 136.98 22.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.003 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.53 HG12 ' HA ' ' A' ' 113' ' ' LEU . 31.6 m -121.91 131.98 71.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.004 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -95.16 124.2 39.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.606 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.483 ' CE1' HG23 ' A' ' 126' ' ' VAL . 0.8 OUTLIER -87.09 138.17 31.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.98 -179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -145.92 127.47 15.1 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.491 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 96.5 m -89.29 145.32 25.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.692 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 134' ' ' PHE . 3.2 t70 -55.63 146.79 43.58 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.616 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 131' ' ' ASP . 88.4 Cg_exo -36.82 137.0 0.27 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.863 2.376 . . . . 0.0 112.593 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 51.5 m-20 75.0 22.21 1.85 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.512 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.501 ' HB2' ' O ' ' A' ' 131' ' ' ASP . 16.9 m-85 -134.97 131.54 37.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.562 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -106.03 135.23 47.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.926 0.393 . . . . 0.0 110.836 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.823 HD11 ' HG2' ' A' ' 154' ' ' PRO . 17.5 tp -78.15 143.07 37.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.406 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.526 ' O ' HG13 ' A' ' 137' ' ' VAL . 14.5 p -134.92 59.61 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -178.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.87 ' HA3' ' HB3' ' A' ' 154' ' ' PRO . . . 169.28 -126.15 1.34 Allowed Glycine 0 C--N 1.332 0.337 0 C-N-CA 119.013 -1.565 . . . . 0.0 113.764 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.941 ' HB3' ' HD3' ' A' ' 154' ' ' PRO . 29.9 t -65.66 65.8 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.796 0.332 . . . . 0.0 111.258 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.649 ' HA ' HD21 ' A' ' 136' ' ' LEU . 95.6 p -61.88 -26.55 68.22 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.331 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 77.7 mtp180 -140.68 125.23 17.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.502 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 73.8 m -116.35 137.33 52.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.793 0.33 . . . . 0.0 110.736 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.567 HG22 ' HG2' ' A' ' 125' ' ' ARG . 92.3 t -131.32 115.45 29.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.038 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . . . . . . . . . 69.7 m -80.31 153.19 28.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.832 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.61 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 40.8 t -152.43 -23.01 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.661 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -146.58 46.18 1.2 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.15 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.504 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 64.74 24.18 69.58 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.882 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -141.7 132.74 26.12 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 122.293 0.237 . . . . 0.0 110.483 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.528 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 72.4 m95 -66.41 145.22 55.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.786 0.327 . . . . 0.0 110.864 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.414 ' CB ' ' H ' ' A' ' 143' ' ' VAL . 47.3 t -56.27 -48.61 76.24 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.294 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.75 HG23 ' OG ' ' A' ' 139' ' ' SER . 1.0 OUTLIER -135.52 139.24 30.59 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-O 120.847 0.356 . . . . 0.0 111.765 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 17.8 Cg_endo -59.76 137.7 78.44 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.444 2.763 . . . . 0.0 113.842 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.838 ' HD3' ' HD2' ' A' ' 154' ' ' PRO . 2.7 tppp? -50.42 126.75 22.72 Favored Pre-proline 0 N--CA 1.464 0.229 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.77 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.941 ' HD3' ' HB3' ' A' ' 139' ' ' SER . 96.1 Cg_endo -85.03 -140.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.096 2.531 . . . . 0.0 112.278 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.505 ' O ' HG12 ' A' ' 137' ' ' VAL . 18.4 p-80 -153.69 149.31 27.39 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.876 0.369 . . . . 0.0 111.077 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 74.3 m -95.32 132.74 40.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.363 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 68.5 tp60 -123.58 139.4 54.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.359 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 78.2 t -64.23 133.73 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.779 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.934 179.942 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.701 0.286 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -174.37 45.94 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.1 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -60.71 137.18 58.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.003 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -58.33 145.11 39.14 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.4 m -151.1 137.42 12.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.329 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.861 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -171.82 -161.89 0.2 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.817 179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.858 HG13 ' HG2' ' A' ' 97' ' ' ARG . 91.1 mt 64.44 129.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.771 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 63.7 m -63.43 153.1 36.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.635 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.412 ' C ' ' H ' ' A' ' 102' ' ' SER . 47.7 t -39.44 104.02 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.167 0.508 . . . . 0.0 110.879 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.639 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -66.46 3.95 0.85 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.328 -179.491 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 100' ' ' SER . 47.7 t -68.11 -38.62 82.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.49 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.637 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.3 m-85 -51.5 -38.4 53.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.13 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.543 HD21 HD23 ' A' ' 113' ' ' LEU . 83.1 mt -53.77 -43.51 69.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.725 -179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.2 t -92.61 136.59 33.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.833 0.349 . . . . 0.0 111.338 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.592 HD13 ' CE ' ' A' ' 153' ' ' LYS . 34.8 tp -145.42 128.94 17.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.909 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -80.92 42.24 0.62 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.284 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -154.08 -31.31 0.11 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.801 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.552 ' HA2' ' OD1' ' A' ' 131' ' ' ASP . . . -153.9 -148.37 4.91 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.174 -179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -131.15 137.42 49.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.779 0.323 . . . . 0.0 110.827 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.637 HG21 ' O ' ' A' ' 103' ' ' TYR . 60.1 t -108.72 121.82 62.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.864 179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -69.17 124.32 23.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.513 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.705 HD22 ' H ' ' A' ' 114' ' ' THR . 3.1 tm? -99.7 142.16 31.55 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.395 0.617 . . . . 0.0 111.804 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.705 ' H ' HD22 ' A' ' 113' ' ' LEU . 22.6 m -157.47 42.93 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.861 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.553 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . 162.0 95.81 0.11 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 114.691 -1.14 . . . . 0.0 111.629 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.32 43.28 0.4 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.354 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.531 ' O ' HD23 ' A' ' 118' ' ' LEU . 53.1 p-10 -173.13 33.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.942 0.401 . . . . 0.0 110.647 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.617 ' HB2' HD23 ' A' ' 121' ' ' LEU . 86.1 mt -141.13 140.76 21.71 Favored Pre-proline 0 N--CA 1.454 -0.252 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.526 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.861 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 51.0 Cg_exo -52.54 117.36 3.58 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.579 2.186 . . . . 0.0 112.813 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.651 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 71.18 -38.03 0.41 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.686 HD22 ' HB2' ' A' ' 124' ' ' ALA . 46.5 mt 63.04 55.23 1.99 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.799 0.333 . . . . 0.0 110.789 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -76.54 48.97 0.58 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.617 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.16 -20.11 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.789 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.848 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.97 143.02 4.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.895 0.379 . . . . 0.0 111.672 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.621 ' HD2' HH22 ' A' ' 141' ' ' ARG . 84.9 mtm180 -136.57 141.6 43.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.818 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 33.8 m -138.13 136.2 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -114.27 113.4 24.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.484 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 3.0 m-85 -77.99 147.03 35.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.148 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.415 HH11 ' HG3' ' A' ' 129' ' ' ARG . 38.1 ttt85 -158.07 129.34 6.59 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.078 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 31.1 m -89.07 139.52 30.37 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.02 -179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.552 ' OD1' ' HA2' ' A' ' 109' ' ' GLY . 82.3 m-20 -52.63 151.44 7.92 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.232 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.69 77.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.023 2.482 . . . . 0.0 112.422 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 131' ' ' ASP . 65.1 t0 -179.44 -41.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.432 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.499 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 2.9 m-85 -110.09 140.93 43.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.229 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -102.72 127.8 49.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.863 0.364 . . . . 0.0 110.573 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.572 HD12 ' HB3' ' A' ' 140' ' ' SER . 2.7 tm? -77.35 129.34 35.7 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.07 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.553 ' N ' HD13 ' A' ' 136' ' ' LEU . 39.4 t -136.82 72.46 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.24 -135.89 2.41 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 119.632 -1.271 . . . . 0.0 113.318 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.477 ' HB3' ' OG1' ' A' ' 151' ' ' THR . 68.6 m -76.37 54.54 0.92 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.708 0.29 . . . . 0.0 110.94 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.572 ' HB3' HD12 ' A' ' 136' ' ' LEU . 88.8 p -47.07 -37.46 9.58 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.541 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.621 HH22 ' HD2' ' A' ' 125' ' ' ARG . 40.6 ttt85 -99.4 138.27 36.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.505 179.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 48.1 t -150.37 132.0 14.88 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.726 0.298 . . . . 0.0 110.655 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 125' ' ' ARG . 83.5 t -117.66 127.41 75.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.298 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.848 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 49.9 t -71.43 140.17 49.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -169.19 129.35 1.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.592 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 56.76 40.28 29.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.498 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 59.12 22.54 55.75 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.773 -0.649 . . . . 0.0 112.407 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.18 132.51 24.98 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.648 0.261 . . . . 0.0 110.687 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 70.9 m95 -69.5 141.29 53.95 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.839 0.352 . . . . 0.0 111.034 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 70.0 m -57.4 -54.41 47.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.05 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.477 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 65.0 p -115.71 137.34 23.17 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.399 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 139' ' ' SER . 31.7 Cg_exo -58.76 142.2 98.54 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.817 2.345 . . . . 0.0 112.227 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.592 ' CE ' HD13 ' A' ' 106' ' ' LEU . 62.6 tttp -50.42 130.93 25.89 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.247 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.475 ' HG2' HD21 ' A' ' 136' ' ' LEU . 59.4 Cg_endo -72.39 -152.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 122.649 2.232 . . . . 0.0 112.555 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.4 p-80 -153.63 143.7 22.12 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.133 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 81.1 m -98.15 129.68 44.93 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.37 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -119.28 140.82 49.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.937 0.398 . . . . 0.0 111.516 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.07 135.92 27.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.786 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.888 179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.629 0.252 . . . . 0.0 111.104 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 64.57 134.19 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.457 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -61.89 133.84 55.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.856 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.14 -145.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.686 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 35.5 m -63.96 140.13 20.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.764 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.738 ' HG2' HG13 ' A' ' 98' ' ' ILE . 0.4 OUTLIER -66.79 -156.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.033 179.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.058 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 94.5 mt 67.19 127.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.368 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 66.8 m -62.48 150.52 39.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.717 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 102' ' ' SER . 57.5 m -40.68 105.07 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.603 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -69.13 15.38 0.07 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.719 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 100' ' ' SER . 46.9 t -68.92 -35.38 76.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.061 0.458 . . . . 0.0 110.029 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -51.65 -35.19 41.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.241 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.731 HD21 HD13 ' A' ' 113' ' ' LEU . 91.4 mt -53.47 -43.93 68.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.211 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 91.4 m -92.56 128.61 38.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.937 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.541 HD13 ' CE ' ' A' ' 153' ' ' LYS . 34.9 tp -145.45 132.91 20.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.366 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -69.41 132.91 47.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.492 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 56.24 43.98 25.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.545 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.81 163.82 32.99 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.519 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.58 ' NZ ' ' HB2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -138.89 134.39 33.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.775 0.322 . . . . 0.0 110.684 -179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' A' ' 126' ' ' VAL . 57.7 t -114.13 126.96 71.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.647 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -73.34 124.82 26.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.211 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.731 HD13 HD21 ' A' ' 104' ' ' LEU . 52.9 tp -89.54 143.35 26.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.225 0.535 . . . . 0.0 112.088 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.577 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.2 m -162.37 52.4 0.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.395 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.641 ' O ' HD11 ' A' ' 121' ' ' LEU . . . 161.95 103.39 0.18 Allowed Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.709 -179.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -168.86 47.84 0.22 Allowed Glycine 0 CA--C 1.518 0.266 0 C-N-CA 120.54 -0.838 . . . . 0.0 113.113 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.643 ' O ' HD13 ' A' ' 118' ' ' LEU . 2.7 p30 -174.5 36.43 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.836 0.35 . . . . 0.0 111.156 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.643 HD13 ' O ' ' A' ' 117' ' ' ASP . 2.2 mm? -134.98 151.85 76.22 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.582 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.4 124.26 11.64 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.345 2.03 . . . . 0.0 111.424 179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 97' ' ' ARG . . . 53.16 32.0 12.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.069 0.461 . . . . 0.0 110.279 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 1.058 ' HB2' ' HA ' ' A' ' 98' ' ' ILE . 14.7 tp 50.58 46.73 25.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.927 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -66.68 141.08 57.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.122 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 64.8 31.36 80.65 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.469 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.919 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . . . -85.65 145.17 27.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.737 0.303 . . . . 0.0 110.976 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.577 ' O ' ' HB ' ' A' ' 114' ' ' THR . 53.4 ttt-85 -160.4 127.07 4.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.692 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 113' ' ' LEU . 28.3 m -137.54 136.96 46.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.68 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -102.38 122.71 44.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.123 -179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.569 ' HE2' ' HG3' ' A' ' 153' ' ' LYS . 5.7 m-85 -83.61 150.21 26.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.134 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -157.04 126.13 5.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.588 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 73.4 m -89.91 136.91 32.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.218 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 -57.78 159.33 10.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.965 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 88.3 Cg_exo -40.89 152.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.96 2.44 . . . . 0.0 112.721 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.51 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 57.8 m-20 78.03 -34.38 0.18 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.039 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -106.02 128.21 53.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.3 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.447 ' H ' ' CD2' ' A' ' 135' ' ' HIS . 0.4 OUTLIER -106.27 140.08 39.78 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.14 0.495 . . . . 0.0 111.878 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.817 HD21 ' HA ' ' A' ' 140' ' ' SER . 36.5 tp -78.11 128.44 33.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.704 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.42 64.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.577 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -172.73 -135.83 2.05 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 119.703 -1.237 . . . . 0.0 113.219 -179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.678 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 63.8 m -72.04 63.92 0.51 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 121.114 0.483 . . . . 0.0 110.734 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.817 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.1 t -55.31 -16.96 3.92 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.467 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -140.64 136.03 32.29 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.89 179.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 79.2 p -135.57 141.87 45.23 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.49 ' H ' ' HB3' ' A' ' 150' ' ' SER . 95.5 t -135.82 126.18 42.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.066 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.867 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 57.2 m -92.95 148.46 21.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.039 0.447 . . . . 0.0 111.735 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.6 t -163.15 26.66 0.09 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.148 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 175.86 39.51 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.275 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 62.66 19.37 60.42 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.495 -179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -142.38 132.77 24.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.664 0.268 . . . . 0.0 110.641 179.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 88.8 m95 -64.56 143.01 58.22 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.967 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 48.5 t -57.14 -47.43 81.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.714 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 59.8 p -127.68 133.57 25.25 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.342 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -55.25 142.99 77.61 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.879 2.386 . . . . 0.0 112.619 -179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.569 ' HG3' ' HE2' ' A' ' 128' ' ' PHE . 87.4 tttt -48.86 128.24 14.39 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.28 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.678 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.0 Cg_endo -75.91 -150.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.704 2.269 . . . . 0.0 112.672 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.405 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.6 p-80 -153.69 151.51 29.74 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.08 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 90.2 m -98.61 137.09 37.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.727 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -120.4 135.83 54.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.362 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.6 p -68.65 143.63 14.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.973 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 133' ' ' ASP . 23.5 p30 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.09 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.824 0.345 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -178.21 46.15 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.843 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.5 pt-20 -56.95 135.23 56.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.432 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 2.5 m-85 -60.63 141.61 56.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.88 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 29.3 m -134.12 45.76 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.062 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 1.019 ' HG3' HG13 ' A' ' 98' ' ' ILE . 31.8 ptt180 -172.2 -164.63 0.3 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.984 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 1.019 HG13 ' HG3' ' A' ' 97' ' ' ARG . 12.8 mt 51.42 32.22 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.755 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.539 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 72.9 m 58.77 149.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.876 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 37.4 t -40.41 100.84 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 110.842 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.549 ' HG3' HD12 ' A' ' 104' ' ' LEU . 27.7 ttpp -59.9 -20.61 58.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.861 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 90.8 p -53.24 -33.51 53.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.292 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -56.95 -44.87 82.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.662 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.549 HD12 ' HG3' ' A' ' 101' ' ' LYS . 92.7 mt -49.61 -39.98 37.54 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.093 -179.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 76.7 p -92.55 131.87 37.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.652 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.859 HD13 ' HE3' ' A' ' 153' ' ' LYS . 55.4 tp -145.36 130.68 18.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.18 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -66.57 132.3 47.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.433 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.77 43.89 24.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.566 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.19 164.4 34.92 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.472 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -136.7 134.35 37.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.736 0.303 . . . . 0.0 110.83 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 86.9 t -106.48 126.07 62.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.391 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.585 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.5 m-85 -74.71 127.43 33.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.649 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -81.6 140.97 34.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.076 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.649 ' N ' HD13 ' A' ' 113' ' ' LEU . 28.2 m -158.1 56.11 0.47 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.083 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.99 -101.87 0.2 Allowed Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.012 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.651 ' H ' HD21 ' A' ' 121' ' ' LEU . . . -179.97 -131.55 1.66 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.225 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.699 ' C ' HD12 ' A' ' 118' ' ' LEU . 39.0 t70 -165.8 58.38 0.11 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.974 0.416 . . . . 0.0 110.34 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.699 HD12 ' C ' ' A' ' 117' ' ' ASP . 8.0 mp -131.38 156.98 79.39 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.515 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.737 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 95.6 Cg_exo -42.89 119.89 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.445 2.097 . . . . 0.0 112.468 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.695 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 72.99 -40.24 0.47 Allowed 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.672 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.651 HD21 ' H ' ' A' ' 116' ' ' GLY . 21.2 tp 55.23 57.21 5.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.949 0.404 . . . . 0.0 110.857 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -51.19 137.1 23.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.15 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.22 33.52 64.78 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.895 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.586 ' HB3' ' SG ' ' A' ' 144' ' ' CYS . . . -84.35 148.53 26.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.523 0.201 . . . . 0.0 110.595 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.422 ' O ' ' HB ' ' A' ' 114' ' ' THR . 66.1 mtm-85 -144.87 141.96 29.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.985 0.421 . . . . 0.0 111.338 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.58 HG23 ' CE1' ' A' ' 128' ' ' PHE . 23.9 m -147.8 132.08 9.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.715 179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.7 mt-10 -93.05 131.43 38.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.292 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.58 ' CE1' HG23 ' A' ' 126' ' ' VAL . 4.3 m-85 -103.47 145.84 29.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.029 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.508 ' HG2' HH11 ' A' ' 129' ' ' ARG . 2.9 ptp85 -168.89 129.98 1.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.651 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 26.2 t -89.22 150.5 22.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.235 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -52.68 155.8 3.68 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.32 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 84.9 Cg_exo -46.28 159.21 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.68 2.254 . . . . 0.0 112.149 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.503 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 25.3 m-20 78.27 -37.53 0.22 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.61 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -108.05 128.96 55.13 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -108.66 133.52 52.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.929 0.395 . . . . 0.0 111.596 -179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.551 HD23 ' N ' ' A' ' 137' ' ' VAL . 7.9 tt -71.42 137.53 48.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.02 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.551 ' N ' HD23 ' A' ' 136' ' ' LEU . 42.8 t -131.37 73.08 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.769 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.46 -133.43 2.22 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.081 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.58 ' OG ' ' HD3' ' A' ' 154' ' ' PRO . 43.6 p -73.72 62.6 0.81 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 121.085 0.469 . . . . 0.0 110.917 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.528 ' HB3' HD22 ' A' ' 136' ' ' LEU . 99.8 p -56.27 -14.93 3.19 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.801 -179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.647 ' HD2' ' O ' ' A' ' 141' ' ' ARG . 7.6 ppt_? -140.62 140.52 35.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.599 0.237 . . . . 0.0 110.964 179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 56.1 m -136.55 148.93 47.84 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.855 0.359 . . . . 0.0 111.278 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 6.7 p -143.21 129.87 17.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.374 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.586 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 98.3 m -75.06 174.93 8.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.509 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.7 t -172.21 -30.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.452 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -150.8 49.5 0.86 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.59 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 65.68 19.35 67.08 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.259 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -142.82 132.19 23.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.548 0.213 . . . . 0.0 110.731 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.539 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 97.7 m95 -65.15 135.83 55.95 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.647 0.261 . . . . 0.0 110.941 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.8 t -57.48 -52.76 64.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.483 179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.7 p -104.3 146.15 32.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.971 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.83 -152.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.622 2.215 . . . . 0.0 112.739 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.859 ' HE3' HD13 ' A' ' 106' ' ' LEU . 59.0 tptt -121.77 123.62 27.38 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.262 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.782 ' HD2' ' HD2' ' A' ' 153' ' ' LYS . 98.3 Cg_endo -85.45 -146.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.66 2.24 . . . . 0.0 113.214 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.445 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 21.7 p-80 -153.72 -149.28 0.28 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 85.6 m -133.07 134.83 44.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.533 ' NE2' HG21 ' A' ' 137' ' ' VAL . 8.3 tt0 -116.85 130.03 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.456 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.0 p -62.14 137.99 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.125 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.6 p30 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.954 -179.846 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.848 0.356 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.52 -135.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.713 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.468 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -59.95 130.22 45.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.68 0.276 . . . . 0.0 110.859 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 63.93 138.03 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.49 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p -172.03 134.9 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.756 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.854 ' HG2' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -65.84 -152.87 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.694 -179.371 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.854 HG23 ' HG2' ' A' ' 97' ' ' ARG . 11.4 pt 52.63 127.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.409 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.609 ' SG ' HD22 ' A' ' 121' ' ' LEU . 3.2 p -60.7 136.04 57.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.726 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.401 ' C ' ' H ' ' A' ' 102' ' ' SER . 80.4 p -39.89 130.31 2.02 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.592 -179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.581 ' NZ ' HD12 ' A' ' 98' ' ' ILE . 60.5 mttp -75.11 16.12 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.345 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.401 ' H ' ' C ' ' A' ' 100' ' ' SER . 79.6 p -68.96 -44.8 72.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.905 0.383 . . . . 0.0 110.866 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -59.07 -36.83 75.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.412 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.412 HD21 HD23 ' A' ' 113' ' ' LEU . 94.9 mt -50.55 149.39 3.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.747 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 30.3 p 62.66 137.8 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.115 -179.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.796 HD13 ' HE2' ' A' ' 153' ' ' LYS . 36.1 tp -145.41 139.66 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.26 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -68.04 130.0 41.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.235 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 74.4 m-80 57.37 41.74 25.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.713 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 178.49 152.82 10.68 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.636 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -114.48 132.01 56.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.724 0.297 . . . . 0.0 110.685 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.757 HG22 ' HA ' ' A' ' 128' ' ' PHE . 98.5 t -108.32 121.96 62.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.288 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.493 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.7 m-85 -74.82 126.08 30.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.152 179.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.681 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -108.58 142.06 39.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.411 -179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.681 ' N ' HD13 ' A' ' 113' ' ' LEU . 94.7 m -163.58 97.66 0.88 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.608 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.493 ' O ' ' HG ' ' A' ' 121' ' ' LEU . . . 163.08 -30.26 0.27 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.575 -0.822 . . . . 0.0 112.883 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . -41.58 150.14 0.26 Allowed Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.528 -0.368 . . . . 0.0 113.901 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.672 ' C ' HD22 ' A' ' 118' ' ' LEU . 32.5 m-20 72.23 37.11 0.99 Allowed 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 122.826 0.45 . . . . 0.0 111.704 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.672 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.3 mm? -142.44 148.67 48.2 Favored Pre-proline 0 C--N 1.331 -0.205 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.953 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -50.86 97.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.797 2.332 . . . . 0.0 112.616 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.81 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 55.64 17.06 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.574 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.777 HD13 ' HA ' ' A' ' 98' ' ' ILE . 10.4 mp 46.11 62.44 2.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.25 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -75.53 46.02 0.33 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.169 0.509 . . . . 0.0 110.376 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.86 27.05 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.029 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.784 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -81.46 142.08 33.27 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.754 0.311 . . . . 0.0 111.397 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -135.56 130.29 34.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.621 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 113' ' ' LEU . 19.0 m -136.1 144.13 34.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.468 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 111' ' ' VAL . 87.2 tt0 -119.09 122.05 41.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.229 179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.757 ' HA ' HG22 ' A' ' 111' ' ' VAL . 9.4 m-85 -85.65 53.51 2.79 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.965 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.499 ' HB3' ' NH1' ' A' ' 129' ' ' ARG . 12.8 mtp-105 -58.88 128.62 38.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.841 0.353 . . . . 0.0 111.001 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 61.3 m -89.55 147.21 24.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.891 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.452 ' O ' ' N ' ' A' ' 133' ' ' ASP . 52.6 p-10 -52.81 153.0 6.27 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.031 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.36 75.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.001 2.468 . . . . 0.0 112.755 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 131' ' ' ASP . 8.5 t70 179.93 -40.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.074 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.435 ' CE2' ' HB ' ' A' ' 158' ' ' VAL . 3.5 m-85 -108.63 139.65 43.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.259 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -102.86 131.45 49.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.053 0.454 . . . . 0.0 110.757 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.852 HD21 ' HA ' ' A' ' 140' ' ' SER . 23.2 tp -69.91 131.9 45.14 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.982 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.1 t -136.25 67.8 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.94 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -178.59 -136.5 2.59 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 119.47 -1.348 . . . . 0.0 113.376 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.495 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 62.2 m -74.62 58.12 0.77 Allowed 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.997 0.427 . . . . 0.0 110.565 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.852 ' HA ' HD21 ' A' ' 136' ' ' LEU . 39.3 t -47.63 -44.03 26.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.416 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.8 ptt180 -102.62 133.03 48.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.968 179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 45.7 t -138.32 125.23 21.18 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.64 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 96.8 t -111.89 125.62 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.086 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.784 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 73.9 m -72.83 143.35 47.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.017 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.5 p -163.51 128.69 3.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.097 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.475 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 1.5 mp0 55.79 38.21 29.79 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.048 0.451 . . . . 0.0 109.917 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.402 ' H ' ' HB1' ' A' ' 120' ' ' ALA . . . 62.29 28.21 70.53 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.351 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -143.23 131.53 22.07 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.576 0.227 . . . . 0.0 110.593 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -69.85 137.43 51.73 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.926 0.393 . . . . 0.0 111.117 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.2 t -57.49 -56.46 21.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.644 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.442 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 82.0 p -111.75 137.64 21.32 Favored Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 32.2 Cg_exo -58.41 147.17 86.96 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.879 2.386 . . . . 0.0 112.268 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.796 ' HE2' HD13 ' A' ' 106' ' ' LEU . 85.9 tttt -52.79 125.65 39.16 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.221 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.495 ' HB3' ' N ' ' A' ' 139' ' ' SER . 74.8 Cg_endo -76.78 -154.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.76 2.306 . . . . 0.0 112.655 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.9 p-80 -153.67 150.67 28.82 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.229 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 76.5 m -97.33 134.91 39.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.228 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 2.7 tm0? -124.47 131.42 53.49 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.715 0.293 . . . . 0.0 110.721 -179.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.435 ' HB ' ' CE2' ' A' ' 134' ' ' PHE . 7.3 p -74.09 129.27 36.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.976 0.417 . . . . 0.0 111.641 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.2 p30 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.184 -0.913 . . . . 0.0 111.091 179.758 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.798 0.332 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -173.15 -141.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.865 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -67.27 -42.19 84.27 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.045 0.45 . . . . 0.0 110.896 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.547 ' O ' ' HD3' ' A' ' 97' ' ' ARG . 1.5 m-85 -59.88 129.53 42.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.66 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 28.7 m -63.28 144.55 14.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.557 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.764 HH21 HD12 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -165.59 62.71 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.54 0.685 . . . . 0.0 111.021 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.764 HD12 HH21 ' A' ' 97' ' ' ARG . 0.2 OUTLIER -145.25 133.59 16.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.104 -179.769 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.584 ' HB3' ' CE2' ' A' ' 149' ' ' TRP . 39.1 m -57.1 143.77 37.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.866 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 47.6 t -39.88 128.56 2.12 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.075 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.69 ' HD2' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -72.73 -14.27 61.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.364 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 81.5 p -53.1 -47.06 68.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.53 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -59.44 -41.27 89.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.252 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 111' ' ' VAL . 86.8 mt -51.86 -36.89 49.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.23 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 79.5 p -92.49 141.42 28.53 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.608 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.498 HD22 ' H ' ' A' ' 108' ' ' ASN . 1.9 tt -140.84 120.93 13.74 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.971 -0.558 . . . . 0.0 109.532 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 108' ' ' ASN . 3.8 mm-40 -82.64 30.05 0.43 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.498 ' H ' HD22 ' A' ' 106' ' ' LEU . 72.3 m-80 -166.14 25.68 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.54 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.15 -156.67 23.93 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.656 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -141.96 134.01 27.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.632 0.253 . . . . 0.0 110.571 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 104' ' ' LEU . 94.0 t -106.59 121.18 58.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.927 0.394 . . . . 0.0 111.023 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.525 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.2 m-85 -74.78 116.35 15.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.437 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 51.2 tp -83.28 142.77 30.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.393 . . . . 0.0 111.422 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 114' ' ' THR . 32.3 m -163.28 61.17 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.393 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.486 ' O ' HD13 ' A' ' 118' ' ' LEU . . . -152.39 -39.35 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.839 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 78.06 -125.74 7.35 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.885 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.457 ' HA ' HD11 ' A' ' 121' ' ' LEU . 52.0 p-10 -147.47 48.3 1.11 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.999 0.428 . . . . 0.0 111.163 -179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 121' ' ' LEU . 6.7 mp -80.77 161.38 63.96 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.402 179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.705 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 83.6 Cg_exo -43.82 94.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.459 2.106 . . . . 0.0 112.343 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.471 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 69.25 -9.03 0.65 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.961 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.723 HD12 ' O ' ' A' ' 118' ' ' LEU . 7.6 mp 61.46 57.68 2.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.593 0.235 . . . . 0.0 110.883 -179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -75.12 49.63 0.45 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.956 0.408 . . . . 0.0 110.587 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 178.99 -13.68 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.905 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.993 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -50.75 147.54 4.74 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.928 0.394 . . . . 0.0 111.335 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.684 ' CD ' HG22 ' A' ' 143' ' ' VAL . 43.8 mmm-85 -146.25 133.57 20.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.657 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.415 ' HB ' ' CG1' ' A' ' 111' ' ' VAL . 35.7 m -127.03 132.13 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 111.584 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 52.4 mm-40 -103.32 138.63 39.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.839 179.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -105.58 145.06 31.47 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.043 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 25.1 tpt85 -148.52 122.53 9.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.355 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 134' ' ' PHE . 59.3 m -89.22 143.89 26.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.052 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 133' ' ' ASP . 1.4 m-20 -52.8 151.94 7.63 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.883 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_endo -57.28 75.07 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.13 2.553 . . . . 0.0 112.722 -179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 131' ' ' ASP . 38.9 t70 178.89 -36.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.646 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 1.6 m-85 -108.8 136.67 47.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.068 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -102.84 130.13 49.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.902 0.382 . . . . 0.0 110.532 179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.812 HD21 ' HA ' ' A' ' 140' ' ' SER . 35.8 tp -71.46 130.32 41.0 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.056 -179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.0 t -136.33 68.82 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.785 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 174.61 -129.21 1.55 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 119.512 -1.327 . . . . 0.0 113.347 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.736 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 30.1 t -68.86 63.63 0.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.89 0.376 . . . . 0.0 111.259 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.812 ' HA ' HD21 ' A' ' 136' ' ' LEU . 93.4 p -57.77 -23.99 54.96 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.526 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.7 ptp85 -140.61 136.17 32.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.79 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.548 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 46.7 t -127.92 125.48 39.67 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.559 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.684 HG22 ' CD ' ' A' ' 125' ' ' ARG . 46.3 t -97.72 120.24 46.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.244 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.993 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 52.7 t -77.94 122.94 26.18 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.4 p -104.65 -123.72 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.703 -179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -75.88 55.89 0.92 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.907 0.384 . . . . 0.0 110.68 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 80.03 21.13 66.13 Favored Glycine 0 CA--C 1.522 0.478 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.776 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -143.09 137.07 28.91 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.65 0.262 . . . . 0.0 111.239 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.584 ' CE2' ' HB3' ' A' ' 99' ' ' CYS . 83.3 m95 -67.24 139.79 57.37 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-O 120.875 0.369 . . . . 0.0 111.51 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.508 ' HB3' ' H ' ' A' ' 143' ' ' VAL . 46.7 t -57.49 -53.86 53.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.978 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.587 HG23 ' OG ' ' A' ' 139' ' ' SER . 2.4 t -127.06 141.41 40.59 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.698 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.3 145.32 98.19 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.174 2.583 . . . . 0.0 112.979 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -49.91 134.76 21.24 Favored Pre-proline 0 N--CA 1.463 0.201 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.381 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.736 ' HB3' ' H ' ' A' ' 139' ' ' SER . 97.0 Cg_endo -79.48 -149.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.749 2.299 . . . . 0.0 112.759 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.404 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.2 p-80 -153.72 145.71 23.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.861 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 75.2 m -96.81 127.52 42.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.544 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -111.09 129.48 55.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.064 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.3 p -70.22 136.29 26.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.826 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.886 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 54.1 mt-10 . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.704 0.288 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 52.77 42.53 31.83 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 92' ' ' GLU . 15.9 pt-20 -174.24 135.69 0.46 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.757 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -172.65 131.56 0.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.027 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.9 p -89.24 141.35 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.286 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.644 ' HD3' ' N ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -167.29 110.19 0.67 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.278 179.765 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.633 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -161.38 141.5 3.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.693 179.63 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.537 ' SG ' ' HB3' ' A' ' 121' ' ' LEU . 61.2 m -55.88 135.7 51.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.509 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 80.4 p -42.15 127.27 3.49 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -77.86 16.23 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.371 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.5 m -68.26 -42.25 79.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.011 0.434 . . . . 0.0 110.359 179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.503 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.2 m-85 -62.03 -46.28 89.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.728 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.423 ' HA ' HG11 ' A' ' 111' ' ' VAL . 92.4 mt -64.64 -30.63 71.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.979 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 70.2 p -92.46 72.63 5.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.633 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.796 HD22 ' H ' ' A' ' 109' ' ' GLY . 1.3 tt -94.54 124.27 38.46 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.529 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 38.5 tt0 -81.84 34.99 0.41 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.082 0.468 . . . . 0.0 111.38 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.417 ' N ' HD22 ' A' ' 106' ' ' LEU . 7.3 m120 -160.75 -49.17 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.4 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.796 ' H ' HD22 ' A' ' 106' ' ' LEU . . . -86.68 -151.96 20.51 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.964 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' O ' ' O ' ' A' ' 111' ' ' VAL . 86.0 tttt -142.04 -42.33 0.34 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.811 0.339 . . . . 0.0 110.602 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 10.5 p 48.55 115.6 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.947 179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -75.17 127.48 33.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.111 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 56.3 tp -90.84 146.23 24.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.065 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 24.8 m -157.11 53.97 0.5 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.398 0.618 . . . . 0.0 109.912 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.664 ' C ' HD11 ' A' ' 121' ' ' LEU . . . 164.96 107.68 0.2 Allowed Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.702 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -153.53 140.67 7.72 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.862 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.726 ' C ' HD12 ' A' ' 118' ' ' LEU . 9.4 t70 73.87 53.38 0.11 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.137 0.494 . . . . 0.0 111.073 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.726 HD12 ' C ' ' A' ' 117' ' ' ASP . 9.3 mp -140.27 152.4 66.89 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.657 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.544 ' HA ' ' CG ' ' A' ' 97' ' ' ARG . 14.3 Cg_endo -57.24 113.75 1.63 Allowed 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.228 1.952 . . . . 0.0 110.999 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.573 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 56.55 18.27 3.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.143 0.497 . . . . 0.0 109.887 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.778 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 14.9 tp 45.54 42.94 8.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.069 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -62.78 137.39 58.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 71.63 37.53 61.8 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.979 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.822 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -98.73 142.76 29.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.685 0.279 . . . . 0.0 110.867 179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.512 ' O ' ' HB ' ' A' ' 114' ' ' THR . 66.2 mtm-85 -131.49 138.54 49.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.94 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.6 m -144.53 134.75 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.273 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.6 tp10 -113.68 105.93 13.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.39 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 66.3 m-85 -68.78 146.49 52.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.102 0.477 . . . . 0.0 111.625 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.41 HH11 ' HG3' ' A' ' 129' ' ' ARG . 41.3 ttt85 -153.16 125.42 8.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.657 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.637 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 56.5 m -89.26 139.97 29.96 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.558 -178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.501 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 47.4 p-10 -54.26 161.09 2.1 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.703 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.559 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 1.8 Cg_endo -45.04 152.44 0.57 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.835 2.357 . . . . 0.0 111.899 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.559 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 35.0 t70 79.62 -29.57 0.14 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.485 ' CE2' HG22 ' A' ' 158' ' ' VAL . 35.6 m-85 -106.45 132.43 52.47 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.694 0.283 . . . . 0.0 110.711 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -112.28 136.02 52.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.992 0.425 . . . . 0.0 111.191 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.896 HD21 ' HA ' ' A' ' 140' ' ' SER . 29.6 tp -77.3 129.77 36.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.921 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.3 t -136.2 68.91 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.861 -179.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 176.82 -129.99 1.57 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 119.55 -1.309 . . . . 0.0 113.267 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.741 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 31.3 t -70.06 62.7 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.035 0.445 . . . . 0.0 111.206 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.896 ' HA ' HD21 ' A' ' 136' ' ' LEU . 36.2 t -58.13 -23.13 53.9 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.81 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -127.28 139.71 52.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.654 179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.6 t -144.48 134.82 24.4 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.687 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 85.9 t -122.54 125.56 72.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.883 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.822 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 7.5 m -64.46 148.46 50.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.331 0.586 . . . . 0.0 112.091 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.6 p -166.82 124.26 1.29 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.069 -0.968 . . . . 0.0 109.32 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 98.0 mm-40 59.3 39.02 22.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.082 0.468 . . . . 0.0 110.079 -178.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.573 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 62.11 24.1 64.74 Favored Glycine 0 CA--C 1.52 0.381 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.659 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -142.42 135.93 29.01 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.505 0.193 . . . . 0.0 110.81 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.457 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 59.5 m95 -64.33 133.03 51.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.741 0.305 . . . . 0.0 110.546 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.5 t -57.44 -59.43 5.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.009 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 41.9 p -94.11 135.48 24.54 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.778 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -64.16 142.91 82.37 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.726 2.284 . . . . 0.0 111.915 179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -50.72 129.29 27.41 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.302 -179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.741 ' HB3' ' H ' ' A' ' 139' ' ' SER . 73.8 Cg_endo -75.69 -148.94 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.692 2.261 . . . . 0.0 112.47 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.422 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 15.5 p-80 -153.69 143.32 21.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.172 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 88.3 m -97.63 130.85 44.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.031 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -124.02 143.36 50.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.184 0.516 . . . . 0.0 111.794 -179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.485 HG22 ' CE2' ' A' ' 134' ' ' PHE . 4.5 t -66.0 137.27 25.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.982 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.2 p30 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.173 -0.917 . . . . 0.0 111.002 -179.968 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.498 0.19 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -177.91 49.65 0.01 OUTLIER 'General case' 0 C--O 1.232 0.181 0 CA-C-O 120.758 0.313 . . . . 0.0 111.243 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -170.88 138.46 1.34 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.021 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.488 ' H ' ' HD1' ' A' ' 95' ' ' PHE . 2.1 m-85 -61.25 130.7 47.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.393 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.36 126.9 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.611 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.901 ' HG2' ' H ' ' A' ' 98' ' ' ILE . 13.0 ttp-105 -175.97 -155.98 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.269 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.96 HG22 ' HB2' ' A' ' 121' ' ' LEU . 4.4 pt -56.96 140.24 15.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.029 0.443 . . . . 0.0 111.82 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.673 ' HA ' ' HA2' ' A' ' 147' ' ' GLY . 2.4 p -53.5 136.55 38.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.698 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.452 ' C ' ' H ' ' A' ' 102' ' ' SER . 46.8 t -40.4 128.83 2.41 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.973 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -74.46 23.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.528 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.571 ' O ' HG22 ' A' ' 105' ' ' THR . 77.7 p -68.87 -41.16 78.75 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.029 0.442 . . . . 0.0 110.506 179.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.476 ' HB3' ' HZ ' ' A' ' 128' ' ' PHE . 1.7 m-85 -67.92 -25.29 65.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.449 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.409 HD21 HD23 ' A' ' 113' ' ' LEU . 79.0 mt -68.86 23.9 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 102' ' ' SER . 9.2 t -148.36 129.55 14.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 178.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.56 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 43.5 tp -145.44 127.37 15.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 107' ' ' GLU . 41.9 tp10 -82.36 46.15 1.02 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.095 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -158.89 -30.24 0.07 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.215 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.643 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -158.33 -150.77 5.86 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.386 -0.912 . . . . 0.0 113.349 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 29.6 mtmm -130.23 152.07 50.06 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.816 0.341 . . . . 0.0 111.005 -179.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.429 HG21 ' O ' ' A' ' 103' ' ' TYR . 61.0 t -105.79 126.4 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.809 179.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -80.17 69.18 6.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.379 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.977 ' HA ' HG12 ' A' ' 126' ' ' VAL . 3.3 tm? -63.73 145.12 56.35 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.654 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.705 ' N ' HD13 ' A' ' 113' ' ' LEU . 56.4 m -149.06 81.74 1.43 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.022 0.439 . . . . 0.0 111.391 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.613 ' HA3' HD11 ' A' ' 121' ' ' LEU . . . 177.03 -103.01 0.17 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.216 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 117' ' ' ASP . . . 59.58 144.2 0.01 OUTLIER Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.073 0.389 . . . . 0.0 114.073 178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.705 ' C ' HD22 ' A' ' 118' ' ' LEU . 57.6 m-20 71.86 49.84 0.25 Allowed 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.705 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.4 mm? -142.23 138.68 16.88 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.883 178.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.869 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 70.1 Cg_endo -74.55 33.94 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.376 2.051 . . . . 0.0 112.192 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 119' ' ' PRO . . . 172.19 -44.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.732 179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.96 ' HB2' HG22 ' A' ' 98' ' ' ILE . 15.2 tp 59.7 43.9 14.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.088 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.444 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 64.4 t0 -79.97 58.49 2.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.822 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -174.37 -27.09 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.738 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.735 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -48.83 153.53 0.83 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.063 0.458 . . . . 0.0 111.707 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -139.5 136.67 34.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.369 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.977 HG12 ' HA ' ' A' ' 113' ' ' LEU . 29.1 m -125.66 139.26 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.07 0.462 . . . . 0.0 111.942 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -120.71 98.24 5.92 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.397 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.476 ' HZ ' ' HB3' ' A' ' 103' ' ' TYR . 4.6 m-85 -64.65 147.45 52.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.973 0.416 . . . . 0.0 111.347 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -159.95 115.52 2.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.409 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.643 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 91.7 m -89.17 149.16 23.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.456 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.469 ' OD1' ' HA2' ' A' ' 109' ' ' GLY . 1.3 m-20 -52.7 158.35 2.2 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.083 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.509 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 99.3 Cg_exo -43.04 159.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.906 2.404 . . . . 0.0 112.564 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 49.8 m-20 80.76 -31.88 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.79 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -105.86 143.97 33.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.414 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -133.99 131.31 38.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.973 0.416 . . . . 0.0 111.015 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.768 HD11 ' HG2' ' A' ' 154' ' ' PRO . 24.4 tp -78.32 133.77 37.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.668 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 39.5 t -131.99 71.25 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.66 -179.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -179.67 -133.61 2.02 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.955 179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.597 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 58.7 m -76.05 54.82 0.88 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 120.739 0.304 . . . . 0.0 110.958 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.424 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 95.7 p -50.0 -41.31 46.85 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 15.1 ptp180 -99.38 130.23 45.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.482 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.51 ' O ' HG22 ' A' ' 126' ' ' VAL . 44.0 t -134.9 127.27 30.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.902 0.382 . . . . 0.0 110.74 -179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 64.5 t -93.81 128.67 45.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.357 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.735 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 48.9 t -83.03 134.43 35.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.887 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 79.3 p -175.04 132.95 0.32 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.972 0.415 . . . . 0.0 111.853 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 53.53 46.29 26.42 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.881 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.673 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . 52.76 23.35 14.52 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.961 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -142.49 130.22 21.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.66 0.267 . . . . 0.0 110.824 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.466 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 65.3 m95 -75.98 135.18 40.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.892 0.377 . . . . 0.0 111.03 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 m -57.52 -53.98 51.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.036 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.542 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 80.8 p -107.5 129.53 24.11 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.477 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.425 ' O ' ' HB2' ' A' ' 139' ' ' SER . 38.8 Cg_exo -60.74 142.87 98.97 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.745 2.296 . . . . 0.0 111.866 179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.56 ' NZ ' HD13 ' A' ' 106' ' ' LEU . 57.1 tttm -51.76 125.87 30.74 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.305 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.768 ' HG2' HD11 ' A' ' 136' ' ' LEU . 80.8 Cg_endo -79.26 -149.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.666 2.244 . . . . 0.0 112.433 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 -153.95 141.47 19.8 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.741 0.305 . . . . 0.0 111.446 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 95.1 m -98.58 132.76 43.73 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.602 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -103.03 133.92 47.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.426 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.86 138.67 21.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.738 179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' A' ' 133' ' ' ASP . 24.6 p30 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.198 -0.906 . . . . 0.0 111.029 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.599 0.238 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.07 134.26 56.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.939 0.4 . . . . 0.0 111.271 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -66.25 135.73 54.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.043 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -60.62 -44.45 96.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.769 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.5 p -172.38 129.42 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.937 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.904 ' HD3' ' H ' ' A' ' 97' ' ' ARG . 0.0 OUTLIER -68.68 -176.31 0.79 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.455 -179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.764 HD13 ' HG2' ' A' ' 97' ' ' ARG . 1.6 mp 68.94 135.45 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.943 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.47 ' O ' HG22 ' A' ' 98' ' ' ILE . 69.4 m -57.44 146.54 29.19 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.518 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 99' ' ' CYS . 52.8 m -35.85 120.98 0.63 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.017 0.437 . . . . 0.0 111.491 -178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.566 ' NZ ' ' HB3' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -72.82 3.22 5.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.883 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.6 p -66.48 -41.95 88.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.353 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.554 ' HD2' ' HZ ' ' A' ' 128' ' ' PHE . 2.1 m-85 -54.23 -42.28 69.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.307 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.413 ' HA ' ' HB ' ' A' ' 111' ' ' VAL . 84.8 mt -59.25 -35.89 74.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 111.079 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 m -92.55 69.39 4.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.05 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.648 HD13 ' HE2' ' A' ' 153' ' ' LYS . 28.7 tp -94.61 130.99 40.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.187 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 -67.57 136.06 53.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.289 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.522 ' HB3' ' OD1' ' A' ' 131' ' ' ASP . 75.4 m-20 55.83 44.11 26.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.353 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -176.59 164.65 34.44 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.493 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -136.99 130.91 32.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.784 0.326 . . . . 0.0 110.489 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 48.5 t -106.5 123.09 61.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.3 m-85 -78.4 125.84 29.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.019 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.473 HD12 ' H ' ' A' ' 114' ' ' THR . 60.8 tp -85.18 150.91 24.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.252 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.473 ' H ' HD12 ' A' ' 113' ' ' LEU . 27.8 m -156.59 56.8 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.531 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -157.0 -105.15 0.22 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.21 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 173.57 -127.43 1.34 Allowed Glycine 0 CA--C 1.516 0.146 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.752 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.494 ' C ' HD11 ' A' ' 98' ' ' ILE . 38.8 t70 -152.15 41.84 0.66 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.298 0.57 . . . . 0.0 110.466 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.5 mt -95.02 152.01 39.24 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.36 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.505 ' HA ' ' CB ' ' A' ' 97' ' ' ARG . 86.6 Cg_exo -42.96 123.11 3.01 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.369 2.046 . . . . 0.0 111.998 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.695 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 73.63 -37.44 0.37 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.401 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.808 ' HG ' ' HB2' ' A' ' 124' ' ' ALA . 22.9 tp 55.88 45.15 24.63 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.963 0.411 . . . . 0.0 111.18 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.509 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 8.1 t70 -65.51 133.42 51.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.246 179.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.69 -28.54 13.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.477 -179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 1.044 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.15 143.3 3.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.742 0.306 . . . . 0.0 110.933 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.595 ' CD ' HG22 ' A' ' 143' ' ' VAL . 40.6 mmm-85 -129.6 144.9 51.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.21 -179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 32.8 m -142.38 134.93 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.553 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -107.97 116.84 32.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.704 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.554 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.5 m-85 -80.16 147.68 31.23 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.993 179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -156.19 124.91 5.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.974 0.416 . . . . 0.0 110.815 179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.461 ' SG ' ' HB2' ' A' ' 136' ' ' LEU . 68.7 m -89.52 146.42 24.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.119 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.522 ' OD1' ' HB3' ' A' ' 108' ' ' ASN . 12.1 p-10 -55.28 154.97 10.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.735 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.525 ' O ' ' HB2' ' A' ' 133' ' ' ASP . 2.3 Cg_endo -45.08 155.38 0.34 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.935 2.423 . . . . 0.0 111.906 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 132' ' ' PRO . 1.4 m-20 78.57 -34.72 0.17 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.776 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.638 ' HA ' ' HA ' ' A' ' 158' ' ' VAL . 10.7 m-85 -106.53 126.51 52.36 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.4 p-80 -106.89 137.19 45.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.982 0.42 . . . . 0.0 111.296 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.631 HD21 ' HA ' ' A' ' 140' ' ' SER . 33.6 tp -71.24 136.84 48.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.724 179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.6 t -134.31 67.78 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.577 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -176.75 -136.06 2.32 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 119.595 -1.288 . . . . 0.0 113.295 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.57 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 92.9 p -74.13 59.74 0.76 Allowed 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.873 0.368 . . . . 0.0 110.75 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.631 ' HA ' HD21 ' A' ' 136' ' ' LEU . 97.0 p -47.94 -34.72 9.53 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.179 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 141' ' ' ARG . 21.2 mmt85 -109.55 138.79 45.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.706 179.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.411 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 45.3 t -143.57 127.03 16.84 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.595 HG22 ' CD ' ' A' ' 125' ' ' ARG . 24.0 t -103.91 117.8 50.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.775 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 1.044 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 50.7 t -71.82 140.43 49.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.936 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 43.8 t -169.43 131.97 1.21 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.819 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 56.35 41.8 28.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.583 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.67 25.06 50.25 Favored Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -141.68 132.51 25.83 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.489 0.185 . . . . 0.0 110.662 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.411 ' HB3' ' OG ' ' A' ' 142' ' ' SER . 72.6 m95 -71.26 138.95 49.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.845 0.355 . . . . 0.0 111.074 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.9 t -57.44 -58.46 8.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.279 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.509 ' OG1' ' HB2' ' A' ' 139' ' ' SER . 82.8 p -101.78 136.55 19.52 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.6 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 33.3 Cg_exo -60.44 138.83 83.1 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.736 2.291 . . . . 0.0 111.954 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.648 ' HE2' HD13 ' A' ' 106' ' ' LEU . 84.5 tttt -47.99 131.48 12.01 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.341 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.57 ' HB3' ' H ' ' A' ' 139' ' ' SER . 88.4 Cg_endo -84.37 -148.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.873 2.382 . . . . 0.0 113.029 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.439 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 17.6 p-80 -153.66 149.69 27.81 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.965 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 91.4 m -97.91 136.16 38.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.01 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -136.93 133.98 36.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.014 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 134' ' ' PHE . 8.7 p -65.6 142.55 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.277 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.884 -179.946 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 N--CA 1.485 1.312 0 CA-C-O 120.748 0.309 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 59.16 44.81 15.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.212 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -174.83 -50.35 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.106 0.479 . . . . 0.0 110.686 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -81.45 55.52 2.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.874 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.518 ' O ' ' HG2' ' A' ' 97' ' ' ARG . 97.1 t -140.12 140.68 34.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.257 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.837 ' HD2' ' HA ' ' A' ' 119' ' ' PRO . 37.9 ptt180 44.01 -147.61 0.07 Allowed 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.411 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.818 HG23 ' HG3' ' A' ' 97' ' ' ARG . 14.7 pt 48.27 30.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.418 -0.81 . . . . 0.0 112.52 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.503 ' HB3' ' NE1' ' A' ' 149' ' ' TRP . 36.1 m 55.97 142.03 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 79.3 p -44.08 130.67 6.04 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.944 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.544 ' HB2' HD12 ' A' ' 104' ' ' LEU . 18.0 ptpt -77.45 10.75 2.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.513 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.2 m -68.93 -44.76 72.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.969 0.414 . . . . 0.0 110.693 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.401 ' CD1' ' N ' ' A' ' 103' ' ' TYR . 1.2 m-85 -62.63 -33.1 74.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.253 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.759 HD22 HD22 ' A' ' 113' ' ' LEU . 65.8 mt -49.8 -45.45 49.94 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 7.1 t -92.51 138.65 31.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.109 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.803 HD13 ' HE3' ' A' ' 153' ' ' LYS . 28.6 tp -143.75 126.41 16.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.023 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.496 ' HG3' ' ND2' ' A' ' 108' ' ' ASN . 17.0 tp10 -73.45 124.59 26.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.018 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.496 ' ND2' ' HG3' ' A' ' 107' ' ' GLU . 74.4 m-20 56.3 49.15 15.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.795 0.331 . . . . 0.0 110.524 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -170.74 148.42 11.37 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.891 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.722 ' HB2' ' HD2' ' A' ' 129' ' ' ARG . 55.1 mtpt -102.53 138.84 38.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.537 -0.332 . . . . 0.0 110.702 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 59.5 t -111.74 119.22 59.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.86 0.362 . . . . 0.0 111.541 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.615 ' C ' HG23 ' A' ' 126' ' ' VAL . 2.6 m-85 -83.14 60.43 5.51 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.268 178.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.759 HD22 HD22 ' A' ' 104' ' ' LEU . 63.2 tp -59.52 145.99 42.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.15 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.649 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 27.1 m -158.86 53.31 0.41 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.587 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.467 ' HA3' ' HB1' ' A' ' 124' ' ' ALA . . . 177.14 105.08 0.19 Allowed Glycine 0 N--CA 1.443 -0.848 0 CA-C-N 114.747 -1.115 . . . . 0.0 111.147 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.503 ' N ' HD21 ' A' ' 121' ' ' LEU . . . -163.12 138.16 5.18 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.955 -0.64 . . . . 0.0 112.784 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.687 ' C ' HD12 ' A' ' 118' ' ' LEU . 8.2 t70 73.2 42.21 0.45 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.98 0.419 . . . . 0.0 111.055 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.756 ' H ' HG22 ' A' ' 98' ' ' ILE . 9.5 mp -137.38 150.1 67.63 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.828 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.837 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 92.7 Cg_exo -44.87 89.83 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.987 2.458 . . . . 0.0 112.818 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.458 ' H ' ' HB2' ' A' ' 97' ' ' ARG . . . 56.0 13.58 1.18 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.734 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.746 HD23 ' HB2' ' A' ' 118' ' ' LEU . 58.7 mt 50.09 60.32 3.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.538 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.817 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 9.1 t70 -76.11 45.07 0.34 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.229 0.538 . . . . 0.0 110.412 179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 166.59 25.32 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.127 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.946 ' HB3' ' HB2' ' A' ' 144' ' ' CYS . . . -84.13 153.19 23.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.719 0.295 . . . . 0.0 111.002 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.649 ' O ' ' HB ' ' A' ' 114' ' ' THR . 4.4 tmm_? -151.48 140.67 21.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.441 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.615 HG23 ' C ' ' A' ' 112' ' ' PHE . 1.6 p -151.35 148.28 14.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 121.493 0.663 . . . . 0.0 112.107 -179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -113.3 118.11 33.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.689 179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.527 ' HB2' ' HA ' ' A' ' 140' ' ' SER . 6.3 m-85 -89.0 145.58 25.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.097 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.722 ' HD2' ' HB2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -159.57 138.94 11.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.437 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 66.0 m -89.24 144.21 26.27 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.681 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.537 ' HB2' ' HD2' ' A' ' 132' ' ' PRO . 9.0 p-10 -54.02 160.68 2.15 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.819 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.556 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 2.8 Cg_endo -44.98 149.72 1.12 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.86 2.374 . . . . 0.0 111.692 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.556 ' HB3' ' O ' ' A' ' 132' ' ' PRO . 36.1 t70 80.64 -31.37 0.12 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.578 -178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -108.86 132.44 54.03 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.191 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -108.94 148.09 31.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.169 0.509 . . . . 0.0 111.925 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.686 HD12 ' HB2' ' A' ' 140' ' ' SER . 1.1 tm? -79.2 128.73 33.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.701 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.668 ' N ' HD13 ' A' ' 136' ' ' LEU . 21.7 t -132.63 60.31 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.66 0.266 . . . . 0.0 111.602 -179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . 0.402 ' H ' ' CD1' ' A' ' 136' ' ' LEU . . . -176.65 -133.85 1.87 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 119.994 -1.098 . . . . 0.0 113.206 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.585 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 63.9 m -73.4 59.64 0.6 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 120.766 0.317 . . . . 0.0 111.392 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.686 ' HB2' HD12 ' A' ' 136' ' ' LEU . 38.9 t -62.49 -2.48 1.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.406 ' H ' ' C ' ' A' ' 139' ' ' SER . 79.2 ttt180 -140.65 133.96 29.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.517 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 61.2 m -147.41 134.02 19.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.52 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.526 HG13 ' O ' ' A' ' 124' ' ' ALA . 94.3 t -128.73 122.35 56.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.919 0.39 . . . . 0.0 111.316 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.946 ' HB2' ' HB3' ' A' ' 124' ' ' ALA . 55.4 m -85.16 140.87 30.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.497 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.817 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 79.7 p -169.65 31.56 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.063 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 177.47 34.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.061 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 59.6 14.97 31.02 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 115.949 -0.569 . . . . 0.0 112.465 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -142.63 133.73 25.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.536 0.208 . . . . 0.0 110.686 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.503 ' NE1' ' HB3' ' A' ' 99' ' ' CYS . 74.2 m95 -66.89 137.61 56.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.699 0.285 . . . . 0.0 110.761 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.0 m -57.39 -56.22 24.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.556 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 66.9 p -106.23 136.69 19.31 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.764 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 53.2 Cg_exo -55.89 151.58 40.31 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.865 2.377 . . . . 0.0 112.187 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.803 ' HE3' HD13 ' A' ' 106' ' ' LEU . 4.8 tmtm? -51.21 121.74 16.96 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.575 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.585 ' HB3' ' N ' ' A' ' 139' ' ' SER . 47.7 Cg_endo -69.71 -160.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.676 2.25 . . . . 0.0 112.975 -179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -153.74 148.98 27.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.72 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 97.1 m -97.88 139.6 33.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 0.0 111.408 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -130.98 129.77 42.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.863 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 10.1 p -63.7 143.31 15.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.189 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.432 HD22 ' N ' ' A' ' 159' ' ' ASN . 2.6 m120 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.973 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.808 0.337 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -171.3 39.97 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.8 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -66.8 140.91 57.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.021 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -56.81 146.28 26.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.435 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.738 HG12 HD12 ' A' ' 98' ' ' ILE . 48.2 t -67.7 136.3 26.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.371 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.635 HH11 ' HB2' ' A' ' 120' ' ' ALA . 25.2 ttm-85 -91.59 104.06 16.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.584 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.738 HD12 HG12 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -162.27 42.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.497 178.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.464 ' HB3' ' CZ2' ' A' ' 149' ' ' TRP . 80.4 m 64.27 133.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.243 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.536 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 37.3 t -41.56 127.69 3.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.905 0.383 . . . . 0.0 111.245 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -75.5 -37.42 60.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.503 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.9 t -53.21 -43.38 67.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.664 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.797 ' HA ' ' HD3' ' A' ' 153' ' ' LYS . 2.4 m-85 -59.38 -34.89 72.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.514 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.22 -43.87 74.9 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.988 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.9 t -92.55 145.98 24.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.975 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.618 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 22.0 tp -144.36 130.1 19.2 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.342 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -74.15 132.95 42.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.392 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.416 ' N ' HD22 ' A' ' 108' ' ' ASN . 2.6 m120 57.49 41.01 26.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.614 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.97 152.0 10.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.057 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -104.78 154.02 20.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.58 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.476 ' CG1' ' HB ' ' A' ' 126' ' ' VAL . 99.1 t -131.17 118.52 41.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.298 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.599 ' HB2' ' HB2' ' A' ' 127' ' ' GLU . 2.2 m-85 -73.08 80.08 1.23 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.513 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.877 ' HA ' HG12 ' A' ' 126' ' ' VAL . 7.7 tt -51.88 140.25 20.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.155 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.622 ' N ' HD23 ' A' ' 113' ' ' LEU . 20.6 m -153.33 53.73 0.74 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.267 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.455 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . 128.0 110.24 1.55 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.869 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -171.31 50.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.024 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.768 ' C ' HD22 ' A' ' 118' ' ' LEU . 12.3 p-10 -171.29 39.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.897 0.379 . . . . 0.0 110.821 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.768 HD22 ' C ' ' A' ' 117' ' ' ASP . 3.2 mm? -145.36 153.68 52.39 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.248 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.606 ' HA ' ' HG2' ' A' ' 97' ' ' ARG . 5.0 Cg_endo -48.41 81.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.959 2.439 . . . . 0.0 111.873 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.635 ' HB2' HH11 ' A' ' 97' ' ' ARG . . . 75.2 -40.81 0.44 Allowed 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.035 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.609 ' HB2' ' HB2' ' A' ' 118' ' ' LEU . 19.2 tp 53.07 58.98 4.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.06 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -57.35 84.5 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.588 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 121' ' ' LEU . . . 163.9 -35.8 0.3 Allowed Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.912 -179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.545 ' HB2' HD23 ' A' ' 121' ' ' LEU . . . -49.81 150.67 2.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.725 0.298 . . . . 0.0 111.171 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.55 ' O ' ' HB ' ' A' ' 114' ' ' THR . 58.6 ttp180 -157.67 118.02 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.906 0.384 . . . . 0.0 111.232 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.877 HG12 ' HA ' ' A' ' 113' ' ' LEU . 30.4 m -97.89 133.65 39.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.83 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 112' ' ' PHE . 55.2 mt-10 -92.56 115.99 28.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -76.33 150.88 36.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.996 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.47 ' HG2' HH11 ' A' ' 129' ' ' ARG . 11.3 tpt180 -158.65 131.78 7.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.018 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 83.6 m -90.28 155.71 18.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.155 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -52.6 158.03 2.29 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.223 179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.55 62.97 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.178 2.585 . . . . 0.0 112.737 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -177.12 -29.39 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.781 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 4.1 m-85 -108.66 139.91 42.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.335 178.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -102.85 133.37 48.04 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.95 0.405 . . . . 0.0 111.179 -179.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.768 HD21 ' HA ' ' A' ' 140' ' ' SER . 37.1 tp -76.17 131.16 39.19 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.871 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.3 t -135.92 68.04 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.789 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 179.54 -131.94 1.76 Allowed Glycine 0 C--N 1.331 0.282 0 C-N-CA 119.839 -1.172 . . . . 0.0 113.151 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 62.5 p -71.39 63.29 0.38 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 110.661 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.768 ' HA ' HD21 ' A' ' 136' ' ' LEU . 93.0 p -55.67 -20.28 13.61 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.911 -179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -140.59 136.58 32.92 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.712 0.291 . . . . 0.0 111.141 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.596 ' HB3' ' HB3' ' A' ' 149' ' ' TRP . 60.5 m -129.58 136.22 49.53 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.708 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 82.2 t -117.85 132.82 66.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.274 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' ' 124' ' ' ALA . 75.4 m -60.19 142.74 53.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.299 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.7 t -173.02 120.01 0.35 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.71 179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 58.15 42.68 21.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.902 0.382 . . . . 0.0 110.782 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 64.48 11.57 48.38 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.667 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -142.84 135.66 27.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.271 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 142' ' ' SER . 54.4 m95 -67.22 142.23 57.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.669 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.4 m -55.08 -57.48 11.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.919 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 72.8 p -98.91 133.78 22.02 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.807 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.455 ' HA ' ' CE2' ' A' ' 103' ' ' TYR . 40.1 Cg_endo -67.08 -160.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.315 2.01 . . . . 0.0 112.255 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.797 ' HD3' ' HA ' ' A' ' 103' ' ' TYR . 4.5 mmmp? -84.95 130.23 53.25 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.831 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.551 ' HD2' ' HZ2' ' A' ' 153' ' ' LYS . 90.1 Cg_endo -81.1 -151.79 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.636 2.224 . . . . 0.0 112.545 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.432 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 22.4 p-80 -153.73 139.94 18.48 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 134' ' ' PHE . 78.6 m -98.71 127.72 44.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.541 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -105.17 141.03 37.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.337 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.31 140.22 18.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.078 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 24.3 p30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.971 179.929 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.544 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 8.9 mp0 . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.712 0.291 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 58.04 45.78 17.36 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.108 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.544 ' HG2' ' HB3' ' A' ' 92' ' ' GLU . 66.4 mm-40 -81.53 47.29 1.04 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.75 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.493 ' CE1' HG13 ' A' ' 96' ' ' VAL . 21.4 t80 -69.71 134.85 49.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.734 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.543 ' O ' HG13 ' A' ' 98' ' ' ILE . 35.5 m 40.37 46.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 116.024 -0.534 . . . . 0.0 112.193 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.859 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -61.36 129.65 42.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.813 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 97' ' ' ARG . 1.5 pp -166.98 146.86 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-O 121.499 0.666 . . . . 0.0 112.003 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.652 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 3.6 m -83.36 146.09 28.67 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.144 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 50.4 m -40.21 121.21 1.32 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 111.029 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -70.73 -24.06 62.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.154 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.5 t -53.05 -42.15 65.51 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.722 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.521 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.0 m-85 -62.93 -42.96 99.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.545 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 94.2 mt -57.07 -38.24 73.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.414 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 t -92.5 135.69 33.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.89 0.376 . . . . 0.0 111.312 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.589 ' HB3' ' O ' ' A' ' 109' ' ' GLY . 21.3 tp -145.41 129.76 17.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.715 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -81.4 38.52 0.49 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.49 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.9 p30 177.21 26.63 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.388 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 106' ' ' LEU . . . 168.84 155.89 10.08 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.945 -1.121 . . . . 0.0 113.535 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.589 ' NZ ' ' HB2' ' A' ' 110' ' ' LYS . 9.8 mtmp? -101.32 146.01 28.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.334 -0.433 . . . . 0.0 110.116 179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 103' ' ' TYR . 64.5 t -105.4 120.77 56.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.978 0.418 . . . . 0.0 111.38 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.432 ' CE1' ' HD2' ' A' ' 129' ' ' ARG . 1.6 m-85 -84.59 68.26 10.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.841 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.965 ' HA ' HG12 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -62.56 147.52 48.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.02 0.438 . . . . 0.0 111.295 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.9 m -133.2 70.84 1.46 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.1 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -165.18 -98.25 0.12 Allowed Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.94 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.601 ' H ' HD21 ' A' ' 121' ' ' LEU . . . 61.06 127.6 0.01 OUTLIER Glycine 0 CA--C 1.519 0.324 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.391 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.561 ' O ' HD23 ' A' ' 118' ' ' LEU . 62.1 t0 60.31 49.48 7.02 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.973 0.416 . . . . 0.0 111.369 179.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.657 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . 68.8 mt -131.83 143.3 48.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.732 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.859 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 50.6 Cg_exo -52.5 85.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.667 2.245 . . . . 0.0 111.581 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.533 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 61.79 17.11 8.49 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.202 -178.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.657 ' HG ' ' HB2' ' A' ' 118' ' ' LEU . 7.4 mp 40.72 53.84 3.13 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.844 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -76.43 45.59 0.39 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.228 0.537 . . . . 0.0 110.234 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -176.2 -25.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.779 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.629 ' HB3' ' HB3' ' A' ' 121' ' ' LEU . . . -57.51 147.4 26.81 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.875 0.369 . . . . 0.0 111.211 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.472 ' HG2' HH11 ' A' ' 125' ' ' ARG . 50.5 ttp85 -133.36 137.81 46.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.629 179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.965 HG12 ' HA ' ' A' ' 113' ' ' LEU . 32.8 m -120.12 135.76 59.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.017 0.437 . . . . 0.0 111.643 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -112.89 113.58 25.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.095 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -76.01 141.86 42.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.09 0.471 . . . . 0.0 111.654 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.432 ' HD2' ' CE1' ' A' ' 112' ' ' PHE . 71.1 mtt-85 -148.91 108.88 4.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.117 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 95.6 m -89.54 160.75 16.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.957 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 51.4 p-10 -52.69 156.6 3.12 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.448 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.5 56.07 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.06 2.507 . . . . 0.0 112.588 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -153.07 -37.45 0.1 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.648 179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -108.8 134.18 51.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.636 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 21.0 p-80 -101.22 132.92 46.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.171 0.51 . . . . 0.0 111.176 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.696 HD21 ' HA ' ' A' ' 140' ' ' SER . 23.0 tp -76.39 129.99 37.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.693 -179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.5 t -136.3 61.99 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.697 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -170.14 -138.01 2.41 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.503 -1.332 . . . . 0.0 113.406 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.66 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 67.4 m -74.6 57.8 0.75 Allowed 'General case' 0 N--CA 1.453 -0.309 0 CA-C-O 120.946 0.403 . . . . 0.0 110.975 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.696 ' HA ' HD21 ' A' ' 136' ' ' LEU . 38.0 t -49.94 -38.36 36.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.001 -179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.04 136.18 44.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.434 ' O ' HG22 ' A' ' 126' ' ' VAL . 53.4 m -146.42 125.99 13.31 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.811 0.339 . . . . 0.0 111.304 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 76.5 t -104.95 125.39 59.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.669 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 48.1 t -71.42 151.86 43.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.099 0.476 . . . . 0.0 111.587 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.5 t -168.72 122.97 0.87 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.892 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 146' ' ' GLN . 52.6 tt0 54.48 43.23 30.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.263 0.554 . . . . 0.0 109.634 -179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.533 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 58.01 29.2 61.95 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.858 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -139.69 131.34 27.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.641 0.258 . . . . 0.0 110.408 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -75.45 139.34 42.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.951 0.405 . . . . 0.0 111.625 -179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.1 t -57.42 -58.48 8.1 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.199 -179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 139' ' ' SER . 77.3 p -106.93 134.64 19.77 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.514 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 139' ' ' SER . 35.5 Cg_exo -57.8 142.41 96.16 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.668 2.246 . . . . 0.0 112.041 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.517 ' CE ' HD13 ' A' ' 106' ' ' LEU . 87.2 tttt -51.62 125.86 29.43 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.131 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.66 ' HB3' ' N ' ' A' ' 139' ' ' SER . 61.1 Cg_endo -73.21 -152.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.595 2.197 . . . . 0.0 112.427 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -153.68 133.67 13.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.905 0.383 . . . . 0.0 111.295 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 16.6 m -98.83 132.46 44.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.912 179.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.4 ' HA ' ' NE2' ' A' ' 157' ' ' GLN . 2.9 tp-100 -124.38 139.66 53.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.051 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -59.97 134.52 25.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.112 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 23.3 p30 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.171 -0.919 . . . . 0.0 110.984 -179.858 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.715 0.293 . . . . 0.0 111.273 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.34 -42.4 98.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.94 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 57.06 44.27 22.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.016 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 34.5 t80 64.42 132.4 0.02 OUTLIER 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.219 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.0 m -64.76 135.84 27.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.93 ' HG2' HG23 ' A' ' 98' ' ' ILE . 0.0 OUTLIER -65.41 -155.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.18 -179.675 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.93 HG23 ' HG2' ' A' ' 97' ' ' ARG . 15.3 pt 51.81 134.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.856 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.557 ' HB2' ' NE1' ' A' ' 149' ' ' TRP . 2.4 p -62.01 136.84 58.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.563 178.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -40.02 127.54 2.16 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.253 -179.593 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.496 ' HE2' HD12 ' A' ' 98' ' ' ILE . 68.5 mttm -77.43 14.94 0.86 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.434 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.8 m -68.9 -39.01 79.97 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.027 0.442 . . . . 0.0 110.432 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.769 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.6 m-85 -56.3 -34.08 66.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.523 179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.559 HD11 HD13 ' A' ' 113' ' ' LEU . 86.3 mt -74.71 38.95 0.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.685 -179.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 74.2 m -147.46 114.48 6.16 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.751 0.31 . . . . 0.0 111.0 179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 89.5 mt -145.5 128.21 16.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.098 179.777 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -82.58 43.13 0.8 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 15.8 p30 -177.02 -43.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.017 179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 130' ' ' CYS . . . -79.11 -162.37 23.19 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.732 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.427 ' O ' ' O ' ' A' ' 111' ' ' VAL . 22.7 tptm -142.12 -43.81 0.34 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.723 0.297 . . . . 0.0 110.805 179.831 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 128' ' ' PHE . 11.9 p 49.1 120.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.187 -0.915 . . . . 0.0 113.015 179.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 1.3 m-85 -84.38 117.92 23.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.579 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.559 HD13 HD11 ' A' ' 104' ' ' LEU . 55.1 tp -83.52 145.51 28.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.118 0.485 . . . . 0.0 111.447 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.533 ' HB ' ' O ' ' A' ' 125' ' ' ARG . 25.0 m -158.51 53.06 0.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.803 179.558 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.46 ' HA3' ' CB ' ' A' ' 124' ' ' ALA . . . 165.33 105.48 0.19 Allowed Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.825 -179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -157.64 140.02 6.79 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.634 -179.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.494 ' O ' HD23 ' A' ' 118' ' ' LEU . 57.2 m-20 62.52 43.98 7.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.86 0.362 . . . . 0.0 111.216 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.563 ' HB2' ' CD2' ' A' ' 121' ' ' LEU . 84.5 mt -134.82 144.68 51.54 Favored Pre-proline 0 C--N 1.331 -0.209 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -46.18 96.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.965 2.443 . . . . 0.0 113.796 -179.203 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.462 ' HA ' ' H ' ' A' ' 98' ' ' ILE . . . 68.62 -29.83 0.17 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.3 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.715 HD22 ' HB2' ' A' ' 124' ' ' ALA . 32.0 mt 65.11 51.27 1.7 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.829 0.347 . . . . 0.0 111.019 -179.178 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -77.17 51.42 0.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.548 179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -179.64 -21.03 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 121.132 -0.556 . . . . 0.0 112.205 -179.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.962 ' HB3' ' HB3' ' A' ' 144' ' ' CYS . . . -47.94 148.45 1.67 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.735 0.302 . . . . 0.0 111.418 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.533 ' O ' ' HB ' ' A' ' 114' ' ' THR . 70.1 mtt-85 -141.73 141.07 33.27 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.939 -179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 112' ' ' PHE . 34.5 m -133.59 137.02 53.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 120.885 0.374 . . . . 0.0 111.14 179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -116.17 99.25 7.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.696 ' HA ' ' HA ' ' A' ' 111' ' ' VAL . 46.3 m-85 -68.06 139.39 56.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.983 0.42 . . . . 0.0 111.106 179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 20.4 mmt85 -142.71 133.17 24.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.243 179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.529 ' HA ' ' HA2' ' A' ' 109' ' ' GLY . 60.7 m -89.19 148.7 23.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.116 -179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 133' ' ' ASP . 45.7 p-10 -52.67 153.93 5.21 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.087 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.31 72.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 123.235 2.623 . . . . 0.0 113.204 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.416 ' N ' ' O ' ' A' ' 131' ' ' ASP . 38.9 t70 178.66 -39.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.048 179.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' A' ' 130' ' ' CYS . 5.6 m-85 -107.0 139.18 41.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.904 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -102.83 134.26 46.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 0.0 111.151 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 140' ' ' SER . 19.8 tp -76.54 131.92 39.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.923 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 26.3 t -136.58 66.23 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.861 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -171.98 -136.91 2.22 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 119.792 -1.194 . . . . 0.0 113.149 179.949 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.632 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 45.4 p -76.55 53.98 0.91 Allowed 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 120.989 0.423 . . . . 0.0 110.717 179.848 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.634 ' HA ' HD21 ' A' ' 136' ' ' LEU . 47.6 t -49.07 -43.91 41.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.246 -179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -99.48 133.24 44.09 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.657 179.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.419 ' OG ' ' HB3' ' A' ' 149' ' ' TRP . 47.5 t -141.23 125.08 17.03 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.684 -179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 90.5 t -100.19 123.64 53.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.385 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.962 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 47.2 t -76.7 136.12 39.09 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.621 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 43.2 t -172.68 134.01 0.61 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.774 0.321 . . . . 0.0 111.183 -179.79 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.427 ' OE1' ' N ' ' A' ' 146' ' ' GLN . 0.5 OUTLIER 57.4 41.44 26.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.995 179.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 56.85 18.55 25.89 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.998 179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -141.09 131.09 24.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.85 0.357 . . . . 0.0 110.619 179.427 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.557 ' NE1' ' HB2' ' A' ' 99' ' ' CYS . 33.6 m95 -73.03 138.29 45.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.173 -179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 54.0 m -57.45 -52.99 63.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.004 179.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 78.8 p -114.4 136.95 22.38 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.481 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 30.0 Cg_exo -62.03 -159.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.512 2.141 . . . . 0.0 112.428 -179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.769 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 60.8 mtpt -96.66 125.77 45.68 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.965 179.854 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.632 ' HB2' HD11 ' A' ' 136' ' ' LEU . 68.1 Cg_endo -74.36 -148.66 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.282 1.988 . . . . 0.0 111.939 179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -153.74 143.11 21.56 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.902 0.382 . . . . 0.0 111.283 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 79.3 m -96.72 132.99 41.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.168 179.508 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -131.31 140.26 49.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.935 0.398 . . . . 0.0 111.481 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 6.7 p -64.34 137.72 24.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.01 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.881 179.975 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.739 0.304 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . 55.97 49.61 15.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.188 179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -168.15 -40.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.086 -179.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.45 ' HB3' HH21 ' A' ' 97' ' ' ARG . 2.8 m-85 57.93 54.0 6.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.783 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 27.5 m -49.74 144.5 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.702 -179.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.63 HH11 ' HA ' ' A' ' 119' ' ' PRO . 13.2 ptp180 -165.24 129.18 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.765 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.599 HD13 ' N ' ' A' ' 98' ' ' ILE . 0.2 OUTLIER -152.66 137.18 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.236 0.541 . . . . 0.0 111.463 179.935 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.671 ' SG ' ' HB2' ' A' ' 121' ' ' LEU . 3.2 m -63.58 173.4 1.68 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.55 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.404 ' HB2' ' CD1' ' A' ' 149' ' ' TRP . 52.0 m -42.4 129.22 3.93 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.891 0.377 . . . . 0.0 111.195 179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.759 ' HD2' HD12 ' A' ' 104' ' ' LEU . 24.0 tptm -76.89 -31.43 56.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.432 -179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 80.8 p -53.08 -43.86 67.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.945 -179.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.845 ' HA ' ' HD2' ' A' ' 153' ' ' LYS . 2.3 m-85 -56.9 -41.45 78.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.694 0.283 . . . . 0.0 111.065 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.759 HD12 ' HD2' ' A' ' 101' ' ' LYS . 90.9 mt -58.65 139.95 55.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.919 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 87.3 m 65.35 137.72 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.168 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.542 HD13 ' NZ ' ' A' ' 153' ' ' LYS . 46.2 tp -145.43 133.68 21.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.417 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.76 140.51 56.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.22 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 65.19 30.82 11.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.394 -179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.544 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . 175.7 -168.26 40.52 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.042 179.339 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.694 ' HD3' ' N ' ' A' ' 111' ' ' VAL . 1.5 tmtp? -141.95 143.29 33.17 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.694 ' N ' ' HD3' ' A' ' 110' ' ' LYS . 71.2 t -106.39 120.73 57.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.929 0.395 . . . . 0.0 111.458 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.558 ' HE1' ' HB3' ' A' ' 129' ' ' ARG . 3.3 m-85 -70.22 125.99 28.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.045 179.343 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.648 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -105.78 141.64 36.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.939 0.4 . . . . 0.0 110.94 -179.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.648 ' N ' HD13 ' A' ' 113' ' ' LEU . 35.6 m -158.89 65.61 0.42 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.619 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.527 ' O ' ' HG ' ' A' ' 118' ' ' LEU . . . -156.83 -43.53 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.649 -179.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.464 ' O ' HD11 ' A' ' 121' ' ' LEU . . . 71.76 -132.46 19.91 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.886 179.695 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -115.7 34.78 4.75 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.987 0.422 . . . . 0.0 111.225 -179.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' A' ' 120' ' ' ALA . 96.5 mt -64.19 162.91 27.9 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.911 179.093 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.63 ' HA ' HH11 ' A' ' 97' ' ' ARG . 81.9 Cg_exo -43.57 80.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.772 2.315 . . . . 0.0 112.01 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.774 ' HB1' ' N ' ' A' ' 147' ' ' GLY . . . 59.19 22.96 11.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.405 -178.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.676 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 6.8 mp 44.41 62.7 1.92 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.228 179.773 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.705 ' HA ' ' HA ' ' A' ' 145' ' ' SER . 38.7 t70 -74.97 42.38 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.096 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 161.89 28.72 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.394 179.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 121' ' ' LEU . . . -77.58 122.17 24.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.706 0.288 . . . . 0.0 111.1 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 86.2 mtm180 -90.88 134.79 34.18 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.655 179.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 113' ' ' LEU . 30.1 m -145.78 140.59 21.76 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 111.669 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -121.25 120.43 35.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.415 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.445 ' O ' HD22 ' A' ' 136' ' ' LEU . 2.0 m-85 -84.38 47.3 1.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 110.992 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.558 ' HB3' ' HE1' ' A' ' 112' ' ' PHE . 21.2 tpp180 -64.33 126.77 28.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.509 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.544 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 65.3 m -98.47 158.95 15.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.324 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.42 ' O ' ' N ' ' A' ' 133' ' ' ASP . 55.6 m-20 -52.69 148.28 13.43 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.831 -179.516 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -55.18 79.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.204 2.602 . . . . 0.0 112.717 -179.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 131' ' ' ASP . 9.1 t0 -179.14 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.599 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.406 ' HB3' ' HB3' ' A' ' 156' ' ' CYS . 2.5 m-85 -108.78 130.85 55.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.199 179.41 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.5 p-80 -102.75 130.64 49.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.004 0.43 . . . . 0.0 110.904 179.859 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.766 HD11 ' HG2' ' A' ' 154' ' ' PRO . 22.8 tp -75.48 133.82 40.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.412 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 40.7 t -128.86 70.94 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.688 -179.088 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.46 -132.65 1.96 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.819 179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.507 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 70.8 m -76.12 55.13 0.92 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 120.708 0.29 . . . . 0.0 111.028 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.549 ' HA ' ' CD2' ' A' ' 136' ' ' LEU . 90.0 p -49.25 -43.11 42.58 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.671 -179.914 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -100.46 133.93 44.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.229 178.844 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.405 ' O ' HG22 ' A' ' 126' ' ' VAL . 47.4 t -144.02 136.22 26.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.389 . . . . 0.0 110.953 -179.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 57.5 t -122.46 117.05 50.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.343 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.696 ' HA ' ' HA ' ' A' ' 149' ' ' TRP . 46.1 t -65.8 155.31 36.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.109 0.481 . . . . 0.0 111.502 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.705 ' HA ' ' HA ' ' A' ' 122' ' ' ASP . 46.5 t -166.44 122.01 1.2 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.838 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 57.68 44.13 21.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.081 0.467 . . . . 0.0 110.62 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.774 ' N ' ' HB1' ' A' ' 120' ' ' ALA . . . 64.72 20.65 66.45 Favored Glycine 0 C--N 1.331 0.286 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.636 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -141.4 127.03 18.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.64 0.257 . . . . 0.0 110.749 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.696 ' HA ' ' HA ' ' A' ' 144' ' ' CYS . 58.0 m95 -71.94 139.36 48.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.934 0.397 . . . . 0.0 111.372 -179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.4 t -57.53 -62.46 1.77 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.378 -179.813 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' A' ' 139' ' ' SER . 71.1 p -95.38 137.08 22.12 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.755 -179.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.477 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 45.1 Cg_endo -67.69 140.38 51.26 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.882 2.388 . . . . 0.0 112.418 179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.845 ' HD2' ' HA ' ' A' ' 103' ' ' TYR . 64.4 tttm -53.87 121.2 27.51 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.264 -179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.766 ' HG2' HD11 ' A' ' 136' ' ' LEU . 86.5 Cg_endo -81.32 -147.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.832 2.355 . . . . 0.0 112.932 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.423 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 19.5 p-80 -153.61 144.72 22.89 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.144 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . 0.473 ' SG ' HD13 ' A' ' 136' ' ' LEU . 64.8 m -98.47 142.64 29.82 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -133.7 139.24 46.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.829 -179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.59 138.41 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.507 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 75.3 m-80 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.889 179.935 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.841 0.353 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -170.72 131.3 0.86 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.8 179.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.56 ' HG3' ' H ' ' A' ' 95' ' ' PHE . 4.5 tp10 -173.42 -129.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.526 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.56 ' H ' ' HG3' ' A' ' 94' ' ' GLU . 19.3 t80 -177.76 132.52 0.16 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.66 0.267 . . . . 0.0 110.689 -179.606 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 33.1 m -58.5 141.14 15.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.532 179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.826 ' HD2' ' HA ' ' A' ' 119' ' ' PRO . 39.0 ptt180 -163.64 49.96 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.543 -179.221 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.8 HG21 ' HA ' ' A' ' 117' ' ' ASP . 4.9 pt -158.82 41.8 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.861 0.362 . . . . 0.0 110.839 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.599 ' HB3' ' CD1' ' A' ' 149' ' ' TRP . 74.6 m 62.31 134.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.971 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 52.3 m -40.32 119.97 1.14 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.716 -179.297 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -74.83 -9.72 58.82 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.869 179.755 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.6 t -58.75 -19.93 44.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.837 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.472 ' HD2' ' HZ ' ' A' ' 128' ' ' PHE . 4.7 m-85 -64.62 -46.28 83.26 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.166 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.794 HD12 HG23 ' A' ' 105' ' ' THR . 1.7 pp -76.98 33.3 0.14 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.822 0.344 . . . . 0.0 111.893 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.794 HG23 HD12 ' A' ' 104' ' ' LEU . 61.6 p -147.54 58.54 1.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.36 179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 44.4 tp -94.49 135.75 35.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.5 -178.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.53 ' HG2' ' ND2' ' A' ' 108' ' ' ASN . 87.9 tt0 -66.59 138.48 57.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.352 179.31 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.53 ' ND2' ' HG2' ' A' ' 107' ' ' GLU . 75.1 m-20 56.56 40.13 29.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.428 . . . . 0.0 110.304 -179.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -172.28 168.46 41.53 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.214 -179.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 129' ' ' ARG . 28.9 mtpp -141.68 139.52 32.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.733 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.681 HG12 ' HB ' ' A' ' 126' ' ' VAL . 35.7 t -118.76 126.13 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.087 -179.81 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 2.4 m-85 -80.25 121.4 25.58 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.141 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.774 ' HA ' HG12 ' A' ' 126' ' ' VAL . 3.1 tm? -85.04 143.5 28.86 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.917 179.716 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.657 ' H ' HD22 ' A' ' 113' ' ' LEU . 43.4 m -152.96 65.96 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.574 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.409 ' HA3' HD21 ' A' ' 121' ' ' LEU . . . -158.1 -107.4 0.24 Allowed Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.886 -179.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 161.15 -124.29 1.3 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.848 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.8 ' HA ' HG21 ' A' ' 98' ' ' ILE . 37.6 t70 -148.68 47.84 1.02 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.237 0.541 . . . . 0.0 110.644 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.585 ' HB2' HD13 ' A' ' 121' ' ' LEU . 2.9 mm? -94.19 150.89 39.07 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.505 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.826 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 88.9 Cg_exo -43.47 105.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.37 2.047 . . . . 0.0 111.985 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 119' ' ' PRO . . . 72.45 -37.95 0.4 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.357 -179.224 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.725 ' HB2' HG22 ' A' ' 98' ' ' ILE . 14.1 tp 58.06 56.24 4.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 0.0 111.16 179.365 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -70.14 69.29 0.34 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.096 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 179.59 -30.48 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.237 -179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.54 ' HB2' ' HG ' ' A' ' 121' ' ' LEU . . . -49.05 153.04 0.97 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.972 0.415 . . . . 0.0 111.398 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.505 ' HD2' ' NH2' ' A' ' 141' ' ' ARG . 53.9 ttp180 -153.56 135.86 14.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.714 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.774 HG12 ' HA ' ' A' ' 113' ' ' LEU . 34.4 m -127.52 137.16 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.108 -179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -100.94 121.15 41.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.37 -179.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.472 ' HZ ' ' HD2' ' A' ' 103' ' ' TYR . 2.3 m-85 -86.03 150.77 24.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.475 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 110' ' ' LYS . 15.8 ptm180 -163.96 134.86 4.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.759 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . . . . . . . . . 68.0 m -89.2 155.11 19.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.496 -179.304 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -52.71 163.27 0.82 Allowed Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.383 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.73 52.07 0.95 Allowed 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.205 2.603 . . . . 0.0 112.708 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -155.59 -39.35 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.62 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.41 ' N ' ' CD1' ' A' ' 134' ' ' PHE . 1.5 m-85 -108.9 141.02 41.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.651 179.095 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -102.1 134.11 45.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.123 0.487 . . . . 0.0 110.98 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.551 HD21 ' CG ' ' A' ' 154' ' ' PRO . 3.4 tm? -72.97 130.86 41.3 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.622 -179.506 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.534 ' N ' HD13 ' A' ' 136' ' ' LEU . 26.6 t -134.57 66.89 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.573 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 177.03 -129.68 1.51 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 119.71 -1.233 . . . . 0.0 113.212 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.691 ' H ' ' HB3' ' A' ' 154' ' ' PRO . 31.3 t -68.75 65.41 0.12 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.979 0.419 . . . . 0.0 111.384 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.476 ' HB3' HD12 ' A' ' 136' ' ' LEU . 94.5 p -63.12 -18.35 63.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.874 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.505 ' NH2' ' HD2' ' A' ' 125' ' ' ARG . 50.2 mtp85 -140.66 137.31 33.48 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.768 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 90.0 p -135.21 128.17 31.46 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.55 -0.295 . . . . 0.0 110.758 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 97.4 t -100.91 126.63 54.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.96 179.646 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 41.9 t -73.36 139.21 45.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.016 179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 79.5 p -170.57 131.41 0.9 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.552 179.799 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 58.76 38.58 24.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.57 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 99' ' ' CYS . . . 60.9 19.14 55.69 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-N 115.901 -0.59 . . . . 0.0 112.998 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -144.7 133.11 21.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.619 0.247 . . . . 0.0 111.239 179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . 0.599 ' CD1' ' HB3' ' A' ' 99' ' ' CYS . 94.1 m95 -70.34 135.58 48.97 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.83 0.348 . . . . 0.0 110.995 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.0 t -57.42 -56.26 24.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.372 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.499 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 55.4 p -97.08 133.14 24.49 Favored Pre-proline 0 C--N 1.331 -0.224 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 151' ' ' THR . 8.2 Cg_exo -71.97 149.11 52.55 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.22 2.613 . . . . 0.0 111.941 179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -47.42 125.57 9.64 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-O 120.64 0.257 . . . . 0.0 111.216 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.691 ' HB3' ' H ' ' A' ' 139' ' ' SER . 58.0 Cg_endo -71.49 -146.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.63 2.22 . . . . 0.0 112.401 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . 0.426 ' H ' ' HB2' ' A' ' 154' ' ' PRO . 18.4 p-80 -153.7 145.41 23.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.451 179.632 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 70.8 m -96.66 133.64 40.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.82 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -124.76 136.29 53.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.907 -179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 8.8 p -64.67 137.15 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.035 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.958 179.937 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 42.5 tp10 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.784 0.326 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.629 ' HB1' ' CD1' ' A' ' 95' ' ' PHE . . . 63.66 127.76 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.396 179.87 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -83.45 40.9 0.75 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.399 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.629 ' CD1' ' HB1' ' A' ' 93' ' ' ALA . 3.0 m-85 -82.58 45.36 0.97 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.21 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 61.4 t 65.19 139.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.199 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.473 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.881 ' HG3' ' HA ' ' A' ' 119' ' ' PRO . 0.0 OUTLIER -172.44 121.58 0.43 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.896 -179.928 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.775 HG23 ' O ' ' A' ' 97' ' ' ARG . 1.5 pp -173.45 39.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.953 179.315 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.1 m 61.18 160.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.197 179.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.9 t -39.82 128.67 2.08 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.662 -179.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.684 ' HA ' HD23 ' A' ' 104' ' ' LEU . 17.5 tppt? -76.6 -27.94 55.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.362 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 55.2 m -53.14 -38.33 62.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.317 -179.395 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.472 ' O ' HG21 ' A' ' 111' ' ' VAL . 2.8 m-85 -60.85 -39.23 88.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.278 179.82 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.684 HD23 ' HA ' ' A' ' 101' ' ' LYS . 2.1 mm? -53.37 -42.45 66.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.222 -179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.7 m -92.54 141.26 28.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.533 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 107' ' ' GLU . 5.3 tt -142.57 127.05 17.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.836 0.351 . . . . 0.0 110.611 -179.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.528 ' N ' HD23 ' A' ' 106' ' ' LEU . 17.3 tp10 -67.14 128.08 35.01 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.821 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 60.36 36.51 20.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.753 -179.777 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.504 ' HA3' ' HA ' ' A' ' 130' ' ' CYS . . . -177.02 -177.96 46.37 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.446 -0.883 . . . . 0.0 113.06 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -142.8 144.84 32.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.624 0.25 . . . . 0.0 110.779 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 103' ' ' TYR . 65.3 t -105.21 124.98 60.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.862 0.363 . . . . 0.0 110.888 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -75.53 127.52 33.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.056 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.682 HD13 ' N ' ' A' ' 114' ' ' THR . 3.4 tm? -90.97 143.3 26.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.529 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.682 ' N ' HD13 ' A' ' 113' ' ' LEU . 33.7 m -156.19 62.17 0.56 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.235 0.54 . . . . 0.0 110.573 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -159.62 -102.26 0.18 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.017 -179.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.768 ' H ' HD21 ' A' ' 121' ' ' LEU . . . 174.59 -128.4 1.44 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.008 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.422 ' HA ' ' CG2' ' A' ' 98' ' ' ILE . 52.7 p-10 -159.27 48.19 0.31 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.931 0.396 . . . . 0.0 111.004 -179.686 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.528 ' N ' HD12 ' A' ' 118' ' ' LEU . 6.1 mp -98.99 163.57 18.49 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.221 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.881 ' HA ' ' HG3' ' A' ' 97' ' ' ARG . 81.2 Cg_exo -39.63 106.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.433 2.088 . . . . 0.0 112.193 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.471 ' H ' ' CG ' ' A' ' 97' ' ' ARG . . . 72.54 -32.29 0.24 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.716 -179.453 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.768 HD21 ' H ' ' A' ' 116' ' ' GLY . 27.5 tp 56.12 47.59 19.26 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.114 0.483 . . . . 0.0 110.228 -179.738 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -54.81 136.18 46.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.968 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.456 ' HA2' HG22 ' A' ' 143' ' ' VAL . . . 76.74 31.96 51.94 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.168 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.815 ' H ' ' HB2' ' A' ' 144' ' ' CYS . . . -80.33 119.87 23.63 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 178.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.533 ' HB2' ' HB ' ' A' ' 114' ' ' THR . 67.0 mtt-85 -84.58 134.59 34.4 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -178.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 28.0 m -149.7 134.14 9.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.422 179.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -114.45 112.96 23.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.964 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.467 ' CE2' ' HG3' ' A' ' 153' ' ' LYS . 1.9 m-85 -80.29 136.5 36.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.635 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -165.04 131.79 2.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.343 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' CYS . . . . . 0.504 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 40.9 m -89.3 157.17 18.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.33 0.586 . . . . 0.0 112.497 -179.069 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.449 ' HB3' ' HD2' ' A' ' 132' ' ' PRO . 58.2 m-20 -52.67 159.24 1.79 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.041 -0.982 . . . . 0.0 111.997 -179.407 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 131' ' ' ASP . 21.1 Cg_endo -59.9 75.31 0.06 OUTLIER 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.17 2.58 . . . . 0.0 112.43 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 131' ' ' ASP . 64.5 t0 -174.63 -40.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.048 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -116.08 132.33 56.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.182 178.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 22.3 p-80 -102.74 127.45 49.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.138 0.494 . . . . 0.0 111.288 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.675 HD12 ' HB3' ' A' ' 140' ' ' SER . 3.4 tm? -69.98 132.88 46.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.262 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.509 ' N ' HD13 ' A' ' 136' ' ' LEU . 36.6 t -134.82 76.08 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.816 -179.184 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 178.44 -133.96 2.26 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 119.862 -1.161 . . . . 0.0 113.247 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.729 ' N ' ' HB3' ' A' ' 154' ' ' PRO . 40.9 t -74.61 56.42 0.69 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.846 0.355 . . . . 0.0 111.186 -179.78 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.675 ' HB3' HD12 ' A' ' 136' ' ' LEU . 95.7 p -53.86 -30.33 45.14 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.825 -179.889 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.578 ' HD2' ' OG ' ' A' ' 140' ' ' SER . 7.9 mpt_? -99.41 137.06 38.45 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.449 -0.342 . . . . 0.0 110.496 178.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.5 m -150.63 137.73 19.31 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.256 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 124' ' ' ALA . 13.8 p -134.05 131.17 55.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.99 0.424 . . . . 0.0 111.036 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.815 ' HB2' ' H ' ' A' ' 124' ' ' ALA . 4.1 m -58.14 154.93 12.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.332 0.587 . . . . 0.0 112.226 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 91.4 p -173.28 113.64 0.23 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.759 179.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.406 ' O ' ' HG2' ' A' ' 146' ' ' GLN . 8.0 tt0 60.92 48.46 6.68 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.096 0.474 . . . . 0.0 110.544 -179.411 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 58.22 18.08 33.76 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.355 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -141.63 138.22 32.4 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.633 0.254 . . . . 0.0 110.639 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -68.1 135.29 51.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.929 0.395 . . . . 0.0 111.219 -179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.9 t -57.48 -60.18 4.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.176 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.486 ' HB ' ' OG ' ' A' ' 139' ' ' SER . 33.3 p -99.79 132.69 22.55 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.799 0.333 . . . . 0.0 111.889 -179.728 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.424 ' HA ' ' OH ' ' A' ' 103' ' ' TYR . 37.2 Cg_exo -60.6 150.75 80.22 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.977 2.452 . . . . 0.0 112.442 179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.467 ' HG3' ' CE2' ' A' ' 128' ' ' PHE . 57.5 tttp -55.91 129.81 72.41 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.878 -179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.729 ' HB3' ' N ' ' A' ' 139' ' ' SER . 59.4 Cg_endo -72.37 -152.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.729 2.286 . . . . 0.0 112.996 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -153.72 139.61 18.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.088 -179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' CYS . . . . . . . . . . . . . 86.4 m -98.72 143.31 29.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.494 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -128.2 136.44 51.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.576 179.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.67 135.65 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.305 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.917 179.814 . . . . . . . . 0 0 . 1 stop_ save_